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Scope of the thesis
Multicellular organisms contain a complete set of genes in nearly all of their cells. However most 
cells are very different to each other and are able to form organs with distinct functions. The 
identity and survival of the cell is regulated by the activity of specific genes in time and space. 
Specific sets of genes encoding proteins become activated, whereas others are repressed. CTCF 
is a protein that mediates distinct processes of gene regulation, including transcription and the 
structural organization of the genome.
The aim of this thesis is to investigate the different functions of CTCF by a combined analysis 
of CTCF-interacting proteins and by deletion of CTCF in vivo and in vitro. Using these approaches 
we aimed to improve our understanding of the molecular mechanism underlying its functions.
Chapter 1 gives an overview of the information required to understand the foundations of 
studies presented and discussed in this thesis. It gives an introduction to gene regulation and how 
this process is influenced by chromatin modifications, nuclear organization and compartmentation. 
A specific nuclear compartment, the nucleolus, and its involvement in ribosomal RNA synthesis, 
are highlighted. Furthermore the characteristics of CTCF and its homolog CTCFL are described in 
detail. 
Chapter 2 describes the generation and characterizations of a mouse line in which the Ctcf 
gene can be conditionally deleted. The chapter describes the phenotype of T cells lacking CTCF. 
The data show that CTCF controls cell cycle progression of β-selected T-cells. We propose that 
CTCF regulates cell size by controlling the activation of key metabolic processes in these rapidly 
proliferating and growing cells.
Chapter 3 describes experiments that were performed to identify proteins that interact 
with CTCF. A mouse line was generated that can be used to identify CTCF-interacting partners in a 
cell-type and developmental specific manner by making use of a biotinylation tagging approach. 
After identification of these factors by pull down assays coupled to mass spectrometry additional 
verification experiments were performed. These experiments provide insight in to what factors 
bind to CTCF and for which function they are important.
Chapter 4 describes the role of CTCF in ribosomal RNA transcription. We show that UBF, 
a factor involved in this process, is a novel binding partner of CTCF. We further show that CTCF 
controls transcription from one of the promoters present on the ribosomal DNA locus, namely the 
spacer promoter and that CTCF controls binding of UBF, RNA polymerase I, and other important 
proteins to the region near the spacer promoter. We propose that CTCF and UBF function together 
in enhancing transcription from the spacer promoter.
Chapter 5 describes a system that can used to study the regulation of expression of 
imprinted genes in the absence of CTCF. The data show that expression of some imprinted genes 
is changed in the absence of CTCF. Although the function of CTCF in regulating the imprinted 
genes Igf2 and H19 has been extensively characterized, our data indicate that CTCF may have 
other roles as well. 
Chapter 6 gives an overall discussion of the work carried out in this thesis. Hypotheses on 
the implications of this work are presented and future directions for the work are put forward. 
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Chapter 1 Introduction
Development of a single fertilized oocyte into a fully functional organism requires the highly 
regulated processes of cell division, growth and differentiation. All the information needed 
for the formation and functioning of an organism is present in its genetic material, called DNA 
(deoxyribonucleic acid). The functional diversity among cells that form different organs is, among 
others, the result of a variable read-out of this genetic information at different stages during 
development. This occurs in a process called transcription.
A functional unit of DNA controlling a discrete hereditary characteristic is called a gene. 
Most genes contain information to make proteins. The transfer of information from DNA to 
protein is achieved by “reading” the genetic DNA-code, which consists of four different bases 
arranged in a unique order, and “translating” it into a protein in a series of complex steps. A 
protein is composed of amino acids, which, like the bases in the DNA, are arranged in a specific 
order. The amino acid sequence determines how a protein will fold and what activities it will 
have. Each protein has a unique function in a cell. Examples of proteins are hormones, enzymes, 
and antibodies.
Some proteins function to regulate the “read out” of genetic information, a process termed 
transcription of DNA. The transcription of genes during development must be tightly regulated 
in order to produce, at the right moment and place, the multitude of different gene products 
(for example, proteins) for different cell types and tissues. Abnormal gene expression can lead 
to defects that eventually result in diseases such as cancer. In this chapter an overview will be 
provided about the organization of DNA in the nucleus, the regulation of transcription and the 
factors that play a role in these highly fascinating processes.
1.1 Transcription and organization of the chromatin template
1.1.1 Transcription
Genes are transcribed by RNA polymerases, enzymes that catalyze the synthesis of RNA from a 
DNA template. Three different RNA polymerases are present in eukaryotic cells. These enzymes 
share some common subunits and many structural features, but they transcribe different types of 
genes. RNA polymerase I transcribes the genes for ribosomal RNA (rRNA), which is incorporated 
into ribosomes, the megadalton factories acting in the cytoplasm to produce proteins. RNA 
polymerase II transcribes the protein encoding genes into pre-messenger-RNA (mRNA), while RNA 
polymerase III transcribes the genes for transfer RNA (tRNA) and various small RNAs. Ribosomes 
catalyze the translation of mRNA into proteins. The tRNA molecules carry the necessary amino 
acids towards the ribosome in order to make a protein from mRNA. Thus, it is at the ribosome 
that the products of all three RNA polymerases meet.
Transcription by the three polymerases begins with their binding at promoters, DNA 
elements that are found directly upstream of the transcription start site of genes and that 
are typically about 40-50 base pairs in length. RNA polymerases cannot bind DNA directly. 
Each polymerase needs a different set of general transcription factors (TFI’s, TFII’s, and TFIII’s, 
respectively) to help it bind DNA (Reese, 2003). Promoters are involved in recruiting these TFs, 
and in stabilizing and initiating transcription by RNA polymerase. In the case of RNA polymerase 
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II a preinitiation complex (PIC) is formed consisting of most of the TFII subunits. In general TFIID 
is the first PIC component to bind to its recognition site (the so-called TATA-box) via its integral 
TATA-box binding protein (TBP). This provides the first signal for the start of transcription.
Of the general transcription factors, TFIIH, contains helicase activity which is thought 
to be required for access at the transcriptional start point. Then, upon phosphorylation of its 
carboxy-terminal domain (CTD), RNA polymerase II undergoes a conformational change, is 
released from the PIC and begins transcribing a gene. Once the polymerase has begun elongating 
the RNA transcript most of the general transcription factors are released from the DNA. The 
phosphorylated tail of RNA polymerase II recruits factors that are important for elongation and 
for mRNA processing (Buratowski, 2003). Transcription can be broadly divided into transcription 
initiation, elongation and termination.
1.1.2 Transcription factors
Besides the general transcription factors for RNA polymerases, there is a wide variety of other 
transcription factors, which are defined as proteins that can activate or repress the rate of 
transcription by the RNA polymerases. The importance of transcription factors in the regulation 
of gene expression is highlighted by the fact that approximately 6% of genes in the genome code 
for these factors, making this one of the largest classes of proteins (Babu et al., 2004). 
Most transcription factors bind DNA directly and are classified into families based on 
structural characteristics of their DNA binding domain. Examples of such domains are the zinc-
finger (ZF) motif, the helix-loop-helix (HLH) region and the POU- and homeo-domains. These 
regions form a specific motif that recognizes DNA (Harrison, 1991). However, DNA binding motifs 
can also be used for RNA recognition or for protein-protein interactions. Transcription factors 
interact with other proteins forming functional complexes that are important for the regulation 
of activation or repression of particular genes. They can, for instance, bind the basal transcription 
machinery, and recruit this complex to the correct transcription initiation site. Moreover they can 
bind proteins that influence the structure of chromatin (see paragraph 1.1.7), thereby influencing 
the accessibility of DNA and in this way influence gene expression (Cosma et al., 1999).
The specificity of DNA recognition and binding by a transcription factor can be very high. 
The smallest change in the DNA or the amino acid sequence of its DNA binding domain will 
modify the binding efficiency of a transcription factor. However, there is also a set of transcription 
factors that function primarily as DNA-bending proteins. Most of these proteins are characterized 
by a DNA-binding element called the HMG box, which is less specific in binding. These proteins 
are not thought to activate transcription by directly interacting with the transcription apparatus. 
Rather, they are able to bend the DNA so that activators and repressors can be brought into 
contact with the promoter (Falvo et al., 1995).
1.1.3 Chromatin
Humans have 2-3 times as many genes as a fruit fly. However, their whole genome is 23 times 
as big. If stretched out the entire human DNA would have a length of about 2 meters, yet it is 
stored in a nucleus with a diameter as small as 3-10 µm. In order to fit the complete DNA into 
such a small volume DNA is folded and compacted by proteins in a structure called chromatin 
that, during mitosis, is even further compacted into a chromosome (Kornberg, 1974). When the 
information that is embedded into the DNA needs to be read, a cell has to know which genes 
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need to be transcribed, and at what time. Here, the one-dimensional process of transcription 
(which involves reading a linear strand of DNA) is linked to the three-dimensional problem of 
DNA looping and compaction. Clearly, in order to understand transcription one also needs to 
understand the structure and composition of the highly compacted chromatin template.
In the first level of chromatin compaction, DNA is wrapped around a histone octamer, 
which consists of two copies each of histones H2A, H2B, H3 and H4. This so-called nucleosome 
is the fundamental packaging unit of chromatin. The nucleosome subsequently coils into what 
is termed a 30 nm fibre. Condensation into this structure is dependent on histone tails and is 
stabilized by H1 linker histones and other proteins (Fan et al., 2005). Further compaction into 
higher order chromatin structures is probably the result of self-association of these 30 nm fibers 
into a series of chromatin loops and coils (Bednar et al., 1998) (Figure 1.1) (see paragraph 1.2).
Chromatin can be broadly divided into two fractions: euchromatin, which is permissive for 
transcription, and heterochromatin, which is repressive. Heterochromatin itself occurs in two 
varieties, constitutive and facultative. DNA within constitutive heterochromatin is permanently 
silenced. Examples include centromeric regions and inactivated repetitive elements. In contrast, 
facultative heterochromatin is silenced only in certain contexts, for example throughout 
development or differentiation.
1.1.4 Gene regulatory regions
At the level of the DNA the proper spatial and temporal control of gene expression is achieved by 
the presence of cis-regulatory DNA sequences, which attract general and specific transcription 
factors. One example of a cis-acting element has already been mentioned above: the promoter. 
The simple model in which transcription is initiated from a single defined nucleotide position 
within a promoter is not correct, as genome wide characterization of core promoters revealed 
Figure 1.1 Organization of DNA in chromosomes
The organization of DNA in the nucleus of a 
eukaryotic cell. DNA is organized in the nucleus 
as chromosomes that compact the DNA more 
than 1000 fold. Unwrapping this compacted 
chromosome structure shows that the compacted 
state is a result of looping and higher order 
structures. The basis of these loops and structures 
is the (30 nm) chromatin fiber. This structure is the 
result of packaging of nucleosomes that consist of 
the naked DNA that is wrapped around histones. 
DNA the carrier of genetic information is present 
as two long entwined strands that forms a double 
helix structure.
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that most genes have multiple promoters within which there are multiple start sites (Sandelin et 
al., 2007).
The TATA-box was thought to be important for transcription factor promoter binding, 
however it was shown that this element is present in only 10-15% of the human core promoters 
(Kim et al., 2005). Based on these observations it was proposed that the TATA-box is not a general 
promoter motif but that there is considerable diversity in core promoter structure and function. 
Examples of other DNA elements that contribute to core promoter activity and specificity include 
initiator (INR) and downstream core promoter elements (DPE). The latter regions were shown to 
often overlap with G/C rich sequences (CpG islands) (Yang et al., 2007).
Besides promoters, there are other cis-acting elements, including enhancers, silencers, 
locus control regions (LCR) and chromatin insulators. A common feature of these elements is 
that they can act at a distance, whereas a promoter cannot. Enhancers are elements capable 
of enhancing the basal transcription of a linked promoter. Enhancers were shown to differ in 
their strength of enhancement and span 200-1000 bp (Arnosti and Kulkarni, 2005). One of the 
first characterized enhancers was the SV40 repeat element. Transient expression experiments 
showed that this element could dramatically enhance transcription of a linked β-globin gene 
(Banerji et al., 1981). The increase in transcription was due to the recruitment of transcription 
factors, which enhanced the binding of RNA polymerase and thereby increased the level of 
transcription. Enhancers cannot only influence the level of transcription but are also involved in 
antagonizing gene silencing (Martin, 2001). Further studies on enhancer function have shown 
that they can act over long distances in an orientation independent manner. Since enhancers can 
be some distance away from a gene, they are thought to act by looping out the intervening DNA, 
forming protein interactions with promoter bound factors. Silencers act in a similar manner as 
enhancers, except that they are involved in repression of transcription.
The properties of a locus control region (LCR) are best understood in the context of 
experiments with the human β-globin locus and its linked LCR. When stably inserted into the 
genome of transgenic mice, it was shown that the LCR shielded the human β-globin locus (and 
other transgenic constructs) from position effects that are due to the random integration into the 
host genome. Besides this position-independent activity it was shown that the LCR has the ability 
to fully activate a linked gene in a tissue-specific and copy-number-dependent manner (Grosveld 
et al., 1987). Thus, an LCR differs from an enhancer in that it confers position-independent, 
copy-number dependent activity to a linked gene. Since the discovery of the β-globin LCR, other 
domains with LCR-like activity have been characterized in multiple loci, including the human 
growth hormone (GH) locus and in the Rad50 gene of the T-helper cell 2 (Th2) cytokine locus (Ho 
et al., 2006; Lee et al., 2003).
In contrast to enhancers, LCRs regulate transcription of linked genes not only if they are 
placed in euchromatic regions but also if they are present in heterochromatin regions (Dean, 
2006). However the exact role of the LCR in the establishment or maintenance of an active 
chromatin environment is unclear and contradictory data exist between the human and mouse 
β-globin locus (Forrester et al., 1990; Schubeler et al., 2001). Deletion of the LCR from the 
mouse genome by homologous recombination tested its function at the endogenous location. 
β-globin expression was strongly reduced and a major effect on RNA polymerase II elongation at 
the β-globin gene could be observed (Bender et al., 2000; Epner et al., 1998) Besides its strong 
transcriptional enhancer activity the β-globin LCR also includes enhancer blocking/insulator 
abilities (Chung et al., 1993).
A consequence of DNA compaction is an increased resistance to enzymes that act upon 
the DNA, such as DNAse I, a non-sequence specific nuclease. In contrast, gene regulatory 
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regions have are generally more accessible to this enzyme, i.e. they are DNAse I “sensitive” or 
even “hypersensitive”. This is because these regions are less occupied by histones and more by 
transcription and other factors (Szutorisz et al., 2005). The globin LCR, for example, contains 
multiple DNase I hypersensitive sites (HSS). Recently a genome wide analysis was performed 
in order to map ubiquitous and cell type specific regulatory elements by combining DNaseI 
hypersensitive site mapping, expression arrays and chromatin immunoprecipitation followed 
by hybridization to tiled arrays (ChIP-chip) (Xi et al., 2007). Using this approach it was shown 
that nearly all of the ubiquitous DNaseI hypersensitive sites correspond to either promoters, 
enhancers or insulator elements.
1.1.5 Chromatin insulators 
Insulator elements are defined as elements that serve to restrict the action of regulatory elements 
to appropriate genomic targets. Insulators often demarcate independently regulated domains 
of eukaryotic genomes. They have been proposed to have enhancer-blocking and/or boundary 
functions. Enhancer blocking is the ability to inhibit enhancer-stimulated gene expression when 
the insulator is placed between an enhancer and promoter element. The boundary function is 
defined as the ability to counteract chromosomal position effects, for example preventing the 
spreading of heterochromatin. Although these functions should be seen as separable activities 
insulators may harbor both properties (Recillas-Targa et al., 2002).
Much of the early work that defined the properties of insulators was carried out in 
Drosophila. The first DNA sequences to be described as having properties of an insulator were 
the scs and scs’ elements in Drosophila that were initially identified as marking the chromatin 
boundaries of a heat shock locus (Udvardy et al., 1985). When scs elements are placed on either 
side of a gene for eye color and this gene is introduced into Drosophila, the resulting flies all have 
similar eye color independent of the transgene’s site of integration, an indication that scs has 
protected the reporter gene from both negative and positive endogenous influences or position 
effects (Kellum and Schedl, 1991). Moreover it was shown that the element could block enhancers 
from activating a promoter (Kellum and Schedl, 1992). Sequences that can act as insulators 
were subsequently identified and studied in multiple organisms (Bell et al., 2001; West et al., 
2002). In fission yeast boundary elements have been isolated from the regions flanking the silent 
mating loci (Noma et al., 2001). In Drosophila, five different insulator binding proteins have been 
identified, Zw5, BEAF-32, GAGA factor, Su(Hw) and dCTCF while in vertebrates the only known 
insulator with enhancer-blocking abilities is CTCF. The observation that in Drosophila multiple 
insulator factors are present is likely due to its compact but largely euchromatic genome. 
Evidence suggesting that insulators play a role in the regulation of higher-order chromatin 
structure has been provided, in part, by the analysis of the gypsy insulator. The gypsy insulator 
confers its activity through its associated protein complex consisting of Su(Hw), Mod(mdg4)2.2 
and CP190. The ubiquitin ligase dTopors can also associate with this insulator complex and is 
important for gypsy insulator function because it mediates association of the complex to the 
nuclear lamina at the periphery of the nucleus (Capelson and Corces, 2005). In diploid cells 
Su(Hw), Mod(mdg4)2.2, and CP190 insulator proteins co localize at 20–25 large foci. These foci 
represent co localization of gypsy elements placed on different chromosomes. These complexes 
of gypsy insulators are called ‘insulator bodies’ (Gerasimova et al., 2000; Gerasimova and Corces, 
1998). They are formed via association of multiple insulators and localize to the nuclear matrix 
(Nabirochkin et al., 1998; Pathak et al., 2007). The finding of insulator bodies implied a role 
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for insulators in organizing chromatin, but did not prove a role for these elements in creating 
functionally independent chromatin domains. The discovery of gypsy insulator bypass helped to 
solidify this role. Using the enhancer-blocking assay, the gypsy insulator was shown to have the 
ability to block an enhancer from driving transcription of a promoter when placed in between 
two elements. Two independent groups found that placing two gypsy insulators between the 
enhancer and promoter restores enhancer-promoter communication (Cai and Shen, 2001; 
Muravyova et al., 2001). This implied that two insulators interacting to ‘loop-out’ specific sections 
of DNA might create independent chromatin domains. 
Recently it was shown that RNA interference (RNAi), a conserved gene silencing mechanism 
that causes the degradation of specific RNA molecules or hinders the transcription of specific 
genes, is involved in regulating the gypsy insulator. It was shown that Insulator activity is decreased 
when Argonaute genes required for RNAi are mutated. An improvement of insulator function can 
be detected when the levels of the Rm62 RNA helicase, which is likely involved in unwinding or 
remodeling of RNA-insulator protein complexes, are reduced (Lei and Corces, 2006) (Figure 1.2). 
1.1.6 Epigenetic modifications
Posttranslational modifications of histones, incorporation of histone variants and methylation of 
DNA can result in (heritable) changes in gene expression without changes in the actual genetic 
code. These so-called “epigenetic modifications” can alter nucleosome structure and accessibility 
of the DNA and thereby generate specific domains of chromatin in the genome (Jin et al., 2005). 
Specific epigenetically regulated processes include genomic imprinting and X chromosome 
inactivation. Genomic imprinting is a phenomenon whereby specific genes are expressed either 
from the allele inherited from the mother or from the allele inherited from the father. Imprints 
can be erased and re-established through each generation but not through cell division (Reik and 
Lewis, 2005).
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Figure 1.2 Loop formation stabilized by proteins and 
RNA bound to gypsy sites in Drosophila 
For clarity, one set of interactions leading to the 
formation of a single loop is shown. Clusters of such 
sites form insulator bodies in vivo. The proteins 
recruited to the gypsy insulator include Su(Hw), CP190, 
Mod(mdg4)2.2 and Topors. Topors is an ubiquitin 
ligase, which associates with the nuclear lamina and 
the insulator complex and is required for insulator 
function. Loop formation and insulator activity also 
involve RNA and are dependent on members of the 
RNAi processing pathway. Loop formation can be 
interfered by the RNA-binding protein Rm26. The 
protein CP190 is additionally involved in insulator 
function at sites that do not contain Su(Hw) (Adapted 
from (Wallace and Felsenfeld, 2007))
18 Chapter 1
Histones and histone modifications
The four ‘core’ histones (H2A, H2B, H3 and H4) are relatively similar in structure and are highly 
conserved throughout evolution. The nucleosome core is formed of two H2A-H2B dimers and a 
H3-H4 tetramer, forming two nearly symmetrical halves. This octamer of core histones represents 
a 108 kD protein complex around which 147 base pairs can be wrapped to form a nucleosome. 
Each of the core histones has a long N-terminal amino acid tail, which extends out from 
the DNA-histone core. These histone tails are subject to several different types of covalent 
modifications, including acetylation, methylation, ubiquitination and sumoylation of lysines, 
and phosphorylation of serines (Kouzarides, 2007). Histone modifications control many aspects 
of chromatin structure. For example, these alterations regulate the accessibility of DNA for 
transcription factors, and create recognition signals to anchor protein complexes such as 
chromatin remodeling complexes (see paragraph 1.1.7).
Histone acetyl transferases (HATs) add acetyl groups to histone tails while histone 
deacetylases (HDACs) are involved in removing them. Modifications of the tails have little direct 
effect on the stability of an individual nucleosome but they seem to affect the stability of the 
30-nm chromatin fiber and of higher-order structures. Acetylation of chromatin tails is generally 
linked to gene expression and histone deposition. By adding the acetyl group the positive charge 
of the lysine is removed making it more difficult to neutralize the charges on DNA as chromatin 
is compacted. Methylation of histone tails can affect gene expression depending on the residue 
that is methylated and the number of methylgroups that are present on the amino acid.
In general transcriptionally active regions are associated with methylation of lysine 4 
of histone 3 (H3K4) and acetylation of histones H3 and H4. By contrast, inactive regions are 
marked by methylation of lysine 9 of histone 3 (H3K9) and histone hypoacetylation (Dillon and 
Festenstein, 2002) (Table 1.1). H3K9 methylation is mediated by the histone methyltransferase 
Suv39h and provides a high-affinity binding site for heterochromatin protein 1 (HP1). Suv39h/
HP1 mediated repression is mainly associated with constitutive heterochromatin, but might also 
be involved in gene repression in euchromatic regions (Nielsen et al., 2001). Long term silencing 
DNA modification Site of modification Transcriptional role
Methylated cytosine (meC) CpG (but not CpG islands) Repression
Histone post translational 
modification
Site of modification Transcriptional role
Acetylated lysine 
(KAc)
H3(9,14,18,56), H4(5,8,13,16), H2A, H2B
Activation
Repression
Phosphorylated serine/threonine 
(S/Tph)
H3(3,10,28), H2A, H2B Activation
Methylated arginine (Rme) H3(17,23), H4(3) Activation
Methylated lysine
(Kme)
H3(4,36,79)
H3(9,27),H4(20)
Activation
Repression
Ubiquitylated lysine (Kub)
H2B(123*/120#)
H2A(119#)
Activation
Repression
Sumoylated lysine (Ksu) H2B(6/7), H2A(126) Repression
Isomerized proline (Pisom) H3(30-38) Activation/Repression
Table 1.1 Chromatin modifications
DNA modifications and histone post-translational modifications and their role in transcriptional activation or repression. 
* yeast: S. Cerevisae, # mammals (Adapted from (Li et al., 2007))
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by polycomb group proteins is associated with H3K27 methylation and H2A ubiquitination (Cao 
et al., 2002; Wang et al., 2004), indicating a role for histone modifications in cellular memory and 
stable maintenance of cell fates throughout development. However, histone modifications are 
dynamic and their mode of inheritance through cell division remains to be defined.
Multiple other methyltransferases have been identified that are involved in methylating 
lysine residues. Also the group of histone demethylases that can remove methylated marks from 
lysines is growing rapidly. Histone modifying enzymes need specialized protein domains to bind 
to histones such as the chromodomain, WD40-repeat and tudor domain (Flanagan et al., 2005; 
Huang et al., 2006; Schuetz et al., 2006). 
Recent observations suggest that in many cases there is not a strict division between active 
and repressive modification states. Modifications are not a simple code but transcription occurs 
against a mixture of complex modifications, which probably have several roles. The location of 
the modification and the combination with other modifications must be considered in order to 
understand its biological meaning (Berger, 2007). For example in embryonic stem cells there are 
unusual chromatin domains that include both H3K4 trimethylation and H3K27 trimethylation, a 
combination of what was thought to be positive and negative marks. These bivalent domains were 
shown to correlate with locations for genes encoding developmentally important transcription 
factors. These observations suggest that such developmental genes are transcriptionally silenced 
but poised for activation during differentiation (Bernstein et al., 2006). Recently it was shown 
that ubiquitination of H2A is the crucial modification involved in maintaining the poised state of 
this subset of genes (Stock et al., 2007).
Histone variants
Histones that are homologous to the standard histones but also have their own feature that is 
distinct from the major histones, are called variant histones. These variant histones can substitute 
for standard histones and modify nucleosomes to carry out specific functions. All the conventional 
histones, except H4, have a variant counterpart. Some variants like H3.3, H2A.X and H2A.Z are 
not considerably different from the main forms. Two variants, macroH2A1 and macroH2A2, have 
however a low level of homology with main histone forms (Henikoff et al., 2004). 
Histone variants are distinguished from canonical core histones mainly by the fact that 
they are synthesized outside the S-phase and incorporated into chromatin in a DNA replication-
independent manner (Kamakaka and Biggins, 2005). Variant histones can differ from canonical 
histones in their tails, fold domains, or in only a few key amino acid residues (Doyen et al., 2006; 
Henikoff and Ahmad, 2005). 
Incorporation of histone variants can impact chromatin structure in various ways. H3.3 and 
H2A.Z, for example, exert an effect by affecting nucleosome stability. Promoters and enhancers 
of transcriptionally active genes and coding regions of highly expressed genes have nucleosomes 
that carry both H3.3 and H2A.Z and are therefore extremely sensitive to disruption (Jin and 
Felsenfeld, 2007). H2A.Z is mainly localized in promoter regions and boundaries and is not only 
associated with activation but also with repression (Jin et al., 2005). The centromere incorporates 
a specific H3 variant called CENP-A, which associates with centromeric heterochromatin (Smith, 
2002). Centromere structure and function is blocked if H3 cannot be substituted for CENP-A in 
this specific region (Howman et al., 2000). How CENP-A is specifically loaded onto centromeres 
is not known. The histone variant macroH2A is concentrated on one of the two copies of the X 
chromosome present in female mammals, namely on the inactive X chromosome (Changolkar 
and Pehrson, 2006). Thereby this histone variant was suggested to be involved in silencing of one 
X chromosome in female mammals for reasons of dosage compensation (X inactivation). Later 
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it was shown that macroH2A is not important for silencing the X chromosome but is involved in 
fine-tuning the expression of specific genes (Changolkar et al., 2007). Another H2A variant H2A.X 
binds to DNA with double strand breaks and marks regions that undergo DNA repair (Redon et 
al., 2002).
Accessibility of cis-regulatory elements is not only characterized by nuclease sensitivity and 
nucleosomes depletion, but also by a high frequency of histone replacement (Mito et al., 2007). 
The rapid H3 replacement with H3.3 at Drosophila boundary-associated-regions suggests that 
constant replacement of nucleosomes serves to erase laterally spreading chromatin domains. 
Recently the epigenetic memory of an active gene state in the absence of transcription was shown 
to depend on H3.3 incorporation (Ng and Gurdon, 2008). This suggests that histone variants are 
important for epigenetic regulation and memory and might help to stabilize gene expression in 
normal development.
Histone variants can be exchanged by chaperones (like HIRA, FACT, CAF1) or by ATP-
dependent nucleosome remodeling complexes like SWI/SNF and ISWI (Belotserkovskaya et 
al., 2003; Bruno et al., 2003). Also the cooperative binding of transcription factors and actively 
transcribing RNA polymerase II can mediate histone exchange (Kireeva et al., 2005; Lorch et 
al., 2001; Workman, 2006). How the complexes that facilitate incorporation of histone variants 
recognize where to perform their activity is not well known. Perhaps transcription factors or 
histone modifications provide positional clues. The functional interplay between variant histone 
incorporation and histone modifications is an important area of research that needs to be further 
explored.
DNA methylation
DNA methylation is a modification that is associated with stable gene silencing (X inactivation, 
genomic imprinting) through interference with transcription factor binding or through recruitment 
of repressors that specifically bind methylated DNA. DNA methylation is a more stably maintained 
chromatin mark than the reversible histone modifications mentioned above. In mammals, DNA 
methylation occurs upon cytosines within CpG dinucleotide residues. Between 60-70% of all CpGs 
present in the genome is methylated. CpGs are often grouped in clusters called ‘CpG islands’ that 
are present in the 5’ regulatory regions of many genes. However cytosine methylation occurring 
at CpA and CpT dinucleotides is also reported in embryonic stem (ES) cells (Haines et al., 2001). 
The enzymes that catalyze the methylation of CpG’s are called DNA methyltransferases 
(Dnmt’s). These enzymes both generate new methylation marks and maintain (and restore) 
existing DNA methylation patterns after cell division. Dnmt1 is a maintenance methyltransferase 
while Dnmt3b and 3a are de novo methyltransferases (Bird and Wolffe, 1999). After DNA replication 
DNA sequences are methylated on only one of the two DNA strands (hemimethylated). Dnmt1 
recognizes hemimethylated CpG methylation patterns and methylates the opposite strand. In 
this way Dnmt1 stably transmits methylation patterns after each cell division. Although Dnmt1 
can carry out de novo methylation in vitro, there is little evidence that it can do this in vivo by 
itself. Inactivation of Dnmt1 in mice causes global loss of methylation and bi-allelic expression or 
silencing of imprinted genes (Howell et al., 2001). DNA methylation is a primary imprint signal for 
imprinted gene clusters but between those clusters different mechanisms are used to establish 
and maintain this mark (Edwards and Ferguson-Smith, 2007). Dnmt3a and Dnmt3b are essential 
for de novo DNA methylation, mainly acting in embryonic stem cells and early postimplantation 
embryos (Okano et al., 1999). Knockout mouse models of Dnmt3a and Dnmt3L have shown that 
both proteins are necessary for appropriate establishment of maternal and paternal imprinting. 
Dnmt3b may participate in methylation of specific imprinted loci but is not absolutely essential 
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(Hata et al., 2002; Kaneda et al., 2004; Webster et al., 2005). 
DNA methylation and histone modifications are able to influence each other (Fuks, 2005). 
For example, methyl-CpG binding domain proteins (MBDs) can recruit histone deacetylases 
(HDACs) and other chromatin remodeling proteins that can modify histones, thereby forming 
a compact inactive chromatin state (i.e. methylated DNA and modified histones). Moreover 
histone deacetylation and methylation at lysine 9 of H3 contribute to the establishment of DNA 
methylation patterns. Dnmt’s and histone deacetylase (HDAC) can bind to each other and connect 
the two processes. The combination of the two modifications could be relevant to situations 
were a strong stable epigenetic state is crucial (Burgers et al., 2002). In embryonic stem cells 
that lack both Dnmt3a and 3b global levels of H3 acetylation and methylation are altered and 
the mobility of linker histones is decreased. These changes, however, do not have effects on 
compaction of chromatin but they do affect nuclear organization and nucleosome structure 
(Gilbert et al., 2007).
DNA methylation is involved in propagating the state of activity of particular genes. Beside 
DNA methylation another important system involved in memorizing gene expression patterns 
of developmentally important genes are the polycomb (PcG/Trx) group proteins (Bird, 2002). 
Polycomb and trithorax group of proteins work to maintain repressed or active transcriptional 
states respectively. The mechanism by which silencing or activation is transmitted between cell 
generations remains obscure.
1.1.7 Chromatin remodeling complexes
Modification of histone tails can result in decondensation of chromatin in the regions of 
promoters, but the modification cannot disrupt the structure of the nucleosome. This requires 
so-called “chromatin-remodeling complexes”, which can displace nucleosomes from enhancer 
and promoter regions. Chromatin-remodeling complexes utilize energy of ATP hydrolysis to 
displace or exchange histones and in this way they change structure and position of nucleosomes 
temporarily (Saha et al., 2006; Workman, 2006). This results in DNA becoming less tightly bound 
to the histone core and being more accessible for transcription factors (Workman and Kingston, 
1998).
Three chromatin-remodeling complexes are conserved from yeast to human: SWI/SNF, 
ISWI and a complex called Mi-2/CHD or NuRD (Eisen et al., 1995). The INO80/SWR chromatin-
remodeling complex is present only in yeast (Eberharter and Becker, 2004; Narlikar et al., 2002). 
All of the ATP-dependent chromatin-remodeling complexes contain an ATPase subunit that 
belongs to the SNF2 super family of proteins. Remodeling enzymes contains specific histone 
binding domains so that they can be targeted to specific modified histones. For example, SWI/
SNF family can bind acetylated histones with their bromo-domain, ISWI has a SANT domain to 
bind modified histones and the CHD complex binds methylated histones with its chromo-domain 
(Boyer et al., 2004; Flanagan et al., 2005; Hassan et al., 2002). While the SWI/SNF proteins 
disrupt DNA-histone contacts and release the histones and disassemble complete nucleosomes, 
the ISWI family member NURF merely slides the nucleosomes along the DNA (Hamiche et al., 
1999; Langst et al., 1999).
The relationship between SWI/SNF complex and chromatin became apparent when the 
complex was purified and found to alter nucleosome structure in an ATP-dependent manner 
(Cote et al., 1994; Peterson and Herskowitz, 1992). Several mutations that suppressed SWI/SNF 
phenotypes appeared to correspond to genes encoding histones and other chromatin proteins 
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(Kruger et al., 1995; Recht and Osley, 1999). The SWI/SNF family contains, besides SWI/SNF, Brm 
and BRG1, also actin-related proteins. It has been suggested that these proteins link remodeling 
complexes to actin-binding proteins, to components of the nuclear matrix, or to chromatin itself 
(Chen and Shen, 2007).
The second group of ATP-dependent remodeling complexes contains the ISWI protein as 
the ATPase subunit. Using biochemical methods the most extensively studied members of this 
group (ACF, NURF and CHRAC) were originally purified from Drosophila extracts based on their 
ability to disrupt and generate regularly spaced nucleosomal arrays. The NuRD complex was 
shown to possess both chromatin remodeling and deacetylase activities (Tong et al., 1998; Xue 
et al., 1998). However, the question of how the chromatin-remodeling complexes and HDACs/
HATs might act in concert to activate transcription still remains unanswered (Hogan and Varga-
Weisz, 2007).
Remodeling complexes are recruited to promoters via interactions with sequence-specific 
transcription factors or through their association with RNA polymerase II. Not all genes require 
the function of a chromatin-remodeling complex for full activation. The strength of a particular 
promoter might play a role in its dependence on chromatin-modifying complexes. Thus, a weak 
promoter may require the complex for full activity, while a strong promoter may not. Another 
possibility is that remodeling complexes are only required for the transcription of promoters that 
possess positioned nucleosomes, which leave transcription factor sites unavailable for binding 
(Burns and Peterson, 1997).
Some important questions that remain to be addressed in this field include the extent of 
modifications that remodeling complexes exert on a given gene. It will be interesting to determine 
whether only the nucleosomes that are positioned on the promoter are remodeled or whether 
these modifications extend beyond the regulatory region, maybe also facilitating elongation by 
the RNA polymerase. Another important aspect is the effect that ATP-dependent remodeling 
complexes might have on higher-order chromatin structure (Vignali et al., 2000).
Besides recruiting transcription factors both enhancers and locus control regions (LCRs) 
can recruit complexes that carry out alterations in chromatin structure such as nucleosome 
remodeling and posttranslational modifications of histones. By altering the chromatin structure , 
the accessibility of DNA for transcription can be regulated. The order of recruitment of chromatin 
remodeling factors, transcriptional activators, general transcription factors and RNA polymerase 
II is not absolute an can vary depending on the gene that is activated (Agalioti et al., 2000).
1.2 Nuclear architecture
1.2.1 Chromatin organization in nuclear space
The subnuclear localization of chromatin is not random, specific genetic loci or whole chromosomes 
reside in specific locations within the nucleus (Cremer and Cremer, 2001). In interphase each 
chromosome tends to occupy a discrete and relatively small territory in the nucleus. Chromosomes 
are shown to have not only preferred positions within the nucleus but also with respect to each 
other (Parada and Misteli, 2002)(Figure 1.3). Changes in transcriptional activity are often coupled 
with changes in subnuclear localization of chromosomes (Chambeyron and Bickmore, 2004). 
Transcriptional regulatory elements such as LCRs, enhancers and insulators appear to act by 
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repositioning specific genetic loci to regions or loops with active and silent transcription (Ragoczy 
et al., 2003). Multiple active genes and gene clusters are often located together at places in 
the nucleus that have a high local concentration of the transcriptional and mRNA processing 
machinery. These sites are called “transcription factory” (Faro-Trindade and Cook, 2006). In 
a transcription factory individual genes that are widely separated on a chromosome, or even 
situated on different chromosomes, are brought in close proximity (Osborne et al., 2004). 
Fluorescent in situ hybridization (FISH) and chromosome conformation capture (3C) are 
two main techniques used to understand how the genome is organized in the nucleus. In 3C, 
formaldehyde is used to cross-link DNA fragments that are close together in nuclear space. Cross-
linked chromatin is subsequently digested with an excess of restriction enzyme. DNA ends are 
ligated under conditions that favor junctions between cross-linked DNA fragments, cross-links are 
reversed and the frequency of interaction between chromatin segments can be determined by 
semi-quantitative PCR (Dekker et al., 2002; Tolhuis et al., 2002). Using 3C, cis-regulatory elements 
of the β-globin locus were shown to form an erythroid specific spatial conformation (Palstra et 
al., 2003).
The recently developed chromosome conformation capture-on-chip (4C) technique can 
be used to identify not only intra- but also interchromosomal interactions. In contradiction to 
3C,  it allows for a high throughput genome wide analysis in an unbiased manner. In this way 
all DNA segments that physically interact with a DNA fragment of choice can be mapped. Using 
this technique it was demonstrated that both active and inactive genomic regions could interact 
over long distances with many loci in nuclear space. Active genes were shown to preferentially 
cluster with active genomic regions, but this is not absolute. Moreover 4C analysis shows that 
intrachromosomal interactions are favored over interchromosomal interactions (Simonis et al., 
2006; Zhao et al., 2006).
 For the β-globin locus it was determined that regions interacting with it in erythroid cells 
do not preferentially contain erythroid-specific genes (Simonis et al., 2006). Thus, one cannot 
predict locus interactions based on function. Interactions can also differ depending on species or 
cell-type. For example, the active α- and β-globin genes are located on different chromosomes 
and often come together in human, but not in mouse, erythroid cells. These data show that spatial 
proximity between these two loci is not conserved and therefore this interaction in humans is not 
expected to be functionally important for α- and β-globin gene regulation (Brown et al., 2006).
 The T-helper cell 2 cytokine locus and interferon-γ genes were shown to contact each 
other (Spilianakis et al., 2005). Subsequently interchromosomal interactions were also detected 
Figure 1.3 Nuclear organization of the genome
Colocalization of genes in the nucleus for 
expression or coregulation. Active genes on 
decondensed chromatin loops that extend outside 
territories can co localize both in cis and in trans 
at sites in the nucleus with local concentrations of 
RNA polymerase II and adjacent to splicing-factor 
enriched speckles. Interactions can also occur 
between regulatory element and/or gene loci and 
lead to co-regulation in trans (Adapted from (Fraser 
and Bickmore, 2007))
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of the olfactory-receptor locus, H19/Igf2 locus and HoxB1 locus (Lomvardas et al., 2006; Wurtele 
and Chartrand, 2006; Zhao et al., 2006). The relevance of these interactions is difficult to interpret 
since the characteristics of the associations were not always addressed in detail. In the case of 
the olfactory receptor locus, the initially reported chromosomal contact, proposed to be involved 
in regulating gene expression, were questioned by additional experiments (Fuss et al., 2007). 
 One question is whether the interactions detected by 4C originate from multiple dynamic 
interactions that occur transiently in almost all cells, or whether they reflect different interactions 
that occur from cell to cell and are just an average sampling of the population. Therefore, it 
will be important to clarify the cell-type, developmental and functional consequences of 
interchromosomal interaction. A combination with high-throughput FISH could be used to verify 
interchromosomal interactions.  
1.2.2 Nuclear matrix
The nuclear matrix or scaffold has been defined as the insoluble non-DNA material left in the 
nucleus after a series of biochemical extraction steps. Transmission electron microscopy showed 
the nuclear matrix to be a network of protein fibers that extends throughout the nucleus and 
connects to the cytoskeleton at the nuclear envelope (Capco et al., 1982; Long et al., 1979). Some 
of the proteins that constitute the nuclear matrix were shown to bind specific DNA sequences 
called scaffold-associated- or matrix-associated regions (SAR/ MAR). These DNA sequences 
have been postulated to form the base of chromosomal loops and are implicated in attaching 
them to the nuclear envelope or other structures in the nucleus. MARs or SARs usually contain 
ATC sequences with AT-repeats (Izaurralde et al., 1989). Thus, the nuclear matrix might help to 
organize chromosomes, localize genes, and regulate gene expression and DNA replication by S/
MARs (Pemov et al., 1998). Experiments with isolated nuclear halos suggested that S/MARs are 
necessary but not sufficient for formation of chromatin loops (Heng et al., 2004; Iarovaia et al., 
2005).
Several proteins such as lamins, nucleolar proteins, topoisomerase II and histone H1 were 
reported to be components of the nuclear matrix (Calikowski and Meier, 2006). Also proteins 
involved in DNA replication such as DNA polymerase, primases and PCNA have been classified as 
matrix-attached (Mika and Rost, 2005). A protein called SATB1 was originally identified as a protein 
that binds to MARs of the immunoglobulin heavy chain intronic enhancer (Dickinson et al., 1992). 
Later it was shown to be the first MAR-binding protein that is important for global regulation of 
expression of multiple genes (Alvarez et al., 2000). Several recent lines of evidence suggested a 
role for SATB1 in the formation of chromatin loops. A transcriptionally active chromatin structure 
is formed at the cytokine locus upon T-helper 2 (Th2) activation and subsequent induction of 
SATB1 expression. This structure is composed of numerous small and folded chromatin loops all 
anchored to SATB1 at their base. Moreover it was shown that upon knock-down of SATB1 not 
only chromatin loops are lost but that also the expression of interleukin genes present in the 
cytokine locus drops (Cai et al., 2006). The role of SATB1 in organizing higher-order chromatin-
loop structures is directly coupled to its ability to tether MARs to the nuclear matrix associated 
PML bodies (Galande et al., 2007; Kumar et al., 2007).
Visualization in live cells of proteins that are supposed to form the nuclear matrix has never 
shown a structure of fibers. The existence of a matrix structure is therefore still controversial 
and, by some, claimed to be an artifact (Pederson, 2000). The degree in which gene expression 
depends on nonchromatin nuclear structure therefore remains an intriguing but unsolved issue.
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1.2.3 Nuclear bodies 
Although the nucleolus (see chapter 1.3) is the most prominent structure in the nucleus, several 
other nuclear bodies have been visualized and studied. These include the well-characterized Cajal 
bodies, nuclear speckles and promyelocytic leukemia nuclear bodies (PML) (Handwerger and Gall, 
2006). In general, nuclear bodies organize the delivery and storage of essential RNAs and proteins 
that play a role in transcription, pre-mRNA biosynthesis and splicing (Figure 1.4). Moreover they 
are involved in sequestering and degradation of certain regulatory proteins (Zimber et al., 2004). 
Posttranscriptional modification of RNAs and of proteins is emerging as an important regulatory 
function of subnuclear organelles. These modifications can dramatically change the localization 
of molecules and thereby modify the structure and function of entire organelles. Despite the 
marked progress in characterization of these RNA and protein modifications, many questions 
remain about the enzymes and substrates that participate in these events.
Nuclear speckles contain high concentrations of pre-mRNA splicing factors and small 
nuclear ribonucleoprotein particles (snRNPs). In mammalian cells, the composition and 
intranuclear localization of speckles responds to changes in mRNA transcription and protein 
phosphorylation (Lamond and Spector, 2003). Speckles might serve not only as a reservoir of 
factors that participate in the co-transcriptional splicing of mRNA at the chromosomes, but also 
as a way-station for components that accompany mRNA on its journey to the nuclear pore and 
cytoplasm (Mermoud et al., 1994).
Cajal bodies are involved in processing of nuclear RNA, small nuclear RNAs (snRNAs) and 
small nucleolar RNAs (snoRNAs) that are recycled or undergo their final modifications. They 
appear as a tangle of coiled threads and are characterized by the presence of the p80 coilin 
protein. Control of Cajal body number is mediated by phosphorylation of the C-terminus of Coilin, 
but how this mechanism operates is unknown (Hebert et al., 2002; Shpargel et al., 2003).
PML bodies are structures enriched for the promyeolocytic leukaemia RING-finger protein 
and are implicated in transcriptional regulation, apoptosis and DNA repair. Mice that lack the 
PML gene have impaired immune function, exhibit chromosome instability and are sensitive to 
carcinogens (Bernardi and Pandolfi, 2003; Wang et al., 1998). Upon DNA damage PML bodies 
disassemble and thereby enhance interactions between PML-associated factors involved in 
regulating DNA repair and apoptosis (Dellaire and Bazett-Jones, 2004; Dellaire and Bazett-Jones, 
2007). The stability of PML bodies is not only affected by DNA damage but also by other forms of 
cellular stress and by changes in chromatin structure. 
Figure 1.4 The nucleus and its sub-
nuclear domains
Schematic overview of the nucleus 
and its different domains and bodies. 
Including the nucleolus, PML-bodies, 
Cajal bodies and speckles (Adapted 
from http://www.abcam.com).
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Association with nuclear bodies is involved in organization of chromatin within the nucleus. 
For example, perinucleolar regions are involved in anchoring chromatin loops and in this way 
chromatin states can be maintained during replication by spatial separation in the nucleus (Zhang 
et al., 2007). PML bodies can associate with specific regions of high transcriptional activity in 
the genome and chromatin-modifying proteins can accumulate in them. It has been proposed 
that PML bodies functionally interact with chromatin and are important for the regulation of 
gene expression (Ching et al., 2005). Recently a direct link between PML, higher-order chromatin 
organization and gene regulation was demonstrated (Kumar et al., 2007).
1.3 The nucleolus
The nucleolus is a typically round granular body mainly composed of protein and RNA. Its 
primary role is to produce ribosomes, a complex that catalyzes the synthesis of proteins. However 
the nucleolus is also involved in signal recognition particle assembly, small RNA modification, 
telomerase maturation, trafficking of small RNAs, sensing of cellular stress and cell cycle 
regulation (Boisvert et al., 2007; Lo et al., 2006; Visintin and Amon, 2000). Nucleoli differ in size 
depending on the demand of the cell for rRNA (and, hence, for protein synthesis).  They are large 
during periods of active protein synthesis, small in quiescent cells and completely invisible during 
cell division.
1.3.1 Nucleolar structure
Different substructures are present inside the nucleolus that can be visualized with an electron 
microscope. Three distinct regions have been identified: the fibrillar center (FC), the dense 
fibrillar component (DFC) and the granular component (GC). The spatial organization of these 
regions differs between cell types and organisms and is also dependent on nucleolar activity 
(Shaw and Doonan, 2005).
It is still debated in which of the different substructures transcription and processing of 
rRNA takes place. Several studies have shown that transcription occurs in the fibrillar regions 
of the nucleolus where RNA polymerase I is concentrated (Hozak et al., 1994). Using a pulse-
chase procedure and an elongation inhibitor it was demonstrated that the ribosomal transcripts 
elongate in the cortex of the FC and then enter into the surrounding DFC (Cheutin et al., 2002).
During mitosis the nucleolus breaks down and the ribosomal DNA (rDNA) is arranged in a 
partially condensed form on the chromosome, which is recognizable, and has been termed the 
nucleolar organizer region (NOR). Inactive RNA polymerase I and UBF remain bound to most 
NORs during this stage of the cell cycle. Upon exit from mitosis these NORs fuse into one or more 
nucleoli. NORs lacking UBF and RNA polymerase I remain inactive and are not incorporated into 
nucleoli (Dousset et al., 2000; Roussel et al., 1996; Sullivan et al., 2001).
1.3.2 Ribosomal RNAs
Ribosomal RNAs (rRNAs) form the basic structure of the ribosome. There are four types of 
eukaryotic rRNA, each of which is present in one copy per ribosome. Three out of the four rRNAs 
(18S, 5.8S and 28S) are generated in the nucleolus (see below). The 5S rRNA is synthesized from a 
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separate cluster of genes by a different polymerase, RNA polymerase III. It is not known why this 
fourth RNA is transcribed separately.
rRNA synthesis is highly efficient and can account for 80% of total cellular RNA synthesis. 
The 18S, 5.8S and 28S rRNAs are generated from a large 45S rRNA precursor after multiple 
cleavage steps (Figure 1.5). The 45S precursor rRNA needs to be modified and processed by 
small nucleolar single strand RNAs (snoRNAs) before it can be correctly cleaved (Schneider et 
al., 2007). Both the synthesis and processing occur in the nucleolus and for correct ribosome 
assembly a tight coordination of rRNA transcription, processing and maturation is crucial. 
1.3.3 rRNA “gene” structure
Multiple copies of the 45S rRNA gene are present, divided over different chromosomes. 
Mammalian cells, for example, contain about 400 rRNA genes, which are organized in a head-to-
tail fashion and spread over 5-8 chromosomes. Thus, each repeat contains about 50 copies. About 
half of these genes is transcribed at any given time. The 45S rRNA “coding units” are separated 
from each other by an intergenic spacer (IGS) that contains transcription termination signals on 
both ends, presumably to prevent “spill-over” of transcription. Besides terminators the IGS also 
contains enhancers, a spacer promoter, replication elements and an upstream control element 
(UCE) (Grummt, 2003; Russell and Zomerdijk, 2005). The IGS is in mammals about 30 kb in length, 
while in Xenopus and Drosophila this region is much smaller. However the relative position of 
regulatory elements that are present in the IGS is similar compared to mammals (Figure 1.6). 
The mammalian rRNA gene promoter contains a core element (-45 to +18 relative to the start 
site (+1)), which is essential for accurate transcription initiation. Furthermore the promoter 
contains an UCE (-156 to -107) that has a modulatory role in transcription initiation. Followed by 
a transcriptional terminator site (-170), the enhancer repeat and the spacer promoter (around -2 
kb). The enhancers function by increasing transcription rates of active rRNA genes (Banditt et al., 
Figure 1.5 Organization of the rRNA genes
Each cell contains hundreds of copies of rDNA in the form of tandem 
repeats that are spread out on multiple chromosomes. At any given 
time, only a subset of rDNA repeats is actively being transcribed. 
Miller spreads (electron microscopic visualization of spread 
transcription units, RNA being synthesized from DNA templates) 
of transcriptionally active rDNA repeats demonstrate Christmas 
tree–like transcription units. The rRNA genes are present in a single 
transcription unit, transcribed by RNA polymerase I to yield a 45S 
precursor rRNA that is, in part, co-transcriptionally processed and 
modified by methylation and pseudo-uridinylation to produce the 
mature 18S, 5.8S and 28S rRNAs. 
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1999). More upstream (around -5 kb) the IGS contains sequences that are called amplification 
promoting sequences (APS).
The APS play a role in rDNA replication, they stimulate amplification of cis-linked plasmid 
DNA and coincide with nuclease hypersensitive sites (Langst et al., 1997). APS1 and 2 are 
methylated and located close to the zone of replication initiation (Wegner et al., 1989). 
The enhancers and the spacer promoter are involved in enhancement of rRNA transcription 
(Paalman et al., 1995). Spacer promoter transcripts are terminated at the promoter proximal 
terminator, which is located between the enhancers and the UCE. This promoter proximal 
terminator is also involved in remodeling chromatin over the promoter (Langst et al., 1998). 
The spacer promoter contains only very little sequence homology with the gene promoter. The 
mechanism by which the spacer transcription might stimulate pre-rRNA transcription initiated 
from the gene promoter is unclear, particularly in light of recent data suggesting that spacer 
transcription participates also in NoRC-dependent rRNA gene silencing (Mayer et al., 2006).
1.3.4 rRNA transcription
EM studies suggested that a single 45S rRNA gene could be transcribed by a large number of 
RNA polymerase enzymes. Nascent 45S rRNAs form ‘Christmas trees’, the trunk representing 
the rDNA copy and each branch of the tree representing a transcript with a nascent ribosome 
forming at its tip. Transcription by RNA polymerase I is a comparatively simple process with a 
basic mechanism of regulation. Compared to RNA polymerase II only a few transcription factors 
are associated with RNA polymerase I. Because of this relative simplicity, RNA polymerase I can 
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Figure 1.6 Intergenic sequence of the rDNA repeat
Overview of the organization of the rDNA repeat with indicated the main differences between species in the intergenic 
sequence (IGS). Organization of the mouse, Xenopus and Drosophila IGS with positions of spacer promoters, terminators 
and enhancers indicated. The relative position of these elements with respect to the transcriptional start is conserved. 
The Xenopus 100bp-repeats of the repeat organizer (RO) are reported to have enhancer-blocking abilities. Drosophila 
contains multiple spacer promoters that function as enhancers.
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optimally performed its function as polymerase with the highest synthesis rate (Grummt, 2003). 
Alterations in cell proliferation result immediately in a change in the transcriptional rate of rRNA 
genes.
‘Basal’ levels of transcription in vitro can be achieved in the presence of a pre-initiation 
complex (PIC) comprising only RNA polymerase I and selectivity factor 1 (SL1/TIF-IB) at the rDNA 
promoter. SL1 is a complex consisting of the TATA-box-binding protein (TBP) and its associated 
factors TAF110, TAF63 and TAF48 (Zomerdijk et al., 1994). These associated TAFs are involved 
in promoter- and polymerase recognition. SL1 recruits RNA polymerase I to the promoter via 
interaction of its TAFs with the RNA polymerase I associated factor RRN3/TIF-IA. RRN3 is tethered 
to RNA polymerase I by interacting with its core-subunit RPA43 and associated factor PAF67 
(Miller et al., 2001; Peyroche et al., 2000). Activated transcription requires, in addition to RNA 
polymerase I and SL1, the upstream binding factor UBF (Bell et al., 1988). This is achieved by 
recruitment of RNA polymerase I by DNA bound UBF via an interaction with TIF-IB/SL1 and also 
by a direct interaction with the RNA polymerase I subunit PAF53 (Hanada et al., 1996). After 
recruitment of RNA polymerase I and its binding to the UBF/SL1 complex transcription starts 
(Figure 1.7).
If UBF cannot bind the UCE impaired PIC formation and repression of RNA polymerase 
I transcription is observed (Santoro and Grummt, 2001; Santoro et al., 2002). UBF is however 
not absolutely required for specific initiation on the promoter, but plays a role in activation of 
transcription. Addition of UBF to depleted extracts increases the efficiency of in vitro transcription 
in a dose dependent manner (Jantzen et al., 1990; Jantzen et al., 1992). Recently UBF was shown 
to activate transcription by stimulating promoter escape of the polymerase (Panov et al., 2006).
UBF binds to the enhancer region, core regions of the promoter and the UCE but does not 
have high sequence specificity and is also shown to bind weakly throughout the entire rDNA 
repeat (O’Sullivan et al., 2002). UBF can rapidly exchange from enhancer-bound to free UBF, so 
that a high UBF concentration can be maintained near the promoter (Putnam and Pikaard, 1992). 
Although UBF does not have high sequence specificity, it has a high affinity for bend or distorted 
DNA, and can bent linear DNA itself (Agresti and Bianchi, 2003). Moreover UBF functions in 
opening up chromatin to provide access to the DNA for transcription factors and RNA polymerase 
I. UBF dependent large-scale chromatin decondensation can be induced by its interaction with 
SL1 and does not involve common chromatin remodeling complexes (Chen et al., 2004). Rather 
UBF can form an open chromatin structure by competing with histone H1 binding and thereby 
displacing or dissociating it from a nucleosome core (Kermekchiev et al., 1997). 
Figure 1.7 RNA polymerase I complex bound to the 
promoter region
Binding of the pre-initiation complex to the UCE and core 
region of the rRNA promoter. The UBF dimer bind via its 
first three HMG-boxes to the DNA and its C-terminal tail 
interacts with the PAF53 subunit of RNA polymerase I 
and with the SL-1/TIFIB complex. The TIFIB/SL-1 complex 
consists of TAF48, TAF68, TAF95 and TBP. SL1/TIFIB binds 
to RNA polymerase I via RRN3 and can bind to the UCE 
and core region of the rRNA promoter via its TAFs. In 
this way RNA polymerase I, which itself has no sequence 
specific DNA-binding activity is recruited to the DNA. The 
transcriptional termination factor TTF-I is bound to the 
promoter proximal terminator and can enhance as well 
as repress transcription from the gene promoter. 
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Elongation and termination of transcription
If RNA polymerase I transcription starts UBF and SL1 remain bound to the promoter poised to 
recruit the next RNA polymerase I complex and reinitiate transcription from the same promoter 
(Panov et al., 2001). The RNA polymerase I-associated factor TIF-IC can stimulate the overall rate 
of transcription elongation and suppress pausing of RNA polymerase I (Schnapp et al., 1994). If 
the process of elongation is interrupted by DNA damage, transcription-coupled repair proteins 
like TFIIH and CSB bind to RNA polymerase I and repair the damage (Bradsher et al., 2002).
A specific protein, called TTF-I, binds the transcription termination sites at the 5’ and 3’ 
ends of the rRNA gene. At the 3’ end of rRNA genes TTF-I stops RNA polymerase I and dissociates 
it from the DNA with the help of the transcriptional release factor PTRF (Jansa and Grummt, 
1999). After termination of transcription the released polymerase and other components can be 
reused to produce initiation-competent RNA polymerase I (Panov et al., 2001). TTF-I binding to 
the 5’ end of the rRNA gene (the so-called promoter-proximal terminator site) serves to terminate 
transcripts originating from the spacer promoter (Langst et al., 1998).
Number of active rRNA genes
About half (i.e. 150-200) of all copies of mammalian rRNA genes are transcriptionally active. 
The ratio of active and inactive rRNA genes is stably propagated throughout the cell cycle and is 
independent of cellular rRNA synthetic activity (Conconi et al., 1989). Adjustments to the number 
of active copies are made only during development and differentiation (Haaf et al., 1991). rRNA 
transcription is therefore regulated by changing the rate of transcription initiation rather than 
by activating or silencing transcription units. Yeast is an exception, as it can actively regulate the 
number of active rRNA genes (Sandmeier et al., 2002). Because virtually all organisms contain 
a large number of inactive rRNA genes, this must have some kind of evolutionary advantage. 
However, what exactly the purpose is for maintaining such a large fraction of rRNA genes in a 
silenced state remains to be elucidated.
Re-establishment of the same number of active genes after mitosis is regulated by UBF 
and SL1, that remain bound to DNA, but are inactivated by phosphorylation in mitosis (Klein and 
Grummt, 1999; Voit and Grummt, 2001). TTF-I is also phosphorylated during mitosis but remains 
only weakly bound to the DNA in this stage of the cell cycle (Sirri et al., 1999). At first it was 
thought that RNA polymerase I also remains associated with DNA during mitosis. However, more 
detailed analysis using time-lapse imaging of single cells showed that during a small window at 
metaphase RNA polymerase I is not associated with the rDNA (Leung et al., 2004).
Silencing of ribosomal RNA transcription
In human and mouse the transcriptionally silent state of rDNA is established by the nucleolar 
remodeling complex NoRC. One component of this complex, TIP5, was identified in a yeast two 
hybrid screen for TTF-I interacting proteins. Subsequent analysis revealed that TIP5 is present 
together with the ATPase SNF2h and that these two subunits form the NoRC complex (Strohner 
et al., 2001). NoRC shares homology with the remodeling proteins CHRAC and WCRF that belong 
to the family of ISWI chromatin remodeling machines. NoRC is targeted to rDNA by interaction of 
TIP5 with TTFI that is bound to the promoter-proximal terminator (T0). The acetylation mark at 
lysine 16 of histone H4 (acH4K16) is required for TIP5 binding to DNA (Zhou and Grummt, 2005). 
Overexpression of NoRC reduces the size and number of nucleoli, impairs cell proliferation and 
represses RNA polymerase I transcription by increasing heterochromatic marks at the promoter 
(Li et al., 2005; Santoro et al., 2002).
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NoRC can perform part of its silencing properties by recruiting the SIN3 corepressor 
complex that subsequently deacetylates histones near the rDNA promoter (Zhou et al., 2002). 
NoRC is able to establish heterochromatic features at the rRNA gene promoter not only by 
mediating histone H4 deacetylation but also by methylating histone H3 lysine 9 and by de novo 
DNA methylation (Santoro and Grummt, 2005). Methylation of a single CpG within the UCE of 
the mouse rDNA promoter can result in impairment of UBF binding, thereby preventing initiation 
complex formation (Santoro and Grummt, 2001). This result suggests that methylation is involved 
in inactivating rDNA genes and could play a role in the propagation of transcriptional silencing 
through cell division. Cells lacking the maintenance methyltransferase Dnmt1 that is recruited by 
NoRC show a complete disruption of nucleolar structure (Espada et al., 2007).
Another study shows that NoRC is able to silence rRNA transcription by positioning 
nucleosomes in such a way that the UCE and the core promoter element are separated not 
allowing cooperative binding of UBF and TIF-IB/SL1 (Li et al., 2006). This results in the inability 
to form a PIC needed for efficient rRNA transcription. Binding of NoRC to a small piece of RNA 
that covers the rDNA promoter and originates from the upstream spacer promoter is required 
for the association of NoRC with rDNA and formation of heterochromatin (Mayer et al., 2006). 
Taken together these results imply a major role for NoRC in the silencing of ribosomal RNA 
transcription.
Activation of ribosomal RNA transcription
The rate of rRNA gene transcription initiation is found to be mainly determined by RNA polymerase 
I promoter escape (Panov et al., 2001), that is, the rate-limiting step in rRNA transcription is the 
initiation of transcription itself and not the formation of the PIC. UBF was shown to be crucial 
for regulating promoter escape independent of the promoter-specific targeting of SL1 and RNA 
polymerase I during PIC assembly (Panov et al., 2006). It was suggested that changes in UBF 
protein amount during differentiation and quiescence affect the rRNA transcription rate (Glibetic 
et al., 1995; Poortinga et al., 2004). However, upon cell cycle-arrest UBF protein levels remain 
unaffected (Hannan et al., 2000). The question whether levels of UBF protein change throughout 
the cell cycle is a point of debate (Junera et al., 1997; Klein and Grummt, 1999). Furthermore the 
amount of UBF or its degree of phosphorylation is not necessarily correlated with its activity to 
effect rDNA transcriptional rates. Studies have led to the notion that UBF can be sequestered into 
an inactive complex, for example with Rb (Cavanaugh et al., 1995; Voit et al., 1997). 
The promoter regions of active rRNA genes can be distinguished from inactive ones by the 
presence of histone H4 acetylation and H3K4 methylation marks, and by a different nucleosome 
position, which allows UBF and TIF-IB/SL1 binding to each other (Li et al., 2005). TTF-I binding 
to the rRNA gene promoter is not only required for repression but also for activation of RNA 
polymerase I transcription. The Cockayne syndrome B (CSB) protein, a member of the SWI/SNF2-
like family of chromatin remodelers, binds to TTF-I and is involved in activating rDNA transcription. 
CSB is present in a complex with RNA polymerase I, TFIIH and TIF-IB/SL1 that is recruited to rDNA 
by TTF-I. Overexpression of CSB stimulates rDNA transcription, whereas in CSB-deficient cells 
rRNA synthesis is impaired (Bradsher et al., 2002). To establish an open chromatin structure at 
active rDNA, CSB binds to the remodeling complex WICH (Percipalle et al., 2006). Recently it was 
shown that CSB is directly involved in promoting transcription from the active rDNA promoter 
by recruiting histone methyltransferase G9a, which is able to methylate histone H3 on lysine 9 
(H3K9me2) in the pre-rRNA coding region. This was suggested to facilitate RNA polymerase I 
transcriptional elongation (Yuan et al., 2007).
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1.4 CTCF, a vertebrate chromatin organizer
1.4.1 Discovery and characterization of CTCF
CTCF (CCCTC binding factor) was identified independently by two labs: as NeP1, a factor involved 
in silencing of the chicken lysozyme gene (Baniahmad et al., 1990) and as CTCF, a factor binding 
to the c-myc promoter (Lobanenkov et al., 1990). Later studies showed that NeP1 and CTCF were 
one and the same protein (Burcin et al., 1997). Other studies then showed that CTCF is not only 
involved in transcriptional silencing but also in activation, both of the c-myc gene and of the 
amyloid β-protein precursor (APPβ) gene (Klenova et al., 1993; Vostrov and Quitschke, 1997).
CTCF is highly conserved and can be traced back in evolution down to zebrafish (Danio 
rerio) and fruitfly (Drosophila melanogaster) (Moon et al., 2005; Pugacheva et al., 2006). Fungi, 
yeast, plants, or the nematode Caenorhabditis elegans do not contain a CTCF-like protein. CTCF 
contains two conserved protein domains, an eleven zinc finger domain and a proline-rich region 
containing an AT-hook domain (Figure 1.8).
C2H2-type (classical) zinc fingers were the first class of zinc-fingers characterized. This motif 
forms a short β-hairpin and an α-helix. Conserved amino acids are involved in the folding of the 
module. Most notably, two cysteine and histidine (C2H2) residues hold a single zinc atom in 
place in a tetrahedral array. This, in turn, allows specific amino acid residues from the zinc finger 
module, some of which are not conserved, to make highly specific contacts with DNA. C2H2 
zinc fingers are the most common DNA-binding motifs found in eukaryotic transcription factors, 
and have also been identified in prokaryotes (Bouhouche et al., 2000). Zinc fingers are not only 
capable of making contact with DNA, this domain is also known to bind RNA and other protein 
motifs (Wolfe et al., 2000). The binding properties of a transcription factor largely depend on the 
binding specificity of individual zinc fingers, on the number of fingers and on the linker region 
between the zinc fingers (Iuchi, 2001).
It was initially proposed that only a few zinc fingers of CTCF are necessary to bind DNA 
(Quitschke et al., 2000). Subsequent studies showed that four zinc-fingers in the middle of the 
protein are sufficient for CTCF to bind to multiple different sites. Moreover it was shown that 
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Figure 1.8 Schematic representation of mouse CTCF and CTCFL proteins 
Mouse CTCF and CTCFL protein domains are shown. Including the eleven zinc-finger (ZF) region involved in protein-
DNA and protein-protein interactions. CTCF contains a proline rich region with an AT-hook motif involved binding to 
AT-rich DNA sequences in the minor groove. CTCF and CTCFL are highly homologous in the eleven zinc-finger region, but 
in their N- and C-terminus the proteins differ from each other. On the top post-translational modifications are shown 
P:phosphorylation.
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one zinc finger is responsible for recognizing the methylation status of the CTCF binding site in 
the Igf2/H19 locus. The presence of a methyl group is interfering with the interaction of this zinc 
finger with DNA (Renda et al., 2007). 
The AT-hook motif was first described in HMG-I(Y) group of proteins, where it was shown 
to direct binding to the minor groove of AT-rich DNA regions (Reeves and Nissen, 1990). AT-hook 
motifs, cooperate with other DNA-binding activities and play a role in facilitating changes in the 
structure of the DNA. It was proposed that the AT-hook plays a role in translocating proteins to 
MAR/SARs and positions chromatin fibers (Fujimoto et al., 2004). Interestingly AT-hook domains 
can be found in chromatin architectural factors and chromatin remodeling complexes such as 
Mdg4, ISWI, MeCP2, Swi/Snf2, and in the NoRC subunit TIP5 (Aravind and Landsman, 1998). The 
AT-hook domain in the CTCF protein is conserved down to zebrafish, however Drosophila CTCF is 
not reported to contain other domains than the eleven zinc-fingers. The exact role of this domain 
for CTCF functioning has not been addressed.
Although the Ctcf gene encodes only one protein isoform with a predicted molecular 
mass of 82 kD, CTCF is reported to be present in multiple different isoforms. The major isoform 
migrates at approximately 130 kD in SDS-PAGE (Klenova et al., 1993). It is unknown what causes 
this aberrant migration pattern of CTCF. Besides this isoform a protein of 70 kD is detected in 
many cell types and might represent a C-terminal truncation of CTCF (Klenova et al., 1997). 
Furthermore, poly(ADP-ribosyl)ation of CTCF results in a 180 kD form that is present in only very 
small amounts compared to the 130 kD protein (Yu et al., 2004). Moreover CTCF was reported to 
form dimers of ~200 kD (Yusufzai et al., 2004). Dimerization of the protein was suggested to be 
involved in stabilizing long range interactions between distant pairs of sites that bind CTCF (Ling 
et al., 2006; Splinter et al., 2006; Yusufzai et al., 2004).
1.4.2 Posttranslational modifications of CTCF
As mentioned above, CTCF can be posttranslationally modified. Both phosphorylation and 
poly(ADP-ribosyl)ation of the protein have been described (Klenova et al., 2001; Yu et al., 2004). 
These modifications might modulate CTCF function as they affect DNA binding. Casein kinase II is 
involved in phosphorylating four serines in a conserved part of the CTCF C-terminus. Substituting 
all serines resulted in enhanced repression of vertebrate c-myc promoters that contain CTCF 
binding sites (Klenova et al., 2001).
Poly(ADP-ribose) (PAR) is a negatively charged polymer whose polymerization onto acceptor 
proteins is catalyzed by a family of poly(ADP-ribose) polymerases (PARPs). The N-terminus of 
CTCF is the preferred in vitro target for this type of modification although the exact sites are not 
defined. PARP-1 was suggested to be involved in modifying these sites by interacting with CTCF 
(Yusufzai et al., 2004). Since PARP-1 can interact with nucleophosmin as well, and was shown to 
localize to the nucleolus, it was suggested that CTCF target sites are tethered to this subnuclear 
organelle and that de novo poly(ADP-ribosyl)ation of CTCF is essential for this localization (Meder 
et al., 2005). Indeed the poly(ADP-ribosyl)ated form of CTCF was predominantly found in nucleoli 
(Torrano et al., 2006).
When bound to the maternal H19 ICR, CTCF appears to be poly(ADP-ribosyl)ated as well. 
Treatment of cells with 3-ABA, an inhibitor of PARPs, results in loss of H19 ICR insulator function 
and bi-allelic expression of Igf2 (Klenova and Ohlsson, 2005). This result has led to the notion 
that poly(ADP-ribosyl)ation of CTCF is involved in regulating its insulator properties. However, the 
poly(ADP-ribosyl)ation dependent insulator function of CTCF appears to be required on only 1% 
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of its binding sites (Yu et al., 2004). This indicates that this is not a general regulatory mechanism 
of CTCF insulator function. Indeed, besides the H19/Igf2 ICR, no other poly(ADP-ribosyl)ation 
sensitive CTCF insulators have been described to date.
1.4.3 CTCF binding partners
To unravel the function of CTCF it is essential to know the proteins it interacts with. Logically, 
there have been many attempts to identify interaction partners of CTCF. Several techniques have 
been used, including GST-pull downs, yeast-two hybrid screens, and affinity chromatography 
procedures, including a two-step anti-Flag/anti-HA immunopurification protocol (Chernukhin et 
al., 2000; Defossez et al., 2005; Lutz et al., 2000b; Yusufzai et al., 2004). A short conclusion of 
these studies is that CTCF binding partners that have been identified to date are involved in 
multiple processes in the nucleus, reflecting the diversity of functions of CTCF (Figure 1.9).
CTCF was reported to bind to transcription factors, histone-modifying proteins and other 
regulatory proteins, including enzymes (Lutz et al., 2000b; Yu et al., 2004). Proteins that were 
reported to bind to the zinc-finger region of CTCF are Sin3, YB-1 and CHD8 (Chernukhin et al., 
2000; Ishihara et al., 2006; Lutz et al., 2000b). Kaiso and RNA polymerase II were shown to bind 
to the C-terminus of CTCF, whereas Yy1 has affinity for the N-terminus (Chernukhin et al., 2007; 
Defossez et al., 2005). Proteins that were shown to bind in vivo to CTCF-dependent boundaries 
are CHD8, nucleophosmin and the largest subunit of RNA polymerase II. The interaction of 
CTCF with the latter is interesting in that CTCF has been implicated in blocking the transfer of 
RNA polymerase II between an enhancer and a gene (Zhao and Dean, 2004). The interactions 
of CTCF with nucleophosmin, CHD8 and Kaiso have been implicated in its insulator function. 
Nucleophosmin was suggested to tether the β-globin cHS4 insulator to the nucleolar periphery 
by binding to CTCF (Yusufzai et al., 2004). Using cell lines carrying a transgene with wild type or 
mutated CTCF sites it was shown that CTCF is required for localization of the transgene array to 
the nucleolus. Binding of CTCF insulators to the nucleolar periphery could be involved in spatially 
separating the communication between an enhancer and promoter. It remains to be determined 
whether the interaction with the nucleolar periphery is a general phenomenon and involved in 
tethering multiple CTCF dependent insulators (Yusufzai et al., 2004). It was suggested that the 
association of CTCF with the nuclear matrix also mediates its boundary function (Dunn et al., 
2003). 
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Proteins reported to interact with CTCF are indicated 
and separated in groups regarding their function. 
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CTCF using purified proteins is confirmed, light grey: 
proteins of which a direct interaction with CTCF is 
not confirmed.
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CHD8, a Snf2-like chromodomain helicase, was reported to be present at multiple CTCF 
sites. Interestingly, knockdown of CHD8 disrupts enhancer blocking at the H19 insulator, leading 
to biallelic Igf2 expression without affecting CTCF binding at this site. Lack of CHD8 also results in 
a gain of DNA methylation and a decrease of acetylated histone H3 around the CTCF binding site 
at the c-myc insulator (Ishihara et al., 2006). CHD8 might affect epigenetic conditions near CTCF 
binding sites by bringing modifying enzymes and chromatin remodeling complexes together at 
CTCF dependent insulators.
The transcription factor Kaiso was shown to interact with CTCF and to bind close to the human 
HS5 β-globin insulator. A plasmid based enhancer-blocking assay showed that the presence of a 
Kaiso binding site reduces the enhancer-blocking activity of CTCF by half. These data indicate that 
the Kaiso-CTCF interaction negatively regulates CTCF insulator activity (Defossez et al., 2005).
In vitro GST-CTCF pull down assays showed CTCF binding to a histone modifying protein, 
the Sin3a/HDAC complex. It was shown that the ability of CTCF to retain histone deacetylase 
activity by binding to Sin3a correlates with the ability to repress gene activity (Lutz et al., 2000b). 
However, in another study using a different cell-type, CTCF was reported not to associate with 
HDACs (Dunn et al., 2003). The physiological significance of the CTCF-Sin3a/HDAC interaction 
therefore remains unclear.
The transcription factor Yy1, which contains four zinc fingers, interacts with CTCF. Together 
the two proteins function in activating Tsix, a transcript running antisense to the Xist gene. CTCF 
and Yy1 thereby appear to regulate X chromosome inactivation (Donohoe et al., 2007). Paired 
CTCF-Yy1 elements are present in a region that regulates X-chromosome counting and pairing. 
However it was recently shown that CTCF and not Yy1 is required for X-chromosome pairing (Xu 
et al., 2007). Furthermore, Yy1 binding elements are present in several imprinted loci suggesting 
that Yy1 may interact and bind next to CTCF not only at the X chromosome but also at imprinted 
domains (Kim et al., 2003; Kim et al., 2006). Interestingly, Yy1 was shown to regulate CTCF 
expression by binding to the Ctcf promoter and stimulating transcriptional activity of the gene 
(Klenova et al., 1998).
Another DNA binding protein, YB-1, interacts with CTCF and functions together in repression 
of the Myc oncogene, as shown in reporter assays (Chernukhin et al., 2000). Later it was reported 
that YB-1 also interacts with the serotonin transporter (5-HTT) and that CTCF can interfere with 
the ability of 5-HTT to support YB-1 directed gene expression in vitro (Klenova et al., 2004).
Recently Drosophila CTCF was shown to interact with the centrosomal protein 190 (CP190). 
dCTCF binding sites largely overlap with CP190 binding sites and binding of dCTCF to these sites 
requires CP190 in many cases (Mohan et al., 2007). The Fab-8 insulator requires for example 
both dCTCF and CP190 to perform its enhancer-blocking activity. Mammals are not reported to 
contain a homolog of the Drosophila CP190 protein. 
Several other proteins interacting with CTCF were identified by mass spectrometry after 
anti-Flag/anti-HA pull downs. These include the histone variant H2A.Z, the molecular chaperone 
Taf-1/Set, Topoisomerase II, Lamin A/C and Importin α3/ α1 (Yusufzai et al., 2004). These 
interactions should be interpreted with caution since experiments to confirm them were not 
shown.
1.4.4 The multiple roles of CTCF
In vivo analysis of CTCF
Despite the enormous interest in CTCF only one study has appeared to date that describes its 
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in vivo function in mice. In this study, CTCF protein amounts were specifically knocked down in 
oocytes using a transgenic RNAi approach (Fedoriw et al., 2004). Reduction in CTCF levels resulted 
in the inability of zygotes to develop to blastocyst-stage embryos. These data demonstrate a 
requirement for CTCF during early developmental processes (Fedoriw et al., 2004). CTCF null 
mutations in Drosophila cause late pupal lethality and a homeotic phenotype showing a critical 
requirement for CTCF during early development in flies (Mohan et al., 2007). By making use of a 
conditional Ctcf knockout allele we have recently been able to examine the role of CTCF in T cell 
development (Heath et al submitted, see chapter 2 of this thesis).
CTCF, cell cycle and cancer
Most in vitro studies on CTCF have been done in immortal cell lines. It was shown that CTCF 
overexpression results in inhibition of proliferation without apoptosis. Viable CTCF overexpressing 
cells could be maintained for several days, but these cells did not divide. The cell cycle profile of 
CTCF overexpressing cells did not show a clear block in a particular stage of the cell cycle (Rasko 
et al., 2001).
B-cell receptor cross linking on immature B-cells results in cell-cycle arrest and induces 
repression of Myc and expression of p53, p21, p27 and CTCF. Conditional expression of CTCF has 
been shown to mimick this situation, resulting in repression of Myc and expression of p27, p21, 
p53 and p19ARF while a reduction in CTCF results in the opposite effect on those genes. These 
results showed CTCF to be a determinant of growth arrest and apoptosis signaling in immature 
B cells (Qi et al., 2003).
Furthermore CTCF has been shown to bind regulatory regions of several genes implicated 
in cell proliferation and cancer. For example, removal (or mutation) of CTCF binding sites in the 
c-myc promoter resulted in an increased Myc expression in transient reporter assays (Filippova 
et al., 1996; Lobanenkov et al., 1990), indicating that CTCF acts as a repressor of this important 
oncogene. However in another study mutant CTCF sites fused to a reporter gene showed a 
reduction in Myc expression, indicating that CTCF is an activator instead of a repressor of c-myc 
(Klenova et al., 1993). Another CTCF binding element was found upstream of the c-myc promoter. 
This site is located next to a MAR and is active in enhancer-blocking assays, suggesting not only 
a transcriptional role for CTCF but also a role in higher-order nuclear organization of the c-myc 
locus (Gombert et al., 2003). CTCF was also shown to bind the promoter of the gene encoding 
another important cell cycle regulator, i.e. the Retinoblastoma (Rb) tumor suppressor protein. 
CTCF binds the human Rb gene promoter in a methylation sensitive manner and ablation of the 
CTCF binding site induces silencing of reporter gene expression, suggesting that CTCF functions 
as an activator of Rb (De La Rosa-Velazquez et al., 2007).
RNA polymerase and most transcription factors cannot remain their binding to DNA during 
mitosis, since during this stage of the cell cycle chromosomes condense and are less accessible. 
However it was shown that CTCF does remain bound to mitotic chromosomes and that the 
CTCF-dependent chromatin loop at the Igf2/H19 locus is maintained during mitosis. CTCF might 
therefore provide a novel form of epigenetic memory that is maintained throughout cell division 
(Burke et al., 2005). During mitosis CTCF not only binds to chromosomes but also associates 
with the centrosome, especially from metaphase to anaphase. At telophase, CTCF dissociates 
from the centrosome and localizes to the midbody (Zhang et al., 2004). In contrast, it was shown 
recently that the structure and binding of CTCF to the c-myc insulator is not preserved during 
mitosis (Komura et al., 2007). Indicating that this insulator element must be reassembled de 
novo with each new cell generation. This suggests that transfer of epigenetic information and 
reconstitution of domain structure after the completion of mitosis is not generally applicable to 
Introduction 37
all CTCF insulators. 
The human CTCF gene is located in an area on chromosome 16q22 that is commonly deleted 
in sporadic breast and prostate tumors (Filippova et al., 1998).  In breast-, prostate- and Wilms’ 
tumors four different CTCF somatic missense mutations were observed that involved amino 
acids within the zinc finger domain. These mutations did not completely abrogate CTCF binding 
to the promoters of specific genes (i.e. c-myc, p19ARF, Igf2 and Plk) as analyzed by gel mobility 
shift assays. However expression of these genes was slightly altered in the tumors (Filippova et 
al., 2002). Besides mutations affecting CTCF binding, an increased expression of CTCF itself was 
also found in breast cancer cells, this was associated with resistance of these cells to apoptosis 
(Docquier et al., 2005). Furthermore, deletion of CTCF target sites in the H19 ICR appears to be 
necessary, but is not sufficient, to cause Beckwith-Wiedemann syndrome and Wilms’ tumors 
associated with misregulation of Igf2 (Prawitt et al., 2005). In conclusion, extensive searches for 
CTCF defects in tumors have not revealed convincing evidence for a role of CTCF in cancer. On the 
other hand, CTCF does appear to be involved in regulating the cell cycle.
CTCF and the β-globin locus 
The 5’HS4 element of the chicken β-globin locus, which is located at the 5’ end of the locus, was 
the first element with insulating (i.e. enhancer blocking) properties to be described in vertebrates 
(Chung et al., 1993). Enhancer-blocking activities were subsequently found in the mouse and 
human β-globin locus (see below), as well as in the T-cell receptor αδ locus and in a matrix 
attachment 5’-boundary of the chicken lysozyme gene (Bell et al., 1999; Saitoh et al., 2000).
After narrowing down the enhancer-blocking activity to ~250 bp (Chung et al., 1997), the 
protein responsible was identified as CTCF (Bell et al., 1999). Subsequently, it was shown that 
enhancer blocking and another insulator property (i.e. a barrier function protecting against the 
spread of chromatin marks) are actually two separate activities at the 1.2-kb cHS4 element. 
Deletion of the CTCF binding site showed that CTCF is only responsible for enhancer-blocking 
activity at this site (Recillas-Targa et al., 2002). The transcription factor USF was identified as 
the protein important for boundary function at the cHS4 element. It was shown to function by 
recruiting histone modification complexes that are involved in H3K4 methylation and histone 
acetylation. In this way USF is likely to maintain the barrier by creating a local environment of 
active chromatin that counteract the propagation of condensed chromatin structures (Huang et 
al., 2007; West et al., 2004).
CTCF binding sites, their relative positions, and enhancer-blocking abilities are conserved 
between chicken, mouse and human. The CTCF binding sites are present at the 3’ end of the 
locus (3’HS1), in the LCR (5’HS5/cHS4) and in mouse additional sites in the 5’ end are reported 
(HS-62.5 and HS-85) (Bulger et al., 2003; Farrell et al., 2002) (Figure 1.10A). The role of CTCF 
and other factors in the regulation of β-globin gene expression and chromatin organization was 
defined by deleting the different binding sites in the locus. Deletion of the whole β-globin LCR 
that contains binding sites for multiple regulatory factors resulted in a large decrease in β-globin 
gene expression, but did not alter chromatin structure (Epner et al., 1998). Targeted deletion 
of the 5’HS5 showed only minimal effects on expression of globin genes, indicating that it does 
not function in maintaining the locus in an active conformation (Bender et al., 1998). Further 
studies on 5’HS5 function showed that its enhancer-blocking activity is restricted to embryonic 
erythroid cells (Wai et al., 2003). It was initially thought that the CTCF-bound HS-62.5 and 3’HS1 
sites that flank the β-globin locus were involved in maintaining an open chromatin domain and 
were present to prevent regulatory effects of neighboring domains. HS-62.5 and 3’HS1 were 
shown to interact with the LCR to form a ‘chromatin hub’ involved in β-globin gene activation 
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specifically in erythroid cells (Palstra et al., 2003; Tolhuis et al., 2002)(Figure 1.10B). These results 
indicate that the formation of certain chromatin loops is important for regulating interactions 
between other regulatory elements and the β-globin genes. Both conditional deletion of CTCF as 
well as deletion of its 3’HS1 binding site were shown to be important for maintaining long-range 
interactions in the β-globin locus. However deletion of the CTCF binding sites HS-62.5 and 3’HS1 
had no effect on transcription of the β-globin genes or the neighboring olfactory genes (Bender 
et al., 2006; Splinter et al., 2006). Absence of CTCF at 3’HS1 was shown to cause a local loss of 
histone H3 acetylation and gain of repressive H3K9/K27 di-methylation specifically at the CTCF 
binding site.
Combined these results imply that CTCF is involved in formation of a chromatin structure 
holding the LCR and the outside HSs together. Deleting individual CTCF binding sites apparently 
has no functional relevance to globin gene expression and the data indicate that CTCF does not 
function to prevent activation/silencing of neighboring regions. However, it is possible that in 
cells where specific CTCF binding sites have been deleted new sites are used to build specific 
chromatin hubs. Thus, CTCF could be involved in the formation of an alternative loop (with an 
increased size) and in this way the β-globin genes might still benefit fully from the presence of the 
LCR. One could call this “in-cis” redundancy of sites. Alternatively, cis-regulatory elements bound 
by other factors could substitute for the deleted regions.
LCR
OROR
5
123456
Bmaj BminEy Bh1
B-globin
CTCF 
CTCF
CTCFCTCF
3’HS1
5’HS-62
5’HS5
3’
5’
Bmin
Bmaj
Bh1
EG
GATANF-E2
YY1
A
B
Beta globin locus
4 3 2 1
5’HS
-62.5/-60.7
OR
3’HS1
1 2 3 4
10 kb
Figure 1.10 CTCF binding in the mouse β-globin locus
A. Schematic representation of the mouse β-globin locus with the position of CTCF binding sites indicated. Boxes above 
the horizontal line represent genes. The β-globin genes, aligned in the order of their developmental expression, are 
indicated by black boxes. Olfactory receptor genes (OR) are represented by white boxes and flank the locus. DNase I 
hypersensitive sites (HS) are indicated with arrows. B. Presentation of interactions that occur between regulatory DNA 
elements of the β-globin locus in erythroid progenitor cells. Several proteins that bind to the regulatory DNA elements 
are indicated. Contacts between distant CTCF-bindings sites (HS-62, 5’HS5, 3’HS1) in erythroid progenitor cells are shown. 
The β-globin genes are expressed at basal levels in these cells (Palstra et al., 2003; Splinter et al., 2006; Tolhuis et al., 
2002). 
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CTCF, imprinting and X-inactivation
The Insulin-like growth factor 2 (Igf2) and H19 genes are imprinted genes expressed only from 
the paternal or maternal allele, respectively. Identification of the region that shows allele-
specific DNA methylation (DMR/ICR) and the subsequent deletion of this region suggested how 
imprinted expression of Igf2 and H19 might be established (Ferguson-Smith et al., 1993; Leighton 
et al., 1995). At first a model was proposed whereby H19 and Igf2 compete for a common set 
of enhancers downstream of H19 under the influence of the ICR. However, the location of the 
enhancers appeared to be a critical determinant and thus an enhancer-blocking model was 
subsequently proposed (Webber et al., 1998). CTCF was identified as the protein that binds only 
to the maternal unmethylated ICR and was shown to function as an enhancer blocker and a 
crucial regulator of Igf2/H19 imprinting (Bell et al., 1999; Hark et al., 2000) (Figure 1.11A). 
Both maternal inheritance of mutated CTCF sites in the ICR as well as knock down of CTCF 
in oocytes resulted in loss of Igf2 imprinting and a gain of methylation at the imprinting control 
region (ICR) (Fedoriw et al., 2004; Schoenherr et al., 2003). These results showed the requirement 
for CTCF to maintain the hypomethylated maternal ICR in somatic cells as well as during a critical 
period in the female germline when methylation marks are being set.
Besides the DMR/ICR that is located 2-4kb upstream of H19 three other DMRs are present 
close to the Igf2 gene. DMR0 is reported to be placenta-specific, DMR1 functions as a methylation 
sensitive silencer of Igf2 in mesodermal tissues and DMR2 functions as a methylation sensitive 
activator of Igf2 (Constancia et al., 2000; Feil et al., 1994). Using an approach whereby the ICR 
was tagged by knocking in a GAL4-binding motif (UAS) together with expression of a GAL4-myc 
fusion protein, interactions involving the ICR could be detected. The interactions were detected 
by performing a pull down with antibodies against the myc epitope.  The results were confirmed 
using the 3C technique. It was shown that the DMRs in the Igf2/H19 locus can interact with 
the ICR and partition imprinted Igf2 and H19   genes into parental-specific chromatin loops. 
On the maternal allele, the CTCF bound ICR interacts with DMR1 resulting in two chromatin 
domains, with H19 in an active domain with its enhancers and Igf2 in an inactive domain away 
from the enhancers. On the paternal allele, the methylated ICR was shown to associate with 
the methylated DMR2. Formation of the parental-specific chromatin loops was proposed to be 
dependent on the methylation status of the DMRs and differential CTCF binding (Murrell et al., 
2004) (Figure 1.11B/C).
Using mice with mutated CTCF binding sites in the ICR it was confirmed that the maternal-
specific interactions and chromatin loops depend on CTCF. A matrix attachment region (MAR3) 
located at the 3’ end of the Igf2 gene was also shown to participate with the ICR and DMR1 in 
the formation of a loop structure of the maternal allele. Moreover CTCF was shown to interact 
with the unmethylated maternal DMR1. CTCF binding to the maternal DMR1 was lost when the 
mutated ICR allele was inherited maternally. This suggests that CTCF is likely to be recruited to 
DMR1 through the physical interaction between the ICR and DMR1 (Kurukuti et al., 2006). 
Examination of the chromatin loop detected on the maternal Igf2/H19 allele during mitosis 
revealed that the structure is maintained throughout the cell cycle (Burke et al., 2005). It should 
be noted that the chromatin loops present in the Igf2/H19 locus have never been examined in a 
quantitative manner or confirmed by DNA FISH so the frequency of specific interactions remains 
to be determined.
The crucial role for CTCF in maintaining correct imprinted expression of the Igf2 and H19 
genes indicates that CTCF might perform a similar function in other imprinted genes. Imprinted 
gene clusters that contain parental specific methylation-sensitive CTCF binding sites in their 
DMRs are Rasgrf 1, Kvlqt/P57Kip2, Meg3/Gtl2 and Meg1/Grb10 (Fitzpatrick et al., 2007; Hikichi 
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et al., 2003; Rosa et al., 2005; Yoon et al., 2005). It would be interesting to determine the role of 
CTCF in organizing chromatin structure and regulating gene expression in these loci.
In mice, X inactivation is imprinted in extra-embryonic tissues and occurs randomly in the 
embryo (Takagi and Sasaki, 1975). To start X-chromosome inactivation the two X-chromosomes 
need to communicate in trans through homologous pairing of the X-inactivation center (Xic). 
The pairing is necessary for counting and mutually exclusive choice (Lee, 2005; Xu et al., 2006). 
The Xic contains multiple regulatory elements including the Xist gene. Initiation of X inactivation 
depends on the coordinated expression of the Xist and Tsix genes, which overlap and are oriented 
antisense with respect to each other. The Xist RNA is exclusively expressed from, and coats, the 
inactive X chromosome (Xi). Tsix RNA is initially expressed on both X chromosomes and is down 
regulated on the Xi before inactivation, conversely Tsix expression persists longer on the active X 
chromosome (Xa) (Lee et al., 1999; Lee and Lu, 1999). Enhancers that are present in the Xite and 
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Figure 1.11 Action of CTCF at the mouse Igf2/H19 locus
A. Schematic representation of the Igf2/H19 locus. On the maternally transmitted allele, CTCF binds to sites in the 
imprinting control region (ICR) and prevents downstream enhancers from activating Igf2 expression. The ICR of the 
paternal allele is methylated, CTCF does not bind and the enhancers are no longer blocked and activate the Igf2 gene. B/C) 
representation of chromatin loop structures in the presence (B) and absence (C) of CTCF binding to the ICR upon deletion 
of its binding sites as analyzed by 3C (Kurukuti et al., 2006; Murrell et al., 2004). B. It is proposed that the conformation 
of the paternal allele allows contacts between Igf2 promoters and the enhancers that are blocked on the maternal allele. 
The ICR on the maternal allele makes contact with the DMR1 located upstream of the Igf2 promoters. It was suggested 
that the ICR-DMR1 interaction places the Igf2 promoters in a repressive domain. On the paternal allele the ICR contacts 
another such site, DMR2, downstream of Igf2. This should make the Igf2 promoters accessible to the enhancers located 
downstream of H19. C. Upon deletion of CTCF binding sites in the ICR. The ICR-DMR1 interaction is lost and resulting in 
access of the enhancers to the Igf2 promoter. A gain of methylation is observed on the maternal ICR, which spreads over 
the H19 gene and results in silencing. ICR: imprinting control region, DMR: differentially methylated region, MAR: matrix 
attachment region, Me: methylated site, small white circles: endodermal enhancers, light grey boxes: H19 exons, black 
boxes: Igf2 exons. Maternal and paternal alleles are indicated.
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DXPas34 elements developmentally regulate Tsix.
Multiple CTCF binding sites were identified in the DXPas34 element in Tsix and they were 
shown to possess enhancer-blocking activity in vitro (Chao et al., 2002). Differential methylation 
of these CTCF binding sites and of Xite correlate with X chromosome choice in mice (Boumil et al., 
2006). Therefore CTCF was proposed to be a candidate factor involved in choice. 
Using a bioinformatics approach additional CTCF binding sites were found in the Tsix gene 
that were frequently paired by Yy1 binding sites (Donohoe et al., 2007) (Figure 1.12). ChIPs 
confirmed binding of Yy1 to Tsix DNA and immunoprecipitations showed an interaction between 
Yy1 and CTCF. Furthermore it was shown that a deficiency of Yy1 leads to diminished Tsix levels 
and Xist up regulation. CTCF knockdown through RNA interference yielded an identical phenotype, 
indicating an important role for Yy1 and CTCF in transcriptional activation of Tsix. These results 
implied that a CTCF-Yy1 complex could potentially function as a key component in X chromosome 
pairing, counting or choice in both random and imprinted X chromosome inactivation (Donohoe 
et al., 2007). 
Subsequently it was shown that homologous X-chromosome pairing requires CTCF binding 
and co-transcriptional activity of Tsix and Xite. By contrast, the CTCF-interacting partner Yy1 was 
shown not to be required for pairing (Xu et al., 2007). Whether CTCF could directly mediate pairing 
or collaborate with additional factors remains to be determined. It was speculated that together 
with Tsix and Xite RNAs CTCF might form a RNA-protein bridge holding the two X chromosomes 
together.
Interchromosomal interactions
CTCF was recently shown to mediate interchromosomal interactions. Using two different 
methods, networks of chromosomal interactions with the CTCF-bound maternal H19 ICR 
were identified (Ling et al., 2006; Zhao et al., 2006). In one approach a modification of the 3C 
technique, called associated chromosomal trap (ACT), was used (Ling et al., 2006). The procedure 
is similar to 3C except that the ligated fragments are cleaved by a frequently cutting second 
restriction enzyme followed by linker ligation and amplification with a linker primer and a specific 
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Figure 1.12 CTCF binding sites in the mouse Xist/Tsix locus 
Schematic representation of the locus involved in mouse X chromosome inactivation. The regulatory elements implicated 
in counting and choice are shown. Xist and regulatory antisense Tsix transcripts are indicated, including their transcriptions 
status. Arrow indicates active transcription. X-inactivation intergenic transcription element (Xite), X inactivation centre 
(Xic) and DXPas34 element are indicated. Reported binding sites of CTCF and its interacting protein Yy1 in the Xist/Tsix 
locus are shown with small rounds (CTCF) or blocks (Yy1).  Xa: active X chromosome, Xi: inactive X chromosome are 
indicated (Based on: (Donohoe et al., 2007; Navarro et al., 2006)).
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primer. Sequencing subsequently identifies the putative interacting DNA segments of unknown 
identity. Using this approach it was shown that the maternal H19 ICR on chromosome 7, which 
binds CTCF because it is unmethylated, colocalizes with an intergenic sequence on chromosome 
11. This intergenic sequence is located between the Wsb1 and Nf1 genes. ChIP experiments 
confirmed CTCF binding to the paternal allele of Wsb1/Nf1. If the full maternal ICR is deleted, or 
if CTCF levels are diminished, the interaction between the ICR and Wsb1/Nf1 cannot be detected 
anymore and the two genes show an altered expression pattern (Ling et al., 2006). While the 
ACT approach identified only three different interactions with the ICR, a 4C approach yielded 114 
unique sequences identified from mouse neonatal liver (Zhao et al., 2006). Technical differences 
might underlie the discrepancy between these two approaches.
In the 4C study the authors show that the maternal H19 ICR interacts in trans with many 
imprinted regions on other chromosomes (Zhao et al., 2006). For example, the maternal 
H19 ICR allele was shown to interact with the maternal DMR of the imprinted Impact gene. 
Three-dimensional DNA FISH confirmed that this interaction is lost in mice with a maternal 
inheritance of the ICR CTCF binding site mutant. In these mice a reduction in gene expression 
of the imprinted Impact gene can be observed compared to wild-type mice. The expression 
of its neighboring non-imprinted gene Osbpl1a was up regulated in neonatal livers from mice 
with a maternal inheritance of the mutated ICR CTCF binding site (Zhao et al., 2006). This study 
shows that imprinted domains can be functionally connected in trans via DMRs and in this way 
are able to regulate transcription in trans. Both studies provide proof for a central role of CTCF 
binding sites in a network of chromatin interactions. It is however a point of debate whether 
interchromosomal interactions represent true physical interactions between loci or simply reflect 
the close proximity of loci.
Discovery and functional analysis of Drosophila CTCF 
Multiple different insulator binding proteins are present in Drosophila, these are Zw5, BEAF-32, 
GAGA factor and Su(Hw). None of these have an obvious counterpart in vertebrates. However, 
vertebrate CTCF was recently found to actually have a Drosophila counterpart (Moon et al., 
2005). 
Subsequent work showed that dCTCF is bound to several hundred loci on polytene 
chromosomes. Polytene chromosomes are formed in specialized cells that undergo repeated 
rounds of DNA replication without cell division. The banding patterns of these chromosomes 
provide easy visualization of transcriptionally active and inactive chromatin and the general 
chromatin structure. The banding pattern of dCTCF binding sites displayed no overlap with 
binding sites of other well known insulator proteins Su(Hw) and BEAF-32 (Mohan et al., 2007). 
The fact that dCTCF binds different targets indicates that it does not have a redundant function.
In Drosophila correct anterior-posterior patterning in the thorax- and abdominal segments 
is dependent on the precise expression of Hox genes of the Bithorax complex (BX-C) in specific 
parasegments. This is achieved by the subdivision of the regulatory regions of each of the three 
BX-C genes (Ubx, Abd-A and Abd-B) into distinct enhancer domains (Martin et al., 1995). There 
are at least nine distinct regulatory domains controlling the three genes of the BX-C in specific 
parasegments.  Of the eight boundaries between those domains, three have been shown to 
have enhancer-blocking activity: Mcp, Fab-7 and Fab-8.  At first dCTCF was shown to bind the 
Fab-8 boundary of BX-C, but more detailed analysis revealed dCTCF is bound to all but one 
(Fab-7) of these elements (Holohan et al., 2007). Fab-7 is bound by the boundary factor GAGA 
(Schweinsberg et al., 2004). 
Introduction 43
Strikingly, the binding pattern of a Su(Hw) cofactor called CP190 did show a significant 
overlap with that of dCTCF and the two proteins were subsequently shown to interact (Mohan 
EMBO J 2007). In CP190 mutant flies the total number of dCTCF labeled sites is reduced on the 
other hand the number of CP190 sites was not affected by dCTCF mutants (Mohan et al., 2007). 
Although it was subsequently reported by another group that in CP190 mutant flies the total 
number of dCTCF-bound sites is completely abolished and the number of CP190 sites is reduced 
in dCTCF mutants (Gerasimova et al., 2007). It is however not clear why there is a discrepancy 
between these two reports, but they indicate that dCTCF and CP190 are likely to cooperate with 
each other to bind to the DNA. Indeed, CTCF and CP190 were shown to occupy similar target 
sites in the BX-C. The Fab8 enhancer blocker was shown to require both CTCF and CP190 for its 
activity. The importance of CTCF binding to the BX-C elements was shown by a reduction in Abd-B 
expression in dCTCF mutants (Mohan et al., 2007). 
Although dCTCF does not show an overlap in distribution with Mod(mdg4)2.2 on polytene 
chromosomes the proteins were reported to co localize in the nuclei of diploid cells. This 
supported the idea that dCTCF and gypsy are both involved in the formation of insulator bodies 
(Gerasimova et al., 2000). In the absence of CP190, both dCTCF and Mod(mdg4)2.2 fail to form 
insulator bodies and have an aberrant cellular localization. These results suggest that gypsy and 
dCTCF insulators share CP190 and cooperate in the formation of insulator bodies to regulate the 
organization of the chromatin fiber in the nucleus (Gerasimova et al., 2007). 
The importance of dCTCF for fly development, enhancer-blocking function at specific sites, 
organization of chromatin structure and the shared binding site consensus points to conserved 
similarities between Drosophila and vertebrate CTCF. 
1.4.5 Characteristics of binding sites
A first attempt to map CTCF binding sites in a genome-wide fashion was performed using ChIP-
on-chip on fetal liver cells (Mukhopadhyay et al., 2004). However, only 200 new target sites 
were identified and it was suggested that more than two-third of the binding sites could not be 
identified in the mouse genome due to the fact that they mapped to heterochromatic regions. 
Most but not all of the newly identified binding sites were reported to be free of DNA methylation 
(Mukhopadhyay et al., 2004). As the chip used for this work contained only 2200 clones, the 
approach was inheritantly limited in scope.
More recent approaches have revealed a much more extensive, genome-wide distribution 
of CTCF binding sites, and allowed delineation of a characteristic CTCF consensus site (Barski et 
al., 2007; Kim et al., 2007; Xie et al., 2007). In one of the improved approaches a mixture of nine 
CTCF monoclonal antibodies was used for ChIP-on-chip analysis; detection was performed using 
high-resolution genome-tiling microarrays. About 14.000 CTCF binding sites were identified in 
the human genome. This result implies that CTCF binds on average once every 200 kb. Nearly half 
of the CTCF-binding sites are found in sequences between genes and likely define boundaries 
for gene clusters. An equivalent number of CTCF sites are located close to genes, in promoter 
regions (20%) or within genes (34%) (Kim et al., 2007). From these binding sites a twenty basepair 
conserved consensus sequence for CTCF binding was derived (Figure 1.13). Interestingly, a 
similar consensus was found independently by using a screen for regulatory motifs in conserved 
non-coding regions (Xie et al., 2007). The 20 basepair consensus site differs somewhat from a 
minimal CTCF DNA binding site that was determined to be twelve basepairs in length (Renda et 
al., 2007).
44 Chapter 1
Another study published recently reported on the genome-wide distribution of histone 
methylation- and CTCF-binding-profiles (Barski et al., 2007). In this approach ChIP was followed 
by adaptor ligation and direct sequencing using the Solexa 1G Genome Analyzer. In this study 
20.000 CTCF binding sites were identified, and the nature of the different sites was analyzed in 
more detail. By linking histone modification profiles to gene expression data and RNA polymerase 
II and CTCF occupancy a genome-wide pattern of promoter and boundary characteristics was 
generated. CTCF-dependent insulators were found to be enriched for all three forms of H3K4 
methylation, for H3K9me1 and for histone variant H2A.Z (Barski et al., 2007). CTCF is preferentially 
bound to ubiquitous and common DNaseI HS sites and not to cell-type specific HS sites (Xi et al., 
2007). The conclusion from these experiments is that CTCF-dependent insulators play a major 
role in the genome. The question is whether the main function of CTCF is in chromatin folding, 
without necessarily having a positive or negative influence on gene expression. 
Recently it was shown that half of the CTCF binding sites is associated with cohesin. 
Interestingly it was shown that CTCF is dispensable for cohesin loading onto DNA, but is needed 
to enrich and position cohesin at specific binding sites. Cohesin was shown to contribute to CTCF 
insulator function and it was suggested that cohesin is the crucial factor that performs insulating 
activities. How exactly cohesin contributes to transcription insulation remains to be determined, 
it is conceivable that cohesin physically connect different sites thereby creating DNA loops or 
blocks the spreading of chromatin remodeling or transcription factors on DNA (Parelho et al., 
2008; Stedman et al., 2008; Wendt et al., 2008). 
To date only a few CTCF binding sites that are flanked by thyroid hormone response 
elements (TREs) are reported. Examples include the silencer element of the chicken lysozyme 
gene and a region upstream of the human c-myc gene. Upon binding to the F1 element of the 
chicken lysozyme gene silencer CTCF can mediates repression by v-ERBA, thyroid hormone 
receptor, or retinoic acid receptor in a synergistic manner (Burcin et al., 1997). CTCF and thyroid 
hormone receptor (T3R) could potentially mediate this repression through recruitment of histone 
deacetylase activity by Sin3A (Lutz et al., 2000a).
Interestingly thyroid hormone is able to relieve the enhancer blocking activity of CTCF, when 
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CTCF and thyroid hormone receptor are bound to adjacent sites, even as CTCF remains bound 
to the TRE (Lutz et al., 2003). Loss of enhancer blocking activity after the addition of thyroid 
hormone is correlated with increased histone H4 acetylation at the CTCF binding site.
1.5 CTCFL, the testis-specific paralogue of CTCF
1.5.1 Discovery and initial characterization of CTCFL
CTCFL, or BORIS (Brother Of the Regulator of Imprinted Sites) was discovered in a database search 
for CTCF-like proteins (Loukinov et al., 2002). Like CTCF, CTCFL contains 11 zinc fingers. Most of 
these are of the C2H2-type, yet one matches an U1-type zinc finger, a C2H2-type-like module, 
which is present in matrin, U1 small nuclear ribonucleoprotein C, and other RNA-binding proteins 
(Dumortier et al., 1998). Mouse CTCFL is similar for about 71% to CTCF in the eleven zinc-finger 
region, but the N- and C-terminus of CTCF and CTCFL are very different (Figure 1.8). Furthermore, 
CTCFL does not contain the AT-hook domain that is present in the CTCF C-terminus. Thus, CTCF 
and CTCFL are alike, but only in the zinc finger domains. Consistently, both proteins can bind the 
same DNA probes in vitro (Loukinov et al., 2002).
In contrast to CTCF, CTCFL is expressed in a very restricted manner, i.e. the protein is found 
only in the male germ cells of the testis, in spermatogonia and spermatocytes, but not in the 
later stages of spermatogenesis (Loukinov et al., 2002). CTCFL is present in mammals, but absent 
in lower organisms. A comparison of mouse and human CTCFL reveals considerable divergence 
between these proteins. This is completely unlike CTCF, which is extremely well conserved. 
Perhaps the testis-specific expression of CTCFL allows for more mutations in the protein because 
of a reduced number of important interactions.
1.5.2 CTCFL and imprinting
It has been suggested that CTCF and CTCFL are expressed in a mutually exclusive manner (Loukinov 
et al., 2002). This excludes competition for binding sites and instead suggests that binding sites 
require a different protein depending on the differentiation stage. Although it was stated that 
the sequential expression of CTCFL and CTCF in the testis takes place at the moment of erasure 
and re-setting of DNA methylation marks during male germ-line development (Loukinov et al., 
2002), this clearly is not correct, as this takes place earlier during gametogenesis (Davis et al., 
2000; Ueda et al., 2000). Thus, the switch from CTCFL to CTCF expression is not linked with the 
initiation or targeting of de novo DNA methylation to paternal imprinting marks, like that of the 
H19 ICR (Loukinov et al., 2002).
In a subsequent study it was reported that CTCFL expression could be detected much 
earlier in male germ-cell development, at 14.5 dpc, in pro-spermatogonia (Jelinic et al., 2006). 
Nuclear transfer analysis revealed that the erasure process of DNA methylation in primordial 
germ cells takes place around day 10.5 to day 11.5 (Lee et al., 2002). The paternal H19 allele 
becomes hypermethylated in the ICR around 14.5 and 15.5 d.p.c. in pro-spermatogonia (Davis et 
al., 2000; Ueda et al., 2000). CTCFL is clearly not associated with erasure of methylation marks, a 
process that takes place earlier than expression of the protein. CTCFL expression, however, does 
coincide with DNA methylation and acquirement of allele specific imprints in the male germline. 
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Whether CTCFL plays a role in re-setting of the methylation imprint in the male germline remains 
to be determined. This should involve an association of the protein with factors like the de novo 
methyltransferases (Dnmts) that are responsible for setting methylation imprints. In order to 
identify proteins interacting with CTCFL a yeast two-hybrid screen was performed. PRMT7, a 
protein arginine methyltransferase was identified from this screen and further experiments 
confirmed its interaction with CTCFL (Jelinic et al., 2006). PRMT7 was shown to methylate histone 
H2A and H4 (Lee et al., 2005).
The interaction between CTCFL and PRMT7 appeared to be important for stimulation 
of PRMT7 activity and its interaction with histones. The question whether or not CTCFL and 
PRMT7 could participate in specific ICR methylation was addressed by co-injection of different 
expression constructs in Xenopus oocytes. These experiments showed that CTCFL and PRMT7 
could contribute, in addition to Dnmt3a/3b, to methylation of the H19 ICR. It was suggested 
that CTCFL-PRMT7 binding leaves a histone methylation mark on the ICR that is subsequently 
recognized by a complex that recruits Dnmt3a and Dnmt3b for de novo DNA methylation (Jelinic 
et al., 2006). However, the nature of this histone methylation mark that should recruit the Dnmts 
remains to be defined. Moreover Dnmts are not known to bind to PRMTs, although interactions 
could of course be modulated by another protein.
ChIP experiments showed that CTCFL binds to the H19 ICR, both in young (15.5 dpc) and 
adult testis. It was not shown whether CTCFL binds in an allele-specific manner and whether 
CTCFL binding is sensitive to DNA methylation. To gain more insight in a possible role for CTCFL in 
re-setting methylation imprints it would be interesting to know whether CTCFL binds the ICR at 
the moment of the first methylation wave around 13.5-14.5 d.p.c.
1.5.3 CTCFL and cancer
Genome-wide DNA methylation patterns are frequently altered in cancer. A role for CTCFL in 
human cancer was proposed based on its potential function in setting up methylation marks. 
Indeed, besides its expression at certain stages of spermatogenesis CTCFL was also found to 
be expressed in certain tumors, including spermatocytic seminomas, in immortal cell lines, and 
several lung cancer cell lines (Looijenga et al., 2006; Risinger et al., 2005; Vatolin et al., 2005). 
High levels of CTCFL expression correlate with specific types of cancers for example, uterine 
cancers (Risinger et al., 2007). However in other cancer tissues and carcinoma cell lines, such as 
from the prostate and bladder, expression of CTCFL remained largely unchanged compared to 
normal tissues (Hoffmann et al., 2006).
Interestingly, DNA methylation itself appears to be an important mechanism in the 
control of CTCFL transcription. It was shown that increased DNA methylation and functional 
p53 negatively regulate expression from all three CTCFL promoters (Renaud et al., 2007). In 
another study CTCFL was dramatically induced in cancer cell lines upon treatment with the DNA 
methylation inhibitor 5-aza-2’-deoxycytidine (5-AzadC) (Hoffmann et al., 2006). Furthermore, it 
was reported that cancer-associated genome-wide demethylation results in aberrant expression 
of cancer/testis (CT) antigens that are encoded by genes that are normally expressed only in the 
human germ line (Old, 2001; Simpson et al., 2005). This led to the hypothesis that CTCFL could 
be itself a cancer/testis antigen or could be involved in regulating such genes. Derepression of 
CTCFL upon 5-AzadC treatment results indeed in expression of multiple cancer-testis antigens 
including NY-ESO-1 and MAGE-A1 in lung cancer cells (Hong et al., 2005; Vatolin et al., 2005). It 
was shown that overexpression of CTCFL is associated with changing methylation patterns of the 
Introduction 47
MAGE-A1 promoter and in derepression of the gene. This implies that CTCFL is directly involved 
in regulation of those genes. Both CTCF and CTCFL were shown to bind a region within the MAGE-
A1 promoter in a methylation sensitive manner.
Gel shift and ChIP experiments in the NY-ESO-1 promoter also showed a binding site for 
CTCF/CTCFL. It was suggested that binding of this site by CTCF is associated with silencing of the 
NY-ESO-1 promoter whereas switching from CTCF to CTCFL on this site resulted in derepression 
of NY-ESO-1 (Hong et al., 2005). Later it was suggested that CTCFL and not CTCF could recruit Sp1 
to mediate de-repression of NY-ESO-1 during pulmonary carcinogenesis (Kang et al., 2007). Thus, 
while in testis CTCF and CTCFL are not expressed in the same cells, in a variety of human cancers 
they are. In human fibroblasts that are negative for CTCFL, it was shown that CTCFL expression 
could be induced by a reduction in CTCF protein levels (Renaud et al., 2007). Despite these data 
the existence of a CTCFL/CTCF switch and its role in regulating DNA methylation, remains to be 
identified in vivo.
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Summary
CTCF is a highly conserved protein, involved in imprinting, long-range chromatin interactions 
and transcription. To investigate its function in vivo, we generated mice with a conditional Ctcf 
knockout allele. Consistent with previous studies we found that CTCF was indispensable for early 
embryonic development. We subsequently inactivated CTCF specifically in early double-negative 
(DN) thymocytes, using Lck-Cre transgenic mice. This resulted in the accumulation of immature 
single positive (ISP) cells, which were smaller and inhibited in their cell cycle, and which contained 
highly elevated amounts of the cyclin-CDK-inhibitors p21 and p27 levels. In vitro studies provide 
evidence for a crucial role of CTCF in the activation and proper localization of key proteins, such 
as nucleophosmin, a CTCF-interacting factor. Using two independent approaches we show that 
CTCF levels increase with T cell size. Combined, our results show that CTCF controls cell cycle 
progression of β-selected T-cells. We propose that CTCF regulates cell size by controlling the 
activation of key metabolic processes in these rapidly proliferating and growing cells.
Introduction
The 11-zinc finger protein CCCTC-binding factor (CTCF) is a widely expressed and highly conserved 
transcriptional regulator implicated in many important processes in the nucleus (for reviews, see 
(Lewis and Murrell, 2004; Ohlsson et al., 2001). In line with this view, murine CTCF is essential for 
early embryonic development (Fedoriw et al., 2004). CTCF is the archetypal vertebrate protein 
that binds insulator sequences, DNA elements that have the ability to protect a gene from outside 
influences (Bell et al., 1999). Its methylation-sensitive interaction with the imprinting control 
region of the H19/insulin-like growth factor 2 (Igf2) genes indeed controls enhancer access (Bell 
and Felsenfeld, 2000; Fedoriw et al., 2004; Hark et al., 2000). CTCF-mediated insulator activity has 
been predicted at several other sites including the DM1 locus and boundaries of domains that 
escape X-chromosome inactivation (Filippova et al., 2005; Filippova et al., 2001). We have shown 
that CTCF mediates long-range chromatin interactions and regulates local histone modifications 
in the β-globin locus (Splinter et al., 2006). Evidence has furthermore been presented for a role 
of CTCF in inter-chromosomal interactions between Igf2 and other loci (Ling et al., 2006). During 
mitosis, CTCF remains bound to mitotic chromosomes, possibly facilitating reformation of higher 
order chromatin loops after mitosis (Burke et al., 2005). Combined these data suggest that CTCF 
is an essential organizer of imprinting, long-range chromatin interactions and transcription.
Genome-wide mapping of CTCF-binding sites revealed ~14,000 sites, whose distribution 
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correlated with genes but not with transcriptional start sites (Kim et al., 2007). Strikingly, the 
20-bp consensus motif found in the majority of the sites is virtually identical to a consensus 
sequence LM2*, bound by CTCF and found in ~15,000 conserved non-coding elements in the 
human genome (Xie et al., 2007). High-resolution profiling of histone methylation in the human 
genome showed that CTCF marks boundaries of histone methylation domains (Barski et al., 
2007) consistent with a role for CTCF as an insulator protein. CTCF may tether insulators to 
subnuclear sites together with nucleophosmin, a CTCF-interacting partner (Yusufzai et al., 2004). 
Very recently it was shown that CTCF binding sites on mammalian chromosomes largely overlap 
with those of cohesin (Parelho et al., 2008; Wendt et al., 2008). Interestingly, CTCF is required for 
cohesin localization to these sites, but cohesin might function as the actual insulator protein.
 Genome-wide analyses also revealed CTCF-binding sites near genes displaying extensive 
alternative promoter usage, including protocadherin γ, the immuno-globulin λ light chain and the 
TCR α/δ and β chain loci. In mice, CTCF-dependent insulators were found downstream of the TCR 
α/δ and the immunoglobulin H chain loci (Garrett et al., 2005; Magdinier et al., 2004). Combined, 
these data suggest an important role for CTCF in lymphocytes, in particular in the regulation of 
gene transcription or recombination targeting in complex loci. To understand how CTCF regulates 
lymphocyte proliferation and differentiation in vivo, we generated mice with a conditional Ctcf 
allele (Ctcff/f), and deleted the gene in early T cell development. T cell progenitors differentiate 
in the thymus, where early double-negative (DN) precursors, expressing neither CD4 nor CD8 co-
receptors, begin locus-specific recombination of their TCR loci (for review, see (Rothenberg and 
Taghon, 2005). Upon productive TCRβ gene rearrangement, the TCRβ chain associates with the 
invariant pTα chain on the cell surface. Cells that successfully pass this β-selection checkpoint 
enter the cell cycle and acquire CD4 and CD8 co-receptors to become double-positive (DP) 
thymocytes. Upon productive TCRα locus recombination in DP cells, TCRαβ is expressed on the 
cell surface. Positive selection results in the differentiation to CD4 and CD8 single positive (SP) 
cells, which express TCRαβ and recognize peptide antigens presented by MHC class II or class I 
molecules, respectively. Mature SP cells exit the thymus and circulate to the periphery as naive 
CD4+ and CD8+ T cells.
Here we show that CTCF acts as a critical regulator of cellular proliferation and differentiation 
following β-selection in the thymus. We demonstrate that CTCF is expressed at higher levels 
in immature single positive (ISP) cells, which normally form a relatively big and actively cycling 
subpopulation of T cells. In Ctcf knockout mice ISP cells are small and are blocked in their cell 
cycle. Interestingly, we detect increased expression of p2 and p27, two major cell cycle regulators, 
in Ctcf knockout ISP cells. Using in vitro cultures we show that CTCF is also required for the 
activation and localization of key factors in cell metabolism. Thus, CTCF regulates cell size and the 
cell cycle in β-selected T cells.
Results
Conditional deletion of the Ctcf gene in developing T lymphocytes
We generated a conditional Ctcf allele (Ctcff) by inserting loxP-sites upstream of exon 3 and 
downstream of exon 12 (Figure 2.1A). Normal amounts of CTCF were expressed in Ctcff/f mice 
(data not shown). Ctcf+/f mice were crossed with mice expressing Cre recombinase ubiquitously 
(Sakai and Miyazaki, 1997). This caused removal of Ctcf exons 3-12 from Ctcff, yielding the Ctcf- 
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allele, in which a Ctcf-lacZ fusion transcript is expressed instead of Ctcf (Figure 2.1A). Ctcf+/- mice 
appeared normal and were fertile, but we were unable to generate homozygous knockouts from 
Ctcf+/- crosses (Table 2.1), consistent with an essential role for CTCF in early development (Fedoriw 
et al., 2004). Surprisingly, crosses among Ctcf+/- mice and between wild type and Ctcf+/- mice 
yielded more wild type animals than would be expected on the basis of Mendelian segregation 
(Table 2.1). These data suggest that CTCF is required in a dose-dependent manner.
In order to obtain a T-cell specific deletion of the Ctcf gene we crossed Ctcff/f mice with Lck-
Cre transgenes, in which the Cre recombinase is driven by the proximal Lck promoter (Lee et al., 
Figure 2.1 Conditional targeting of the mouse Ctcf gene
A. Murine Ctcf locus and gene targeting constructs. Exons of the Ctcf gene (solid boxes) are numbered, scale is in kilobase 
(K). Exon 1 is embedded in a CpG island. Exon 3 contains the start codon and exon 12 the stop codon. Southern blot 
probes are shown above the Ctcf gene. The two targeting constructs, with loxP sites (small triangles), flanking a PMC1-
neomycin cassette (neor) or a PGK-puromycin cassette (puror), are shown with homologous regions. TK: thymidine kinase 
gene, SA-LacZ: Splice acceptor-lacZ cassette (Hoogenraad et al., 2002). PCR primers for genotyping (p8563, p8946, p260 
and p261, large triangles) are indicated on targeting cassettes. Underneath the targeting constructs the deleted Ctcf gene 
is shown, that is generated after complete Cre-mediated recombination at the outermost loxP sites. Due to alternative 
splicing, the splice acceptor (SA) site, present at the 5’end of the reporter LacZ cassette, is spliced on to Ctcf exon 1 or 
2, thereby generating a hybrid Ctcf-lacZ transcript. B. Southern blot analysis of Lck-Cre recombinase activity. Digested 
genomic DNA from thymus and spleen of mice of the indicated genotypes was analyzed by hybridization with the HIII-
probe (see panel A). The positions of the wild type (WT), Ctcff/f (flox) and Ctcf-/- (del) alleles are indicated (asterisk indicates 
a polymorphic WT allele from the FVB background). C. Western blot analysis of thymus. Total thymus lysates from Lck-Cre 
Ctcff/f and WT mice (+ indicates presence of Cre transgene; - indicates absence) were analyzed for CTCF, DNMT1 and UBF 
protein levels. D. Flow cytometric analysis of lacZ expression in CTCF conditionally deleted mice. LacZ expression was 
analyzed in conjunction with cell surface markers. The indicated cell populations were gated and lacZ expression data are 
displayed as histogram overlays of Lck-Cre Ctcff/f mice (green) on top of background signals in wild type mice (black).
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2001; Wolfer et al., 2002). Southern blotting showed almost complete deletion of the Ctcf gene in 
thymus, while in spleen deletion was not evident (Figure 2.1B). These data reflect the specificity 
of the Lck-Cre transgene; they further indicate that Ctcf knockout T cells do not repopulate the 
spleen in large numbers. To evaluate the onset of Ctcff gene deletion we analyzed lacZ expression 
in T cells using fluorescein-di-β-D-galactopyranoside (FDG) as a substrate. We found that deletion 
was almost complete from DN2 onwards (Figure 2.1D). Western blotting showed that in thymic 
nuclear extracts from Lck-Cre Ctcf/f mice CTCF protein levels were reduced to ~8 % of control 
(Figure 2.1C). We conclude that ablation of the Ctcf gene results in an efficient depletion of the 
protein in vivo.
Defective TCRαβ lineage development in Lck-Cre Ctcff/f mice
To examine the effects of a Ctcf deletion, thymocyte subpopulations in 6-8 week-old mice were 
analyzed by flow cytometry. Lck-Cre Ctcff/f mice displayed reduced thymic cellularity, with a severe 
decrease in the proportions of DP and CD4 SP cells, and a concomitant increase in the proportions 
of DN and CD4-CD8+ cells (Figure 2.2A, B). CD4-CD8+ cells were mainly of the CD3loCD69lo type, 
indicative for ISP cells (see also below). αβ T cell development was partially arrested at the ISP to 
DP transition, causing accumulation of DN3, DN4 and ISP cells (Figure 2.2B). Heterozygous Lck-
Cre Ctcf+/f mice also displayed a phenotype at the DP stage, showing that normal CTCF levels are 
important for proper T cell development. In these mice, thymic cellularity was modestly reduced 
and no accumulation of ISP cells was detected (Figure 2.2B). In agreement with impaired thymic 
SP cell production, the numbers of mature CD4+ and CD8+ T cells in spleen and lymph nodes of 
Lck-Cre Ctcff/f and heterozygous Lck-Cre Ctcf+/f mice were significantly reduced (Figure 2.2A, B and 
unpublished data).
CTCF-deficiency had no adverse effect on γδ T cell development, since the number of 
CD3+TCRγδ+ thymocytes in Lck-Cre Ctcff/f mice was ~2-fold higher than in wild type littermates 
(Figure 2.2C, D). The relative proportion of γδ T cells in the spleens of Lck-Cre Ctcff/f mice was also 
markedly increased (Figure 2.2C), due to impaired αβ T cell production. In fact, in vitro culture of 
anti-CD3/CD28 antibody-stimulated peripheral T cell fractions from Lck-Cre Ctcff/f mice resulted 
in a selective outgrowth of TCRγδ  T cells (Supplementary Figure S2.1A). We could not detect 
CTCF protein in a mixed population of in vitro activated TCRαβ and TCRγδ T cells from Lck-Cre 
Ctcff/f mice  (Supplementary Figure S2.1B, C). We therefore conclude that CTCF is essential for 
TCR-mediated activation and proliferative expansion of TCRαβ but not of TCRγδ T cells.
The accumulation of CTCF-deficient ISP cells in Lck-Cre Ctcff/f mice could result from a 
developmental arrest at the ISP stage or reflect defective up-regulation of CD4 expression in 
CD3+TCR+ cells (i.e. DP cells), similar to thymocytes deficient for the chromatin remodeler Mi-
2β (Williams et al., 2004). To distinguish between these possibilities, we assessed expression of 
Ctcf+/- x Ctcf+/-
Age
genotype and number
wild type Ctcf+/- Ctcf-/-
E 9.5 13 14 0
E 3.5 10 7 0
adult 88 92 0
Ctcf+/- x wild type
adult 101 74 n.a
Table 2.1 Genotype of Ctcf+/-  x Ctcf+/- offspring
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various cell surface markers. CD3 and TCRβ expression were very low in CTCF-deficient ISP cells, 
suggesting that these were true ISP cells (Figure 2.3A). The cells also expressed low levels of CD5, 
which is normally up-regulated on DP cells (Azzam et al., 1998), and of CD69, which is induced in 
a sub-fraction of DP cells, reflecting TCR-mediated activation (Bendelac et al., 1992). Expression 
of CD24 (HSA), which is normally high on DN and ISP cells and down-regulated at the ISP to 
DP transition (Williams et al., 2004), was reduced in CTCF-deficient cells throughout thymocyte 
differentiation (Figure 2.3A). Remarkably, differentiation of TCRβ+ cells from Lck-Cre Ctcff/f mice 
was possible from the DN4 towards the ISP cell type, but cells were significantly smaller compared 
to wild type (Figure 2.3B, see also Figure 2.4). Combined our data show that a CTCF-deficiency 
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Figure 2.2 Defective TCRαβ lineage development in CTCF-deficient mice
A. Flow cytometric analyses of the indicated cell populations in thymus or spleen from the indicated mice. Expression 
profiles of surface markers are shown as dot plots and the percentages of cells within quadrants or gates are given. B. 
Absolute numbers of the indicated thymic and splenic T cell subpopulations. Each symbol represents one individual 
animal and lines indicate average values. Lck-Cre Ctcff/f had increased numbers of DN3 (p<0.01), DN4 (p=0.0002) and ISP 
cells (p<0.002). In Lck-Cre Ctcff/f mice and heterozygous Lck-Cre Ctcff/+ mice DP, CD4 SP and CD8 SP subsets in the thymus 
were significantly reduced (p<0.0001). CD4 and CD8 T cells in the spleen were significantly reduced in Lck-Cre Ctcff/f 
mice (p<0.00001) and in heterozygous Lck-Cre Ctcff/+ mice (p<0.01). C. Flow cytometric analyses of total thymocytes and 
CD3+ splenocytes. For the thymus, expression profiles of CD3 and TCRγδ surface markers are shown as dot plots and 
the percentages of CD3+TCRγδ+ cells are given. For the spleen, data are displayed as histograms and the percentages 
represent the fractions of CD3+ cells that are TCRγδ+. D. Absolute numbers of TCRγδ+ T cells in thymus and spleen of the 
indicated mouse groups. TCRγδ+ T cells were significantly increased in the thymus of Lck-Cre Ctcff/f mice (p<0.05) Data 
shown are representative of 10-20 animals per group. 
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blocks β-selected T cells at the ISP stage. Lack of CTCF affects ISP cell size, suggesting that CTCF 
forms part of the regulatory network that monitors this fundamental property of cells.
Tcr rearrangements occur in Lck-Cre Ctcf/f mice
As our findings indicated a specific role for CTCF at the ISP to DP transition, we focused our 
attention on possible molecular mechanisms underlying the hampered differentiation of these 
cells. We first analyzed TCR rearrangement, because of the many CTCF-binding sites found in the 
genes encoding the different receptors. Tcrβ rearrangement is generally initiated and completed 
in DN3. This stage consists of early small cells that have not yet productively rearranged the 
Tcrβ locus, and more mature large proliferating cells expressing TCRβ (Hoffman et al., 1996). We 
detected a significant population of large DN2 cells in Lck-Cre Ctcff/f mice that already contained 
intracellular TCRβ+ (Figure 2.4). The proportion of large TCRβ+ cells was still elevated in DN3 cells, 
thus the Tcrβ locus can undergo functional V(D)J recombination in DN3 (and apparently even in 
DN2) cells that have deleted the Ctcf gene.
The severe reduction of DP cell numbers and low surface CD3/TCR expression on CTCF-
deficient DP cells, together with the reported presence of CTCF-binding sites in the Tcr α gene 
locus (Garrett et al., 2005; Kim et al., 2007), suggest that defective TCRα V(D)J recombination 
may contribute to the arrest of CTCF-deficient thymocytes. We therefore crossed Lck-Cre Ctcff/f 
A DN DP SPISP SP
CD3
TCRB
CD5
CD69
HSA
B
320
DN3E DN3L DN4 ISP DP
360
400
440
480
520
560
CD3-CD4-CD8- CD3-CD4+CD8- CD4+CD8+ CD4+ CD8+
M
ed
ia
n 
Fo
rw
ar
d
 S
ca
tt
er
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
10
0
10
1
10
2
10
3
10
4
0 200 400 600 800 1000
WT
FSC
icTCRB
DN2DN1 DN3 ISPDN4
27 19 90 97
153 27 89 82
KO
Figure 2.3 Characterization of CTCF-depleted cells in Lck-Cre Ctcff/f 
mice
A. Flow cytometric analyses of HSA, CD3, TCR, CD5 and CD69 in 
the indicated thymocyte subpopulations, displayed as overlays 
of wild type mice (black histograms) and Lck-Cre Ctcff/f mice (red 
histograms). Data shown are representative of 5-8 mice per group. 
B. Flow cytometric analyses of intracellular TCRβ protein expression 
in the indicated thymic subsets from wild type (WT) and Lck-Cre 
Ctcff/f mice (KO). TCRβ/forward scatter (FSC) profiles are shown as 
dot plots and the percentages of TCRβ+ cells are shown.
Figure 2.4 TCRβ rearrangements in Lck-Cre 
Ctcff/f mice 
Quantification of forward scatter values of the 
indicated thymocyte subpopulations in wild 
type (gray bars) and Lck-Cre Ctcff/f mice (red 
bars). Data are average values ± SEM from 5-8 
mice per group.
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mice with transgenic mice expressing either the pre-rearranged OTII TCRαβ that is specific for 
albumin (Barnden et al., 1998), or the HY TCR, which is positively selected in HY Tg female mice 
(Kisielow et al., 1988). These molecules normally drive thymocytes into the CD4 or CD8 lineage, 
respectively. However, the impaired developmental progression of CTCF-deficient cells was not 
rescued (Figure 2.5). Rather, the presence of the OTII and HY TCR transgenes resulted in an even 
more severe arrest of T cell development in the thymus (Figure 2.5A and B, respectively), as 
in both cases we observed an almost complete absence of mature T cells in the spleen. These 
findings indicate that the developmental block in Ctcf knockout T cells is independent of TCRα 
rearrangement. Consistent with this, in vivo induction of DP cells by stimulation with anti-CD3ε 
antibodies, which mimics pre-TCR signaling (Azzam et al., 1998), was reduced in CTCF-deficient 
Rag2-/- DN cells, compared to CTCF-expressing Rag2-/- DN cells (Supplementary Figure S2.2).
Cell cycle arrest during TCRαβ lineage development in Lck-Cre Ctcff/f mice
Interestingly, the CTCF-deficient ISP population from lck-Cre Ctcff/f mice contain less cycling cells 
(29% ± 1 in S/G2/M phase), compared to wild type (53% ± 8; see Figure 2.6A for an example 
analysis from individual mice), indicating that CTCF is important for cell cycle progression in 
β-selected cells. To examine the underlying cause we analyzed mRNA expression patterns of 
important T cell factors using real-time PCR. We sorted wild type and CTCF-deficient T cells into 
DN, ISP, and DP fractions. In wild type cells Ctcf mRNA levels increased from the DN to ISP stage 
and then decreased again in DP cells (Figure 2.6B). Ctcf expression was severely reduced in the 
DN fraction from lck-Cre Ctcff/f mice (Figure 2.6B). It should be noted that residual Ctcf mRNA is 
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Figure 2.5 The arrest of CTCF-deficient thymocytes is 
independent of TCRα rearrangement 
A. The OTII TCRαβ recognizes the OVA
323-339
 peptide in 
the context of C57BL/6 MHC class II. OTII TCR transgenic 
thymocytes are positively selected towards the CD4 lineage 
{Barnden, 1998 #253}. B. The MHC class I-restricted HY 
TCRαβ recognizes a male-specific HY antigen peptide and 
in the C57BL/6 H-2b class I female background {Kisielow, 
1988 #221}; HY-specific thymocytes are positively selected 
towards the CD8 lineage. Providing Lck-Cre Ctcff/f mice with 
a pre-rearranged TCRαβ transgene does not correct the 
developmental arrest of DP cells. Flow cytometric profiles 
of CD4/CD8 and CD3/TCRγδ in the indicated tissues are 
shown as dot plots; percentages of cells within quadrants 
or regions and total thymic cell numbers are given. The 
expression profiles of total TCRβ (A) or HY idiotype-specific 
T3.7 TCR (B) within the indicated cell populations are shown 
on the right as histogram overlays of TCR Tg Lck-Cre Ctcff/f 
mice (bold lines) on top of profiles of TCR Tg wild-type 
littermates (gray filled histograms). 
CTCF regulates cell cycle progression during β-selection in the thymus 57
still present in the DN pool because the Ctcf gene is deleted from DN2 onward (see Figure 2.1D). 
Thus, a small portion of DN cells still contains the Ctcf gene, and, consequently, Ctcf mRNA.
We next examined other T cell factors in the sorted cells. CTCF was reported to be a 
negative transcriptional regulator of c-Myc (Lobanenkov et al., 1990; Qi et al., 2003), and c-Myc 
is important for T cell development. In T cells we found that c-Myc was expressed in a different 
pattern than Ctcf in wild type cells and was not at all affected in CTCF-deficient cells (Figure 2.6B), 
showing that in T cells CTCF does not regulate expression of the c-Myc gene. GATA3 is critically 
involved in β-selection and development of CD4 SP cells (Pai et al., 2003), while SATB1 organizes 
cell type-specific nuclear architecture (Cai et al., 2006). Expression levels of these transcription 
factors mirrored the level of CTCF in wild type cells and were only somewhat reduced in CTCF-
deficient cells (Figure 2.6B). These data suggest that neither GATA3 nor SATB1 is regulated by 
CTCF. PreTα expression was not affected in ISP cells and was up- rather than down-regulated in 
DP cells in the absence of CTCF (Figure 2.6B), indicating that this factor is not directly regulated 
by CTCF, but that its expression level is eventually strongly influenced by a Ctcf deletion. The 
expression of GIMAP4, which is induced by pre-TCR signaling and accelerates T-cell death (Schnell 
et al., 2006), was also increased in CTCF-deficient T cells (Figure 2.6B).
As ISP cells from lck-Cre Ctcff/f mice are blocked in the cell cycle, we next tested expression 
of two major cell cycle inhibitors, p21 and p27. In wild type cells, the expression of both factors 
mirrored that of the Ctcf gene, indicating that in ISP cells CTCF might act as a repressor of the 
p21 and p27 genes (Figure 2.6B). Strikingly, Ctcf knockout cells showed significantly increased 
p21 and p27 expression, consistent with a cell cycle arrest and defective proliferation of CTCF-
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Figure 2.6 Impaired proliferation and differentiation of β-selected cells in Lck-Cre Ctcff/f mice
A. Cell cycle status of DN, ISP and DP cells, using 7-AAD. B. Quantitative RT-PCR analysis in sorted DN, ISP and DP cell 
fractions from wild type (WT) and Lck-Cre Ctcff/f mice. The DP fraction also contained CD4 SP cells. C. Quantitative RT-
PCR analysis in wild type and Ctcff/f MEFs, after treatment with Cre recombinase. Expression in Cre-treated Ctcff/f MEFs is 
shown relative to wild type. Although residual Ctcf mRNA is present in the MEFs p21 expression is increased. D. Chromatin 
immunoprecipitation (ChIP) analysis in wild type and Ctcff/f MEFs, after treatment with Cre recombinase. ChIP analysis 
was performed with anti-CTCF antibodies on four regions in the p21 gene. Potential CTCF binding sites in the mouse p21 
gene were chosen based on a genome-wide analysis in human cells {Barski, 2007 #207}. An identical binding pattern was 
observed in wild type MEFs, with relatively weak CTCF binding 2.3 kb upstream of the p21 promoter (up) and on the 
promoter (pr), and very strong binding on two adjacent regions within intron 1 (i-1a, i-1b).
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deficient β-selected cells at the ISP stage. The expression of p21 appeared to be particularly 
tightly regulated by CTCF levels, i.e. in wild type cells p21 expression exactly mirrored that of 
CTCF and in cells from lck-Cre Ctcf/f mice the drop in p21 was mild (~2-fold) in DN cells (where 
residual CTCF is still present), whereas in ISP cells p21 expression was increased more than 50-
fold (Figure 2.6B). Our data suggest that cell cycle progression in β-selected CTCF-deficient T cells 
is blocked due to the upregulation of the p21 and p27 genes.
To test whether p21 and p27 upregulation is a general consequence of a reduction of CTCF 
levels, we treated mouse embryonic fibroblasts (MEFs) from Ctcff/f mice (Van de Nobelen et al, 
manuscript in preparation) with Cre recombinase (Splinter et al., 2006). Expression of p21, but 
not p27, was increased in the absence of CTCF (Figure 2.6C), consistent with a proliferation defect 
in CTCF-deleted MEFs (Van de Nobelen et al, manuscript in preparation). These data indicate 
that the p21 gene is a target of CTCF in different cell types. A genome-wide CTCF-binding site 
analysis (Barski et al., 2007) suggested that the human p21 gene contains four CTCF binding 
sites in the vicinity of its promoter, including two adjacent and very strong binding sites in intron 
1. Chromatin immunoprecipiations (ChIP) in MEFs on the corresponding regions of the mouse 
p21 gene revealed a virtually identical binding pattern of CTCF (Figure 2.6D). Our experiments 
were performed with different anti-CTCF antibodies than those used in human cells (Barski et 
al., 2007) verifying the CTCF binding pattern near the promoter of the p21 gene. Thus, CTCF 
binding appears conserved across cell types and between species; we therefore propose that 
CTCF regulates p21.
CTCF is required in actively dividing cells
CTCF-deficient ISP cells were small and, with some notable exceptions, many of the genes that 
we tested in the RT-PCR were downregulated. These results indicate that besides a cell cycle 
block other defects contribute to the ISP phenotype of lck-Cre Ctcff/f mice. We performed several 
experiments to examine this in more detail. First, CTCF has been proposed to be required for the 
maintenance of methylation at the Igf2/H19 locus (Schoenherr et al., 2003). Aberrant methylation 
of this locus, or of other loci, might cause defects in T cells. As CTCF deletion is highly efficient in 
T cells from lck-Cre Ctcff/f mice and DNMT1, a maintenance methyltransferase with an important 
role in T cell development (Lee et al., 2001), is not significantly affected by deletion of CTCF in 
thymocytes (Figure 2.1C), we used these cells to examine DNA methylation in the Igf2/H19 locus 
in the absence of CTCF. We found similar methylation of a CTCF-binding site in the Igf2/H19 
imprinted locus in wild type and CTCF-deleted thymocytes (Supplementary Figure S2.3A). We 
also examined the methylation status of the ribosomal DNA (rDNA) repeats in Ctcf knockout cells, 
as these repeats have been shown to be heavily methylated (Bird et al., 1981), and CTCF binds 
to a region of the rDNA repeat upstream of the transcription start site (Van de Nobelen et al, 
manuscript in preparation). We could not detect differences in rDNA methylation in the thymus 
(where CTCF is virtually absent) and spleen (where CTCF is not deleted) from lck-Cre Ctcff/f mice 
(Supplementary Figure S2.3B). We conclude that a deletion of CTCF does not lead to aberrant 
methylation and that this cannot underlie the defects observed in Ctcf-negative ISP cells.
It is known that the paralogue of CTCF, named CTCF-L or BORIS, can bind the same DNA 
sequences as CTCF (Loukinov et al., 2002), and it has been suggested that CTCF-L can compete 
with CTCF and might antagonize its function (Vatolin et al., 2005). However, we did not detect 
Ctcf-l mRNA in T cells in the presence or absence of CTCF (Supplementary Figure S2.3C). Thus, 
the defects observed in T cells are not due to CTCF-L acting in a dominant-negative fashion in 
cells lacking CTCF.
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Nucleophosmin is a multifunctional nuclear-cytoplasmic shuttling protein with an important 
role in cell division and, when mutated, in cancer (Grisendi et al., 2006). It has been proposed that 
insulator sequences are tethered to the peri-nucleolar rim by nucleophosmin, which interacts with 
CTCF and which binds insulators in a CTCF-dependent manner (Yusufzai et al., 2004). Importantly, 
the expression of nucleophosmin increases dramatically upon stimulation of T cells (Feuerstein 
et al., 1988). We examined nucleophosmin distribution in cultured T cells. These were derived 
from Ctcff/f mice that were crossed with a CD4-Cre transgenic line (Lee et al., 2001; Wolfer et al., 
2002), as much higher numbers of naive CTCF-deficient T cells could be obtained from these mice 
(Ribeiro de Almeida et al, manuscript in preparation). Consistent with other studies (Feuerstein 
et al., 1988) stimulation of wild type CD4+ T cells with anti-CD3 and anti-CD28 caused a strong 
increase in the level of nucleophosmin after 1 day of culture, which resulted in the abundant 
accumulation of nucleophosmin at the perinucleolar rim (Figure 2.7A). These data indicate that 
nucleophosmin-mediated subnuclear tethering of insulators might be prominent in activated T 
cells. Strikingly, both the level as well as the distribution of nucleophosmin was severely affected 
in Ctcf knockout cells (Figure 2.7A), suggesting that CTCF controls nucleophosmin behaviour in 
activated T cells.
We could recently show that CTCF binds the ribosomal DNA (rDNA) repeat and regulates 
its epigenetic state (Van de Nobelen et al, manuscript in preparation). We therefore visualized 
the organization of rDNA repeats in CTCF-deficient T cells by fluorescent in situ hybridization 
(FISH) with an rDNA probe (Akhmanova et al., 2000). An example of such an experiment is 
shown in Supplementary Figure S2.4. Based on the FISH signals we counted the number of rDNA 
dots in CD4+ and CD8+ T cells, derived from Ctcf knockout (KO) and wild-type (WT) mice (Table 
2.2). We found a very small shift towards a lower number of dots in Ctcf knockout cells. These 
Figure 2.7 CTCF deletion affects nuclear organization in 
activated T cells
A, B. Immunofluorescent analysis of activated T cells. Cells 
were stimulated for 1 day and subsequently fixed and 
analyzed with antibodies against the indicated proteins. 
WT: T cells derived from wild type mice, KO: T cells derived 
from CD4-Cre Ctcff/f mice. In panel (A) the arrows point to 
the intensely bright staining of nucleophosmin covering the 
perinucleolar rim. In panel (B) the arrows point to fibrillarin-
positive nucleoli.
C. Quantification of fibrillarin-positive nucleolar signal. 
Cells were treated as above. Images were collected and a 
threshold was applied with Image J. The fibrillarin-positive 
surface area above the threshold was calculated and plotted 
(SEM is indicated). An unpaired t-test showed a significant 
(P<0.05) difference between WT and KO cells in fibrillarin-
positive areas.
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data indicate that in naive resting T cells nucleolar organization is not dramatically perturbed. 
However, the disorganized state of nucleophosmin (which normally abuts the nucleolus) in 
activated Ctcf knockout T cells suggested that CTCF might play a role in rRNA output upon T cell 
activation. Fibrillarin is an essential nucleolar enzyme involved in pre-rRNA processing (Newton 
et al., 2003) and an excellent tool to mark nucleolar activity. We therefore measured the intensity 
of fibrillarin staining in T cells from Ctcf knockout (KO) and wild-type (WT) mice after one day of 
in vitro activation. Whereas in wild type cells we detected increased fibrillarin staining, KO cells 
were unable to upregulate this marker of nucleolar activity (Figure 2.7C), suggesting that rRNA 
synthesis is hampered in activated T cells lacking CTCF. Thus, lack of CTCF causes a defective 
nuclear and nucleolar organization in fast growing T cells.
CTCF levels correlate with cell size
The mRNA expression data (Figure 2.4B) indicate that Ctcf is specifically upregulated in ISP cells. 
This result is consistent with lacZ staining data that indicate increased expression from the Ctcf 
gene promoter in ISP cells (not shown). However, both the RT-PCR and LacZ staining results 
reflect mRNA rather than protein levels of CTCF. To analyze the dynamic behaviour of CTCF in 
vivo we used a Ctcfgfp knock-in allele in which GFP-CTCF is expressed instead of CTCF (Heath et al, 
manuscript in preparation). We isolated T cells from mice carrying the GFP-Ctcf knock-in allele 
and used flow cytometry with markers for CD3, CD4 and CD8, as well as CD44, CD25, and TCRγδ, 
to subdivide cells from thymus and spleen and to identify GFP-CTCF levels in the different T cell 
compartments (Supplementary Figure S2.5). Interestingly, during αβT cell differentiation CTCF 
levels increased 2-3 times from the DN to the ISP stage (Supplementary Figure S2.5A). CTCF levels 
decreased again in DP cells (Supplementary Figure 2.5A). These data are in line with the mRNA 
expression pattern of Ctcf. In TCRαβ CD4+ and CD8+ T cells in the spleen, CTCF levels were identical 
to the levels in SP cells in the thymus. CTCF was somewhat up in γδT cells (Supplementary Figure 
S2.5B). Plotting GFP intensity versus T cell size (forward scatter) revealed a strict correlation 
between the amount of CTCF and cell size (data not shown). Collectively, these data indicate that 
CTCF levels specifically increase in large T cells with a high proliferative capacity. It is noteworthy 
that the major block in T cell differentiation in lck-Cre Ctcff/f mice is observed in those cells that 
normally express high levels of CTCF.
CD4+ number of rDNA dots (%)
0 1 2 3 4 5 6 7 Total
WT 0 2 17 20 32 22 5 1 100 (n=358)
KO 0 3 16 29 26 18 6 1 100 (n=368)
CD8+ number of rDNA dots (%)
0 1 2 3 4 5 6 7 Total
WT 1 5 9 27 26 21 7 3 100 (n=351)
KO 0 6 12 27 28 18 8 1 100 (n=354)
Table 2.2 Number of nucleoli in wild-type and CTCF-negative T cells
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Discussion
Here we report on the in vivo function of CTCF, a protein involved in chromatin organization and 
epigenetic regulation of gene expression. Consistent with previous studies (Fedoriw et al., 2004), 
we find that a knockout of Ctcf in early embryonic development is lethal. We also show that CTCF 
is essential for β-selected T cells. Somewhat surprisingly CTCF is neither required for γδ T cell 
development in mice, nor for proliferation of these cells in vitro. However, this result is similar to 
what has been reported for DNMT1 (Lee et al., 2001) and for the RNaseIII enzyme Dicer (Cobb et 
al., 2006). Apparently cell division, the regulation of chromatin structure, and gene expression in 
γδ T cells are quite different from αβ T cells, as they do not depend on proteins like CTCF, DNMT1 
or Dicer, proteins that are absolutely essential in many other cell types.
It should be noted that we did not observe a more severe phenotype in CTCF-deficient 
female thymocytes compared to male cells suggesting that absence of CTCF does not cause 
deregulated expression of genes on the inactive X-chromosome. Also, the deletion of CTCF did not 
have an effect on the maintenance of methylation in the imprint control region of the Igf2/H19 
locus. Unlike other studies (Filippova et al., 2005; Schoenherr et al., 2003), our results therefore 
indicate that CTCF is not required to maintain X-inactivation and DNA methylation status of the 
Igf2/H19 locus. Furthermore, within the T-cell lineage, we found that CTCF is not essential for V(D)
J recombination at the TCRα or TCRβ loci.  The developmental block of CTCF-deficient ISP into DP 
cells was not rescued when we crossed Lck-Cre Ctcff/f mice with transgenic mice expressing a pre-
rearranged αβ TCR. Therefore, the arrest of CTCF-deficient DP cells cannot result from impaired 
TCRα gene rearrangement. Because also the TCRγ and δ loci could undergo functional V(D)J 
recombination in the absence of CTCF, we conclude that the multiple CTCF-binding sites reported 
to be present in TCR loci (Barski et al., 2007; Garrett et al., 2005; Magdinier et al., 2004) are not 
essential for the process of V(D)J recombination.
Our findings show that CTCF is absolutely required for the efficient proliferation of 
β-selected cells, in particular for their maturation from ISP to DP cells, and for TCR up-regulation 
at the cell surface of DP cells. In line with the proliferative block, we detected a strongly increased 
expression of two major cell cycle inhibitors, p21 and p27. As T cells were directly isolated from 
mice, these data provide the first in vivo evidence for an important role of CTCF in cell cycle 
progression. Several lines of evidence suggest that the p21 gene is a target of CTCF. First, ChIP 
analysis shows that CTCF binds the p21 promoter region very efficiently. Thus, CTCF binding is 
conserved between man and mouse. Second, in wild type T cells that differentiate from the DN 
stage towards ISP and, later on, to DP cells, p21 expression is inversely correlated with CTCF levels. 
These data indicate that CTCF functions to repress p21 expression. As a major CTCF binding site 
is located within the p21 gene, the repressive mechanism may simply be the blocking of RNA 
polymerase II elongation. Interestingly, CTCF was found to interact with the largest subunit of 
RNA Polymerase II (Chernukhin et al., 2007). Third, in knockout T cells the p21 gene is massively 
induced, consistent with a repressive role of CTCF. Fourth, the level of p21 induction appears to 
correlate with the reduction in the dose of CTCF. Thus, in DN cells, where some residual CTCF is 
still present, the induction of p21 is less dramatic (~2-fold increase in knockout cells compared 
to wild type cells), than at the ISP stage (>50-fold induction). Fibroblasts lacking CTCF also 
upregulate p21, although the increase in knockout versus wild type cells is much less than in T 
cells. The latter results show that CTCF is not acting alone in its control of p21 expression. Others 
have recently shown that p21 is regulated by the differential localization of histone H2A.Z (Gevry 
et al., 2007). H2A.Z-binding sites were found to be enriched near CTCF-sites (Barski et al., 2007). 
Thus, it is tempting to speculate that CTCF and H2A.Z co-regulate p21.
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Our results on p21 regulation in T cells are completely opposite to those obtained in WEHI 
231 B lymphoma cells, where conditional expression of CTCF resulted in the up- rather than the 
downregulation of p21 and p27, while reduction of CTCF levels decreased (rather than increased) 
the expression of p21 and p27 (Qi et al., 2003). This could be due to the fact that the properties 
of the ISP thymocytes and WEHI 231 B cells are entirely different: whereas ISP thymocytes are 
highly proliferating as a result of pre-TCR stimulation, crosslinking of the B cell receptor on WEHI 
231 immature B cells results in cell-cycle arrest and apoptosis (thereby providing a model for self-
tolerance by clonal deletion). Thus, it may be possible that CTCF function is context-dependent. 
However, we note that our data were obtained in vivo, whereas the data in the WEHI 231 B 
lymphoma cells were obtained with stable transfectant clones selected for high expression of 
CTCF sense or antisense mRNA (Qi et al., 2003). Using our conditional Ctcff/f mice in combination 
with existing B cell-specific Cre transgenes, we will be able to examine the interesting question 
whether CTCF has a different function in the cell cycle in B and T cells.
Despite the effects of a CTCF deficiency on mice and T cells, we found no evidence for an 
increased tumor incidence in heterozygous knockout animals, or for T lymphoid malignancies 
in CTCF-deficient T-cell lineages. These results argue against a role for CTCF as a crucial tumor 
suppressor (Klenova et al., 2002). Increased expression of p21 and p27 in CTCF-negative cells would 
explain why loss of CTCF does not induce tumours. However, we also show that CTCF controls 
nucleophosmin levels and behaviour. The nucleophosmin gene (NPM1) has been implicated in 
cancer pathogenesis, both as a putative proto-oncogene and tumor suppressor gene (Grisendi 
et al., 2006). NPM1 is frequently mutated in acute myeloid leukemia (AML), whereas deletion of 
the NPM1 gene is associated with myelodysplastic syndrome (MDS). Recently it was found that 
reduction in nucleophosmin in mice results in malignancies at higher frequency compared to 
wild type mice (Sportoletti et al., 2008). Thus, the potential role of CTCF in cancer merits a more 
detailed investigation.
Heterozygous Ctcf knockout mice are viable and fertile but are born in less than expected 
numbers. Thymocyte development is also affected when CTCF dosage is reduced by half. On the 
other hand γδ T cell express CTCF but do not require the protein for viability. Combined these 
results suggest that CTCF is required in a cell type- and dosage-dependent manner. Consistent 
with this idea we found, using two independent methods (RT-PCR and GFP-CTCF expression) that 
CTCF levels vary in vivo during T cell differentiation and that this is inversely correlated with p21 
expression. It was recently proposed that CTCF remains bound to most of its ~14,000 cognate 
binding sites irrespective of cell type (Kim et al., 2007). CTCF binding sites largely overlap with 
those of cohesin and deletion of CTCF affects cohesin binding (Parelho et al., 2008; Wendt et al., 
2008). CTCF may work together with cohesin in setting up insulators (Parelho et al., 2008; Wendt 
et al., 2008). We show here that CTCF regulates nuclear organization by acting on nucleophosmin, 
which was proposed to tether insulators together with CTCF (Yusufzai et al., 2004). We also 
found that CTCF controls rRNA output in activated T cells. Accordingly, CTCF-negative ISP cells 
are smaller than their wild type counterparts. We therefore propose that CTCF function is more 
critical for actively proliferating and growing cell types than for non-dividing or resting cells. 
Indeed, we have found that deletion of CTCF does not affect nuclear organization in confluent 
fibroblasts (Van de Nobelen et al, manuscript in preparation) and in resting T cells (Ribeiro de 
Almeida et al, manuscript in preparation). It will be interesting to determine how CTCF performs 
its cell type-specific roles while remaining bound to cognate sites and how variations in the level 
of CTCF influence its dynamic behavior and function.
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Materials and methods
Modified Ctcf alleles, mouse models and embryonic fibroblasts.
Human CTCF cDNA was used to screen a 129S6/SvevTac mouse PAC library (RPCI-21) (Osoegawa et al., 
2000). PAC clones were used to isolate 6.7kb (for 5’ end targeting) and 8kb (for 3’end targeting) EcoRI 
subclones. For 5’end targeting the 6.7kb EcoRI fragment was used to amplify 1360 bp of 5’ end homology 
and 5340 bp of 3’ end homology. The homologous arms were cloned into a vector containing the neomycin 
resistance gene flanked by loxP-sites (Hoogenraad et al., 2002). A viral thymidine kinase gene was inserted 
afterwards. For 3’ end targeting we generated a SpeI-EcoRI subclone from the PAC DNA and used its unique 
BamHI site to insert a cassette containing the puromycin resistance gene flanked by loxP sites, followed 
by splice acceptor sequences and the bacterial β-galactosidase (lacZ) reporter (Hoogenraad et al., 2002). 
Relevant parts of the different constructs were verified by DNA sequencing.
Constructs were targeted into E14 embryonic stem (ES) cells as described (Hoogenraad et al., 
2002). DNA from resistant ES cells was analyzed with external radiolabeled probes by Southern blotting. 
Confirmation of homologous recombination was performed using different 5’ end and 3’ end probes (Figure 
2.1A, B) and a PCR-based assay for genotyping. Ctcff/f mice were maintained on a C57BL/6 background. 
Mouse embryonic fibroblasts (MEFs) were isolated from Ctcff/f mice using published procedures (Akhmanova 
et al., 2005). A more detailed characterization of the MEFs will be described elsewhere (Van de Nobelen et 
al, manuscript in preparation). Fibroblasts were treated with lentiviral Cre constructs as described (Splinter 
et al., 2006).
Ctcff/f mice were bred to mice expressing chicken β-actin-Cre generating Ctcf+/- animals. T cell specific 
deletion of Ctcf was achieved by breeding to Lck-Cre (Lee et al., 2001), which were kindly provided by Dr. C. 
Wilson (University of Washington, Seattle, USA). Cre-specific primers were used for genotyping. HY/Rag2-/- 
(C57BL/10) mice were purchased from Taconic Europe A/S (Denmark). OT-II mice have been described 
(Barnden et al., 1998). Mice were bred and maintained in the Erasmus MC animal care facility under specific 
pathogen-free conditions and analyzed at 6-10 weeks of age. Experimental procedures were reviewed and 
approved by the Erasmus University committee of animal experiments.
DNA, RNA and protein analysis.
Genomic DNA was isolated, digested, and blotted onto Hybond N+ membranes (Amersham), and hybridized 
with radio-labeled probes. Ctcf probes are shown in Figure 2.1. Total RNA was prepared using RNA-Bee RNA 
isolation solvent (Tel-Test Inc.). RNA (0.5-1.0μg) was reverse transcribed (RT) with random and oligo-dT 
primers, in the presence of Superscript reverse transcriptase (Invitrogen). Real-time RT-PCR was performed 
as described (Splinter et al., 2006) with 100ng of each primer and 0.5 units of Platinum taq DNA polymerase 
(Invitrogen). Sybr-green (Sigma) was added to the reactions and PCR was performed on a DNA Engine 
Opticon PCR system (MJ Research Inc.) and Bio-Rad MyiQ iCycler single-color real-time PCR detection system. 
To confirm the specificity of the amplification products, samples were separated by standard agarose gel 
electrophoresis. Threshold levels were set and further analysis was performed using the SDS v1.9 software 
(Applied Biosystems). The obtained Ct values were normalized to the Ct value of Gapdh or β-actin. Each PCR 
was performed at least in triplicate. Primer sequences and PCR conditions used are available on request.
Nuclear extracts were prepared and analyzed by chromatin immunoprecipitation (Splinter et al., 
2006), or western blot (Hoogenraad et al., 2002). Primary antibody incubation was done overnight at 4ºC 
in Tris-buffered saline (TBS), containing 5% (w/v) BSA and 0.15% (v/v) NP-40. Blots were incubated with 
secondary goat anti-rabbit or -mouse antibodies, coupled to horseradish peroxidase (GE Healthcare UK 
Ltd: 1:50000). Signal detection was performed using ECL (Amersham). Anti-CTCF (N3) and anti-fibrillarin 
antibodies were generated as described (Hoogenraad et al., 2000) using GST-linked chicken CTCF (amino 
acids 2-267) and mouse fibrillarin fusion proteins, were used in a 1:300 dilution. DNMT1 (Abcam) and UBF 
(Santa Cruz Biotechnology) mAbs were used 1:100. Western blots were scanned and the levels of protein 
were quantified using the gel macro function in ImageJ (Rasband, W.S., NIH, http://rsb.info.nih.gov/ij/). The 
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amount of CTCF was normalized to DNMT1 in the same sample.
Flow cytometric analyses.
Preparation of single-cell suspensions, FDG-loading, mAb incubations for four-color cytometry have been 
described (Hendriks et al., 1996). All mAbs were purchased from BD Biosciences (San Diego, CA). Samples 
were acquired on a FACSCaliburTM flow cytometer and data was analyzed using CellQuestTM software (BD 
Bioscience).
For cell cycle profiles of thymic subsets, cells were first stained for surface markers, fixed with 0.25% 
paraformaldehyde and permeabilized with 0.2% Tween 20.  Next, 7-AAD was added to a final concentration 
of 15 μg/ml in PBS. Cell cycle status of T cell cultures was determined after fixing in ice-cold ethanol and 
subsequent staining in PBS, containing 0.02 mg/ml propidium iodide, 0.1% v/v Triton X-100 and 0.2 mg/ml 
RNAse. Doublet cells were excluded by measuring peak area and width. 
FACS sorting of DN, ISP and DP cells was performed with a FACSVantage VE equipped with Diva Option 
and BD FACSdiva software (BD bioscience). The purity of fractions was >98%
In vitro T cell cultures
For in vitro T cell cultures from lck-Cre Ctcff/f mice, either total T cells fractions (Figure 2.4A) were purified 
from lymph node by MACS depletion (using anti-B220, anti-NK1.1, anti-Ter119, anti-CD11b and anti-Gr-1 
antibodies) or TCRαβ enriched T cell fractions (Figure 2.4B) were purified by MACS depletion using the same 
antibody mix supplemented with anti-TCRγδ antibodies (Figure 2.4B, C). Purity of obtained fractions was 
>98%, but the TCRαβ enriched T cell fractions still contained TCRγδ low Τ cells (<2% in WT and ~30% in CTCF 
KO mice). T cells were cultured at a concentration of 1 x 106 cells/ml in Iscove’s modified Dulbecco’s medium 
(IMDM) (Bio Whittaker, Walkersville, MD) containing 10% heat-inactivated FCS, 5x10-5M β-mercaptoethanol, 
100 U/ml penicillin and 100 μg/ml streptomycin. Stimulation was with plate-bound anti-CD3 (145-2C11) 
and anti-CD28 (37.51) mAbs (coated at 10 μg/ml each at 4oC overnight for 7 days.
Fluorescent in situ hybridization (FISH) and immunofluorescence (IF)
FACS sorted naïve CD62L+ CD4+ T cells from CD4-Cre Ctcff/f mice were cultured for 1 day (Ribeiro de Almeida 
et al, manuscript in preparation) and allowed to attach to glass slides for 30 min. Cells were fixed for 10 
min with 4% PFA/PBS. For IF slides were used immediately. For DNA-FISH slides were stored in 70% EtOH 
until further use. IF procedures have been described (Hoogenraad et al., 2000). We used the anti-fibrillarin 
antibodies described above and anti-nucleophosmin antisera (Santa Cruz, sc-32256). As secondary 
antibodies we used FITC-conjugated goat antibodies against rabbit and mouse IgG (Nordic Laboratories) 
and Alexa 594-conjugated goat anti-rabbit antibody (Invitrogen) were used. Images were collected with a 
Leica DMRBE microscope equipped with a Hamamatsu ORCA ER camera, or with a Zeiss LSM510 confocal, 
as described (Akhmanova et al., 2005).
For DNA-FISH cells were pretreated by two PBS wash-steps followed by a permeabilization step of 
4 min incubation in 0,1% pepsin in 0,01M HCl at 37 ˚C. Slides were washed once in PBS on ice and fixed 
again for 5 min in 4% PFA/PBS. Slides were washed twice in PBS and dehydrated. Denaturation was done 
for 2 min at 80 ˚C in denaturing solution (70% formamide; 2xSSC; 10 mM phosphate buffer, pH 7), after 
which the slides were cooled in 70% EtOH, dehydrated and hybridised as described (Gribnau et al., 2005). 
The rDNA probe (an 11.8 kb SalI fragment of a murine rDNA cosmid which contains non transcribed rDNA 
only (Akhmanova et al., 2000) was DIG labelled by nick translation (Roche). We used a Zeiss Axioplan 2 
microscope for image acquisition and cell counting. Cells were counted without knowledge of the genotype, 
statistical significance was tested with the chi-square tool (Excel), with a p-value of 0.005.
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Figure S2.1 Selective advantage of TCRγδ cells in anti-CD3/CD28-stimulated cultures of Lck-Cre Ctcff/f mice
A. Flow cytometric analysis of TCRγδ expression in T cell cultures from wild type (WT) and Lck-Cre Ctcff/f mice. Lymph 
node fractions were stimulated by anti-CD3/CD28 and cultured for 7 days. The percentages represent the fractions of 
TCRγδ+ T cells. The proportions of γδ+ T cells in the T-cell enriched cell suspensions before culture was <2% in WT and 
~30% in Lck-Cre Ctcff/f mice (see also Figure 2C). B. Flow cytometric analysis of CD4, CD8 and TCRγδ expression in mixed 
T cell cultures from wild-type and Lck-Cre CTCFf/f mice. Lymph node cell fractions were enriched for CD4 and CD8 cells 
and depleted for TCRγδ+ T cells, stimulated by anti-CD3/CD28 and cultured for 7 days. C. Western blotting, showing 
the absence of CTCF protein in mixed T cell cultures from Lck-Cre CTCFf/f mice. Fibrillarin was used as a loading control. 
Molecular weight markers are indicated in kD. 
Figure S2.2 The arrest of CTCF-deficient thymocytes is independent of TCRα rearrangement
Flow cytometric analyses of the thymus of the indicated mice, which were either untreated or injected with 50 μg of rat 
anti-CD3 antibodies in vivo. CD4/CD8 expression profiles, 3d after injection, are shown as dot plots (upper part). DN cell 
populations were gated and analyzed for CD25 and CD44 (lower part). Data are shown as dot plots and the percentages 
of cells within the quadrants are given.
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Figure S2.3 DNA methylation and CTCFL expression in 
T cells
A. DNA methylation analysis in the Imprinting Control 
Region (ICR) of the Igf2/H19 locus. DNA was isolated 
from the thymus of Ctcff/f mice, either not crossed (-, 
lanes 3 and 5) or crossed (+, lanes 4 and 6) with Lck-
Cre transgenics. Samples were digested with SacI only 
(lane 2) or with both SacI and ClaI (other lanes). ClaI 
cuts within CTCF binding site 1 of the Igf2/H19 ICR 
{Schoenherr, 2003 #158}. Normal tail DNA (lane 1) is 
shown as control. B. Methylation status of ribosomal 
DNA (rDNA) repeats. Southern blot analysis of genomic 
DNA from thymus and spleen of the indicated mice was 
digested with EcoRI (lanes 1),  EcoRI and HpaII (lanes 
2), or (3) EcoRI and MspI (lanes 3) and hybridized with 
the unstable 5’ external transcribed spacer probe 
{Akhmanova, 2000 #227}. C. RT-PCR analysis for CTCF-L/
BORIS expression in sorted naive peripheral CD62L+ 
CD4+ and CD8+ T cell fractions from three wild-type (1-3) 
and three CD4-Cre CTCFf/f (4-6) mice. RNA was reverse 
transcribed, serially diluted, and used as a template for 
amplification. Amplification of testis cDNA samples (Te) 
and RNA samples without RT (-) were performed as 
controls. All samples were done in duplicate. Products 
were fractionated by gel electrophoresis and detected 
with ethidium bromide. M; molecular weight marker.
Figure S2.4 CTCF deletion does not affect nucleolar 
organization in resting T cells 
FISH analysis of nucleolar organization in FACS-sorted 
naive CD62L+ peripheral T cells from the indicated mice. 
Slides were hybridized with a DIG-labeled rDNA probe 
(green) containing non transcribed rDNA {Akhmanova, 
2000 #227}. Cells were counterstained with DAPI (blue).
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Figure S2.5 Flow cytometric analysis of GPF-CTCF 
protein expression
GPF-CTCF protein was analyzed, in conjunction 
with cell surface markers, in cell suspensions from 
thymus (A) and spleen (B) from mice carrying a 
green fluorescent protein (GFP)-Ctcf knock-in allele 
(CtcfGFP, H.H. et al., manuscript in preparation, for 
targeting strategy see {Akhmanova, 2005 #205}. 
The indicated cell populations were gated and 
expression data are displayed as histogram overlays 
of GFP-CTCF (green) on top of background signals 
in wild type mice (black). 
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Identification of CTCF protein partners using a proteomics approach
Summary
CTCF binds to a wide variety of sites in the genome and is implicated in the regulation of gene 
expression by functioning as an activator, repressor or chromatin boundary factor. However, little 
is known about the molecular basis of CTCF function. Using a biotinylation tagging approach we 
isolated and characterized CTCF-interacting proteins in a developmental and cell type-specific 
manner. In addition to several known CTCF-interacting factors we describe novel proteins isolated 
from embryonic stem cells, thymus and lung. The identified protein partners were validated using 
different approaches. We have classified these proteins based on their biological functions. This 
analysis reveals potential roles of CTCF in the regulation of chromatin modifications, in cellular 
organization, and in transcription by RNA polymerases I and II. We also document tissue-specific 
transcriptional processes controlled by CTCF.
Introduction 
CTCF is a ubiquitously expressed eleven zinc-finger transcription factor, which is able to bind to 
a wide variety of sites throughout the genome. Moreover the zinc-finger region is important for 
binding to different protein partners that are involved in modulating the multiple functions of 
CTCF. CTCF is a key player in the correct regulation of processes such as imprinted expression of 
Igf2 and H19 and X chromosome inactivation. A unique property of CTCF is its insulating capacity: 
it can form a boundary preventing the spread of heterochromatin, or, when placed in between 
elements, it can block an enhancer from activating a promoter. CTCF performs this unique 
function by forming chromatin loops and tethering sites to nuclear substructures (Wallace and 
Felsenfeld, 2007).
The mapping of CTCF binding sites has helped tremendously in interpreting its function 
(Kim et al., 2007). Also developmental and cell-type specific deletions of CTCF have revealed 
significant insight (Heath et al submitted). Another way to understand the multiple CTCF functions 
is by identification of interaction partners. In order to do this different approaches have already 
been used. Among them are yeast two hybrid, GST pull downs and Flag-HA two-step purification 
(Chernukhin et al., 2000; Defossez et al., 2005; Lutz et al., 2000; Yusufzai et al., 2004). Pull downs 
were performed with the full length CTCF protein as well as with the zinc-finger domain.
A number of CTCF-interacting partners have been identified to date. Of these, the SNF2-
like chromodomain helicase CHD8 was shown to be important for CTCF insulator activity at the 
H19 locus (Ishihara et al., 2006). Another interacting protein, called nucleophosmin, is involved 
in CTCF insulator function by tethering CTCF binding sites in the β-globin locus to the nucleolar 
periphery (Yusufzai et al., 2004). CTCF can also bind to YY1, a factor reported to act as an insulator 
by itself (Donohoe et al., 2007; Kim et al., 2006). Besides proteins involved in stimulating CTCF 
insulator activity, an interacting protein was identified that shows the opposite effect, i.e. in vitro 
enhancer blocking assay showed the transcription factor Kaiso to have a negative effect on CTCF 
insulator activity (Defossez et al., 2005). Finally, upon binding and modifying CTCF poly(ADP-
ribose) polymerase 1 (PARP-1) changes the insulator activities of CTCF (Klenova and Ohlsson, 
2005; Yusufzai et al., 2004).
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Whereas a number of the proteins identified to interact with CTCF appear to be important 
for its unique chromatin insulating function, other interacting proteins are involved in modulating 
different activities of CTCF. For example, YB-1 and Sin3a are involved in regulating transcriptional 
repression by CTCF (Chernukhin et al., 2000; Lutz et al., 2000). CTCF interaction with the largest 
subunit of RNA polymerase II was suggested to be important for storage of this complex, or 
for initiation of transcription in promoter regions, or in pausing of transcriptional elongation 
(Chernukhin et al., 2007). Proteins suggested to interact with CTCF, but for which an interaction 
was not confirmed, are Topoisomerase II, Lamin A/C, Importin α3/α1, the histone chaperone 
Taf1-set and the variant histone H2A.Z (Yusufzai et al., 2004). Proteins that do not interact with 
CTCF have also been reported. These include the proto-oncogene Myc and the tumor-suppressors 
Rb1, P21 and P53. Regarding the involvement of CTCF in regulating RNA polymerase II some 
factors were excluded to interact with CTCF, such as TAF4 (TAFII 130), TBP and TFIIH. Moreover 
CTCF was shown not to interact with histone H2A or H3 or the thyroid hormone receptor TRα 
(Chernukhin et al., 2007; Chernukhin et al., 2000).
CTCFL is the testis-specific paralogue of CTCF (Loukinov et al., 2002), which is also expressed 
in some human tumors and tumor cell lines (Looijenga et al., 2006; Risinger et al., 2005; Vatolin et 
al., 2005). Recently a report was published describing unique interactions of this protein. CTCFL 
was reported to bind to the transcription factor SP1 and the histone methyltransferase Prmt7, 
neither of these proteins interact with CTCF (Chernukhin et al., 2007; Jelinic et al., 2006; Kang et 
al., 2007). Therefore, to date no common interacting proteins have been reported for CTCFL and 
CTCF.
Although a number of interaction partners of CTCF have been identified, we presume that 
the list is not complete. In order to gain more insight in the different CTCF-dependent molecular 
processes we aimed to identify more of its interaction partners. We used a biotin-tagging 
proteomics approach that involves the use of a small tag that can be biotinylated in vivo and that 
is able to bind with high affinity to streptavidin. In this way protein complexes can be identified in 
a single step high-affinity procedure. Proteins are subsequently identified by mass spectrometry. 
This strategy was previously shown to be highly efficient in isolating protein complexes from 
tagged factors present in the nucleus or in the cytoplasm (Lansbergen et al., 2006; Meier et al., 
2006; Rodriguez et al., 2005). We have used this method to characterize new partners of CTCF. 
In chapter 4 of this thesis we describe UBF as a common interaction partner of CTCF and CTCFL. 
Here we describe the remainder of the proteins identified.
Results 
Characterization of biotin-tagged CTCF
To determine the influence of a biotinylation tag on CTCF and CTCFL function, we tagged CTCF 
and CTCFL mouse cDNAs at the N- or C-terminus with a biotin-tag and transiently expressed each 
protein in HeLa cells (which express endogenous CTCF but which do not appear to express CTCFL), 
which were also transfected with the BirA biotin ligase. As shown in Figure 3.1A BirA biotinylates 
a specific lysine residue of the small biotin-tag. The biotinylation of tagged CTCF as well as CTCFL 
was visualized by streptavidin-HRP (Figure 3.1B). Because of the short length (23AA) of the biotin 
tag the difference in size between tagged and untagged proteins is minor and could hardly be 
visualized using antibodies against CTCF. Placing the biotin tag at the N- or C-terminus of CTCF or 
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CTCFL does not appear to affect the binding to streptavidin (Figure 3.1B).
Subsequently we performed mass spectrometry analysis on nuclear extracts of HeLa cells, 
transiently transfected with CTCF-bio and BirA. This failed to show CTCF itself, although western 
blot analysis did show that biotinylated CTCF was pulled down specifically. We therefore generated 
stable HeLa and MEL cell lines that overexpressed low amounts of CTCF. We isolated multiple CTCF 
expressing clones (unfortunately we could not identify any stable cell line expressing CTCFL). The 
clones expressing the highest level of CTCF-bio were used for further analysis.
It has been reported that CTCF is present in HeLa cells in high molecular weight complexes 
(up to about 400 kDa) (Yusufzai et al., 2004). This result was obtained with a 10-30% glycerol 
gradient. Using a Superose 6 gel filtration column we detected CTCF in complexes of >5 MDa in 
MEL cells (Figure 3.1C) as well as in ES cells (data not shown). CTCF-bio is also present in high-
molecular weight complexes, indicating that tagged and endogenous CTCF behave in a similar 
manner in this assay.
We next tested whether biotinylated CTCF localized in a similar manner as CTCF. Using 
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Figure 3.1 Biotinylation of CTCF and CTCFL
A. CTCF and CTCFL schematic overview of the proteins with domains indicated. Amount of amino acids is indicated 
below the schematic representation of each protein. The sequence of the 23-aa bio tag is shown. The star indicates the 
lysine residue that becomes biotinylated by the BirA biotin ligase. B. Transient biotinylation of N- and C-terminally tagged 
CTCF and CTCFL in HeLa cells. Western blot incubated with an anti-CTCF or anti-CTCFL antibody to detect endogenous 
and tagged CTCF or CTCFL protein (right). Western blot of the same extracts with streptavidin-HRP conjugate to detect 
biotinylated CTCF or CTCFL (left). Note that HeLa cells do not express endogenous CTCFL. C. Size-fractionation profiles 
by Superose 6 column of CTCF. Molecular mass markers are indicated below. V0: void volume, input : nuclear extract. 
Fractionation profile is shown of a MEL cell line stably expressing biotin-tagged CTCF and BirA (upper panel). The profile of 
tagged CTCF resembles that of untagged CTCF in stable MEL cell lines expressing only BirA (lower panel). D. Localization of 
stable expressed biotinylated CTCF and endogenous CTCF in HeLa cells. Immunofluorescent staining shows the expression 
of either endogenous CTCF or biotinylated CTCF in HeLA cell lines stably expressing CTCFbio and BirA or only BirA. Note 
the presence of endogenous biotinylated proteins present in the mitochondria. E. Streptavidin pull downs on MEL cells 
stably expressing biotinylated CTCF (left panel) or BirA only (right panel). U = unbound fraction; b = fraction bound to the 
beads after washes; n = nuclear extract used as input en represents 5% of bound material. Efficiency of CTCF biotinylation 
and binding to streptavidin beads is represented by this experiment.
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streptavidin-based immunofluorescence, we could not recapitulate the typical speckled CTCF 
localization pattern in the nucleus of HeLa cells. Instead we detected a uniform distribution of 
CTCF-bio throughout the nucleus, indicating that in HeLa cells biotinylated CTCF might not mimic 
the behavior of endogenous CTCF (Figure 3.1D).
Streptavidin pull downs showed that in the clone expressing the highest level of biotinylated 
CTCF, this protein was still present in <10% of the endogenous CTCF  (Figure 3.1E). An attempt to 
pull down CTCF-bio protein partners from this MEL cell clone was not successful. We presume 
that CTCF-bio expression levels in cells must be higher with respect to endogenous protein. 
Therefore, tagging of endogenous CTCF would be a preferred approach.
CTCF-bio expression from a knock-in allele 
We generated a Ctcfbio-neo knock-in allele by targeting a construct with the biotinylation sequence 
(preceded by a TEV protease cleavage site) immediately upstream of the stop codon of CTCF, 
followed by a loxP-neor-loxP cassette, using homologous recombination in embryonic stem (ES) 
cells into the Ctcf gene (Figure 3.2A). It is important to remember that the neomycin resistance 
gene (neor) is still present in these ES cells, hence the name Ctcfbio-neo. After selection targeted 
clones with a correct insertion of the construct were identified by PCR and Southern blot. The 
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Figure 3.2 Generation of a CTCFbio knock-in mouse
A. Schematic overview of the targeting strategy used to generate a CTCFbio knock-in allele. The targeting constructs 
aims to remove the CTCF stop codon and place a biotin-tag (bio) at the complete end of the gene with in between a TEV 
protease cleavage site. The boxes represent the CTCF gene exons. Black boxes represent coding exons while white boxes 
indicate non-coding exons. Gray boxes represents the probes, probe 1 was used to select the correct targeted clones after 
XbaI digestion. Probe 2 was used to select the correct targeted clones after PstI digestion. Black arrows indicate primers 
used for genotyping. The triangles surrounding the neomycin (Neo) resistance cassette represent LoxP sites. B. Western 
blot showing expression levels of biotinylated CTCF in a stable MEL celline and in the different ES cell lines one containing 
the neomycin cassette that is placed in the antisense direction and one without the neomycin cassette. C. Western 
blot showing expression of biotinylated CTCF in nuclear extracts isolated from different adult mouse tissues. Incubation 
with streptavidin HRP and subsequent detection shows only biotinylated CTCF that is absent in the BirA only expressing 
tissues. CTCF antibody shows the presence of the protein in the samples and serves as a loading control. D. Streptavidin 
pull downs on biotinylated CTCF present in nuclear extracts isolated from lung and thymus of mice heterozygous for bira 
and CTCFbio. Biotinylated CTCF is specifically pulled down and not present in control bira lanes. b= bound fraction.
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Ctcfbio-neo/+ ES cell line with a correct karyotype was injected into blastocyst to generate Ctcfbio-neo/+ 
knock-in mice.
A second targeting event was performed in Ctcfbio-neo/+ ES cells by inserting the BirA biotin 
ligase into the Rosa26 locus again using homologous recombination. This targeting event was 
verified by PCR. We showed that in this line biotinylated CTCF (CTCF-bio) was expressed and 
was readily detected. This ES cell line was used for the identification of CTCF interacting proteins 
together with a control cell line expressing only BirA (Exp 1; Table 3.2). Since the neomycin 
resistance gene was still present in the Ctcfbio-neo/+;Rosa26bira/+ cell line and transcribed antisense 
to CTCF-bio we argued this could inhibit CTCF-bio expression. In order to remove the neomycin 
resistance cassette we transfected ES cells with Cre recombinase. This yielded Ctcfbio/+;Rosa26bira/+ 
ES cells. Comparison between this ES cell line and the parent line indicated that in the latter 
expression of CTCF-bio was slightly reduced, however the expression levels were significantly 
higher compared to the stably expressing MEL cell lines generated before (Figure 3.2B).
Heterozygous Ctcfbio-neo/+ knock-in mice were crossed with transgenic mice ubiquitously 
expressing Cre recombinase. This yielded Ctcfbio/+ knock-in mice. These were in turn crossed 
with mice expressing the BirA biotin ligase from the ubiquitously active Rosa26 locus (Driegen 
et al., 2005). The expression level of BirA was shown to be sufficient to biotinylate proteins in 
A
Genotype
Age of death
Total number
of mice born
Total number
of breedings
Breedings
without offspringCtcf Rosa 26
bio/bio bira/bira 21 2 5 5
bio/bio bira/+ 16, 16, 34 8 4 4
bio/bio +/+ 30, 36 12 43 34
B
Genotype parents (Ctcf ; Rosa 26)
Genotype offspring
bio/+ X bio/+
and no bira 
(n=29)
bio/+ X bio/+
and bira/+ or bira/bira
(n=36)
bio/+ X bio/bio
and bira/+ or bira/bira
(n=25)
Ctcf Rosa 26 % Predicted % % Predicted % % Predicted %
+/+ +/+ 24.1 25 11.1 7.6
+/+ bira/+ 5.5 12.5
+/+ bira/bira 8.3 4.8
bio/+ +/+ 48.2 50 13.8 15.2 12 20
bio/+ bira/+ 30.5 25 64 30
bio/+ bira/bira 8.3 9.7
bio/bio +/+ 27.5 25 11.1 7.6 4 20
bio/bio bira/+ 8.3 12.5 20 30
bio/bio bira/bira 2.7 4.8
Table 3.1 Inheritance and properties of Ctcfbio/+ alelle
A. Analysis of homozygous Ctcfbio/+ mice. For each genotype as indicated the following properties are shown: number of 
mice found dead in the cage with an age (days after birth) below 70 days, total number of mice born, total number of 
breedings/crossing performed with mice of this genotype, total number of breedings/crossing with mice of this genotype 
that did not give any offspring. Breeding/crossing is defined as a period of 4 weeks in where the mouse (>56 days) is put 
together in a cage with a mouse of the opposite sex. It should be noted that no other mice than indicated were found 
dead below the age of 70 days. B. Inheritance of Ctcfbio/+ alelle combined with or without inheritance of the Rosa26bira 
allele. Offspring and genotype from different Ctcf-bio and Rosa26-birA crosses. Ctcf-bio allele of parents is indicated; 
bira genotype of parents was variable. n=number of mice, % = percentage of mice born with the indicated genotype, 
predicted % = predicted percentage of mice born with the indicated genotype based on mendelian ratio’s.
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vivo (de Boer et al., 2003; Driegen et al., 2005). Double heterozygous Ctcfbio/+;Rosa26bira/+ mice 
were analyzed for the expression of biotinylated CTCF in different tissues. All tissues examined 
showed CTCF-bio except for the liver, where, consistent with a recent report (Wendt et al., 2008) 
endogenous CTCF was not clearly detected either (Figure 3.2C). Expression of biotinylated CTCF 
can also be detected in the embryo (data not shown). Streptavidin pull downs on nuclear extracts 
from several tissues showed efficient purification of CTCF-bio (Figure 3.2D). These data show that 
CTCF-bio is produced in vivo in the mouse.
CTCF-bio is a functional protein
In order to test whether biotin tagged CTCF has the same properties as untagged CTCF its 
functionality was tested in different assays. First, we analyzed offspring number and genotypes 
from different crosses (Table 3.1). Although the numbers are too low to draw any firm conclusion 
we observed that mice with CTCF-bio were born and made it until adulthood without any obvious 
phenotype. However some homozygous Ctcfbio pups died before the age of 36 days, while none 
of the mice with other genotypes were found dead at this young age (Table 3.1A). Furthermore 
homozygous Ctcfbio mice are not efficient in giving offspring (Table 3.1B). Homozygous Ctcfbio 
knock-in mice were born in normal numbers, compared to wild-type littermates. We therefore 
conclude that having CTCF-bio is compatible with viability.
This is in contrast to the N-terminally fused GFP-CTCF knock-in mice, which show early 
lethality at the homozygous level (Heath et al, unpublished observation). The phenotype 
observed in the GFP-CTCF knock-in mice is probably not due to a defective protein but rather 
to the low expression level of the fusion-protein compared to endogenous CTCF. In order to 
analyze whether this also holds true for biotin-tagged CTCF, expression levels of the protein were 
analyzed in thymus extracts from mice with different genotypes (Figure 3.3A). Expression levels 
of biotin-tagged CTCF as well as biotinylated CTCF were equal to untagged CTCF. 
In order to examine binding properties of CTCF-bio we carried out a chromatin 
immunoprecipitation (ChIP) experiment on known CTCF target sites. ChIP was carried out with 
streptavidin beads using Ctcfbio/+ ES cells. CTCF-bio binds both the β-globin 3’HS1 and the c-Myc 
insulator, indicating that biotinylated CTCF is able to bind DNA in vivo (Figure 3.3B). In order to 
compare the DNA binding efficiency we performed bandshifts using the 3’HS1 β-globin CTCF 
binding site as a probe. CTCF-bio binds this probe, albeit with an apparently reduced efficiently as 
compared to CTCF (Figure 3.3C). We asked whether biotinylation affects the nuclear distribution 
of CTCF-bio but in contrast to the HeLa cell system, we observed identical distribution of 
biotinylated CTCF and endogenous CTCF, indicating that the tagged protein behave similarly 
(Figure 3.3D). We conclude that biotinylated CTCF does reflect the nuclear distribution and DNA 
binding characteristics of endogenous CTCF.
Identification of CTCF-interacting partners - technical assessment and first evaluation
Multiple experiments were performed under varying conditions in order to identify CTCF-
interacting partners. Because biotinylated CTCF is expressed at endogenous level a clear band 
representing CTCF-bio was not detected on coomassie stained gels of the different pull down 
experiments (Figure 3.4B/C/D). However, western blot analysis confirmed the presence of 
CTCF-bio in all experiments. We performed benzonase treatment because it reduced aspecific 
background, that is, protein-protein interactions that take place via DNA and/or RNA are 
eliminated. Benzonase is very efficient in the removal of RNA and DNA at low temperatures 
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Figure 3.3 Biotinylated CTCF is a functional protein
A. Expression levels of tagged CTCF is mice with different genotypes are shown. A coomassie stained gel was used as a 
loading control and incubation of western blot with streptavidin HRP was used to detect biotinylated CTCF. n= nuclear 
extract. B. Chromatin IP (ChIP) performed on material from ES cells expressing BirA or biotinylated CTCF. ChIP is performed 
using streptavidin beads to show specific enrichment of biotinylated CTCF to its known binding sites the β-globin 3’HS1 
and cMyc insulator compared to BirA control samples. C. Bandshifts on nuclear extracts isolated from lung and thymus 
tissues of homozygous CTCFbio knock-in (bio/bio) lane 8, heterozygous CTCFbio knock-in mice (bio/+;bira/+) lanes 4,5,7 
or BirA (bira/+) control mice lanes 2,3,6,9,10. Genotypes are indicated above the gel. The probe used for the bandshift 
contains the β globin 3’HS1 CTCF binding site (wt) or a mutant form of this site that abrogates CTCF binding (mut). Lane 9 
shows a supershift using CTCF antibody and lane 10 shows that pre-immune serum is not able to show a CTCF dependent 
shift. D. Immunofluorescent staining on ES cells expressing BirA or biotinylated CTCF. CTCF antibodies were used to show 
CTCF localization in these cellines and avidin was used to detect biotinylated CTCF is these cells.
(Figure 3.4A). The variable conditions further included different stringencies of washing and the 
use of different cell types. CTCF was identified by the mass spectrometer in all experiments, 
except for the experiment that contained high stringency washes (exp. 3). In total seven different 
experiments were carried out, five of which were done with nuclear extracts from ES cells, and two 
with extracts from thymus and lung. In each case proteins were identified by mass spectrometry 
after pull down (Table 3.2).
The complete list of identified proteins, obtained from the different experiments, including 
mascot scores and amounts of identified peptides, is shown in Appendix 1. Some proteins were 
specifically pulled down by CTCF-bio in one experiment but were present in the BirA control 
of another experiment (indicated in Appendix 1). We have included these proteins in the list, 
because the mass spectrometry is not quantitative and it could be that these proteins are 
enriched in the pull down of biotinylated CTCF. This is, for example, illustrated by the known 
CTCF interacting proteins PARP1, YB1 and nucleophosmin, that are identified in CTCF-bio pull 
downs but that are also found in some BirA control samples. Although the number of identified 
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Figure 3.4 Identification of CTCF protein partners
A. Agarose gel showing DNA and RNA material present in nuclear extracts after 2h at 4°C incubation with benzonase (+) 
or without benzonase (-). B. Proteins eluted after direct binding to streptavidin beads of ~5 mg of nuclear extracts from 
biotinylated CTCF expressing ES cells. Coomassie stained gel used for mass spec. analysis showing nuclear proteins pulled 
down by biotinylated CTCF expressed in ES cells using different stringencies of washing (exp. 1, 2 and 3). C. Coomassie 
stained gel used for mass spec. analysis showing proteins pulled down by biotinylated CTCF after benzonase treatment 
Experiment
number
Source
Benzonase
treatment
Wash 
conditions
Proteolytic
digestion
Mass 
spectrometer
1
ES cells
CTCFbio/+ ; Rosa26bira/+
-
100 mM salt /
0,3% NP40
In-gel Q-Tof
2
ES cells
CTCFbio/+ ; Rosa26bira/+; Cre
-
100 mM salt /
0,3% NP40
In-gel Q-Tof
3
ES cells
CTCFbio/+ ; Rosa26bira/+; Cre
-
250 mM salt /
0,3% NP40
In-gel Q-Tof
4
ES cells
CTCFbio/+ ; Rosa26bira/+; Cre
+
100 mM salt /
0,3% NP40
In-gel LTQ
5
ES cells
CTCFbio/+ ; Rosa26bira/+; Cre
+
150 mM salt /
0,3% NP40
In solution Orbitrap
6
Lung
CTCFbio/+ ; Rosa26bira/+; Cre
-
100 mM salt /
0,3% NP40
In-gel LTQ
7
Thymus
CTCFbio/+ ; Rosa26bira/+; Cre
-
100 mM salt /
0,3% NP40
In-gel Orbitrap
Table 3.2 Schematic overview of the different experiments performed to identify CTCF interacting proteins 
In order to identify interacting proteins streptavidin pull down was performed on nuclear extracts from cells expressing 
biotinylated CTCF or birA only expressing negative control cells. Stringency conditions used for streptavidin pull downs 
were similar in all experiments (100 mM NaCl/0,3% NP40). Source of nuclear extracts used for pull downs, removal of 
DNA/RNA by benzonase treatment (+/-), stringency of wash conditions, the way trypsin digestion was performed and the 
mass spectrometer used to identify interacting peptides are indicated for each experiment.
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peptides between sample and control gives some measure of amount, it cannot be taken as a 
truly quantative measurement. 
Previously, splicing factors, ribosome biogenesis components (including snoRNAs and 
hnRNPs), cytoskeleton components (actin, lamin), metabolic enzymes, histones, Fibrillarin, YB1, 
Cdc5l, mRNA processing factors, and nuclear architecture proteins were identified from BirA 
control pull downs in MEL and therefore reported as background binding proteins (de Boer et 
al., 2003). Cytoplasmic factors pulled down by our analysis, like Caprin, G3bp, Dynein and Eif2 
involved in transport, translation and degradation of mRNA are also likely to be background since 
CTCF is expressed only in the nucleus. 
After exclusion of proteins that are likely to be background we sorted CTCF-interacting 
partners based on known biological function (Figure 3.4 and 3.5). Comparison of known 
interacting proteins (Figure 3.4E) with interacting proteins identified from CTCFbio pull downs 
(Figure 3.4F) revealed a novel pathways that CTCF might be involved in. We found, for example, 
CTCF-interacting partners functioning in replication, DNA repair, cell cycle regulation and RNA 
polymerase I transcription. The majority of CTCF-interacting proteins were identified from ES cells 
as the majority of experiments were performed in these cells. There are few common binding 
partners identified from ES cells, lung and thymus (Figure 3.4G). Interestingly, no transcription 
factors were identified in ES cells. The majority of the identified factors (68%) are identified 
in only one of the seven experiments (Figure 3.5B). This could be due to variability between 
experiments, to differences in the conditions used, cell type and/or cycle stage. Furthermore, 
different mass spectrometers were used, of which the sensitivity differs considerably. The number 
of CTCF peptides identified by the mass spectrometer was low compared to experiments using 
overexpressed proteins (Lansbergen et al., 2006; Rodriguez et al., 2005).
The coomassie stained gels of pulled down material show some prominent bands that are 
hardly present in the BirA control lanes (Figure 3.4B/C). These proteins either represent single 
factors that are present in large amounts or multiple interacting proteins with the same molecular 
weight. Some proteins migrate in gel at a different band size than expected from their predicted 
molecular weight. Antibody databases often show at what size proteins migrate, based on this 
information we predicted the identity of the prominent proteins observed on gel after CTCF pull 
downs (Appendix 1).
 In nuclear extracts from lung (exp 6) a prominent band of ~28 kD and a less prominent 
band of ~75 kD were detected. The 75 kD band could represent Paf1, a member of the RNA 
polymerase II-associated Paf complex that was pulled down specifically from lung tissue material. 
The 28 kD band could represent either TAF15 or laminin binding protein. Furthermore, high 
molecular weight proteins (>200 kD) prominently seen in ES cells (exp 2 and 3) could be RIF1 or 
for 2h at 4°C to remove DNA and RNA (exp. 4). The clear band present at 60 kD represents benzonase. D. Coomassie 
stained gel used for mass spec. analysis. Streptavidin pull downs on nuclear extracts from the thymus or lungs of mice 
expressing biotinylated CTCF (bio/+;bira/+) or bira alone (bira/+). Left panel shows the material pulled down from the 
lung (exp.6) and right panel shows lung pull down material (exp. 7). Molecular weights are indicated. E. Published CTCF 
interacting proteins classified according to their most prominent function. Total number of proteins represented in the 
graph is 8. F. Classification by function of CTCF interacting proteins identified by mass spectrometry using extracts from 
ES-, thymus- and lung cells expressing biotinylated CTCF. All factors shown have a known function and were never found in 
BirA controls or reported to be background. Proteins are classified according to their most prominent function. Published 
interacting proteins that were identified by our analysis were not included. Total number of proteins represented in 
the graph is 44. G. Classification by cell type in which CTCF interacting proteins were identified by mass spectrometry. 
Proteins included are as in f). To identify interacting proteins five different experiments were performed on ES, one on 
thymus cell extracts and one on lung cell extracts. Total number of proteins represented in the graph is 44
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Ranbp2. The prominent 57 kD band observed in ES cells (exp 1,2,3) could be the ribonucleoprotein 
Dkc1 and the 90 kD band (exp 1,2,4) might represent Tpx2, DNA topisomerase I or Ssrp1. 
Identified protein complexes that were pulled down by CTCF-bio include the thymus-
specific TCF/LEF family, the RNA polymerase II associated complex Paf1 and the RNA polymerase 
I complex (Figure 3.5A). The thyroid hormone receptor interacting protein 12 (Trip12) is the only 
potential CTCF interacting protein identified from ES cells as well as from the lung and thymus. 
The function of Trip12 remains elusive, based on its protein domains it was suggested to be 
involved in ubiquitinylation and thyroid hormone regulation (Aravind, 2001). Two other proteins 
involved in ubiquitinylation were identified, Usp10 and Ubp2l. Interestingly the TFIID and RNA 
polymerase II associated factor TAF15 was identified from pull downs of both lung and thymus 
(Hoffmann and Roeder, 1996).
Many of the known interacting proteins were reported to be associated with the nuclear 
matrix. These include nucleophosmin, PARP, YY1 and the large subunit of RNA polymerase II. 
Proteins like PCNA, HDAC, Rb binding protein, Ddx5, DNA polymerase and Xrcc5 were also reported 
to be components of the nuclear matrix (Mika and Rost, 2005). Whether CTCF associates with the 
nuclear matrix should be evaluated carefully since nuclear matrix-bound proteins appear to be 
often pulled down non-specifically.
Verification of identified CTCF protein partners 
In order to verify the mass spectrometry data we performed western blot analysis on selected 
partners (Figure 3.6A), co-immunoprecipitations and GST-based pull downs (Figure 3.7). An 
overview of CTCF interacting proteins identified by our analysis and the results of the validation 
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Figure 3.5 Classification of known and newly identified CTCF interacting proteins
A. Classification of CTCF interacting proteins by their most prominent function. All factors show were never found in BirA 
controls or reported to be background and have a known function. Dark grey: direct interaction and functional significance 
confirmed, light grey: interaction and functional significance confirmed but direct interaction is not confirmed, white: 
proteins identified from mass spec. analysis as copurifying with CTCF expect for PCNA/HP1. If boxes surrounding the 
protein names touch these factors are reported to interact with each other. B. Classification of CTCF interacting proteins 
(as described in a)) that were identified from more than one pull down experiment sorted by their most prominent 
function. 
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of interactions are shown in table 3.3. Two known interacting partners of CTCF (PARP1 and 
nucleophosmin) were confirmed by this analysis, validating our approach (note that both proteins 
were also identified in the BirA control sample, but they were enriched in CTCF-bio expressing 
cells). After benzonase treatment an interaction with PARP1 was still detected. Two other known 
CTCF-interacting proteins (YY1 and Sin3a) were not identified in our mass spectrometry analysis. 
However western blot analysis showed that minor amounts of YY1 and Sin3A were pulled down 
in ES cells by CTCF-bio. The Sin3A interacting histone deacetylases HDAC1 and HDAC2 were not 
found back in the mass spectrometry data but also showed an interaction on western blot (Figure 
3.6A).
Western blot analysis showed that CTCF-bio interacts with HP1β and PCNA while 
these proteins were not found back in the mass spectrometry lists. HP1β is a component of 
both pericentric- and telomeric heterochromatin, while HP1α is detected in centromeric 
heterochromatin (Cheutin et al., 2003). HP1α was shown not to colocalise with CTCF, but HP1β 
shows a staining pattern more similar to that of CTCF (Burke et al., 2005). We could not show 
localization of CTCF with PCNA at replication foci (data not shown), leaving the question what the 
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Figure 3.6 Verification of CTCF protein partners using streptavidin pull downs
A. Streptavidin pull downs on nuclear extracts from ES cells expressing biotinylated CTCF and from control BirA only 
expressing cellines. Biotinylated CTCF is detected by streptavidin-HRP and is absent from the BirA only transfected 
cells. Nuclear extract equivalent to 5% used in each pull-down or IP (b) was loaded as control for input material (n). 
B. Streptavidin pull-downs of some nuclear proteins that could potentially interact with CTCF. These nuclear proteins 
were not identified from the mass spec. data as interacting with CTCF. C. Confirmation of new CTCF interacting proteins 
identified by mass spec. using streptavidin pull downs on ES cells followed by western blot analysis
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Figure 3.7 Verification of CTCF protein partners using immunoprecipitation and GST pull downs
A. Confirmation by immunoprecipitations (IP) of proteins identified as co-purifying with CTCF in ES cells. Antibody used 
for immunoprecipitation is indicated above the western blot, pre-immune serum is used as a negative control. Antibody 
used for western is indicated on the left side of the westerns. Note that all IPs were done in the absence of benzonase 
exept for the RNA pol. I IP. B. GST pull downs on ES cell nuclear extracts. GST alone and GST fusion proteins containing 
an unrelated protein and the zinc-fingers of CTCF were purified as shown on the coomassie stained gel. The westerns 
show the different interactions with the purified CTCF zinc-fingers after GST pull downs on ES cell nuclear extracts. C. 
Flag-immunoprecipitations performed in 293T cells overexpressing Flag-UBF or Flag-Lef1. Westerns are incubated with 
CTCF antibody to show an interaction with endogenous CTCF or with Flag-antibody to show the IP worked. Material 
that was left on the beads after washings is indicated with a ‘b’. Input material of nuclear extracts used represents 5% of 
the material shown in the ‘b’ lane and is indicated with an ‘n’ . D. Immunostainings on Hela- and ES cells using different 
antibodies of CTCF and interacting proteins as indicated below.
function of this interaction could be. We tested several other proteins by western blot, including 
CHD4, Dnmt3b, Cohesin (SMC1/SMC3), Sox2 and H2A.Z but could not show binding to CTCF-bio 
(Figure 3.6B).
Western blot analysis confirmed the interaction of CTCF-bio with Dnmt1, RNA polymerase 
I, Snf2h, fibrillarin, RFC2, Ku80 and UBF. However an interaction with Rif1, Ranbp2 and TCOF1 
could not be confirmed, despite identification of these proteins by mass spectrometry. Upon 
benzonase treatment interaction with Dnmt1, UBF and RNA polymerase I could still be detected. 
By contrast, interaction with Snf2h and RFC2 was lost (Figure 3.6C), indicating that the latter 
interactions are indirect. Surprisingly benzonase treatment actually enhanced the interaction of 
CTCF with fibrillarin and revealed an interaction with EZH2 (Figure 3.6C).
In order to further confirm an interaction of CTCF with Dnmt1, fibrillarin, RNA polymerase 
I, Snf2h and UBF co-immunoprecipitations were performed. Furthermore, using FLAG-tagged 
UBF and Lef1 we verified interaction of these proteins with CTCF (Figure 3.7C). A more detailed 
analysis of the interaction between CTCF and UBF is described in chapter 4. Using CTCF antibodies 
fibrillarin and Dnmt1 could be pulled down, but immunoprecipitations with fibrillarin and Dnmt1 
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Function protein Identified from times remarks verification reported
celltype / tissue identified CTCF i.a. CTCF i.a.
Chromatin modifying enzymes Dnmt1 ES cells 3 +
EZH2 ES cells 1 ±
BAF57 thymus 1 SWI/SNF complex n.d.
Snf2h ES cells 1 +
MRG15 ES cells 1 n.d.
Jarid2 ES cells 2 n.d.
Wdr5 ES cells 1 n.d.
Dnmt3b n.i. 0 not found in MS -
HDAC1 n.i. 0 not found in MS + Lutz et al 2000
HDAC2 n.i. 0 not found in MS n.d. Lutz et al 2000
HP1 n.i. 0 not found in MS +
CHD4 n.i. 0 not found in MS -
Sin3a n.i. 0 not found in MS ± Lutz et al 2000
Rbbp7* ES cells 3 n.d.
BAF170* thymus 1 SWI/SNF complex n.d.
Tif1Beta* ES cells 4 ±
RNA pol I associated factors RPA194 ES cells 3 Pol I complex +
RPA116 ES cells 1 Pol I complex n.d.
RPA40 ES cells 1 Pol I complex n.d.
PAF53 ES cells 3 Pol I complex n.d.
PAF49 ES cells 2 Pol I complex n.d.
UBF* ES cells, lung, thymus 2 Pol I complex +
RNA pol II associated factors Paf1 lung 1 Paf1 complex n.d.
Leo1 lung 1 Paf1 complex n.d.
HRPT2 lung 1 Paf1 complex n.d.
Ctr9 lung 1 Paf1 complex n.d.
Cdc68 (FACT) ES cells 3 n.d.
TAF15 lung, thymus 2 n.d.
TFIIH p44 ES cells 1 n.d.
TFIIH p52 ES cells 1 n.d.
Tceb3 lung 1 n.d.
Ssrp1 (FACT)* ES cells 1 n.d.
Transcription factors Stat3 lung 1 n.d.
Lef1 thymus 1 TCF/LEF complex n.d.
TCF1 thymus 1 TCF/LEF complex n.d.
TCF3 thymus 1 TCF/LEF complex n.d.
TCF4 thymus 1 TCF/LEF complex n.d.
THAP11 lung 1 n.d.
YY1 n.i. 0 not found in MS + Donohoe et al 2007
Sox2 n.i. 0 not found in MS -
YB-1* ES cells, lung 3 n.d. Chernukhin et al 2000
Replication/repair RFC4 ES cells 2 n.d.
Orc1 ES cells 1 n.d.
DNA pks ES cells 2 n.d.
Mus81 ES cells 1 n.d.
XRCC1 ES cells 1 n.d.
PCNA n.i. 0 not found in MS +
Ku80/XRCC5* ES cells 1 +
RFC2* ES cells 3 +
RFC1* ES cells 3 n.d.
DNA pol delta* ES cells 2 n.d.
DNA ligase* ES cells 2 n.d.
Cell cycle/cell organisation Tpx2 ES cells 3 n.d.
KIF23 ES cells 2 motor proteins n.d.
KIF2C ES cells 2 motor proteins n.d.
Dynein ES cells 1 motor proteins n.d.
p38-2G4 ES cells 1 n.d.
Prc1 ES cells 1 n.d.
Rif1 ES cells 3 -
Bud13 ES cells 1 n.d.
SMC2 ES cells 1 n.d.
SMC5 ES cells 1 n.d.
SMC1 n.i. 0 not found in MS -
SMC3 n.i. 0 not found in MS -
KIF1C* ES cells 2 n.d.
Protein modifying enzymes Trip12 ES cells, lung, thymus 4 n.d.
Ubp2l ES cells 1 n.d.
Usp10 ES cells 1 n.d.
Parp1* ES cells, lung 1 + Yu et al 2004
Nuclear architecture Nucleophosmin* ES cells, lung 3 + Yusufzai et al 2004
Tmpo* ES cells 3 n.d.
Kpna2* ES cells 2 n.d.
Ranbp2* ES cells 2 -
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antibodies could not bring down CTCF (Figure 3.7A). Immunoprecipitations did not show an 
interaction with Snf2h or RNA polymerase I. Using purified GST-tagged CTCF-zinc finger protein 
we did pull down significant amounts of UBF from ES cell extracts (see Chapter 4), but no Dnmt1 
and only minor amounts of Tif1β were brought down, indicating that UBF can interact directly 
with the purified zinc-finger domain of CTCF but that Dnmt1 might bind another domain of CTCF 
(Figure 3.7B). Immunofluorescent stainings on Hela and ES cells show that CTCF shows some 
overlap in localization with Dnmt1 and nucleophosmin, however with UBF and fibrillarin co-
localization is less clear (Figure 3.7D). 
Discussion
Biotinylation method
The biochemical behavior of CTCF may be a complicating factor in a proteomics-based approach, 
as the protein is tightly bound to DNA (~70% of CTCF is immobile (Heath et al, unpublished 
observations)). This means that CTCF binds most of its interacting partners while attached to 
DNA, either using the DNA to adopt the right conformation, or as a co-factor for binding. Thus, 
even after vigorous washing of streptavidin beads we still observed multiple background bands. 
This contrasts to what is reported for other biotinylated proteins that were overexpressed 
(Lansbergen et al., 2006; Meier et al., 2006; Rodriguez et al., 2005). Upon benzonase treatment 
the background was reduced, but we also detected less specific interactions, as shown by 
western blots of known interacting proteins. Higher background signal might also be due to the 
expression levels in our study, as we used endogenously expressed CTCF-bio. This is reflected by 
the mass spectrometry results that show only minor amounts of CTCF peptides. We conclude 
that the relatively low expression level of tagged CTCF combined with its tight association 
with DNA (and perhaps its association with the insoluble nuclear fraction) makes it technically 
difficult to efficiently isolate intact protein complexes. Others have reported that CTCF is prone 
to aggregation and non-specific interactions (Klenova et al., 2002).
None of the proteins interacting with CTCF were highly enriched in binding, as compared to 
the input. This suggests that the interactions of CTCF with other proteins are often transient, or 
weak explaining why CTCF can interact with multiple factors. Despite the technical problems we 
were able to identify and verify several new (and established) CTCF-interacting proteins. For UBF 
we demonstrate that the interaction is direct (Chapter 4), by using purified proteins (Mackay et 
al., 2007). We have not done this for other interacting proteins. Bearing this in mind we discuss 
the potential physiological significance of several of the interactions, focusing on interacting 
proteins that belong to a complex of proteins or have a shared function.
Table 3.3 Selection of CTCF interacting proteins identified by mass spectrometry classified according to their biological 
function
The cell type or tissue from which the specific protein is identified upon pulled downs for CTCF interacting proteins is 
indicated. The times the protein was identified in different experiments is shown.  A number of these proteins have 
been validates by their interaction with CTCF using streptavidin pull downs. Note that this does not take into account 
an interaction via DNA. Proteins that were tested for an interaction with CTCF but were not found back in de mass spec. 
(MS) list are also indicated. Common background proteins (ribosomal proteins, splicing factors, metabolic proteins) were 
excluded from the list. Note that proteins indicated with a star (*) were identified at least once in the BirA control lane. 
n.d. = not done, n.i. = not identified, - = no interaction, + = interaction, ± = additional experiments needed to confirm this 
result.
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HMG box proteins
Proteins containing high-mobility group (HMG) domains are segregated into two major groups. 
Members of one group are identified by the presence of more than one HMG domain. These 
proteins bind to DNA without sequence specificity. This group includes the HMG/UBF family. In 
contrast, members of the other group possess a single HMG domain and bind with high affinity 
to a specific DNA sequence. Members of this group generally resemble classic tissue-specific 
transcriptional regulators. This group includes members of the MATA/TCF/SOX family (Soullier 
et al., 1999).
Interestingly two proteins were identified from our pull downs that are closely linked to 
UBF, namely Ssrp1, a component of the FACT complex, and the SWI/SNF related protein BAF57. 
A CTCF-UBF interaction is discussed extensively in Chapter 4. Ssrp1 and BAF57 share 50-60% 
identity with the first HMG-box of UBF. Phylogenic and ancestral analysis revealed a related origin 
of these proteins, which is reflected in the nature of their DNA binding (unspecific) and which 
places these proteins in the HMG/UBF family (Wattler et al., 1999). This in contrast to other 
HMG-box containing proteins identified as interacting with CTCF, like Lef1 and TCF, that belong to 
the MATA/TCF/SOX family.
Using a phage display approach it was shown that HMGB1 could recognize several peptide 
motifs. A search through protein databases identified these peptide motifs in known interacting 
proteins of HMGB1, but also allowed to identify new potential candidates. Interestingly among 
them was CTCF, that contains a HMGB1-recognition motif in the proline-rich region present in 
its C-terminal region (Dintilhac and Bernues, 2002). Besides the fact that HMGB1, Ssrp1, UBF 
and BAF57 all belong to the family of HMG/UBF proteins that are able to recognize structural 
motifs of DNA, they contain structural properties themselves and are able to bend or kink DNA. 
However we have not yet confirmed an interaction between all of those proteins and CTCF. In 
Chapter 4 we show that the interactions of UBF with CTCF and CTCFL is mediated via the ZF 
domain of CTCF(L) and not via the C-terminus.
Taking into account the properties of CTCF to affect chromatin structure a link with the 
structural HMG family is very interesting. Like UBF, Lef1 plays a structural role by bending DNA 
in order to facilitate protein-protein interactions (Giese et al., 1992). For Lef1 and UBF we show 
a specific interaction with CTCF. Interestingly UBF2 was shown to associate with Lef1 and to 
stimulate RNA polymerase II dependent transcriptional activation by Lef1 from a Lef/TCF-
responsive synthetic promoter (Grueneberg et al., 2003).
Regulation of RNA polymerase II transcription and elongation
The Paf1 complex is composed of Paf1, Ctr9, Hrpt2 and Leo1 and was originally isolated in yeast in 
association with the large subunit of RNA polymerase II. Paf1 complex components are abundant 
and co localize with RNA polymerase II on chromatin at promoters and in the coding regions of 
actively transcribed genes. Loss of Paf1 and Ctr9 results in a severe phenotype, affecting cell cycle 
regulation, protein synthesis and nucleic acid metabolism (Betz et al., 2002; Mueller and Jaehning, 
2002). Deletion of Hrpt2 results in the dissociation of the remaining Paf1 complex members 
from chromatin and a significant reduction in binding of the complex to RNA polymerase II. In 
addition, loss of Paf1 complex components leads to a reduction in RNA polymerase II carboxyl-
terminal domain (CTD) phosphorylation (on Ser2) and in shortened poly(A) tails on most cellular 
transcripts, suggesting that the Paf1 complex facilitates linkage of transcription and pre-mRNA 
processing (Mueller et al., 2004; Penheiter et al., 2005; Sheldon et al., 2005).
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The Paf1 complex is not only involved in elongation but also in histone methylation. Yeast 
mutants missing Paf1 and Ctr9 are defective in histone 3 lysin 4 (H3K4) methylation (Krogan et al., 
2003). Paf1 is required for the recruitment of the yeast Set1 (COMPASS) methyltransferase to RNA 
polymerase II (Hampsey and Reinberg, 2003). Also the mammalian Paf1 complex is associated 
with a Set1-like histone methyltransferase complex, that methylates H3K4, this also appears to 
involve the MLL complex (Rozenblatt-Rosen et al., 2005). The Paf1 complex also mediates histone 
H3 methylation on lysines 36 and 79, thereby marking regions of active transcription (Hampsey 
and Reinberg, 2003). Recently it was demonstrated that elongation by RNA polymerase II through 
the nucleosomal barrier is dependent on the histone chaperone FACT (Facilitates Chromatin 
Transcription) and the recruitment of Paf1 and the H2B monoubiquitination machinery (Pavri et 
al., 2006). Paf1 plays an important role in controlling binding of histone methyltransferases and 
chromatin regulators (FACT, CHD1) with elongating RNA polymerase II (Warner et al., 2007). Two 
components of the FACT complex were identified from our mass spec analysis, Cdc68/Supt16h 
and the HMG-box containing Ssrp1. These components promote transcription elongation by 
nucleosome disassembly upon transcription (Orphanides et al., 1999).
All components of the Paf1 complex are specifically pulled down from lung nuclear extracts 
by CTCF. We do not exactly know why this complex was not identified from our ES cells or thymus 
experiments. Expression profiles based on ESTs (UniGene) show a higher abundance of Paf1 in 
lung than in thymus, and a more significant presence of this complex in adult than in ES cells/
blastocysts. Moreover, the efficiency of the lung pull down appeared to be higher because more 
CTCF peptides were identified in these pull downs than in the thymus pull downs.
In light of a recently reported interaction of CTCF with the largest subunit of RNA 
polymerase II (Chernukhin et al., 2007) its potential interaction with the Paf1 complex and the 
TFIID component TAF15 is highly interesting. CTCF interacts with RNA polymerase both when the 
latter is associated with the initiation complex as well when it is elongating. Enrichment of RNA 
polymerase II binding to DNA, an indication for pausing, interference or release of the polymerase 
can be detected at some CTCF binding sites (Chernukhin et al., 2007; Filippova et al., 1996). Thus, 
CTCF might potentially pause or stall RNA polymerase II. Another possible function could be at 
the initiation of transcription, where promoter bound CTCF could function in gene activation 
by recruiting RNA polymerase II. Alternatively CTCF could regulate release and early elongation 
of promoter-proximal paused RNA polymerase II. This could explain its potential binding to the 
initiation component TAF15 and to factors that can increase the catalytic rate of RNA polymerase 
II, such as Tceb3/Elongin A. Components of the Paf1 complex are present at transcription initiation 
sites and can recruit transcription factors and modulate histone modifications. Interestingly, such 
a recruitment is reported for STAT3, a component that is found back in our pull downs on lung 
material, maybe via its interaction with the Paf component Ctr9 (Youn et al., 2007).
Boundary formation and chromatin modification
A chromatin barrier can act to maintain silenced chromatin domains and prevent their spreading 
by actively remodeling chromatin. In yeast barrier activity is modulated by histone modifiers, 
SWI/SNF chromatin remodelers, and by TFIID components (Oki et al., 2004). Recently CTCF was 
shown to be involved in organizing histone modification (Han et al., 2008; Splinter et al., 2006). 
Thus, barrier activity of CTCF may be linked to its ability to mediate histone modifications. Several 
chromatin-modifying factors are identified as interacting with CTCF (albeit unconfirmed), including 
BAF57, BAF170 and Snf2h, as well as a histone demethylase (Jarid2), histone methyltransferases 
(EZH2, Wdr5), a histone acetyltransferase (MRG15), and a DNA methyltransferase (Dnmt1). 
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Interestingly, a protein called USF1 that is involved in boundary formation at the β globin cHS4 
has been reported to bind to Wdr5, CHD8 and Snf2h (Huang et al., 2007), which are all (potential) 
CTCF-interacting partners.
BAFs (BRG- or Brm-associated factors) are related to the SWI2/SNF2 group of ATP-dependent 
chromatin remodeling complexes. They include BAF47, BAF53, BAF57, BAF155 and BAF170. 
BAF57 is the only known DNA binding component of the BAF complex (Quinn et al., 1996; Wang 
et al., 1998). The Drosophila homolog of BAF57 is Bap111/Dalao no homolog of BAF57 has been 
found in yeast SWI/SNF complexes. The HMG domain of BAF57 is important since mutants lacking 
this domain are not functional. Thus, the DNA bending activity of the HMG domain is required 
for transcriptional regulation and chromatin remodeling by BAF57 (Chi et al., 2002; Papoulas et 
al., 2001). Mutations in BAF57 impair the function of the BAF complex in both silencing of the 
CD4 locus and activation of the CD8 locus. These loci express the co-receptor molecules CD4 and 
CD8 that cooperate with the T-cell receptor in antigen recognition on the surface of T-cells. BAF57 
impairs CD4 silencing by direct binding to the CD4 silencer elements (Chi et al., 2002). BAF57 was 
identified as a potential CTCF interacting protein in the thymus. Interestingly, deletion of CTCF 
in the thymus result in significant effects on CD4- and CD8-positive T cells, the latter being less 
dependent of CTCF (Heath submitted).
Upon lymphocyte activation the BAF complex is rapidly targeted to chromatin via a 
phosphatidyl-inositol pathway (Zhao et al., 1998). The activity of SWI/SNF remodeling complexes 
can be modulated by inositol polyphosphates, although the biological significance of this regulation 
remains to be determined (Shen et al., 2003). Combined, these data suggest a role for BAF in 
rapid changes of chromatin structure, as for example upon antigenic activation of T lymphocytes. 
Interestingly stimulation of CTCF knockout T cells with inositol polyphosphates (PMA) partially 
but not fully restores the normal function of those cells (Heath submitted). Furthermore, CTCF 
has been shown to respond to insulin signaling, which acts via PI3-kinase (Gao et al., 2007). Thus, 
a CTCF-BAF interaction could be involved in quick transcriptional responses.
SNF2h belongs to the group of ISWI chromatin remodeling enzymes. In the mouse SNF2h 
can form two complexes, together with WSTF to form the WICH-complex, or with TIP5, p50 and 
p80 to form the nucleolar remodeling complex NoRC. In humans SNF2h can also bind to CHD4/
Mi-2, HDAC’s and the Cohesin complex. Interestingly human ACF (SNF2h, Acf1, WCRF) is reported 
to regulate chromatin folding into loop domains together with Sin3a and the transcriptional 
regulator SATB1 (Yasui et al., 2002). Snf2h was identified once in ES cell pull downs and it was 
verified to interact with CTCF. However, upon addition of benzonase the interaction was lost, 
indicating that it might be mediated via DNA. Recently it was shown that Snf2h does not bind to 
the CTCF binding sites in the c-Myc insulator and Igf2/H19 ICR (Stedman et al., 2008).
Jarid2 is a member of the jumonji family involved in transcriptional repression and/or 
chromatin regulation, which plays an important role during development (Takeuchi et al., 2006). 
The jumonji group of proteins is characterized by a novel structural motif, the JmjC domain, which 
is implicated in histone demethylation. JMJD2 is involved in demethylation of H3K9/K36. Of the 
other family members, JMJD6 is involved in the demethylation of arginines 2 and 3 at histone 
H3, whereas JMJD3 is involved in demethylation of H3K27 (Whetstine et al., 2006) (Swigut and 
Wysocka, 2007). Jarid2 is identified in two separate ES cell pull downs, in which benzonase was 
not used. It would be interesting to confirm the interaction with CTCF.
Enhancer of zeste homologue 2 (EZH2) is a histone lysine methyl transferase, which 
is associated with transcriptional repression. It is a component of the polycomb repressive 
complexes PRC2 and PRC3. The PRC2 complex catalyses histone H3 K27 trimethylation, of which 
EZH2 is the catalytic subunit (Cao et al., 2002). EZH2 was shown to bind Dnmt1 and controls DNA 
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methylation thereby mechanistically linking the Polycomb group proteins to DNA methylation 
(Vire et al., 2006). We identified Dnmt1 and EZH2 in separate pull downs. EZH2 only binds to CTCF 
in the absence of DNA/RNA.
Wdr5 is a WD40 repeat protein that is part of MLL1, MLL2 and hSet1 histone H3K4 
methyltransferase complexes. The yeast homolog of the human MLL complex is the Set1-
containing complex COMPASS (Lee et al., 2007). Interestingly the CTCF interacting protein CHD8 
is reported to be present in a complex containing Wdr5-MLL1-MOF (Dou et al., 2005). Wdr5 
recognizes histone methyl-lysine with its WD40 and recruits H3K4 methyltransferases to K4-
dimethylated histone H3.  WDR5 is required for global and gene-specific tri methylation of H3K4 
(Wysocka et al., 2005). Interestingly the MLL1 complex is linked to histone acetylation by its 
interaction with the H4K16 acetyltransferase MOF (Dou et al., 2005). It should however be noted 
that Wdr5 is identified only once in the performed ES cell pull downs with a significance around 
background.
MRG15 is a MOF related component of the NuA4/Tip60 histone acetyltransferase (HAT) 
complex that is involved in transcriptional activation of select genes principally by acetylation 
of nucleosomal histone H4 and H2A (Doyon et al., 2004; Garcia et al., 2007). Furthermore it can 
bind specifically to the methylated lysin 36 of histone H3 (Zhang et al., 2006). It should be noted 
that MRG15 is identified only once in the performed ES cell pull downs with significance around 
background.
The maintenance methyltransferase Dnmt1 is reported to be involved in imprinting and 
gene expression regulation its active mainly in S-phase when new methylation patterns have 
to be set on new daughter strands (Howell et al., 2001).  Recently the RING- and SET finger 
domain containing Np95 was shown to be involved in loading Dnmt1 on newly replicated DNA 
(Sharif et al., 2007). Although CTCF is mainly reported to bind to unmethylated sites and was 
reported to be involved in keeping these sites methylation free it can also bind to methylated 
sites (Mukhopadhyay et al., 2004). At these methylated sites it could potentially cooperate with 
Dnmt1 to maintain DNA methylation.
T cell specific factors
All members of the of the HMG domain containing LEF/TCF family of transcription factors including 
LEF1 (lymphoid enhancer factor) and the T-cell factors TCF1, TCF3 and TCF4 were identified 
from CTCF pull downs on thymus material. In adult mammals, TCF1 is uniquely expressed in 
T lymphocytes, while LEF1 is expressed in T cells and early B cells (Travis et al., 1991). These 
factors play crucial roles in WNT/Wingless signaling, a signal transduction cascade that directs 
cell differentiation. LEF1 is redundant with TCF1 for correct development of T lymphocytes in 
the thymus. The Wnt mediated signaling pathway induces cytosolic β-catenin binding to TCF/
LEF proteins within the nucleus, leading to the enhanced expression of the Wnt target genes. 
The β-catenin-TCF complexes are negatively regulated by the APC tumor suppressor protein, 
which phosphorylates β-catenin and, in turn, increases the degradation of cytosolic β-catenin 
and inhibits the transcriptional activity of the TCF/LEF proteins. 
 The in vivo functions of TCF1 and LEF1 have been explored by gene disruption experiments. 
Tcf1 knockout mice are severely impaired in the generation of T cells, but are otherwise normal. 
Lef1 mice lack hair, teeth and mammary glands and as a consequence die around birth (van 
Genderen et al., 1994). As deduced from direct analyses and from transplantation experiments, 
the Lef1 mutation has no major effects on the immune system. In Tcf1/Lef1 double knockout 
mice, development of T cells is completely abrogated, indicating that LEF1 can substitute for 
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TCF1 in T-cell differentiation. These mice show decreased expression of TCRα gene expression 
but normal TCRβ expression (Okamura et al., 1998; Verbeek et al., 1995).
LEF1 and TCF1 perform a major function in controlling expression of the T cell receptor 
(TCR) genes by binding to the enhancer region (Travis et al., 1991). The alpha enhancer is active 
in T cells and drives TCRα recombination in collaboration with a locus control region-like element 
located downstream of the Cα gene. CTCF was shown to bind in this region and can perform 
enhancer-blocking abilities at this site (Magdinier et al., 2004). This CTCF site is only 230 bp 
separated from the Lef1 binding site, but the two protein could potentially interact with each 
other because Lef1 is reported to bend DNA (Love et al., 1995).  However recently CTCF was 
shown not to be critical for the locus control region activity. The region was shown to contain 
CTCF independent boundaries that have a more pronounced effect on LCR activity (Gomos-
Klein et al., 2007). Also TCRα gene expression is not impaired in the absence of CTCF (Heath 
submitted). Leaving the question what the functional significance of a CTCF interaction with TCF/
LEF could be. Potentially CTCF is involved in Wnt signaling by regulating binding to other LEF/TCF 
targets such as cyclin D1, E-cadherin, c-Myc or the oncogene Fra-1 (Mann et al., 1999; Tetsu and 
McCormick, 1999; van de Wetering et al., 2002).
Cellular organization 
Structural Maintenance of Chromosomes (SMC) family proteins play critical roles in various 
nuclear events that require structural changes of chromosomes, including mitotic chromosome 
organization, DNA recombination and repair and global transcriptional repression. The SMC1-
SMC3 heterodimer is part of the Cohesin complex, the SMC2-SMC4 heterodimer is part of 
Condensin, furthermore a SMC5-SMC6 heterodimer is also crucial for chromosome segregation. 
Our analysis identified SMC2 and SMC5 once in ES cell pull downs done in the absence of 
benzonase. Recently an interaction between CTCF and SMC3 was described, although similar 
studies on CTCF and Cohesin do not report an interaction between the two proteins (Parelho et 
al., 2008; Stedman et al., 2008; Wendt et al., 2008). However Cohesin was shown to mediate CTCF 
dependent transcriptional insulation. Likely an unknown protein factor mediates the positioning 
of Cohesin by CTCF.
SMC2 is a central component of the Condensin complex, a complex required for conversion 
of interphase chromatin into mitotic like condense chromosomes. SMC5 is required for DNA 
repair and segregation of repetitive regions (Torres-Rosell et al., 2005).
SMC’s work together with Topoisomerase and are reported to be involved in higher-order 
chromosome organization. Furthermore it was suggested that Condensin might function as an 
intramolecular DNA cross-linker that folds a single DNA molecule, whereas Cohesin might act 
as an intermolecular DNA cross-linker that holds two different DNA segments together (Hirano, 
1999). In addition to their essential contribution to mitotic chromosome condensation and 
segregation, the Condensin subunits play important functions at non-mitotic stages of the cell 
cycle (Hirano, 2002). Interestingly in Drosophila it was reported that Polycomb group proteins 
and Condensin subunits cooperate to maintain the silenced state of gene expression, possibly by 
assembling condensed heterochromatin-like structures (Lupo et al., 2001).
Some other proteins that are known to have prominent function during mitosis and cellular 
organization and were identified from our CTCF pull downs are RCC1-like, Tpx2, KIF23/MKLP1, 
Prc1, KIF2C/MCAK and Bud13/KAR9. Interestingly these proteins are all involved in organization, 
alignment and formation of the mitotic spindle. Mitotic spindle morphogenesis is a series of 
highly coordinated movements that lead to chromosome segregation and cytokinesis. The 
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mitotic spindle consists of bundles of microtubules, bundled by kinesins and nucleated at the 
centrosomes. During spindle assembly some of the spindle’s microtubules attach to kinetochores 
that assemble on the centromere of the chromosomes.
RanGTP activates spindle assembly by activation and release of microtubule associated 
factors like Tpx2 and Numa (Kalab et al., 2002). RanGTP is generated at this location by the only 
known nucleotide exchange factor for Ran called RCC1, which remains bound to chromatin 
throughout mitosis (Moore et al., 2002). Parallel to the Ran-dependent spindle assembly 
promoting pathway is a second independent pathway exists in which Aurora-B play a role in 
regulating chromosome driven microtubule nucleation. Chromosome orientation and alignment 
within the mitotic spindle requires not only Aurora B but also the mitotic centromere-associated 
kinesin (MCAK) (Andrews et al., 2004). Proper spindle alignment is also ensured by multiple 
factors. The asymmetric loading of APC-related Kar9 onto spindle poles and microtubules is for 
example important in this (Liakopoulos et al., 2003). Localization of the central spindle depends 
on components of the spindle midzone including the microtubule bundling protein Prc1 and 
mitotic kinesin-like protein 1 (MKLP1) (Kurasawa et al., 2004). 
Numa and Tpx2 are found in the interphase nucleus, presumably localized there by Ran/
RCC1 and importins and they are preferentially activated in the vicinity of chromatin (Kahana and 
Cleveland, 2001). Besides its function in mitosis Tpx2 was shown to be involved in post mitotic 
nuclear assembly in Xenopus upon binding to Tmpo/Lap2 that localizes to the inner nuclear 
membrane (O’Brien and Wiese, 2006). LAP2 (lamina-associated polypeptide 2) plays a role in the 
regulation of nuclear architecture by binding lamin B1 and chromosomes. Moreover lamin B has 
been reported to be a structural component of the spindle matrix that promotes microtubule 
assembly and organization in mitosis. Depletion of lamin B resulted in defects in spindle assembly 
(Tsai et al., 2006). The periphery of the nucleus is suggested to provide a platform for sequestering 
transcription factors away from chromatin.
Potentially CTCF could function in chromosome condensation or have specific functions 
during mitosis. The identification of spindle components is interesting with regard to the 
localization of CTCF to the centrosome that is involved in the assembly and organization of the 
spindle during mitosis (Zhang et al., 2004). Moreover it was shown that during mitosis CTCF 
remains bound to mitotic chromosomes and is slightly enriched on centromeres (Burke et al., 
2005). CTCF might play a role in regulating correct chromosome segregation during mitosis. 
The identified factors localize to the nucleus in interphase, indicating that they might 
function in other processes outside mitosis. Interestingly two proteins only reported to function 
during mitosis, Cohesin and Aurora B, were reported to participate in gene regulation in post 
mitotic cells (Sabbattini et al., 2007; Wendt et al., 2008). This indicates that the function of CTCF 
binding to the mitotic factors could also be one outside mitosis. Potentially the factors participate 
in gene regulation or in the structural organization of chromatin together with CTCF. It would be 
interesting to further confirm an interaction of CTCF with the proteins identified and to investigate 
the functional meaning of this in more detail.
In conclusion CTCF interacts with multiple different proteins suggesting that it forms a 
platform that allows many functionalities to take place.
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Materials en methods
Cell culture and generation of DNA constructs
Mouse cDNAs of CTCF (IMAGE 6825952) and CTCFL (Sleutels unpublished) were amplified using PCR with 
primers containing EcoRI and XmaI sites and cloned into the shuttling vector pGEMTeasy. To generate 
N-terminally bio tagged CTCF and CTCFL the cDNAs were cut out of this vector using EcoRI/XmaI and cloned 
into the C1-bio vector that contains the backbone of the pEGFP-C1 vector (Clontech) with the bio-tag cloned 
in place of the eGFP in AgeI/EcoRI sites. To generate C-terminally bio tagged CTCF and CTCFL the cDNA 
were cloned in a similar way to the N1-bio vector that contains the backbone of the pEGFP-N1 vector with 
the bio-tag cloned in place of the eGFP in EcoRI/XmaI sites. For BirA expression the pSCT-HaBirA vector 
was used. Transient transfections were performed using lipofectamine 2000 (Invitrogen) and Optimem 
transfection medium (GiboBRL). Cells were used for experiments 24 hours later or continued culturing in 
medium with 1 ug/ml puro to select single stable expressing clones. Flag-tagged UBF was a kind gift of Dr. 
R. Voit and flag-tagged Lef1 was generated by PCR amplification with primers containing NheI/XhoI sites 
on mouse cDNA (IMAGE 6401514) and cloned in NotI/NheI of the expression plasmid pCBA-Tag1-2xFlag. 
GST-tagged zinc-fingers of chicken CTCF present in pGEX4T1 were produced in BL21 E.Coli and purified using 
glutathione-Sepharose 4B (Amersham Biosciences). Hek293T and HeLa cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum. ES cells were cultured on 0,1% 
gelatin coated dishes in DMEM medium containing 10% FCS, BRL, LIF, NEAA, β-mercaptoethanol and split 
every two days.
Generation of CTCFbio knock-in mice
Oligo’s containing bases to erase the CTCF stop-codon, TEV protease cleavage site followed by the bio-tag 
and a stop codon and a EcoRV or SacII overhang were ordered (Invitrogen) and annealed. The annealed 
fragment was cloned into SacII and EcoRV sites of pBleuscriptKS Lox-Neo-Lox. Afterwards 5’-homology 
and 3’-homology arms were PCR-ed from mouse 129 PAC Clones (Osoegawa et al., 2000) and cloned into 
the pBleuscript biotev-lox-neo-lox vector. Generating the final targeting construct that was confirmed 
by sequencing to be without any mutations and was subsequently linearized and used for homologous 
recombination to generate the CTCFbio/+ allele. In this construct the neomycin resistance cassette was 
transcribed in the antisense direction under the PTK promoter.  Constructs were targeted into 129 embryonic 
stem (ES) cells as described (Hoogenraad et al., 2002). Confirmation of homologous recombination was 
performed using different 5’ end and 3’ end external probes and a PCR-based assay for genotyping. Genomic 
DNA was isolated, digested, and blotted onto Hybond N+ membranes (Amersham) and hybridized with 
radioactive probes. Hybridization was performed in a rotating hybridizer at 65°C for 24h in ChurchHyb-mix 
(0,5 M Na2HPO4 pH 7.2, 7% SDS, 1 mM EDTA). Membranes were washed extensively with Church wash-
buffer at 65°C (40 mM Na2HPO4 pH 7.2, 1% SDS). Hybridization signals were analyzed with a Phoshor 
Imager (Typhoon Amersham). Two targeted ES cell clones with the correct karyotype were chosen to inject 
into C57Bl/6 blastocysts. Chimeric males were mated to C57Bl/6 females to obtain germ line transmission 
of the modified allele. Mice with the modified allele were crossed to CAG-Cre transgenic mice to remove the 
neomycin resistance cassette. Injected CTCFbio ES cells were used for a second targeting event with CMV-
Cre to remove the neomycin resistance cassette and afterwards using homologous recombination Rosa26-
HABirA was inserted. Correct targeting and verification was done by southern blot analysis and PCR. Control 
BirA ES cellines were used as described (Driegen et al., 2005).
Genotyping was routinely performed by PCR using primers:
Rosa26 product (350 bp), Bira product (514 bp), 57°C annealing temperature.
Rosa26 F (265): GTGTAACTGTGGACAGAGGAG
Rosa26 F (266): GAACTTGATGTGTAGACCAGG
BirA_F (91): TTCAGACACTGCGTGACT
BirA_B (92): GGCTCCAATGACTATTTGC
For CTCFbio genotyping the following primers were used:  CTCFbio (599 bp), wt (549 bp)
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CTCFGB1: AGCAAAAGCAAAACCAGGTTA
CTCFGF14: AGGAGCCAGATGCCGAGCCTG
Primers used for probes:
Probe 1F: TCCTGCCTCTGTCCAGTCAGAGA
Probe 1B: GCAGATCACTGTGTGTTCAAGGC
Probe 2F: CGAATGCCACCTTTGACTCTACC
Probe 2B: AAGCCTCGTCCTTCCGAGCCT
Preparation of nuclear extracts and superose 6 size fractionation
Nuclear extracts were prepared as described (Andrews and Faller, 1991). Isolation of nuclear extracts from 
tissues was performed using mice of about 5 weeks old. Tissues were dissected cut into smaller pieces, after 
addition of small amounts of ice cold PBS further homogenizing was performed in a dounce homogenizer. 
Samples were centrifuged for 5 min 4°C at 1000 rpm and pellet of cells was used to isolate nuclear extracts. 
Size fractionation of protein complexes was done on an AKTA FPLC apparatus with a Superose 6 10/30 
column (Amersham Biosciences). Fractions were precipitated with 100% trichloroacetic acid and analyzed 
by western immunoblotting as described. Molecular size standards were thyroglobulin (670 kD) and albumin 
(66 kD) (Amersham Biosciences)
GST pull downs, immunoprecipitation and immunoblotting
Prior to using isolated protein extracts for binding assays the salt and detergent concentrations of nuclear 
extracts samples as well as the protein concentration in the sample was adjusted to 100 mM NaCl/0.3%NP0 
and 0,8-1,2 ug/ul nuclear protein. All binding reactions done for immunoprecipitations and pull downs 
(unless stated differently) were performed under low stringency conditions (100 mM NaCl, 0.3% NP40, 
20 mM Hepes pH8, 0.2 mM EDTA, 10 mM MgCl2, 1x Complete protease inhibitor (Roche)). If indicated 
benzonase nuclease (Novagen) was added for 2h at 4°C to remove DNA and RNA. All pull downs were 
performed at least two times. For IPs nuclear extracts were pre-cleared at 4°C using Protein A sepharose 
beads. Immunoprecipitations were performed upon addition of antibody and samples (nuclear extracts in 
100 mM NaCl/0.3% NP40) were rotated for 1 h at 4°C. Subsequently protein-A sepharose beads were added 
to the samples and incubation was continued for another 1h at 4°C while rotating. Flag-IPs were performed 
using the same protocol except binding was performed for 3h at 4°C upon addition of Anti-flag M2 agarose 
(Sigma). The beads were washed 7 times 5 min. each at 4°C in washing solution. Boiling in 1x Laemmli buffer 
eluted bound material. For immunoblot analysis samples were run on SDS polyacrylamide gels and blotted 
onto PVDF membranes (MilliPore) using a semi-dry blotting apparatus (Biorad). After antibody incubations 
of membranes signal detection was performed using ECL (Amersham). 
Streptavidin pulldown and Mass spectrometry
For streptavidin ChIP preparation of cross linked chromatin (2x107 cells treated with 1% formaldehyde for 
10 minutes at RT), sonication to 300-800 base pair fragments and immunoprecipitations were as described 
in the Upstate protocol (http://www.upstate.com). Exceptions for streptavidin ChIPs were as follows: 
streptavidin beads blocked for 1h RT in 0,2mg/ml sonicated salmon sperm DNA were used, elution was 
performed O/N at 65°C in elution buffer (0,1% NaHCO3, 1% SDS, 0,2M NaCl). For streptavidin pull downs: 
Dynabeads M-280 Streptavidin (Dynal) were blocked by 200 ng/ul chicken serum albumin (CSA) 1h at RT. 
Dynabeads were subsequently incubated with nuclear extracts at 4°C for 2 hours while rotating. After 
magnetic separation the beads were washed seven times in a buffer containing 100 mM NaCl, 20 mM Tris 
pH7.5, 0.3% NP40 and protease inhibitors (Complete; Roche). Subsequently the beads were resuspended 
and boiled in 1x Laemmli buffer. For mass spectrometry samples were run under keratin free conditions 
using a pre-cast 3-8% NuPAGE Tris-Acetate gel and stained with the colloidal blue staining kit (Invitrogen). 
Depending on the experiment mass spectrometric analysis was performed on a Q-Tof, LTQ or Orbitrap (see 
table 3.2). 1D SDS-PAGE gel lanes were typically cut into slices using an automatic gel slicer and subjected 
to in-gel reduction with dithiothreitol, alkylation with iodoacetamide and digestion with trypsin (Promega, 
sequencing grade), For Q-Tof analysis : NanoLC-MS/MS was performed on either a CapLC system (Waters, 
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Manchester, UK) coupled to a Q-ToF Ultima mass spectrometer (Waters, Manchester, UK), operating in 
positive mode and equipped with a Z-spray source, or an 1100 series capillary LC system (Agilent Technologies) 
coupled to an LTQ (Thermo) operating in positive mode and equipped with a nanospray source. Peptide 
mixtures were trapped on a Jupiter™ C18 reversed phase column (Phenomenex; column dimensions 1.5 
cm × 100 µm, packed in-house) at a flow rate of 7 µl/min. Peptide separation was performed on Jupiter™ 
C18 reversed phase column (Phenomenex; column dimensions 15 cm × 50 µm, packed in-house). For LTQ 
or Orbitrap : NanoLC-MS/MS was performed on an 1100 series capillary LC system (Agilent Technologies) 
coupled to an LTQ ion trap mass spectrometer or an LTQ-Orbitrap mass spectrometer (Thermo) operating 
in positive mode and equipped with a nanospray source. Peptide mixtures were trapped on a ReproSil C18 
reversed phase column (Dr Maisch GmbH; column dimensions 1.5 cm × 100 µm, packed in-house) at a flow 
rate of 8 µl/min. Peptide separation was performed on ReproSil C18 reversed phase column (Dr Maisch 
GmbH; column dimensions 15 cm × 50 µm, packed in-house) using a linear gradient from 0 to 80% B (A = 0.1 
M acetic acid; B = 80% (v/v) acetonitrile, 0.1 M acetic acid) in 70 min and at a constant flow rate of 200 nl/
min using a splitter. The column eluent was directly sprayed into the ESI source of the mass spectrometer. 
Mass spectra were acquired in continuum mode; fragmentation of the peptides was performed in data-
dependent mode. Data analysis and protein identification was done by automatically creating peak lists 
from raw data files using the Mascot Distiller software (version 2.0; MatrixScience). The Mascot search 
algorithm (version 2.0, MatrixScience) was used for searching against the NCBI database (release date: 
14/10/05 exp1; 21/10/05 exp2 and 3; 6/1/06 exp4; 5/3/06 exp5 18/6/06 exp6 and 7; taxonomy: Mus 
musculus). The peptide tolerance was typically set to 150 ppm and the fragment ion tolerance to 0.2 Da. 
Only doubly and triply charged peptides were searched for. A maximum number of 2 missed cleavages by 
trypsin were allowed and carbamidomethylated cysteine and oxidized methionine were set as fixed and 
variable modifications, respectively. The Mascot score cut-off value for a positive protein hit was set to 
60. Individual peptide MS/MS spectra with Mowse scores below 40 were checked manually and either 
interpreted as valid identifications or discarded. 
Immunofluorescence
Cells were fixed in 4% paraformaldehyde/PBS for 15 minutes at RT, permeabilised in 0,15% Triton X-100 in 
PBS, blocked in 1% bovine serum albumin in PBS and incubated with antibodies as described previously. For 
secondary antibodies, FITC-conjugated goat antibodies against rabbit and mouse IgG were purchased from 
Molecular probes and Alexa 594-conjugated goat anti-rabbit antibody from Nordic Laboratories. Conjugated 
streptavidin-Alexa594 and avidin Texas red were used to visualize biotinylated protein (Molecular probes). 
Images of cells were collected with a Leica DMRBE microscope.
Bandshifts
Protein extract was preincubated with bandshift buffer (10% Glycerol, 20 mM Hepes pH7.4, 20 mM KCl, 
1 mM MgCl2, 5 mM DTT, 10 uM ZnCl2, 100 ug/ml BSA, 0.02% NP40) and 2-4 ug of salmon sperm DNA as 
a non-specific competitor. The reaction was incubated for 20 min. at the RT. Then upon addition of the 
32P end-labeled probe the binding reaction was performed for 20 min. RT. The complexes were analyzed 
by electrophoresis through a 5% acrylamide (37,5:1) 0.5x TBE non-denaturing gel at 8V/cm2 at 4°C. The 
sequences of the probe were as follows:
3’HS1-wt-s: CGGAAATCAGTGGAACACTTCTGCCCCCTACTGGTATGCAACAGG
3’HS1-wt-as: TCCTGTTGCATACCAGTAGGGGGCAGCCGTGTTCCACTGATTTCCG
3’HS1-mut-s: CGGAAATCAGTGGAACACTTCTGATATCTACTGGTATGCAACAGG
3’HS1-mut-as: TCCTGTTGCATACCAGTAGATATCAGAAGTGTTCCACTGATTTCCG
Antibodies
The following antibodies were used: anti-FLAG M2 monoclonal (Sigma), PARP1 (Alexis biochem / Santa 
Cruz), Sin3a (Santa Cruz / Upstate), CTCF (Upstate), Dnmt1 (Santa Cruz), YY1 (Santa Cruz), Snf2h (Abcam), 
nucleophosmin (Santa Cruz), HDAC1 (Santa Cruz), Dnmt3b, CHD4 (Santa Cruz), RFC2 (Abcam), fibrillarin 
(Heath unpublished), PCNA (mouse), Rif1 (Abcam), UBF (Santa Cruz), Tcof1 (Abnova Corp.), EZH2 (Cell 
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signaling), Tif1β (gift of Dr. Cammas), Sox2 (Santa Cruz), SMC1 (Bethyl labs.), SMC3 (Bethyl labs.), H2A.Z 
(Abcam), Ranbp2 (gift of Dr. Melchior), CTCFL (Sleutels unpublished), HP1 (Abcam), Ku80 (Abcam), anti-
HIS (Qiagen). CTCF N3 rabbit polyclonal and RPA194 rabbit polyclonal were generated as described (Heath 
submitted) (Hoogstraten et al., 2002).
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Summary
CTCF is a highly conserved zinc finger protein, which organizes chromatin domains and RNA 
polymerase II-mediated gene transcription by binding to approximately 15,000 sites in the human 
and mouse genomes. Here we show that UBF, a key regulator of RNA polymerase I, directly 
interacts with CTCF and its testis-specific paralogue CTCFL. We identify conserved CTCF-binding 
sites immediately upstream of the spacer promoter of the ribosomal DNA (rDNA) repeat. CTCF 
is required for the accumulation of RNA polymerase I, variant histone H2A.Z and UBF near the 
rDNA spacer promoter, and regulates the transcription of non-coding RNAs from this promoter. 
Interestingly, these transcripts accumulate strongly after mitosis, marking a fraction of all nucleoli. 
We conclude that RNA polymerase I-mediated transcription at spacer- and gene-promoters can 
be independently regulated and suggest that a CTCF-UBF interaction regulates spacer promoter 
transcription. Interestingly, CTCF organizes chromatin at the rDNA spacer promoter similar to 
RNA polymerase II-promoters. Such a local epigenetic control may maintain the reservoir of 
rDNA genes that are poised for transcription.
Introduction 
CTCF is a conserved and ubiquitously expressed factor, which was shown to both activate and 
repress transcription, and to organize epigenetically controlled chromatin domains (Ohlsson et 
al, 2001). It is generally thought that CTCF acts as an insulator or enhancer-blocker: its binding 
to DNA prevents the spreading of heterochromatin from chromatin domains separated by CTCF 
or inhibits the illegitimate interactions between regulatory elements on adjacent chromatin 
domains, respectively (Wallace & Felsenfeld, 2007).
CTCF function has been studied in detail for a number of genes. In the imprinted Igf2/H19 
locus, for example, CTCF was shown to bind the imprint control region (ICR) when this domain 
is unmethylated, i.e. when the locus is inherited via the mother (Hark et al, 2000). CTCF binding 
blocks the interaction between enhancers downstream of the H19 gene with elements near the 
Igf2 promoter. Consequently, Igf2 expression is inhibited and H19 is expressed. Importantly, DNA 
methylation on CpG-residues in the ICR, as occurs in paternally inherited alleles, abolishes CTCF 
binding, allowing long range interactions between the H19 enhancer and Igf2 promoter and 
leading to the expression of Igf2 instead of H19. These data establish CTCF as a methylation-
sensitive enhancer blocker. CTCF-mediated boundaries have also been described in the Xist/Tsix 
locus involved in X-chromosome inactivation (Chao et al, 2002). In this case CTCF would act as 
an insulator, creating a barrier against the spread of heterochromatin. A third example where 
CTCF function has been studied in detail is the β-globin gene locus. In chicken CTCF acts as an 
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insulator (Chung et al, 1993), whereas in mouse CTCF mediates the formation of a so-called 
active chromatin hub, a chromatin state that coincides with high expression of the β-globin 
genes (Palstra et al, 2003). CTCF deletion causes a local alteration in histone modification and the 
results indicate that CTCF might function to maintain the globin hub in a conformation “poised” 
for activation (Splinter et al, 2006).
Recently, genome-wide studies have revealed a multitude of CTCF binding sites (Barski et 
al, 2007; Kim et al, 2007; Xie et al, 2007). For example, in the human genome ~15.000 sites are 
present, whose distribution over chromosomes correlates with gene density (Kim et al, 2007). 
The CTCF binding sites that were identified with anti-CTCF antibodies turned out to be virtually 
identical to a group of motifs (called LM2*), which were discovered in a bio-informatics screen 
(Xie et al, 2007). These motifs are found within conserved non-coding elements (CNEs), regulatory 
sequences which do not code for proteins but which are conserved between species. Furthermore, 
comparison between CTCF binding sites, RNA polymerase II binding sites, transcription start sites 
(TSSs) and DNAse I  hypersensitive sites (HSs) revealed that CTCF is located somewhat upstream 
of an HS which in turn precedes a TSS (Boyle et al, 2008). CTCF also colocalizes with the variant 
histone H2A.Z. These data emphasize the central role played by CTCF as a general organizer of 
RNA polymerase II-mediated transcription.
CTCF binds DNA through an 11-zinc finger (ZF) domain. Different combinations of individual 
ZFs were originally proposed to modulate binding specificity (Quitschke et al, 2000), however, 
more recent studies have shown that ZF4-8 are sufficient to bind to a number of physiologically 
relevant sites (Renda et al, 2007). Interestingly, a testis-specific paralogue of CTCF has been 
characterized, called CTCFL or BORIS (Brother Of the Regulator of Imprinted Sites), that is highly 
similar to CTCF in the ZF domain, and that has overlapping DNA binding specificity (Loukinov et 
al, 2002). CTCF and CTCFL share very little similarity outside their ZF region. To date no common 
interaction partners of CTCF and CTCFL have been reported.
Although in most localization studies CTCF is not detected inside the nucleolus (Zhang et 
al, 2004), some cell lines do show an enrichment of CTCF within this compartment, and it has 
been suggested that CTCF inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-
dependent mechanism (Torrano et al, 2006). The nucleolus is the site where 18S, 5.8S and 28S 
ribosomal RNAs (rRNAs) are synthesized and processed and, together with 5S rRNA, assembled 
into ribosomes (Grummt, 2003; Shaw & Doonan, 2005). In all organisms the genes for 18S, 5.8S 
and 28 S rRNA are repeated many times and organized in a head-to-tail fashion in clusters spread 
over several chromosomes. In mouse and man each ribosomal DNA (rDNA) repeat spans ~44 kb 
and approximately half of the repeats are inactive (Conconi et al, 1989). Although it is known 
that methylation plays a role in rDNA inactivation, it is still unknown how exactly the active and 
inactive genes are marked and segregated.
Transcription of the rDNA repeats occurs by RNA polymerase I and is tightly coordinated with 
cellular metabolism and cell proliferation. Transcription occurs at two promoters: transcription 
from the gene promoter gives rise to a ~13 kb (or 45S) ribosomal precursor RNA (pre-rRNA), 
that is processed into the three mature rRNAs in a complex manner. Efficient transcription from 
the ribosomal gene promoter requires a multiprotein complex including UBF (upstream binding 
factor), SL1 (selectivity factor 1) and RNA polymerase I (Bell et al, 1988; Comai et al, 1992; Jantzen 
et al, 1990). UBF enhances transcription by regulating initiation of transcription after formation 
of the RNA polymerase I pre-initiation complex (Panov et al, 2006). Another promoter in the 
rDNA repeat, the spacer promoter, is located in the intergenic spacer (IGS) ~2 kb upstream of 
the gene promoter. Transcription from this promoter gives rise to intergenic or non-coding RNA 
(ncRNA), which is thought to serve a regulatory function (Kuhn & Grummt, 1987; Mayer et al, 
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2006; Paalman et al, 1995). 
In order to better understand the function of CTCF we performed a screen for CTCF-
interacting proteins. Here we report that UBF, a key regulator of RNA polymerase I-mediated 
transcription, directly interacts with CTCF and CTCFL. We characterize conserved CTCF binding 
sites immediately upstream of the ribosomal spacer promoter. Our data show that CTCF controls 
the binding of RNA polymerase I, UBF and H2A.Z and acts as a regulator of spacer promoter 
transcription. We suggest that CTCF does this by organizing chromatin near the spacer promoter 
and that it functions to maintain rDNA repeats in a state poised for activation.
Results 
Characterization of biotinylated CTCF
In order to identify CTCF-binding partners we used a biotinylation-tagging and proteomics 
approach (Figure 4.1A) that was shown to be successful in the identification of interacting 
proteins for other transcription factors (Rodriguez et al, 2005). As CTCF levels are critical for 
cells (Heath et al, submitted), we did not generate cell lines overexpressing biotinylated CTCF. 
Instead, we used homologous recombination in embryonic stem (ES) cells to generate a novel 
Ctcf knock-in allele. DNA encoding a small peptide tag of 23 amino acids was inserted in the last 
exon of the Ctcf gene, prior to the stopcodon of CTCF (Figure 4.1B). This tag is biotinylated upon 
addition of the bacterial biotin ligase enzyme, BirA (de Boer et al, 2003). A TEV-protease cleavage 
site was placed in between CTCF and the biotin tag (not indicated in Figure 4.1B). Southern blot 
and PCR analysis identified homologous recombination events (Figure 4.1C). The resulting allele 
was termed Ctcfbiof.
One ES cell line was injected into blastocysts in order to generate knock-in mice carrying a 
Ctcfbiof allele. In these mice CTCF-interacting proteins can be identified in vivo in a developmental 
and tissue specific manner, provided BirA is co-expressed. In addition, the Ctcfbiof ES cells were 
transfected with a plasmid expressing Cre recombinase to remove the neomycin resistance 
gene, thereby generating the Ctcfbio allele (Figure 4.1B). Furthermore, by using homologous 
recombination the BirA biotin ligase was placed into the Rosa26 locus (data not shown). 
Genotyping and verification of these targeting events was done by PCR (Figure 4.1D). This yielded 
an ES cell line expressing normal CTCF (from a wild type allele) and biotinylated CTCF (from the 
Ctcfbio allele). As the biotin tag was placed at the C-terminus of CTCF, the fusion protein was called 
CTCF-bio.
CTCF-bio cannot be distinguished from untagged CTCF using anti-CTCF antibodies because 
the bio-tag does not cause a major difference in migration behavior in SDS-PAGE (Figure 4.1E, 
upper panel). However, CTCF-bio can be clearly detected using streptavidin-based methods 
(Figure 4.1E, lower panel). Our results indicate that CTCF-bio and CTCF are expressed at similar 
levels. A pull down on ES cell extracts using streptavidin-coupled magnetic beads showed highly 
efficient binding of CTCF-bio to the beads (Figure 4.1F). Size fractionation experiments showed 
that CTCF and CTCF-bio are present in high molecular weight complexes in ES cells (Figure 4.1G). 
Furthermore, CTCF-bio binds known CTCF target sites such as the c-Myc insulator and the β-globin 
3’HS1 (Figure 4.1H). Combined these data indicate that CTCF-bio is a functional protein.
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Figure 4.1 Characterization of biotinylated CTCF
A. Biotinylation-based strategy to identify CTCF binding partners. CTCF (grey boxes in middle: zinc-finger region, gray 
box towards the C-terminus: proline-rich region with AT-hook) is tagged at its C-terminus with a 23 amino acid sequence 
(indicated in single letter code), that can be biotinylated on a lysine residue (star) upon addition of the E.Coli BirA biotin 
ligase. Using streptavidin beads biotinylated CTCF (CTCF-bio) and its interacting proteins are pulled down. Interacting 
proteins were identified by mass spectrometry. B. Murine CTCF locus and gene targeting construct. Exons of the The Ctcf 
gene is indicated with a solid line with the exons as boxes. Exon 3 contains the start codon (indicated with arrow) and 
exon 12 the stop codon. Solid boxes indicate coding parts of the exon, open boxes non coding parts. Southern blot probes 
(1 and 2) are indicated below the gene. X: XbaI, P: PstI. The targeting construct, with biotin-tag (BIO) and loxP sites (small 
triangles), flanking a PMC1-neomycin cassette (Neor) are shown together with the homologous arms (1,6 kb at 5’ end, and 
3,8 kb at 3’ end). After homologous recombination in ES cells and Cre-mediated excision of sequences in between loxP 
sites the Ctcfbio knock-in allele is obtained. C. PstI- or XbaI-digested genomic DNA from ES cells was analyzed by Southern 
blotting using probe 1 or 2. Targeted (bio) and non-targetted (wt) alleles are indicated. D. PCR analysis of genomic tail 
DNA after targeting of Ctcfbio knock-in ES cells with Cre recombinase (to remove the Neo cassette) and Rosa26-BirA (to 
biotinylate the biotin tag). Genotypes are shown above the lanes. E. Nuclear extracts from thymus of mice with indicated 
genotypes were analyzed by western blot with the indicated reagents. Coomassie staining shows equals loading of the 
lanes. F. CTCF-bio is specifically pulled down with streptavidin beads. Nuclear extracts from ES cells expressing CTCF-bio 
and BirA were used. The input (n) nuclear extract lane represents 5% of the material used for streptavidin pull down. 
b: material bound to beads, u: unbound fraction (6 %). G. Size-fractionation of CTCF and CTCF-bio. Nuclear extract were 
fractioned using a superose 6 column. Molecular mass markers are indicated at the bottom. V0 : void volume, input : 
nuclear extract (5%). H. Chromatin immunoprecipitations. CTCF-bio was precipitated with streptavidin-coupled magnetic 
beads from formaldehude fixed nuclei. In the extract from Ctcfbio/Rosa26BirA mice CTCF-bio is present, whereas in extracts 
from Rosa26BirA mice CTCF-bio is absent. Binding is shown to two known CTCF binding sites, i.e. the β-globin 3’HS1 and 
c-Myc insulator.
UBF interacts directly with CTCF and CTCFL
CTCF-bio was purified from ES cell nuclear extracts under mild conditions using streptavidin-
coupled magnetic beads (Figure 4.2A). Proteins co-purifying with CTCF-bio were identified 
104 Chapter 4
Figure 4.2 Interaction of CTCF and CTCFL with UBF 
A. CTCF interacts with UBF and RNA polymerase I in ES cells. Nuclear extracts from ES cells expressing only BirA (negative 
control) and ES cells expressing CTCF-bio were used for streptavidin pull downs.  Extracts were treated with benzonase 
for 2 hours at 4°C prior to pull down. Western blot were incubated with the indicated antibodies (CTCF-bio was detected 
with streptavidin-coupled HRP). RPA194: the large subunit of RNA polymerase I. UBF is detected as a doublet consisting 
of UBF1 and UBF2. U: unbound fraction (6%), b: bound fraction, i: input (5%). B. Endogenous CTCF can pull down UBF. 
Immunoprecipitation (IP) and detection were carried out with the indicated antibodies. C: control (rabbit IgG). B: bound 
fraction, i: input (5%). C. UBF interacts with CTCF and CTCFL. IPs were done with anti-FLAG antibodies from HEK293T cells 
transfected with FLAG-UBF. To detect CTCFL cells were also cotransfected with CTCFL (right hand panel). Proteins were 
analyzed with the indicated antibodies.D. Schematic representation of the GST and HIS fusion proteins used in this study. 
E. Purified fusion proteins shown on a Coomassie-stained gel. F. GST pull down assays of CTCF and CTCFL with nuclear 
protein extract from ES cells. Binding was performed under low salt conditions washing was done under more stringent 
conditions. Western blot of pull down material was incubated with antibody against UBF. G. GST pull downs of purified 
GST proteins incubated with UBF N- and C-terminal halfs tagged with HIS (upper panel) and smaller His-UBF fusion 
proteins (lower panel). Western blot of pull down material was incubated with antibody against His.
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by mass spectrometry, classified by BLAST searches and compared to control pull downs. We 
identified known protein partners of CTCF such as YB-1, Parp1 and nucleophosmin (data not 
shown), validating our approach.
The mass spectrometry analysis revealed several proteins involved in RNA polymerase 
I-mediated transcription, including UBF. We also detected proteins that form a complex with UBF, 
such as the large subunit of RNA polymerase I (RPA194) and its associated factor PAF53 (Hanada et 
al, 1996; Panov et al, 2006). Moreover the 40 kD and 135 kD subunit of RNA polymerase I (RPA40, 
RPA135) and the polymerase associated factor PAF49 were pulled down by CTCF-bio (data not 
shown). These data suggest that CTCF interacts with essential components of the machinery that 
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regulates the synthesis of rRNA.
Streptavidin pull downs followed by western blot analysis confirmed the interaction of UBF 
and the large subunit of RNA polymerase I with CTCF (Figure 4.2A). Nuclear extracts were treated 
with benzonase, to exclude the possibility that CTCF interacts with these proteins via DNA and/
or RNA. Co-immunoprecipitation (co-IP) with CTCF antibodies indicated that an interaction exists 
between CTCF and UBF at the endogenous level  (Figure 4.2B). We also showed an interaction 
of CTCF-bio and UBF in thymic extracts (Supplementary Figure S4.1B). However, a co-IP with 
UBF antiserum did not bring down CTCF (Figure 4.2B). These data suggest that the interaction 
between CTCF is not very strong, consistent with the fact that UBF is mainly detected in the 
nucleolus (Jantzen et al, 1990) whereas CTCF is mainly detected in the nucleus (Zhang et al, 
2004).
As CTCF and CTCFL are 71% similar in their ZF domains, we tested the possibility that CTCFL 
also interacts with UBF. We overexpressed a FLAG-tagged form of UBF in 293T cells, either alone 
or with CTCFL, and performed a FLAG co-IP on extracts from these cells. FLAG-UBF brings down 
endogenous CTCF (Figure 4.2C) and overexpressed CTCFL (Figure 4.2C). Interestingly, a diminished 
interaction between CTCF and UBF was detected in cells expressing CTCFL (Figure 4.2C). These 
results reveal UBF as the first common interaction partner of CTCF and CTCFL. They also indicate 
that CTCF and CTCFL compete for binding to UBF.
We next purified bacterially produced GST-CTCF and -CTCFL and his-tagged UBF (for scheme, 
see Figure 4.2D). Equal amounts of purified GST fusion proteins were first incubated with nuclear 
extracts from ES-cells, and analyzed for UBF binding by western blot. The data demonstrate 
that GST-tagged CTCF and CTCFL are able to specifically pull down UBF (Figure 4.2E), verifying 
results with CTCF-bio. As expected, the interaction with UBF occurs mainly via the ZF domains of 
CTCF and CTCFL (Figure 4.2E). Subsequently GST-CTCF(L) and his-UBF (both full length as well as 
truncated fusion proteins, see Figure 4.2D) were incubated with each other. These experiments 
reveal that the CTCF- and CTCFL-ZF domains interact with UBF HMG-box 1 and the dimerization 
domain (Figure 4.2F, G). His-tagged proteins containing either the dimerization domain of UBF 
or HMG boxes 1 and 2 bind less well to CTCF(L) (Figure 4.2G), indicating that for an efficient 
interaction both regions are necessary.
CTCF binds upstream of the rDNA spacer promoter
Chromatin immunoprecipitation (ChIP) analysis has shown that UBF binds throughout the whole 
rDNA repeat with relatively low sequence specificity (Mayer et al, 2006; O’Sullivan et al, 2002). 
We tested whether CTCF also binds to this regulatory region of the rDNA locus, as this would 
provide a functional explanation for its selective binding to UBF. We first examined primary mouse 
embryonic fibroblasts (MEFs) derived from wild type mice. ChIP experiments recapitulated the 
binding pattern of UBF, showing binding at the promoter and spacer promoter regions and a mild 
enrichment at the enhancers (Figure 4.3A left panel, blue line). By contrast, ChIP of CTCF revealed 
highly specific accumulation immediately upstream of the rDNA spacer promoter (Figure 4.3A, 
left panel, red line). CTCF binding coincided with RNA polymerase I (Figure 4.3A, left panel, green 
line). Strong RNA polymerase I binding to the spacer promoter relative to the gene promoter has 
been shown previously (Mayer et al, 2006). Using a ChIP approach we also showed CTCF and 
CTCF-bio binding to the rDNA spacer promoter region in extracts of adult thymus (Supplementary 
Figure S4.1A).
To examine the functional significance of CTCF binding to the rDNA spacer promoter we 
generated a system to deplete CTCF in vitro. MEFs were isolated from mice homozygous for a 
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Figure 4.3 Chromatin organization by CTCF
A., B. Chromatin immunoprecipitations (ChIPs) 
on primary MEFs carrying the conditional Ctcf 
knock-out allele. MEFs were either infected 
(right hand panels) or not infected (left 
hand panels) with a lentivirus expressing Cre 
recombinase. Deletion of CTCF was measured 
by RT-PCR and was always found to be 
higher than 80 %. Nuclei were fixed with 1% 
formaldehyde, and protein-DNA complexes 
were immunoprecipitated with antibodies 
against the indicated proteins (RPA194, CTCF, 
and UBF in A, variant and modified histones in 
B). Primer sets, located in the 5 kb regulatory 
upstream of the gene promoter, are indicated 
with arrows. The location of spacer promoter, 
enhancer repeats and gene promoter are 
shown. Control: ChIP with rabbit IgG. C. 
Chromatin immunoprecipitations (ChIPs) on 
primary MEFs carrying the conditional Ctcf 
knock-out allele. MEFs were either infected 
(right hand panel) or not infected (left 
hand panel) with a lentivirus expressing Cre 
recombinase. ChIP on CTCF and H2A.Z was 
performed in the regulatory region upstream 
of the c-Myc transcriptional start site.
Ctcf conditional knockout allele (Ctcff, Heath et al, submitted) and the Ctcf gene was deleted 
by infecting confluent MEFs with a replication-deficient lenti-virus expressing Cre recombinase 
(Splinter et al, 2006). After four days of culturing only very low levels of Ctcf mRNA were detected 
by qRT-PCR (data not shown), and antibody staining revealed that only a small proportion of 
MEFs still expressed detectable levels of CTCF (data not shown). CTCF binding to the rDNA spacer 
promoter was virtually undetectable in cells treated with virus (Figure 4.3A, right panel, red line). 
These data demonstrate the specificity of the anti-CTCF antibodies in the ChIP experiments. In 
the absence of CTCF, binding of UBF and RNA polymerase I was severely reduced (Figure 4.3A, 
right panel, blue and green line, respectively). Remarkably, only binding at the spacer promoter 
was affected, i.e. the absence of CTCF did not significantly perturb RNA polymerase I binding to 
the gene promoter. Thus, CTCF exerts a local influence.
CTCF maintains specific histone marks at the spacer promoter
CTCF binding close to the c-Myc gene and in the Igf2/H19 locus is associated with high levels 
of histone H3 acetylation (Gombert et al, 2003; Pedone et al, 1999). We have shown that CTCF 
regulates local histone modifications such as histone H3 acetylation and H3K9/K27 dimethylation 
(Splinter et al, 2006). Recently, CTCF boundaries were found to be highly enriched for the histone 
variant H2A.Z, for all three states of H3K4 methylation, and for H3K9 monomethylation, but not 
for H3K9 di- or trimethylation (Barski et al, 2007). H2A.Z (Htz in yeast) was reported to act as a 
boundary that prevents the spreading of silent heterochromatin into flanking euchromatin regions 
(Meneghini et al, 2003). H2A.Z was also found to be enriched at promoter regions and represents 
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a characteristic of active genes in human and chicken (Barski et al, 2007; Bruce et al, 2005). 
We therefore examined the distribution of specific histone marks across the rDNA regulatory 
region in the presence and absence of CTCF. ChIP analysis in normal MEFs revealed peaks of 
histone H3 acetylation, H3K4 dimethylation and H2A.Z, and low levels of H3K9 dimethylation just 
upstream of the CTCF binding site (Figure 4.3B, left panel). In the absence of CTCF H2A.Z, H3K4 
dimethylation and H3 acetylation (i.e. marks of “active” chromatin and of insulator sites) were 
clearly downregulated (Figure 4.3B, right panel). Combined the data show that CTCF not only 
regulates local histone modifications at the spacer promoter but also the presence of a histone 
variant. 
Enrichment of H2A.Z at CTCF binding sites appears to be a general phenomenon (Barski et 
al, 2007; Boyle et al, 2008). Since we found that CTCF is responsible for depositing H2A.Z at the 
rDNA spacer-promoter, we tested whether this also occurs with H2A.Z sites near RNA polymerase 
II-dependent genes. We found that in the absence of CTCF H2A.Z is lost from the c-Myc promoter 
(Figure 4.3C). This results implies that CTCF can mediate deposition of this histone variant close 
to RNA polymerase I and II promoters. The constant levels of H3K9 dimethylation and histone H3 
in the rDNA locus (not shown) indicated that the observed loss of histone modifications and of 
H2A.Z were not caused by a local loss of nucleosomes in the absence of CTCF.
As the effect of a CTCF deletion was most pronounced on H2A.Z and RNA polymerase I 
binding, we analyzed the intracellular distribution of these proteins by immunofluorescence. In 
non-treated MEFs CTCF partially colocalized with H2A.Z (Supplementary Figure S4.2A), consistent 
with genome-wide ChIP results (Barski et al, 2007). Although signals were more intense in the 
nucleus both proteins were also detected in the nucleolus. Absence of CTCF did not cause 
obvious differences in the distribution of H2A.Z and RNA polymerase I (Supplementary Figure 
S4.3). A reduction in the local binding of RNA polymerase I without affecting global protein levels 
was also reported in cells where Cockayne syndrome B (CSB) was knocked down (Yuan et al, 
2007). UBF and other nucleolar markers (fibrillarin, nucleophosmin), as well as the maintenance 
methyltransferase Dnmt1, did not show obviously different staining patterns in cells with or 
without CTCF (data not shown). Immunofluorescence results were confirmed by RT-PCR (data 
not shown). These results indicate that local changes in DNA binding by specific proteins, that are 
seen in the absence of CTCF, are not the result of global changes in the levels of these proteins.
Identification of a conserved CTCF binding site in the rDNA locus
The ChIP experiments suggested the presence of a CTCF binding site near the spacer promoter 
of the mouse rDNA locus. We searched for potential binding sites within the mouse rDNA locus 
using our own algorithm. One site (R30), which conforms to the CTCF consensus sequence 
published recently (Kim et al, 2007), was found in the spacer promoter area (Figure 4.4A). A 
probe (also called R30) was designed and tested in bandshift analysis, using nuclear extracts 
of non-transfected cells and of cells overexpressing CTCF. The known chicken lysozyme F1 site 
(Arnold et al, 1996) was used as control. We detected binding of endogenous CTCF as well as 
bacterially purified GST-CTCF-ZF to the R30 probe (Figure 4.4B, lanes 6-10 and 11-13). Competition 
experiments indicated that CTCF binds the known FI probe less efficiently than R30, (Figure 4.4C, 
lane 3).  These data demonstrate that CTCF binds R30 through its ZF domain. Previous studies 
have shown that the mouse, rat and hamster rDNA repeats share significant sequence similarity 
in the spacer promoter region of the IGS (Tower et al, 1989). Rat and hamster rDNA also contain 
the CTCF binding site (Supplementary Figure S4.3A). Based on alignment information we mutated 
three residues within R30 and performed bandshifts with normal and mutant R30 probes. As 
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Figure 4.4 CTCF binds near the rDNA spacer promoter
A. Schematic representation of the mouse rDNA repeat. Transcription initiation from the spacer-promoter (yielding 
ncRNA) and the gene promoter (yielding pre-rRNA) is indicated by right pointing arrows. The 45S pre-rRNA is divided 
into 5’- and 3’-external transcribed spacer (ETS), internal transcribed spacers (ITS), and 18S, 5.8S and 28S rRNA genes. 
Positions of the CTCF consensus site (grey box), enhancer repeats (white boxes), TTFI binding sites (T) and probes used 
for RNA FISH (enh and u5ETS) are shown. The approximate position of the CTCF binding sites (H37.9 and H42.1) in the 
IGS of the human rDNA repeat are indicated above the mouse rDNA repeat by downward arrows. The sequence of 
the R30 oligo that contains the consensus site (underlined) is shown below the rDNA repeat. CpG di-nucleotides are 
indicated in grey, highly conserved CTCF consensus site residues are indicated by a dot (the asterisk indicates deviation 
between consensus site prediction and real residue). Nucleotides in bold were mutated (R30mut). B., C. EMSA analysis 
to verify binding of CTCF to mouse rDNA. Bandshifts were performed using a known CTCF binding site probe (F1, chicken 
lysozyme) as control, the spacer promoter probe (R30), which is close to the PCR fragment used for ChIP, and the mutated 
R30 site (R30mut). Extracts of HEK293T cells (increasing amounts are indicated), either non-transfected or transfected 
with CTCF (+CTCF), were incubated with the indicated probes. Competitor (non labelled probe) was added in 300-fold 
excess. Bandshifts were also done with purified bacterial proteins (GST only and zinc-fingers of CTCF tagged with GST). D. 
CTCF interacts with human rDNA in vivo. ChIP analysis with CTCF and UBF antibodies showing CTCF binding to the IGS of 
the rDNA repeat. Chromatin was prepared from K562 cells stably transfected with CTCF (KCTCFD11) and the empty vector 
(KpCDNA). Relative enrichment was quantified by real-time PCR with the indicated primer sets. A known CTCF target site 
(MYC-N) was used as positive control for ChIP. Data were normalized against the enrichment for the negative control 
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shown in Figure 4.4C CTCF binds less efficiently to mutant R30 (lanes 5 and 7). Thus, we have 
identified a novel CTCF binding site in the mouse rDNA repeat that serves to assemble important 
RNA polymerase I associated factors. The site is conserved in rat and hamster rDNA repeats. 
Interestingly the CTCF-binding site includes two CpG residues, indicating it can be methylated in 
vivo.
The IGS of the human rDNA repeat is completely divergent in sequence from the mouse 
IGS (Supplementary Figure S4.4) and the presence of a spacer promoter has to our knowledge 
not been described. Despite this divergence we identified two potential CTCF binding sites in 
the rDNA repeat 0.9 kb and 5.1 kb upstream of the ribosomal gene promoter (called H42.1 and 
H37.9, respectively, see Figure 4.4). ChIP analysis revealed occupancy of CTCF in the rDNA at 
H42.1 and H37.9 sites (Figure 4.4D). The MYC-N probe was used as positive control for CTCF 
binding (Ohlsson et al, 2001). We also found binding of UBF to these rDNA regions, as described 
(Mais et al, 2005). Binding of CTCF was more prominent in the region near H42.1 than near 
H37.9 (Figure 4.4D). ChIP results were confirmed in vitro by EMSA analysis (Figure 4.4E). Nuclear 
extracts from cells transfected with CTCF showed stronger binding to H42.1 and H37.9 rDNA 
probes (Figure 4.4E, lanes 5, 8 and 12) compared to extracts from mock-transfected cells (Figure 
4.4E, lanes 4 and 11). The specificity of the binding was shown by competition with unlabeled 
probes (Figure 4.4E lanes 7, 10 and 14) and by supershifts using anti-CTCF antibody (Figure 4.4E 
lanes 6, 9 and 13). Incubation with an anti-actin antibody, used as a negative control, did not 
produce supershifts (data not shown). Altogether these results demonstrate that CTCF associates 
at very similar positions within the IGS of mouse and human rDNA. Why CTCF binds twice in 
human and only once in mouse rDNA is unclear, but it might be linked to the presence of a highly 
repetitive region of Alu repeats in the human rDNA (Supplementary Figure S4.4).
CTCF regulates transcription from the spacer promoter
We next examined the effect of a CTCF deletion on steady state RNA levels using total RNA 
isolated from Ctcff/f MEFs that were either treated or not treated with Cre virus. Using northern 
blot analysis we could not consistently detect an effect on the ratio of pre-rRNA (45S) compared 
to Gapdh mRNA in CTCF depleted MEFs (Figure 4.5A). Furthermore, the ratio of mature 18S rRNA 
versus Gapdh mRNA was comparable in normal and CTCF-depleted cells. These results indicate 
that a deletion of CTCF does not affect steady state rRNA amounts in confluent fibroblasts.
Using nuclear run-on analysis we investigated transcription from spacer and gene promoters 
in the presence and absence of CTCF. In non-treated Ctcff/f MEFs we observed higher transcription 
from the spacer promoter than from the gene promoter (Figure 4.5B). This result is consistent with 
published data (Espada et al, 2007; Kuhn & Grummt, 1987). Deletion of CTCF significantly reduced 
transcription from the spacer promoter but did not affect transcription from the ribosomal gene 
promoter (Figure 4.5B). These results suggest that CTCF regulates transcription from the spacer 
promoter and that it does so independently of transcription from the gene promoter.
3T3L1 cells can be differentiated into adipocytes, which results in the repression of rRNA 
MYC-H.1 (Gombert et al, 2003). The value for the amount of PCR product present from ChIP assay without antibody was 
set as 1 (white bars). Error bars represent s.e.m. of five to seven independent experiments for CTCF and two for UBF. E. 
CTCF interacts with human rDNA in vitro. EMSA analysis with nuclear extracts from 293T cells or K562 cells transfected 
with CTCF or mock transfected. P32-labelled PCR fragments of MYC-N (positive control), H42.1 rDNA and H37.9 rDNA 
were used as probes. Unlabeled (cold) probes were used as competitors. Arrowheads indicate binding of CTCF; asterisks 
indicate supershift bands that appear after incubation with anti-CTCF antibody.
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Figure 4.5 CTCF regulates spacer promoter transcription
A. Northern blot analysis. Total RNA was isolated from Ctcff/f primary MEFs either treated (+) and or not treated (-) with 
Cre (2 samples are shown of each genotype, >10 independent samples were analyzed per genotype). RT-PCR confirmed 
Ctcf deletion (>90 %, not shown) in Cre-treated samples. RNA was blotted and analyzed sequentially with a probe against 
the 5’ ETS region (Akhmanova et al, 2000), which clearly reveal the 45S pre-rRNA precursor, and a probe against Gapdh. 
As the same blot was used, the 45S rRNA is still observed in the second hybridization. B. Spacer promoter transcription is 
repressed in the absence of CTCF. A nuclear run-on analysis was performed for RNA polymerase I-mediatedtranscription 
(α-amanitin added at 100 ug/ml) on the spacer- and gene promoters in Ctcff/f primary MEFs either treated (+) and or 
not treated (-) with Cre. In the upper panel the result of a typical run-on experiment is shown, the graph represents the 
average of three independent experiments (*: P< 0.02, student t-test). C.,D. Chromatin immunoprecipitations (ChIPs) 
on undifferentiated (C) and differentiated (D) 3T3L1 cells. Nuclei were fixed with 1% formaldehyde, and protein-DNA 
complexes were immunoprecipitated with antibodies against the indicated proteins (RPA194, CTCF, UBF and histone H4 
acetylation).
transcription by more than half (Li et al, 2006). Increased heterochromatin features at the rDNA 
promoter, such as DNA methylation and histone H4 hypoacetylation, accompany this repression 
(Li et al, 2006; Santoro et al, 2002). Using this cell system we investigated CTCF, UBF and RNA 
polymerase I binding on the rDNA repeat. ChIP analysis revealed binding of all three proteins 
at the spacer promoter (Figure 4.5C). The binding patterns were indistinguishable from MEFs, 
demonstrating that binding at the spacer promoter is similar in different cell types. As reported 
before (Li et al, 2006) UBF and RNA polymerase I binding to the rDNA repeat were reduced in 
differentiated 3T3L1 cells (Figure 4.5C, D). Interestingly, also CTCF binding was reduced by half 
in differentiated compared to undifferentiated 3T3L1 cells (Figure 4.5C, D). The fact that turning 
down transcription and increasing methylation in 3T3L1 cells affects CTCF binding suggests that 
CTCF might mark the active ribosomal genes in a methylation-sensitive manner. 
Localization of spacer-promoter-derived transcripts
Transcripts arising from the spacer promoter are highly unstable, i.e. they are quickly processed 
into much smaller products (Mayer et al, 2006). The 3’ end product of the spacer-promoter-
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Figure 4.6 Localization of transcripts from the spacer-
promoter
A.-L. RNA FISH on MES cells. Proliferating MES cells were fixed 
and hybridized with a digoxygenin-labelled (green) unstable 5’ 
ETS probe (Akhmanova et al, 2000), which marks all transcribing 
nucleoli, and with a biotin-labelled (red) oligonucleotide 
against the enhancer region. Cells were counterstained 
with DAPI. Two cells that have just undergone mitosis are 
indicated by large arrows. Small arrows indicate enhancer 
signal in nucleoli of cells in interphase. M.-O. Combined RNA-
immuno FISH on MES cells. Proliferating MES cells were fixed 
and hybridized with a biotin-labelled oligonucleotide against 
the enhancer region (red) and subsequently incubated with 
antibodies against phosphorylated histone H3, a cell cycle 
marker. Cells were counterstained with DAPI.
derived transcript binds the Nucleolar Remodelling Complex (NoRC) with high affinity, and is 
required for its activity (Mayer et al, 2006). To examine the intracellular distribution of spacer-
promoter-derived transcripts we performed RNA FISH using a biotinylated oligonucleotide probe 
against the 5’ end region of the spacer-promoter-derived transcript and a digoxygenin-labelled 
probe covering the the 5’ external transcribed spacer (ETS), which marks all nucleoli (Akhmanova 
et al, 2000). We analyzed spacer-promoter-derived transcripts in rapidly proliferating MES cells. 
The advantage of using this cell type is that all phases of the cell cycle are well represented, 
whereas confluent MEFs accumulate in G1.
Spacer-promoter-derived transcripts were most readily detected in cells with compacted 
nuclei (Figure 4.6A-C, large arrows). Signal was often detected in two nearby nuclei, indicative of 
cells exiting mitosis. In cells with larger nuclei we occasionally observed a weak spacer-promoter-
derived signal (Figure 4.6A-C, small arrows). The staining patterns of spacer-promoter-derived 
and 5’ETS probes were overlapping but not identical (Figure 4.6E-L), suggesting a different spatial 
coordination. These data indicate that spacer promoter transcription is highly regulated during 
the cell cycle and underscore the conclusion that transcription from the spacer promoter can 
occur independently of the gene promoter.
Histone H3 is specifically phosphorylated during mitosis, whereas upon exit of mitosis a 
global dephosphorylation of H3 can be observed (Hans & Dimitrov, 2001). We performed immuno-
FISH experiments with the biotinylated probe against spacer-promoter-derived transcripts, 
in combination with antibodies against phosphorylated H3, to examine at which stage of the 
cell cycle spacer promoter transcription is most active. Our analysis revealed that both cells in 
metaphase and telophase contained spacer-promoter-derived transcripts (Figure 4.6M-O). These 
data indicate that transcription from the spacer promoter is most active at the end of mitosis.
112 Chapter 4
Discussion 
Here we identify UBF as the first common interaction partner of CTCF and CTCFL. This 
emphasizes a role for both proteins in the proper chromatin organization of the rDNA repeats. 
We demonstrate a direct interaction between the ZF domains of CTCF and CTCFL and HMG box1 
and the dimerization domain of UBF, explaining the observation that CTCF and CTCFL compete 
for binding to UBF. CTCF and CTCFL may act antagonistically in cultured cells (Vatolin et al, 2005). 
It remains to be determined whether this is the case in rRNA transcription.
We did not observe a clear accumulation of CTCF in nucleoli of MEFs, even though we 
showed an important role for CTCF in ribosomal spacer promoter transcription. This is not 
uncommon, for example, c-Myc is also hardly found in the nucleolus, but is very important for 
rDNA transcription (Arabi et al, 2005). If CTCF is only bound to non-methylated rDNA and one 
CTCF molecule is present per mouse rDNA repeat, then with about half of the rDNA repeats being 
completely methylated (Brock & Bird, 1997) we expect ~200 CTCF molecules in the nucleolus. 
This small number explains why nucleolar CTCF is difficult to detect by immunofluorescence 
procedures in MEFs. UBF on the other hand is abundantly present in the nucleolus, binding with 
~100 molecules per active rDNA repeat. Thus in MEFs only a small fraction of CTCF interacts with 
UBF. This observation and the fact that UBF is highly dynamic (Chen & Huang, 2001) makes it 
likely that the interaction between CTCF and UBF is transient. 
HMG-boxes are involved in protein-protein interactions and DNA binding. The dimerization 
domain of UBF is involved in the formation of hetero- and homodimers (O’Mahony et al, 1992). 
A combination of the dimerization domain and the first three HMG-boxes of UBF is important 
for the formation of small ~175bp DNA loop structures, called enhancesomes (Stefanovsky et al, 
2001), which bring UBF-bound enhancers in close contact to the gene promoter (Bazett-Jones 
et al, 1994; Sullivan & McStay, 1998). The fact that CTCF interacts with the first HMG box of 
UBF argues against cooperative binding of these proteins to DNA, since HMG-box 1 is absolutely 
necessary for UBF binding to DNA (Putnam et al, 1994). Instead, the UBF-CTCF interaction might 
be important for the recruitment of RNA polymerase I to the spacer promoter. Direct binding 
by CTCF to components of the RNA polymerase I complex, as suggested by our mass spec data, 
might aid in this recruitment. Alternatively, CTCF may load UBF on rDNA. UBF, as part of the 
architectural HMG box protein family, might change the topology of the spacer promoter, thereby 
facilitating binding of other factors (Bazett-Jones et al, 1994; Chen et al, 2004).
The importance of CTCF binding near the mouse spacer promoter is underscored by the 
observation that CTCF binding sites are present at similar positions in rat, hamster and human 
rDNA repeats, despite the fact that the IGS’s of these different species are not conserved. ChIP 
analysis shows enrichment of CTCF on two binding sites in K562 cells indicating that CTCF might 
have additional regulatory functions in the human rDNA repeat. Interestingly, a prominent 
nucleolar localization of CTCF was described in K562 cells, which correlates with poly(ADP-
ribosylat)ion and growth arrest of cells (Torrano et al, 2006). Post-translational modifications 
may alter the function of CTCF and influence its interactions. In future studies we will address this 
issue in more detail. Previously, the Xenopus laevis rDNA repeat was reported to contain multiple 
weak CTCF binding sites near its spacer promoter (Bell et al, 1999). Although a physiological 
significance for rDNA transcription was not investigated the result is consistent with our data.
In differentiated 3T3L1 cells reduced binding of CTCF correlates with decreased RNA 
polymerase I binding at the spacer promoter. In MEFs CTCF is essential for the highly localized 
binding of RNA polymerase I and H2A.Z. In the absence of CTCF not only these factors and UBF 
bind much less efficiently, also histone modifications associated with gene activity are reduced 
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Figure 4.7 Models for CTCF function in the rDNA locus
A. Conserved function for CTCF as a local organizer of chromatin. The left hand panel depicts the local chromatin 
environment around CTCF-positive RNA polymerase II promoters, data are based on (Boyle et al, 2008). The graph 
represents an average of multiple active promoters analyzed. Position relative to the transcriptional start (TSS, indicated by 
right pointing arrow) is indicated in base pairs. Peak height is indicative of relative enrichment. HS: DNaseI hypersensitive 
site. The right hand panel represents results of our ChIP analysis in the mouse rDNA locus (note that the accuracy of this 
representation is lower than the actual experiment). The position of the HS is based on (Langst et al, 1997). Positions 
are relative to the transcription initiation site of the spacer promoter. B. A balance between active and inactive rDNA 
repeats. The upper cartoon represents an active (or potentially active, or “poised”) rDNA repeat. CTCF is bound upstream 
of the spacer promoter, thereby regulating the deposition of other critical factors, enhancing transcription of ncRNA, and 
maintaining the fraction of active repeats. ncRNAs are processed and the 3’end product is bound by NoRC, which can 
then act “in trans” to maintain the balance of inactive rDNA repeats (lower cartoon).
and spacer promoter transcription is downregulated. This is the first example of a role for CTCF 
in maintaining promoter activity by regulating the presence of specific histone marks and RNA 
polymerase components.
A subset of the 15,000 CTCF binding sites in the human genome (Barski et al, 2007) have been 
shown to be located immediately upstream of RNA polymerase II promoters (Boyle et al, 2008). 
As depicted in Figure 4.7A, there is a striking similarity in the organization of these promoters 
and of the RNA polymerase I-regulated spacer promoter. First, in both types of promoters CTCF 
binds ~200 bp upstream of the TSS. Second, in both promoters a DNAseI HS has been described 
(Boyle et al, 2008; Langst et al, 1997), which is located in between the TSS and CTCF binding site. 
Furthermore, 200-300 basepairs upstream of the CTCF binding site enrichment of H2A.Z and of 
H3K4me2 (and H3K4me3) is detected in both types of promoters. In the case of RNA polymerase 
II promoters, these modifications were shown to mark active or “poised” promoters. H2A.Z was 
suggested to prevent spreading of heterochromatin into, for example, promoter regions (Fan et 
al, 2004; Meneghini et al, 2003; Raisner & Madhani, 2006). We show here that CTCF is required 
for H2A.Z accumulation at genes transcribed by RNA polymerase I and II. We also demonstrate a 
critical role for CTCF in spacer promoter transcription. We therefore propose that when CTCF is 
bound immediately upstream of a promoter, it is essential for the local organization of chromatin 
near that promoter and is required for proper transcription. Interestingly, it was reported recently 
that the transcription factors p53 and c-Myc provide positioning cues that direct the location 
of H2A.Z-containing nucleosomes (Gevry et al, 2007). We hypothesize that CTCF also regulates 
transcription of genes by positioning H2A.Z within chromatin.
The biological function of the spacer promoter and the ncRNA transcript that is generated 
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from it are still poorly understood. Early experiments suggested that the spacer promoter, as 
well as the enhancer region that is often located in between spacer and gene promoters, act 
together to stimulate pre-rRNA transcription (De Winter & Moss, 1986; Grimaldi et al, 1990; 
Tower et al, 1989). More recent experiments have shown that ncRNAs generated from the spacer 
promoter are unstable; transcripts are rapidly processed and degraded and only the 3’ end (~150 
nt) of the transcript, that matches the rDNA gene promoter, is bound to NoRC (Mayer et al, 
2006). Surprisingly, in this context the spacer-promoter transcript functions in rDNA silencing 
instead of activation (Mayer et al, 2006). This appears to be at odds with earlier results. Our data 
uncouple the regulation of spacer promoter and gene promoter transcription both in terms of 
cell cycle control and in terms of regulatory factors. For example, we show that in rapidly dividing 
cells transcription of the spacer promoter peaks immediately after mitosis. CTCF remains bound 
to mitotic chromosomes (Burke et al, 2005), and it could therefore aid in the upregulation of 
spacer promoter transcription at the end of mitosis. During cell division specific chromatin states 
must be inherited from one generation to the next. We speculate that the increased expression 
of ncRNAs from the spacer promoter at the end of mitosis is required to regulate or mark the 
fraction of active and inactive rDNA repeats.
 We propose a model that incorporates our results into other published data (Figure 4.7B). 
There is a link between inactive rDNA repeats and DNA (hyper)methylation (Grummt, 2007). 
As CTCF binding is sensitive to methylation (Renda et al, 2007) and CTCF binding sites on the 
rDNA contain CpG residues, methylation of these sites may regulate CTCF binding and CTCF may 
therefore act as a methylation-sensitive binary switch that marks a subset of active or “poised” 
ribosomal genes. CTCF binding allows the set-up of an appropriate chromatin environment for 
transcription from the spacer promoter. Consistently, under conditions of repressed pre-rRNA 
transcription in differentiated 3T3L1 cells (Li et al, 2006) CTCF binding to the spacer promoter 
is reduced. Transcription from the spacer promoter is stimulated by CTCF. By generating spacer 
promoter transcripts CTCF is indirectly “feeding” NoRC with its 3’end degradation product. 
The association of NoRC to this short RNA molecule is required for NoRC binding to chromatin 
and for heterochromatin formation. This results in establishment and maintainance of inactive 
rDNA repeats by NoRC (Santoro et al, 2002). We propose that CTCF and NoRC are involved in 
balancing active and inactive rRNA genes and that the ncRNAs coming off one CTCF-driven spacer 
promoter act “in trans” together with NoRC to maintain inactive rDNA repeats. An important 
role in this balance is necessarily played by processing factors that degrade the spacer transcript 
and generate the NoRC substrate. Recent data implicate such factors in the regulation of rRNA 
transcription (Prieto & McStay, 2007).
Materials and methods
Antibodies
CTCF N3 rabbit polyclonal and RPA194 rabbit polyclonal were generated as described (Heath et al submitted) 
(Hoogstraten et al, 2002). The CTCFL polyclonal antibodies are described elsewhere (Sleutels et al, manuscript 
in preparation). Anti-Histone H2A.Z (ab4174), anti-dimethyl-Histone H3 (Lys4) (ab7766), anti-Histone H3 
(ab1791) antibodies were from Abcam. Anti-acetyl Histone H3 (06-599), anti-acetyl Histone H4 (06-866), 
anti-dimethyl-Histone H3 (Lys9) (07-441) antibodies were from Upstate. Anti-UBF (sc-13125) antibody is 
from Santa Cruz. Streptavidin-HRP (RPN1231VS) and secondary HRP labeled anti-mouse (NA931VS) and 
anti-rabbit antibodies (NA934V) are from Amersham. Anti-HIS antibody is from Qiagen.
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Cell lines, transfections and lentiviral transduction
To generate the Ctcfbiof knock-in allele, a CTCF-TEV-bio in-frame fusion DNA was generated by PCR. The 
biotinylation sequence has been published (de Boer et al, 2003), the TEV (Tobacco Etch Virus) protease 
cleavage site of seven amino acids was based on published data (Dougherty & Parks, 1989). The loxP-Neo-
loxP vector (Neo: neomycin resistance gene) has been described (Hoogenraad et al, 2002). The 5’-end and 
3’-end homology arms from the Ctcf gene were generated by PCR using mouse 129 PAC clones (Osoegawa 
et al, 2000) as template. A schematic representation of the knock-in construct is shown in Fig. 1A. Targetting 
into IB10 129 embryonic stem (ES) cells was performed as described (Hoogenraad et al, 2002). ES cell DNA 
was analyzed by Southern blot using radiolabeled probes outside of the region of homology (see Fig. 1A). 
For confirmation of homologous recombination we used different 5’ end and 3’ end probes as well as a PCR-
based genotyping assay (for primer sequences, see Supplementary Table S4.2).
Ctcfbio/f ES cells were transfected with CMV-Cre to remove the neomycin resistance cassette. These 
cells were used in a second round of homologous recombination to target the Rosa26 locus with a construct 
encoding HA-tagged BirA (Driegen et al, 2005). Verification of homologous recombined clones was in this 
case done by PCR only (for primer sequences, see Table S3). Control BirA-positive ES cell lines used in the 
different experiments, have been described previously (Driegen et al, 2005).
3T3L1 cells were purchased from the ATCC (CL-173). The culturing and differentiation of 3T3L1 cells 
was done as described (Li et al, 2006). 293T cells were cultured as described (Splinter et al, 2006). The Ctcff/f 
primary mouse embryonic fibroblasts (MEFs) were isolated as described (Akhmanova et al, 2005) from 
E13.5 embryos derived from conditional Ctcff/f knockout mice (Heath et al, manuscript in preparation).
Transient transfections in 293T cells with Flag-UBF and pcDNA3-CTCFL were done using 
LipofectamineTM2000 (Invitrogen) or Optimem (GiboBRL). Cells were analyzed 24 hours after transfection. 
Cre-lentivirus production and transduction of confluent primary CTCF cKO MEFs was done as described 
(Splinter et al, 2006), with the exception that cells were split and diluted two-fold 24h after transduction. 
Virus titers and Cre functionality were tested using serial dilutions. Recombination was tested after 4 days 
of infection by quantitative RT-PCR.
KCTCFD11 is a subline derived from K562 myeloid leukemia cells, which is stably transfected with a 
constitutive CTCF expression vector and which overexpresses moderate CTCF levels (2-3-fold) compared 
to cells transfected with the empty vector (KpCDNA subline) (Torrano et al, 2005). For EMSA experiments, 
293T cells or K562 cells were transfected with 8 μg of pcDNA3-CTCF expression vector (Torrano et al 2005) 
using LipofectamineTM2000 (Invitrogen).
Affinity chromatography and size fractionation 
Nuclear extracts were prepared as described (Splinter et al, 2006). Salt concentration in the extract was 
adjusted to 100 mM NaCl. Unless stated differently all immunoprecipitation (IP) and pull down reactions 
were performed in 100 mM NaCl, 0.3% NP40, 20 mM Hepes pH8, 0.2 mM EDTA, 10 mM MgCl2, protease 
inhibitors. Benzonase (Novagen) was sometimes added to remove DNA and RNA. Streptavidin pulldowns 
were done as described (Rodriguez et al, 2005) with the exception that wash buffer and binding buffer were 
the same as the IP buffer indicated here. For IPs nuclear extracts were pre-cleared at 4°C using Protein A 
sepharose beads. Washes were done at 4°C in wash buffer (100 mM NaCl, 20 mM Tris pH7.5, 0.3% NP40 
and protease inhibitors (Complete; Roche)). IPs were performed by adding antibodies to the samples 
and incubating for 1h at 4°C. Subsequently protein-A sepharose beads were added and incubation was 
continued for another hour at 4°C while rotating. Beads were washed six times with wash buffer. Flag-IPs 
were performed using the same protocol as for IPs except that anti-flag M2 agarose (Sigma) incubation was 
performed for 3h at 4°C.
HIS-tagged UBF fusion proteins were generated by PCR using mouse UBF cDNA from a FLAG-tagged 
UBF construct (a kind gift of Dr. I. Grummt). Primers contained NheI and BamHI sites for subcloning into 
the pET28a vector. HIS-tagged proteins were purified using Ni-NTA (Qiagen) and eluted from the beads 
with 200 mM imidazole in 20 mM Hepes (pH 7.5), 100mM KCl, 10 mM beta mercaptoethanol, 10% glycerol 
(v/v). Imidazole was removed by dialysis. GST-tagged fusions of mouse CTCF and CTCFL were amplified 
using mouse CTCF (IMAGE 6825952) and CTCFL (Sleutels, unpublished) cDNAs as templates. cDNAs were 
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cloned into pGEX-3X and purified using glutathione-Sepharose 4B (Amersham Biosciences). Chicken CTCF 
GST tagged fusion proteins were described previously (Lutz et al, 2000). Pull downs were performed in 
binding buffer (20 mM Tris-HCl pH 8, 100 mM NaCl, 0.05% Triton X-100) for 2 h at 4°C. Washes were done 
in high salt wash buffer (20 mM Tris-HCl pH8, 400 mM NaCl, 0.05% Triton X-100). GST pull downs on ES cell 
nuclear extracts were done using the binding and washing conditions as described in the IP section.
Size fractionation of protein complexes was done on an AKTA FPLC apparatus with a Superose 6 10/30 
column (Amersham Biosciences). Fractions were precipitated with 100% trichloroacetic acid and analyzed 
by western blotting as described (Lansbergen et al, 2006). Molecular size standards were thyroglobulin (670 
kD) and albumin (66 kD) (Amersham Biosciences).
SDS-PAGE, western blot analysis and mass spectrometry
Bound proteins were eluted from beads by boiling in sample buffer (1x Laemmli buffer). For western blot 
analysis samples were electrophoresed on SDS polyacrylamide gels and blotted onto PVDF membranes 
(MilliPore) using a semi-dry blotting apparatus (Biorad). Signal detection was performed using ECL 
(Amersham).
For mass spectrometry samples were treated and analyzed as described (Wilm et al, 1996). Data 
analysis and protein identification was done as reported (Lansbergen et al, 2006). The Mascot search 
algorithm (version 2.0, MatrixScience) was used for searching against the NCBI database (release date: 
14/10/05 exp1; 21/10/05 exp2 and 3; 6/1/06 exp4; 5/3/06 exp5; taxonomy: Mus musculus). The Mascot 
score cut-off value for a positive protein hit was set to 60. Individual peptide MS/MS spectra with Mowse 
scores below 40 were checked manually and either interpreted as valid identifications or discarded.
Chromatin immunoprecipitation 
We used mouse (Acc. Number: BK000964), human  (Acc. Number: U13369), rat (Acc. Number: X04084) 
and hamster (Acc. Number: DQ235090) rDNA sequences for alignments, PCR and ChIP experiments and for 
probe generation.
Preparation of crosslinked chromatin (2x107 cells treated with 1% formaldehyde for 10 minutes at 
RT), sonication to 300-800 base pair fragments and immunoprecipitations were as described in the Upstate 
protocol (http://www.upstate.com). At least two independent chromatin immunoprecipitations (ChIPs) were 
carried out per experiment. For streptavidin ChIPs exceptions to the protocol were as follows: streptavidin 
beads blocked for 1h RT in 0,2mg/ml sonicated salmon sperm DNA were used, elution was performed 
O/N at 65°C in elution buffer (0,1% NaHCO3, 1% SDS, 0,2M NaCl). Quantitative real-time PCR (Opticon I, 
MJ Research and MyiQ ,Biorad) was performed using SYBR Green (Sigma), Platinum Taq DNA Polymerase 
(Invitrogen) and 100ng of each primer under the following cycling conditions: 95°C for 3 min.,  40 cycles of 
10s at 95°C, 30s at 60°C, 15s 72°C (during which measurements are taken). Enrichment for a specific DNA 
sequence was calculated using the comparative Ct method, and normalized to amylase. PCR products were 
all smaller than 150 bp. Sequences of primers are shown in Supplementary Table S4.3.
For ChIP analysis with nuclei derived from human cell lines 5 x 107 cells were fixed in 1% formaldehyde, 
lysed and sonicated (4 bursts). The ChIP was performed by using Dynabeads-Protein G (Dynal Biotech) 
coupled to anti-CTCF () and anti-UBF (Santa Cruz Biotechnology F9). Dynabeads were incubated with lysates 
for 4 h at 4ºC and washed consecutively with Low Salt, High Salt and LiCl Immune Complex Wash Buffers 
(Upstate). Chromatin was eluted with 200 µl of elution buffer (Upstate), decrosslinked for 8h at 65ºC and 
purified through Qiaquick columns (Qiagen). Real-time PCR of immunoprecipitated DNA was performed 
with primers shown in Table S5. MYC-N amplicon was used as positive control (Ohlsson et al, 2001) and 
MYC-H.1 amplicon as negative control (Gombert et al, 2003) for CTCF binding sites.
Electrophoretic mobility shift analysis (EMSA)
The EMSA, or bandshift analysis, was performed using extracts from mouse and human cells. For the first 
protein extract was preincubated with bandshift buffer (10% Glycerol, 20 mM Hepes pH7.4, 20 mM KCl, 1 
mM MgCl2, 5 mM DTT, 10 μM ZnCl2, 100 μg/ml BSA, 0.02% NP40) and 2-4 μg of salmon sperm DNA as a 
non-specific competitor. The reaction was incubated for 20 min. at the room temperature. Upon addition 
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of the 32P end-labeled probe the binding reaction was performed for 20 min. Complexes were analyzed by 
electrophoresis through a 5% acrylamide (37,5:1) 0.5x TBE non-denaturing gel at 8V/cm2 at 4°C. When 
specified 300 fold excess of unlabeled probe or specific competitor was added at the same time as the 
probe.
For human cells nuclear extracts from 293T cells or K562 cells were prepared as described. EMSA was 
carried out using P32-labelled PCR fragments (MYC-N, H42.1 rDNA and H37.9 rDNA, see primer sequences 
above) and 10 μg of protein from nuclear extracts. For supershift experiments, 1 μl of anti-CTCF mouse 
monoclonal (BD Biosciences) or anti-actin (Santa Cruz Biotechnology sc-1616, used as non-specific antibody) 
was added to the binding reaction prior to the radiolabeled probe. Sequences of primers using for the EMSA 
are shown in Supplementary Tables S4.1 and S4.5.
Northern blot analysis
Total RNA was isolated using RNA-Bee RNA isolation solvent (Tel-Test Inc.). Approximately 6 mg of total RNA 
was size separated by gel electrophoresis and blotted onto Hybond N+ membrane (Amersham). Probes 
were radioactively labeled by PCR. Blots were exposed to PhophorImager screens (Molecular Dynamics) to 
quantify results. Sequences of primers are shown in Supplementary Table S4.4.
Fluorescent in situ hybridization (FISH) and immunofluorescence analysis
Fluorescent in situ hybridization (FISH) experiments were carried out on MES cells as described previously 
(Akhmanova et al, 2000). The unstable 5’ETS probe has been described (Akhmanova et al, 2000), the 
enhancer oligonucleotide was ordered from Eurogentec and was prelabelled with biotin-UTP.
For immunofluorescent staining cells were fixed in 4% paraformaldehyde/PBS for 15 minutes at RT, 
permeabilised in 0,15% Triton X-100 in PBS, blocked in 1% bovine serum albumin in PBS and incubated with 
antibodies as described previously. We used FITC-conjugated goat antibodies against rabbit and mouse IgG 
were purchased from Molecular probes and Alexa 594-conjugated goat anti-rabbit antibody from Nordic 
Laboratories as secondary antibodies. Images of cells were collected with a Leica DMRBE microscope 
equipped with a Hamamatsu ORCA ER camera, or with a Zeiss LSM510 confocal, as described (Lansbergen 
et al, 2006).
Nuclear run-on
Cells were collected and washed twice with cold PBS. The cells were lysed in nuclear isolation buffer (10 mM 
Tris pH7.5; 10 mM NaCl, 10 mM MgCl2, 0.5% NP40). The nuclei were spun at 2000 rpm and resuspended 
in storage buffer (50 mM Tris pH8.5, 0.1 mM EDTA, 5 mM MgCl2, 40% glycerol) 1.106 nuclei (50 μl) were 
pre-incubated for 20 min. on ice with 100 ug/ml α-aminitin. Nuclei were than mixed with 50 ul 2x reaction 
buffer (300 mM KCl; 5 mM MgCl2; 10 mM Tris PH7.5; 5 mM DTT; 20U RNA guard 0.5 mM of each ATP, 
UTP, GTP and 100 μCi of alpha-32P CTP (800 Ci/mmol, 10 mCi/ml, Amersham). The labeling reaction was 
performed for 30 min. at 30°C. The reaction was stopped on ice by adding 1ml of RNA-Bee and total RNA 
was extracted as indicated above. Using a slot blot hybridization system with Hybond-N+ nylon membranes 
(Amersham Pharmacia Biotech), 5 μg of DNA PCR fragments was hybridized with ± 2x105 c.p.m. of labeled 
RNA. Hybridization and detection wash done as described in the ES cell targeting section. Incubation was 
performed in 2 ml of Churchhyb-mix (0,5 M Na2HPO4 pH 7.2, 7% SDS, 1 mM EDTA) in a rotating hybridizer 
at 65°C for 24h. Membranes were washed extensively at 65°C with Church wash-buffer (40 mM Na2HPO4 
pH 7.2, 1% SDS). Hybridization signals were quantified with a Phoshor Imager (Typhoon Amersham) using 
Imagequant software. Signal was corrected for the amount of CTGs in the probe. Sequences of primers are 
shown in Supplementary Table S4.4.
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Figure S4.1 Characterization of CTCF and CTCF-bio in thymic extracts
A. rDNA spacer promoter ChIP analysis. Extracts of adult thymus from wild type and Ctcfbio/+; Rosa26bira/+ mice were 
analyzed for CTCF and CTCF-bio binding to the rDNA spcaer promoter using anti-CTCF antibodies or a control serum (-). 
B. Western blot analysis. Streptavidin pull downs on thymus nuclear extracts isolated from mice expressing biotinylated 
CTCF (CTCF-bio) or non-tagged CTCF (-).
Figure S4.2 Immunofluorescence analysis in primary MEFs
Primary MEFs carrying the conditional Ctcff knock-out allele were either infected (+ Cre) or not infected (- Cre) with a 
lentivirus expressing Cre recombinase. Cells were fixed and incubated with antibodies against the indicated proteins. 
Cells were counterstained with DAPI (blue). The right hand panels show a merge.
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Figure S4.3 Comparison of mouse, rat and hamster rDNA repeat regions
A. Comparison of nucleotide sequences of the mouse, rat and hamster rDNA repeats. Only the regions around the spacer 
promoter are indicated. The CTCF consensus site (Kim et al, 2007) is underlined. CpG di-nucleotides are boxed, highly 
conserved CTCF consensus site residues are indicated by a dot (the asterisk indicates deviation between consensus site 
prediction and real residue).
Figure S4.4 Comparison of mouse and human rDNA 
repeat regions
A. Matrix plot comparison of nucleotide sequences of 
mouse and human rDNA repeats in the region upstream 
of the gene promoter. No significant similarity is 
detected. B. Matrix plot comparison of the nucleotide 
sequence of the human rDNA repeat in the region 
upstream of the gene promoter. Notice the presence of 
a highly repetitive Alu element ~2.5 kb upstream of the 
gene promoter. Remarkably CTCF binding sites (H37.8 
and H42.1) surround this repeat. It is unknown where 
the spacer promoter is localized in the human rDNA. C. 
Matrix plot comparison of the nucleotide sequence of the 
mouse rDNA repeat in the region upstream of the gene 
promoter. The CTCF binding site is indicated. It precedes 
the enhancer repeat region. One could imagine that the 
different local environment of human and mouse rDNA 
repeats has caused a difference in CTCF binding.
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Table S4.1. Primers used for bandshifts
name sequence (5’ to 3’)
R30s TGTATGGTTGATCGAGACCATTGTCGGGCGACACCTAGTGGTGACAAGTTTCGGGAACGCTCCAGGC
CTCT
R30as AGAGGCCTGGAGCGTTCCCGAAACTTGTCACCACTAGGTGTCGCCCGACAATGGTCTCGATCAACCA
TACA
R30mut-s TGTATGGTTGATCGAGACCATTGTCGGGCAATACCTAGTAGTGACAAGTTTCGGGAACGCTCCAGGCC
TCT
F1 _F1) CTAGATGAAGAAATTGAGACCTCTACTGGATAGCTATGGTATTTACGTGTCTA
F1_B1 AGCTTAGACACGTAAATACCATAGCTATCCAGTAGAGGTCTCAATTTCTTCAT
1) From the chicken lysozyme gene (Burcin et al, 1997).
Table S4.2 Primers used for genotyping
name sequence (5’ to 3’)
Probe 1F TCCTGCCTCTGTCCAGTCAGAGA
Probe 1B GCAGATCACTGTGTGTTCAAGGC
Probe 2F CGAATGCCACCTTTGACTCTACC
Probe 2B AAGCCTCGTCCTTCCGAGCCT
Rosa26 F (265) GTGTAACTGTGGACAGAGGAG
Rosa26 F (266) GAACTTGATGTGTAGACCAGG
BirA_F (91) TTCAGACACTGCGTGACT
BirA_B (92) GGCTCCAATGACTATTTGC
CTCFGB1 AGCAAAAGCAAAACCAGGTTA
CTCFGF14 AGGAGCCAGATGCCGAGCCTG
Genotyping yields fragments of 350 bp (Rosa26), 514 bp (BirA), 599 bp (Ctcfbio), and 549 bp (wild type allele).
Table S4.3 Primers used for ChIP
name sequence (5’ to 3’)
Enh4_F (APS1) -4736 GTCACCATTCTGCACTTGCAA
Enh4_B (APS1) -4584 ACATGTGCATGGCAGCCATCTTG
Enh5_F -3736 GTGTGTTTGTGCTCTATCTGCTG
Enh5_B -3641 CACTTATTCTCAGGAGCTGCATG
Enh6_F -3088 GTGAGTTCCAGGACTTACCAGAG
Enh6_B -2988 CTGTGTAGCCCTATCGGACTTG
Enh3_F -2561 CACTGCTTAGATGCTCCCTTCC
Enh3_B -2446 ATCGTTCTTGAAGTCAAAGTACGTC
Enh2_F (spacer prom.) -2087 AGGAGGCCGGGCAAGCA
Enh2_B (spacer prom.) -1975 CGTACAGCAACTCGGTCTGCT
Enh_F (enhancer repeat) -1882 CCTCCAGAAGCCCTCTCTTGTCCC
Enh_B (enhancer repeat) – 1779 CAGCTGGCCGAGCCACACCGG
Prom_UCE_F -162 AGTTGTTCCTTTGAGGTCCGGT
Prom_UCE_B -52 GAGACAGGGAGGAAAGTGACAG
amylase 99 CTCCTTGTACGGGTTGGT
amylase 100 AATGATGTGCACAGCTGAA
Myc_ChIP_1F (cMyc 1,5kb downstr prom.) GCTCCTAAACCAGAGTCTGCTG
Myc_ChIP_1B (cMyc 1,5kb downstr prom.) CATACACCTCCACACAGTTCCAG
Myc_ChIP_2F (cMyc promoter) TGACTCGCTGTAGTAATTCCAGC
Myc_ChIP_2B (cMyc promoter) TCTCACTCCAGAGCTGCCTTC
Myc_5’INS_F (cMyc insulator) CAGAACCTGGAAACCCTGCAG
Myc_5’INS_B (cMyc insulator) GTTGTGGCTCTCGGATTTGTG
3’HS1_529_F (3’HS1) AATCAGTGGAACACTTCTGC
3’HS1_530_B (3’HS1) GTCTCAGGTTGTCAACTAAAGC
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Table S4.4 Primers used for northern blot and nuclear run-on
name sequence (5’ to 3’)
Northern
5’ETS_F GTTCCTATTGGACCTGGAGA
5’ETS_B CGGTTGGAATGGTGGAGCCA
GAPDH_F TGAACGGGAAGCTCACTGG
GAPDH_B TCCACCACCCTGTTGCTGTA
Run-on : promoter probe (290 bp; 129bp overlap transcript)
rDNAprom_F - 161 GTTGTCAGGGTCGACCAGTTGT
IGS_F_B +129 GACAGCTTCAGGCACCGC
Run-on: spacer promoter probe (361bp; 219bp overlap transcript)
IGSB_F -2140 CAGGTTGGTGACACAGGAGAG
Enh_B - 1779 CAGCTGGCCGAGCCACACCGG
Table S4.5 Primers used for northern blot and nuclear run-on
Primers 5’-3’ Human rDNA coordinate site Amplicon size (bp)
MYC-N ACAAGGAGGTGGCTGGAAAC
TTCCCCTCCTGGCTTTTAGT
181
MYC-H.1 CAACGCAACACAGGATATGG
TTCCCCTCCTGGCTTTTAGT
108
H42.1 rDNA GCTTCTCGACTCACGGTTTC
CCGAGAGCACGATCTCAAA
42012-42031
42117-42135
124
H37.9 rDNA CCCTGGTCGATTAGTTGTGG
GTGCTCCCTTCCTCTGTGAG
37818-37837
37997-38016
199
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A system to study the role of CTCF at the imprinted Igf2/H19 locus
Summary
The conserved transcriptional regulator CTCF is involved in many essential processes in the 
cell including the transcriptional regulation of imprinted genes. Imprinted genes are expressed 
in a parental specific manner. The best-characterized locus is that containing the paternally 
expressed Igf2 gene and maternally expressed H19 gene. CTCF binds to the unmethylated 
maternal imprinting control region (ICR) of this locus and thereby functions as a blocking factor 
that prevent enhancers from activating the Igf2 promoter on this allele.
We aimed to define the exact role of CTCF in regulating the imprinted expression of Igf2 
and H19.  Therefore a cellular system was set up that is able to discriminate between the parental 
alleles and can be used to efficiently delete Ctcf in vitro. Using this approach it was shown that 
deletion of Ctcf results in a loss of both Igf2 and H19 expression and results in a change in 
expression level of several other imprinted genes. However a gain of DNA methylation on the 
ICR in the absence of CTCF could not be observed. These results are in contradiction to previous 
reports.
Based on recent reports that show CTCF binding to other sites in the locus we suggest that 
CTCF plays a yet undefined role in regulating expression of Igf2 and H19. We hypothesize that 
CTCF might be involved in enhancing the expression of both Igf2 and H19 by transferring activity 
from the enhancers to the promoters or by maintaining the locus in an open chromatin state. Our 
system provides the basis to address this question in more detail and can moreover be used to 
analyze the role of CTCF in regulating the expression of other imprinted genes.
Introduction 
The role of CTCF in regulating the imprinted Igf2/H19 locus has been studied in detail within the 
last eight years. The imprinting control region (ICR) is the major element involved in regulating 
the paternal specific transcription of the Igf2 gene and the maternal specific transcription of H19 
(Ferguson-Smith et al, 1993; Leighton et al, 1995a). The ICR is located 2-4kb upstream of H19 and 
is methylated on the paternal allele. CTCF was shown to bind to the unmethylated maternal ICR 
and is crucial in controlling imprinted Igf2 and H19 expression (Bell et al, 1999; Hark et al, 2000; 
Kanduri et al, 2000).
The enhancer-blocking model was introduced in order to explain the imprinted expression 
of Igf2 and H19 (Webber et al, 1998). This model states that CTCF, while bound to the maternal 
ICR, prevents the enhancers downstream of H19 from activating the Igf2 promoter on this allele. 
On the paternal allele CTCF cannot bind due to DNA methylation allowing the enhancers to 
activate Igf2. Spreading of methylation over the paternal H19 promoter keeps the gene inactive 
on this allele.
Several studies were performed to test this model. A mouse line was generated in which 
the CTCF binding sites of the ICR were mutated. This resulted in loss of CTCF binding to this 
site. When the mutated sites are maternally inherited a gain of methylation on the ICR could be 
detected, coinciding with loss of Igf2 and H19 imprinting. Loss of imprinting is reflected by biallelic 
expression of Igf2 and repression of H19 (Schoenherr et al, 2003). These results showed CTCF to 
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be a critical determinant in regulating imprinted expression of both Igf2 and H19. Additional 
evidence for the essential role of CTCF in regulating the imprinted expression of Igf2 and H19 
came from transgenic RNA interference (RNAi) experiments. Knocking down CTCF in oocytes 
confirmed a critical requirement for CTCF in maintaining the unmethylated maternal ICR and 
thereby controlling imprinting of Igf2 and H19 (Fedoriw et al, 2004). These experiments showed 
that CTCF functions not only as an enhancer-blocker but also maintains the unmethylated state 
of the maternal ICR throughout development.
In order to address the role of the ICR in regulating and maintaining the imprinting of Igf2 
and H19 in more detail, additional studies were performed. Using an approach whereby the ICR 
was tagged by insertion of a GAL4-binding motif (UAS) together with expression of a GAL4-myc 
fusion protein, interactions involving the ICR were analyzed. ICR dependent interactions with 
other regions in the Igf2/H19 locus were detected by performing a pull down with antibodies 
against the myc epitope (Murrell et al, 2004).  Using this approach it was shown that on the 
maternal allele the unmethylated ICR interacts with the differentially methylated region (DMR1) 
that is present just upstream of the major Igf2 promoters. It was proposed that this interaction 
places H19 in an active domain with the enhancers and Igf2 in an inactive domain. On the paternal 
allele the methylated ICR interacts with DMR2 located in the Igf2 gene body. This places the Igf2 
promoters in an active chromatin domain that is located close to the enhancers. The formation of 
different chromatin loops on the parental alleles provides a model to explain how allele specific 
expression of Igf2 and H19 is regulated by the ICR (Murrell et al, 2004).  
Subsequently an extensive 3C analysis on the whole locus was performed to address the 
role of CTCF in the formation of chromatin loops on the maternal Igf2/H19 allele. This study 
confirmed the ICR-DMR1 interaction on the maternal allele. Moreover this interaction was shown 
to be lost in mice containing mutations in the CTCF binding sites in the ICR. These data together 
with a confirmation that CTCF binds to the unmethylated maternal DMR1 showed CTCF to be 
important for the formation of the maternal ICR-DMR1 chromatin loop. Moreover the enhancers 
needed for transcriptional activation of the Igf2 promoter on the paternal allele were confirmed 
to be in close proximity to the promoter (Kurukuti et al, 2006). 
Recently the CTCF-bound maternal ICR was shown not only to interact with regions within ~ 
200 kb but also with regions on different chromosomes (Ling et al, 2006; Zhao et al, 2006). A co-
localization was reported between the maternal ICR on chromosome 7 and an intergenic sequence 
on chromosome 11, located between the Wsb1 and Nf1 genes. Deletion of CTCF binding sites in 
the ICR and knockdown of CTCF using RNAi showed the association of these regions as well as the 
expression of Wsb1/Nf1 genes to depend on the CTCF bound ICR (Ling et al, 2006). Moreover the 
maternal H19 ICR interacts in trans with many imprinted regions on other chromosomes (Zhao 
et al, 2006). For example, the maternal H19 ICR allele was shown to interact with the maternal 
DMR of the imprinted Impact gene. Three-dimensional DNA FISH confirmed that this interaction 
is lost in mice with a maternal inheritance of the ICR CTCF binding site mutant. In these mice a 
change in gene expression of the imprinted Impact gene and its neighboring non-imprinted gene 
Osbpl1a can be observed compared to wild-type mice (Zhao et al, 2006). This study shows that 
imprinted domains can be functionally connected in trans via DMRs and in this way are able to 
regulate transcription in trans. Both studies provide proof for a central role of CTCF binding sites 
in a network of chromatin interactions.
Here we describe an in vitro system that is suitable to study the role of CTCF in regulating Igf2 
and H19 gene expression in more detail. By making use of M.m. domesticus (C57/Bl6) conditional 
CTCF knockout mice with distal chromosome 7 in a M.m. castaneus background we are able to 
distinguish the parental origin of both Igf2 and H19 genes. In this way we are able to determine 
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the role of CTCF in this locus in an allele specific manner. While setting up this system several 
papers were published describing the role of CTCF in regulating the chromatin conformation of 
the Igf2/H19 locus and its role in regulating interchromosomal interactions associated with this 
locus (Kurukuti et al, 2006; Ling et al, 2006; Zhao et al, 2006). However these studies exclusively 
address the role of CTCF upon binding to the ICR. Our analysis suggests additional roles for CTCF 
beside the ones reported so far. CTCF is likely to be involved in fine-tuning H19 and Igf2 expression 
in different tissues and in regulating the expression of other imprinted genes.
Results 
Selection of a cell system to study Igf2/H19 expression in the absence of CTCF 
Igf2 and H19 expression is reported to be at the highest level just after birth with almost 
undetectable levels in adult mice (Weber et al, 2001). Nearly all studies done on the Igf2/H19 
locus are performed on samples isolated from neonatal livers. In order to study the Igf2/H19 
locus in the absence of CTCF this would be the tissue of choice. Liver specific recombination was 
reported by using transgenic mice expressing the Cre recombinase under the Albumin promoter 
(Postic & Magnuson, 2000). However the recombination efficiency of this line is reported to be 
only 60% one week after birth and to be complete at six weeks after birth. Indicating that this 
mouse line is not suitable for deletion of Ctcf specifically in the neonatal liver where Igf2 and H19 
are expressed.
In order to select an appropriate cell system for in vitro deletion of Ctcf and subsequent 
study of the Igf2/H19 locus, expression levels were checked in different cell types. We confirm 
expression of Igf2 mRNA to be high in embryonic and postnatal liver and low in adult liver. The 
non-coding RNA transcript of H19 is less abundant than Igf2 but present in embryonic and 
postnatal liver and not in adult liver (Figure 5.1A). 
The majority of the cells present in the liver represent erythrocytes and hepatocytes. The 
abundance of these cell types depends on the developmental stage, in the embryo the liver 
consists mainly of erythrocytes and erythroid progenitors while at later stages hepatocytes 
represent a larger population of the cells present in the liver. In order to define in which cell type 
of the embryonic and postnatal liver Igf2 and H19 are expressed adherent cells isolated from 
neonatal livers were cultured and analyzed. This population of cells contains mainly hepatocytes 
but consists also of supporting Kupfer cells and epithelial cells. The p53-/- derived 1/11 cells 
were used as a model system to analyze Igf2 and H19 expression in erythroid progenitors and 
erythrocytes. 1/11 cells can be expanded indefinitely in vitro and upon exposure to stimuli 
such as erythropoietin, they undergo terminal differentiation into enucleated erythrocytes in a 
synchronized manner (Dolznig et al, 2001; von Lindern et al, 2001). Analysis of those cell types 
shows Igf2 and H19 to be expressed at low levels in the erythroid lineage and at more easily 
detectable levels in hepatocytes. In addition to hepatocytes, mouse embryonic fibroblasts (MEFs) 
also show clearly detectable levels of Igf2 and H19 expression, indicating that these cell types can 
be used to study the expression of both genes in the absence of CTCF (Figure 5.1B). 
Expression in the thymus was also analyzed since this tissue can be used to delete Ctcf in 
vivo (Heath submitted). The postnatal thymus shows detectable levels of Igf2 and H19 expression 
however in the adult thymus expression is very low. A transgene expressing the Cre recombinase 
under the Lck promoter is widely used for LoxP recombination specifically in the thymus. However 
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it should be noted that Lck promoter is active at different stages of thymocyte maturation in 
newborn mice compared to adult mice (Molina et al, 1998). 
In addition to analyzing the expression levels of Igf2 and H19 in different cell types we also 
analyzed CTCF binding to the ICR in several cell types and tissues. We confirmed CTCF binding to 
the ICR in MEFs and thymus. Binding of CTCF to the ICR is undetectable in embryonic stem (ES) 
cells (Figure 5.1C). 
The lenti-viral Cre system as a tool to delete Ctcf in vitro 
In a first attempt to set up a system to delete Ctcf in vitro, Ctcf conditional knockout mice 
were crossed to tamoxifen inducible Cre mice. However in vitro addition of tamoxifen to MEFs 
isolated from those mice was not sufficient to delete the Ctcf gene with high efficiency (Sleutels 
unpublished). As an alternative to this system a replication deficient lentivirus expressing the Cre 
recombinase was generated. Retroviral based gene transfer vectors such as lentiviruses provide 
effective means for stable and high-level delivery, integration and expression of exogenous genes 
in primary dividing and non-dividing cells (Delenda, 2004; Miyoshi et al, 1998; Naldini et al, 
1996).
MEFs and hepatocytes were isolated from homozygous (lox/lox) and heterozygous (lox/+) 
Ctcf conditional knockout mice and transduced with lentivirus expressing Cre or GFP. Fine tuning 
the conditions such as virus concentration and days of culturing led to the most efficient protocol 
to obtain a population of cells deleted for Ctcf. In the final protocol the cells were grown to 
almost full confluency and transduced with highly concentrated lentivirus expressing Cre, split in 
two the next day and left for another three days (Figure 5.2A). 
The absence of CTCF protein upon Cre deletion was  visualized by immunostaining with 
CTCF antibody on paraformaldehyde (PFA) fixed cells (Figure 5.2B). The efficiency of deletion can 
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Figure 5.1 Selection of a cell system to study the role of CTCF in Igf2/H19 regulation
A. Relative Igf2 and H19 mRNA levels as determined by quantitative RT-PCR on livers taken at different stages during 
developmental. Embryonic days (E) and days after birth (P) are indicated. B. Relative Igf2 and H19 mRNA levels as 
determined by quantitative RT-PCR on undifferentiated (undiff.) 1-11 cells, differentiated (diff.) 1-11 cells, adherent cells 
isolated from postnatal day two liver (hepatocytes) and whole thymus. C. Chromatin immunoprecipitation (ChIP) using an 
antibody against CTCF. Plotted are relative enrichments measured for CTCF binding sites in the Igf2/H19 locus (ICR), the 
β-globin locus (HS1) and cMyc insulator (cMyc ins.) in (from left to right) primary MEFs, adult thymus and ES cells. 
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be determined quantitatively on the DNA level by southern blot analysis or by RT-PCR to analyze 
mRNA levels. A clear deletion of the Ctcf gene can be detected on southern blot in both MEFs and 
hepatocytes upon transduction with Cre but not with GFP expressing virus (Figure 5.2C). 
If the Cre recombinase is expressed under a cytomegalovirus (CMV) promoter it appears 
to be more efficient in deleting the CTCF gene in hepatocytes than when it is expressed under 
the cytomegalovirus enhancer/chicken β-actin (CAG) promoter (Figure 5.2D). Moreover we 
found that CMV-Cre-ires-GFP lentivirus is less efficient in deleting the CTCF gene than CMV-Cre 
lentivirus. We have not measured the titer (m.o.i.) of the different viruses nor have we analyzed 
expression levels of the Cre recombinase so we do not know which of the two factors is causing the 
difference in deletion efficiency. We found that a high concentration of virus particles is needed 
to infect all cells. This becomes especially important when trying to transduce primary cells. 
Deleting CTCF from immortalized conditional knockout MEFs is more efficient than deleting the 
gene from primary MEFs upon addition of the same amount of lenti-viral Cre (data not shown). 
Cells deleted for Ctcf can be maintained for multiple days without dividing or going into 
apoptosis (data not shown). A similar phenotype is reported for cells overexpressing CTCF (Rasko 
et al, 2001). For this reason the population of cells that we want to delete for Ctcf upon expression 
of Cre should be confluent in order not to be overgrown by non-deleted cells. Populations of 
confluent cells deleted for Ctcf and wild-type cells that were used for experiments are in a 
similar non-cycling state (data not shown). This indicates that the changes we observe between 
Ctcf deleted and wild-type cells are not likely to be caused by difference in cell cycle or cellular 
proliferation.
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Figure 5.2 In vitro deletion of CTCF using the lentiviral Cre system
A. Schematic overview of the strategy used to delete CTCF in vitro. Confluent primary CTCF conditional knock-out MEFs 
are transduced with lentivirus expressing the Cre recombinase at day 0, the next day cells are split 1:2 and left in the 
dish for another 3 days. At day 4 cells show in general a 80-90% deletion of CTCF at the mRNA level and are used for 
experiments. B. Immunostaining with CTCF antibody on homozygous (lox/lox) and heterozygous (lox/+) CTCF conditional 
knockout hepatocytes transduced with lentivirus expressing Cre-GFP. C. Southern blot analysis showing deletion of CTCF 
conditional knock-out alleles in homozygous (lox/lox) and heterozygous (lox/+) MEFs and hepatocytes upon addition of 
Cre lentivirus (Cre) but not after addition of GFP expressing virus (GFP). D) Southern blot analysis showing deletion of 
CTCF conditional knockout alleles in homozygous (lox/lox) hepatocytes upon addition of similar amounts of lentivirus 
expressing Cre under the CMV or CAG promoter. 
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Expression of imprinted genes in the absence of CTCF 
The gain of maternal Igf2 expression and coinciding loss of maternal H19 expression, as seen in ICR 
CTCF binding site mutant mice, is not consistently reported upon knockdown of CTCF using RNAi. 
The expression levels of Igf2 and H19 in the total absence of CTCF were not reported in studies 
using RNAi to knockdown CTCF in oocytes (Fedoriw et al, 2004). Knockdown of CTCF in bone 
marrow fibroblast cell lines results in biallelic Igf2 expression and no change in H19 expression 
compared to wild-type cells (Ling et al, 2006). Recently depletion of CTCF in synchronized (G1 or 
G2) HeLa cells does show an upregulation of Igf2 expression and a loss of H19 expression (Wendt 
et al, 2008).
We analyzed the expression of Igf2 and H19 in the absence of CTCF in both primary 
hepatocytes and MEFs. In heterozygous samples that show a reduction in amount of CTCF mRNA 
by half, Igf2 and H19 expression levels were not affected (Figure 5.3A). Also infection of cells 
with GFP expressing lenti-virus does not change the expression of Igf2 and H19. In cells with 
a reduction in Ctcf mRNA levels to 5-10% compared to wild type both Igf2 and H19 expression 
levels were downregulated (Figure 5.3A). In hepatocytes this effect was more pronounced than 
in MEFs (Figure 5.3B). In hepatocytes Igf2 and H19 mRNAs are downregulated ~80% and ~90% 
and in MEFs ~40% and ~30% respectively (Figure 5.3A/B). This is in contradiction to many reports 
showing Igf2 to be upregulated and H19 to be downregulated upon deletion of CTCF binding in 
the ICR. In order to further clarify these results it would be interesting to examine the imprinting 
status of both genes in the absence of CTCF using an RNase protection assay.
None of the other imprinted genes analyzed showed any difference in expression levels in 
relative expression level compared to non 
virus treated sample
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Figure 5.3 Expression of imprinted genes in the absence of CTCF
A. Relative mRNA levels as determined by quantitative RT-PCR on conditional CTCF knockout primary MEFs. Homozygous 
(lox/lox), heterozygous (lox/+) cells transduced with GFP or Cre expressing lenti-virus are shown.  The expression levels 
are corrected for non-virus treated samples that are set at 1. B. Relative mRNA levels as determined by quantitative RT-
PCR on homozygous (lox/lox) conditional CTCF knockout primary hepatocytes transduced with different amounts (1 and 
2) of Cre expressing lenti-virus are shown.  The expression levels are corrected for non-virus treated samples that are set 
at 1. C) Relative mRNA levels as determined by quantitative RT-PCR on homozygous (lox/lox) conditional CTCF knockout 
primary MEFs transduced with Cre expressing lenti-virus are shown.  The expression levels are corrected for non-virus 
treated samples that are set at 1. D) Relative mRNA levels as determined by quantitative RT-PCR on homozygous (lox/
lox) conditional CTCF knock-out hepatocytes transduced with different amounts (1 and 2) Cre expressing lenti-virus are 
shown.  The expression levels are corrected for non-virus treated samples that are set at 1.
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the absence of CTCF in primary MEFs, while Dnmt1 and Lsh1 both involved in DNA methylation 
do show a drop in expression (Howell et al, 2001; Myant & Stancheva, 2008) (Figure 5.3C). In 
contrast, in hepatocytes imprinted genes are downregulated in the absence of CTCF, while Dnmt1 
and Lsh1 expression remained unchanged. The Igf2 receptor, Grb10 and Gtl2 show a reduction in 
their expression level by half. Snrpn shows a less dramatic downregulation in expression (Figure 
5.3D). Interestingly CTCF was reported to bind the Grb10 promoter in a methylation sensitive 
(and allele specific) manner (Hikichi et al, 2003). CTCF can bind to a maternally unmethylated 
DMR close to the promoter of the non-coding Gtl2 gene (Rosa et al, 2005). This CTCF binding site, 
as well as its allele specific methylation pattern was shown to be conserved in human, mouse and 
sheep (Paulsen et al, 2001; Takada et al, 2002). 
Igf2/H19 parental allele discrimination 
In order to analyze the Igf2/H19 locus in the absence of CTCF in an allele specific manner M.m. 
domesticus C57/Bl6 conditional knockout mice were crossed to the M.m. castaneus mice strain. 
Several single nucleotide polymorfisms (SNPs) in the Igf2/H19 locus were mapped or identified 
by sequencing parts of the locus in the two different strains. The SNPs can result in restriction 
fragment length polymorfisms (RFLPs) or simple sequence length polymorfisms (SSLPs) that can 
be used to discriminate between the two strains by making use of PCR (Figure 5.4A/B). These 
SSLPs and RFLPs were used to genotype the C57/Bl6 conditional CTCF knock-out mouse line with 
distal chromosome 7 containing the imprinted Igf2/H19 and Kvlqt1 locus in a M.m. castaneus 
background (Figure 5.4A). 
Upon crossing this line to full C57/Bl6 mice the parental alleles of those mice can discriminate 
between maternal and paternal alleles. We were able to confirm the imprinting status of both 
Igf2 and H19 in postnatal liver as well as in MEFs by RNase protection (Figure 5.4C/D). The C/B 
postnatal liver sample showed very low expression of H19 from the paternal allele. 
DNA methylation of the Igf2/H19 ICR remains unchanged in the absence of CTCF 
The ability to discriminate between the parental alleles can moreover be used to analyze the 
methylation status of the ICR in an allele specific manner. By making use of an MboI and SacI RFLP 
present in the ICR of M.m. castaneus but not in M.m. domesticus (C57/Bl6) we can discriminate 
the parental origin of the first CTCF binding site in the ICR (Schoenherr et al, 2003; Szabo et al, 
2004). Complete digestion of SacI and MboI is shown by southern blot on single digests with these 
enzymes. Combined digestion of SacI with MboI or of ClaI with HhaI digestion respectively can 
identify methylated or unmethylated alleles, since both enzymes are sensitive to methylation and 
cut only unmethylated DNA (Figure 5.5A). Using these enzymes to digest genomic DNA isolated 
from mice containing the Igf2 and H19 genes in a mixed (M.m. castaneus / M.m. domesticus) 
background we are able to confirm the paternal ICR specific methylation. Mice with a mixed 
background containing either a M.m. domesticus (C/B) or a M.m. castaneus (B/C) paternal allele 
show this allele to be methylated at the ICR and the maternal allele to be unmethylated (Figure 
5.5B). As an alternative bisulphite sequencing can be used to perform more detailed analysis of 
DNA methylation patterns.
Methylation analysis without allele discrimination shows a 60% unmethylated ICR in 
immortalized MEFs and a remarkably methylated ICR in ES cells (Figure 5.5C). The full methylation 
of the ICR in ES cells fits with the observation that CTCF binding is absent at this site and shows 
this cell type to be unsuitable to study Igf2/H19 imprinted regulation (Figure 5.1C). Differentiation 
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of ES cells with retinoic acid (RA) shows a very modest loss of methylation in the ICR (Figure 5.5C). 
This is likely to result in a gain of CTCF binding to the ICR. 
Surprisingly we were not able to detect a gain of methylation in the ICR upon deletion of 
CTCF in primary MEFs (Figure 5.5D). Methylation analysis of the ICR upon in vivo deletion of 
CTCF in T-lymphocytes confirmed this result (Sleutels and Heath unpublished). No difference in 
methylation of the ICR could be detected between wild type and CTCF deleted samples.  This is 
in contradiction to results reported by different groups that show a gain of methylation at the 
maternal ICR in somatic cells upon mutation of its binding sites or in oocytes in the absence of 
CTCF (Schoenherr et al, 2003; Szabo et al, 2004). 
In order to analyse the role of CTCF in the spatial organization of the Igf2/H19 locus 3C 
analysis was set up. After cross-linking DNA fragments that are close together in nuclear space, 
digestion with an excess of restriction enzyme is performed in order to reduce the size of the 
fragments for efficient ligation. Preliminary experiments to optimize the 3C procedure to analyze 
the chromatin conformation of the Igf2/H19 locus in MEFs resulted in low EcoRI digestion 
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Figure 5.4 Igf2 and H19 parental allele discrimination
A. Schematic representation of distal chromosome 7 with indicated the different SSLPs and RFLPs between M.m. 
domesticus and M.m. castaneus. Filled boxes represent the imprinted genes present on this part of the chromosome 
and open boxes represent non-imprinted genes. B. Strain background of mouse distal chromosome 7 analyzed by gel 
electrophoresis after PCR for SSLPs or PCR followed by digestion for RFLPs. The different genotypes are represented on 
top with (C) representing pure M.m. castaneus , (B) C57/Bl6 M.m. domesticus, (C/B) maternal M.m. castaneus allele and 
paternal C57/Bl6 M.m. domesticus allele, (B/C) maternal C57/Bl6 M.m. domesticus allele and paternal M.m. castaneus 
allele. C. Parental allele specific analysis of Igf2 RNA transcripts in MEFs and P2 liver as determined by RNase protection. 
The different genotypes are represented on top with (C) representing pure M.m. castaneus , (B) pure C57/Bl6 M.m. 
domesticus, (C/B) maternal M.m. castaneus allele and paternal C57/Bl6 M.m. domesticus allele, (B/C) maternal C57/
Bl6 M.m. domesticus allele and paternal M.m. castaneus allele. Aprt was used as a loading control. D. Parental allele 
specific analysis of H19 RNA transcripts in MEFs and P2 liver as determined by RNase protection. The different genotypes 
are represented on top with (C) representing pure M.m. castaneus , (B) pure C57/Bl6 M.m. domesticus, (C/B) maternal 
M.m. castaneus allele and paternal C57/Bl6 M.m. domesticus allele, (B/C) maternal C57/Bl6 M.m. domesticus allele and 
paternal M.m. castaneus allele. Aprt was used as a loading control.
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efficiencies (data not shown). When using the standard protocol for 3C analysis a clumping of 
nuclei was observed before starting the digestion step. This resulted in a digestion efficiency 
of about 50% as measured by PCR. At least 60-70% but preferntially 80% or more of the DNA 
should be digested before continuing with the ligation step (Simonis et al, 2007). In order to get 
a more homogenous suspension and thereby achieve higher digestion efficiency the volume of 
restriction buffer during digestion was increased six times compared to the standard protocol. 
This resulted in an improvement of digestion efficiency. The 3C analysis to analyse the role of 
CTCF in the spatial organization of the Igf2/H19 locus is in progress.
Discussion
CTCF is involved in maintenance of allele specific methylation at and around its binding site 
on the ICR (Engel et al, 2006; Fedoriw et al, 2004; Schoenherr et al, 2003; Szabo et al, 2004). 
Elimination of all four CTCF binding sites in the ICR results in an acquirement of methylation 
on the maternal mutant ICR. It was suggested that CTCF binding prevents de novo methylation 
on the maternal allele (Rand et al, 2004). Surprisingly we do not observe a difference in DNA 
methylation in the absence of CTCF. This may be explained by the inability of the majority of cells 
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Figure 5.5 DNA methylation of the Igf2/H19 locus
A. Schematic representation of part of the Igf2/H19 ICR showing the position of restriction enzyme digestion sites used 
for DNA methylation analysis. Gray boxes represent CTCF binding sites in the ICR, dark boxes represent probes used to 
detect specific fragments by southern blot. The indicated RFLPs are present in M.m. castaneus and not in C57/Bl6 M.m. 
domesticus. B. Parental allele specific DNA methylation analysis of the Igf2/H19 ICR. Southern blot analysis on genomic 
DNA isolated from MEFs. ClaI and HhaI are unable to cut methylated DNA. The different genotypes are represented on top 
with (C) representing pure M.m. castaneus , (B) pure C57/Bl6 M.m. domesticus, (C/B) maternal M.m. castaneus allele and 
paternal C57/Bl6 M.m. domesticus allele, (B/C) maternal C57/Bl6 M.m. domesticus allele and paternal M.m. castaneus 
allele. C. Methylation analysis of the Igf2/H19 ICR in different cell types. Southern blot analysis on genomic DNA isolated 
from immortalized (imm.) MEFs, ES cells and ES cells differentiated for 7 days with retinoic acid. D. Methylation analysis 
of the Igf2/H19 ICR in conditional CTCF knockout MEFs (lox/lox) untreated or treated with Cre expressing lentivirus. 
Southern blot analysis on genomic DNA isolated from primary MEFs.
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lacking CTCF to undergo replication, as shown by the low number of BrdU incorporation in these 
cells (Sleutels unpublished). Another explanation for the observed contradictory result could be 
that passage through the germline is needed in order to detect a gain of methylation on the 
maternal ICR in the absence of CTCF. In mice containing CTCF mutated ICR binding sites a gain of 
methylation at this site was not observed in the oocyte but only at later stages of development, 
during postimplantation (Schoenherr et al, 2003). This might be explained by a modulation in 
CTCF binding by cofactors at different stages of development.
We show CTCF binding to the ICR and parental allele specific expression of Igf2 and H19 
in both hepatocytes ad primary MEFs. This indicates that these cell types are suitable to study 
imprinting of the Igf2/H19 or Kvlqt1 locus in more detail. It should however be noted that both 
cell types do not represent a homogenous population of cells making the study of chromatin 
conformations more difficult. For example the Igf2/H19 locus was reported to contain multiple 
cell type- and embryonic lineage specific regulatory elements. MEFs represent a population of 
cells derived from endoderm as well as mesoderm.
The reduction in expression of imprinted genes in the absence of CTCF in hepatocytes but 
not in MEFs is quite striking. The mRNA levels of factors involved in DNA methylation show an 
opposite expression pattern and are reduced in MEFs and not in hepatocytes. Lsh1 has been 
implicated in regulation of specific imprinted genes, such as the Cdkn1c/p57Kip2 gene. In the 
absence of Lsh1 the silenced paternal Cdkn1c/p57Kip2 is reactivated, while expression of Igf2, 
H19 and Igf2r remains unchanged (Fan et al, 2005). However we still have to test expression of 
Cdkn1c/p57Kip2 in the absence of CTCF.
The decrease in expression of not only H19 but also of Igf2 in the absence of CTCF was 
unexpected since it does not match with existing data that show upregulation of Igf2 in the 
absence of CTCF binding to the ICR. It would be interesting to check the parental allele specific 
expression of Igf2 in the absence of CTCF. Igf2 could be biallelicly expressed but at very low levels. 
Multiple tissue- and allele specific elements were reported to be present in the locus suggesting 
additional roles besides the ICR in regulation of Igf2 and H19 expression (Constancia et al, 2000; 
Davies et al, 2002; Drewell et al, 2000; Lopes et al, 2003; Murrell et al, 2001; Schoenfelder et 
al, 2007). These elements could be directly or indirectly regulated by CTCF. Additional unknown 
stimulatory roles for CTCF in regulating the expression of both genes can explain the loss of both 
Igf2 and H19 expression in the absence of CTCF. 
Interestingly recent genome wide mapping of CTCF binding sites in human mesoderm 
derived CD4+ T-cells confirms binding of CTCF to the ICR and the mesoderm specific silencer, 
DMR1 (Barski et al, 2007) (Constancia et al, 2000). Moreover this analysis shows binding to DMR0 
just upstream of the placental specific Igf2 P0 promoter and to a region in between the Igf2 and 
H19 genes (Barski et al, 2007)(Figure 5.6A). This intergenic region (known as: A6A4 or CCD) is 
highly sensitive to nuclease on both parental alleles and conserved between mouse and human 
(Koide et al, 1994). Furthermore the region is unmethylated on both parental alleles suggesting 
CTCF could bind this region on the maternal as well as paternal allele. The CCD was reported to 
function as an enhancer for Igf2 both in specific tissues where the gene is imprinted (i.e., somites, 
tongue, eye) and where Igf2 is biallelically expressed such as the CNS (Charalambous et al, 2004; 
Jones et al, 2001; Ward et al, 1997). The same region was also reported to function as a skeletal 
muscle specific repressor of Igf2 expression (Ainscough et al, 2000). Activity of this region in 
mouse is not reported in blood from which the CD4+ T-cells used for the CTCF binding site analysis 
in human were isolated. Leaving aside the question what the function of CTCF binding to this 
area could be,  it may function as a regulator of the HUC mesodermal enhancers that are present 
in between the CCD and ICR (Drewell et al, 2002). CTCF binding to the DMR1 is not restricted 
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to mesoderm derived tissues were this region function as a silencer also binding is reported in 
neonatal liver (Kurukuti et al, 2006). 
Mapping of CTCF binding sites in human CD4+ T-cells shows not only binding of CTCF within 
the Igf2/H19 locus but also in regions directly flanking it. This separates the locus from the nearby 
(~200 kb distance) Kvlqt imprinted locus. CTCF is likely to form boundaries upon binding to these 
locus-flanking sites and thereby separate these imprinted domains into individually regulated 
clusters. Alternatively upon binding to these locus-flanking sites CTCF functions in maintaining 
the whole locus in an active and open chromatin state (Barski et al, 2007). 
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Figure 5.6 CTCF binding in the Igf2/H19 locus and models that explain its role in regulating this locus
A. Schematic representation of the Igf2/H19 locus and CTCF binding sites present in this locus. Vertical lines indicate 
potential CTCF binding sites. The height of these lines is indicative of the confidence CTCF will bind at that position. 
CTCF binding sites in the Igf2/H19 locus as analyzed using human CD4+ T cells (Barski et al, 2007). UCSC gene predictions 
based on refseq., uniprot, genbank, and comparitive genomics. Relative position of regulatory elements is indicated. 
Endo. enh.: endodermal enhancers, Meso. enh.: mesodermal enhancers, DMR: differentially methylated region, ICR: 
imprinting control region, HUC: mesodermal enhancers, CCD: conserved HSS. B. Model of allele specific chromatin loops 
in the Igf2/H19 locus as analyzed by 3C (Murrell et al, 2004).  It is proposed that the conformation of the paternal allele 
allows contacts between Igf2 promoters and the enhancers that are blocked on the maternal allele. The ICR on the 
maternal allele makes contact with the DMR1 located upstream of the Igf2 promoters. It was suggested that the ICR-
DMR1 interaction places the Igf2 promoters in a repressive domain. On the paternal allele the ICR contacts another such 
site, DMR2, downstream of Igf2. This should make the Igf2 promoters accessible to the enhancers located downstream of 
H19. It should be noted that CTCF was reported to bind the maternal DMR1 (Kurukuti et al, 2006). ICR: imprinting control 
region, DMR: differentially methylated region, MAR: matrix attachment region, Me: methylated site, small white circles: 
endodermal enhancers, light grey boxes: H19 exons, black boxes: Igf2 exons. Maternal and paternal alleles are indicated. 
C) Model proposed by Yoon et al MCB 2007. The authors report an interaction between the enhancers and ICR on the 
maternal allele bringing the enhancers into close contact to the H19 promoter. On the paternal allele an interaction 
between the enhancers and the Igf2 promoter is reported bringing the enhancers in close contact to the Igf2 promoters 
and not the H19 promoter. The authors report predominant binding of CTCF to the maternal enhancers but also binding 
to the paternal enhancers. 
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A similar downregulation in both Igf2 and H19 expression as we observe in the absence 
of CTCF is reported upon deletion of the endodermal enhancers. Deletion of these enhancers 
results in a ~90% reduction of H19 and Igf2 transcripts in liver, which is primarily composed 
of endodermal cells. In gut, kidney and lung where both endodermal and mesodermal cells 
are present a decline of ~70-75% in detected transcripts is observed (Leighton et al, 1995b). 
These results are similar to the H19 and Igf2 mRNA levels we measured in endodermal derived 
hepatocytes and combined endo- and mesodermal derived MEFs. Interestingly it was recently 
shown by ChIP that CTCF is able to bind the endodermal- and mesodermal enhancers and Igf2 
promoter in fetal and postnatal mouse tissues (Yoon et al, 2007). However binding of CTCF to 
enhancers was not reported in mesoderm derived adult human CD4+ T cells (Barski et al, 2007). 
This indicates that CTCF binding to different sites in the Igf2/H19 locus depends on the tissue 
and developmental stage. Binding of CTCF to the enhancers was reported to be biallelic although 
binding to the maternal enhancers was more pronounced (Yoon et al, 2007). 
It would be very interesting to verify the binding of CTCF to the CCD, DMR1, locus-flanking 
sites and enhancers in different postnatal and adult tissues in an allele specific manner. This then 
allows to determine whether CTCF has additional functions in regulating Igf2 and H19 expression 
than reported so far. 
 The data as presented by Murrell et al. and Kurukuti et al. that show allele specific chromatin 
loops in the Igf2/H19 locus can be questioned at some points. The paternal ICR-DMR2 interaction 
is apparently not as solid as the maternal ICR-DMR1 interaction since it was described only by 
Murrell et al. (Figure 5.6B). Kurukuti et al. on the other hand describe another interaction on the 
paternal allele, between the enhancers and Igf2 promoters. However an interaction between the 
enhancers and H19 promoter is detected on both parental alleles. The resolution of the restriction 
fragments that were used in this study is not high enough to analyze interactions between closely 
located fragments such as the enhancer-H19 promoter interactions. Furthermore the quantitative 
manner is which the analysis was done can be criticized. Recent data from another lab show 
indeed some disagreement with the data of Murrell et al. and Kurukuti et al. (Yoon et al, 2007). 
Yoon et al. generated a mouse line whereby the ICR was inserted upstream of the non-
imprinted Afp gene, separating the enhancers from the promoter. In this way the functioning 
of the ICR was analyzed in a context independent manner. It was shown that upon insertion the 
ICR keeps its characteristics such as paternal methylation and absence of methylation and CTCF 
binding on the maternal allele (Park et al, 2004; Yoon et al, 2007). Maternal inheritance of the 
ICR insertion prevents association of the enhancers with the Afp promoter,  resulting in a loss 
of Afp expression from the maternal allele. This result together with experiments comparing 
chromosomes with and without the ICR show that the ability of the ICR to regulate gene 
expression and to organize chromosome conformation is entirely context independent. Locus 
specific interactions such as the ICR-DMR1 interaction were suggested to be dispensable for 
enhancer-blocking activity (Yoon et al, 2007)(Figure 5.6C). Instead it was shown that the maternal 
ICR associates with the enhancers. Implicating a model whereby active insulators associate with 
active promoters and enhancers. This is in contradiction to the results of Kurukuti et al. that 
showed the enhancer-ICR/H19 promoter interaction to be biallelic. It would be very interesting 
to confirm an involvement of CTCF in associating with promoters and enhancers by making use 
of the conditional CTCF knockout cells with a M.m. castaneus allele. If CTCF besides functioning 
as an insulator on the ICR has an additional role in binding to the enhancers on both alleles and 
keeping them active or transferring their activity than this could explain the reduction in Igf2 and 
H19 expression observed in the absence of CTCF. 
The distal end of mouse chromosome 7 contains not only the Igf2/H19 imprinted locus but 
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also a cluster of imprinted genes regulated by the KvDMR1 present in the Kvlqt1 gene. The distal 
chromosome 7 imprinted region is well conserved during evolution and deregulation of the genes 
present in this region results in the overgrowth- and tumor-associated Beckwith–Wiedemann 
syndrome. The opposite functions of the two domains on embryo growth could have facilitated 
the acquisition and/or conservation of imprinting in this cluster. However the two clusters were 
shown to be imprinted by separate mechanisms demonstrating that each of the two domains of 
the cluster contains the cis-acting elements required for the regulation of its own genes. Deletion 
of the H19 ICR was shown not to affect imprinting of Kvlqt1, Mash2 or Cdkn1c/p57(Kip2) (Caspary 
et al, 1998).
All the genes located in the Kvlqt locus are required for normal development and are 
silenced by a KvDMR1 dependent mechanism on the paternal allele (Oh et al, 2008). Interestingly 
CTCF binding sites were identified in the unmethylated paternal KvDMR1 and a potential role of 
CTCF was suggested to be silencing of Cdkn1c (Fitzpatrick et al, 2007; Shin et al, 2008).
It will be interesting to analyze the role of CTCF in regulating the imprinting within the Igf2/
H19 and Kvlqt loci in different cell types in more detail by making use of the lenti-viral Cre system 
and conditional CTCF knockout mice with distal chromosome 7 in a M.m. castaneus background
Materials and methods
Cell culturing and immunofluorescent staining
Culturing and differentiation of 1/11 cells was done as described previously (Kooren et al, 2007). 
Immortalized and primary MEFs were cultured in Dulbecco’s modified Eagle’s medium (DMEM) and ham’s 
F10 supplemented with 10% fetal calf serum and 1 mM β-mercaptoethanol. ES cells were cultured on 
0,1% gelatin coated dishes in DMEM medium containing 10% FCS, 50% BRL, 103 U/ml LIF, 1:200 NEAA, 1 
mM β-mercaptoethanol and cells were split every two days. In order to generate a primary hepatocyte 
culture, livers were isolated from postnatal day 2 (P2) embryos, resuspended by repeated pippeting and 
digestion with shaking for 30 min at 37°C in liver digest medium (GibcoBRL). Cells were cultured in William’s 
E medium with glutamax containing 10% FCS, 1% insulin-transferrin-selenium (ITS) (GibcoBRL) and 10 nM 
dexamethason (Sigma) and grown on dishes coated with 0,1% gelatin. Cells were washed several times 
to get rid of debris and floating hematopoietic cells. Cells were used for experiments about 5 to 7 days 
after isolation. E13.5 embryos were used to isolate MEFs. Head and blood organs were removed and a 
piece of tail was used to isolate genomic DNA for genotyping. The remaining embryo was finely minced 
using scissors and incubated for 15min. 37°C in Trypsin/EDTA. Culture medium was added and dissociated 
tissue was transferred to a cell culture dish and cultured at 37°C with 5% CO2, 3% O2. Next day cells were 
washed and when confluent cells were frozen. To generate immortalized MEFs, cells were cultured for serial 
passages until spontaneous immortalization accured. Primary MEFs were used below passage five. For 
immunofluoresent staining cells were fixed in 4% paraformaldehyde/PBS for 15 minutes at RT, permeabilised 
in 0,15% Triton X-100 in PBS, blocked in 1% bovine serum albumin in PBS and incubated with antibodies as 
described previously. Antibodies used: anti-CTCF (Heath submitted), Alexa 594-conjugated goat anti-rabbit 
(Nordic Lab.). Images of cells were collected with a Leica DMRBE microscope. 
RNA analysis
Total RNA was isolated using Trizol (Invitrogen) reagent according to the manufacturers instructions. RNase 
protection analysis (RPA) was performed with the RPAIII kit (Ambion). The probes for RPA were: Igf2RPA2-12 
(T7): a 422 bp fragment protecting exon 6 of Igf2 and covering a G to A SNP between M.m. domesticus and 
M.m.castaneus. The probe was generated by PCR on BACs RP23-50N22 (244 kb) or RP23-209O22 (194 kb) 
using the following oligo’s: 
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Igf2RPA2_F: CACACTAAGATCTCTCTGCTCCAC and Igf2RPA2_B: GGTTCTGGGATCCAAGTCTTAGC
H19RPA5-2 (T7) 554 bp probe in part of exon 5 covering G to T and G to A SNP between M.m. domesticus 
and M.m.castaneus, SpeI linearized template The probe was generated by PCR on BACs RP23-50N22 (244 
kb) or RP23-209O22 (194 kb) using the following oligo’s: H19RPA2_F: AAGATGGGAGAGCTGGAGGAG and 
H19RPA2_B: CAGCCGCTTCTTCTCACCAG. APRT (T7) probe was described previously (Sleutels & Barlow, 
2001).
Southern blotting and DNA methylation analysis 
Genomic DNA was isolated by the sodium dodecyl sulfate-proteinase K procedure (Sleutels & Barlow, 2001). 
DNA was digested, and blotted onto Hybond N+ membranes (Amersham) and hybridized with radioactive 
probes. Hybridization was performed in a rotating hybridizer at 65°C for 24h in ChurchHyb-mix (0,5 M 
Na2HPO4 pH 7.2, 7% SDS, 1 mM EDTA). Membranes were washed extensively at 65°C with Church wash-
buffer (40 mM Na2HPO4 pH 7.2, 1% SDS). Hybridization signals were quantified with a Phoshor Imager 
(Typhoon Amersham). The following primers were used to generate probes for H19-ICR methylation 
analysis: 
MboI-meF: ATGCAAATGAACCACTAGGAGTTTAG
MboI-meB: TCCACGAGGTACCAGCCTAGA
SacI-meF: CTCAAGAGCTATCTCAGGTATCTGAC
SacI-meB: TTAAGATGACAGTCACCAGCGC
Chromatin immunoprecipitation (ChIP) and analysis of gene expression
cDNA synthesis was performed using Superscript II RNase H-reverse transcriptase (Invitrogen) according 
to the manufacturers instructions using oligo (dT)12-18 primers. ChIP was performed as described in the 
Upstate protocol (http://www.upstate.com), except that cells were cross-linked using 2% formaldehyde for 
5 minutes at room temperature. Real-time quantification of transcripts or precipitated DNA sequences was 
performed on Opticon II PCR machines (MJ Research) using Platinum Taq DNA polymerase (Invitrogen) 
and SYBR Green (Sigma-Aldrich) using the following cycling conditions: 2 min 94°C, 45 cycles of 30 sec 
94°C, 1min 55°C, 15sec 72°C and 15sec 75°C (during which measurements were taken). Enrichment was 
calculated relative to a control gene and all values were normalized to input measurements. The following 
antibodies were used: anti-CTCF (N3) rabbit polyclonal (Heath submitted). Data was normalized to input and 
enrichment was measured over control gene (Amylase). The following primers were used for ChIP :
Myc_5’INS_F (cMyc insulator) CAGAACCTGGAAACCCTGCAG
Myc_5’INS_B (cMyc insulator) GTTGTGGCTCTCGGATTTGTG
3’HS1_529_F (3’HS1) AATCAGTGGAACACTTCTGC
3’HS1_530_B (3’HS1) GTCTCAGGTTGTCAACTAAAGC
Amylase 99 CTCCTTGTACGGGTTGGT
Amylase 100 AATGATGTGCACAGCTGAA
Expression levels were normalized to levels measured for a control gene (Hprt). The following primers were 
used for mRNA expression analysis:
CTCF FRT-PCR: GTGCTGGCCAGATGGCGTAGAG
CTCF BRT-PCR: TTGTCATCGAGATCCGGCTCAGC
HPRT-B: GTTAAAGTTGAGAGATCATCTCCACC
HPRT_F: AGTGATAGATCCATTCCTATGACTGTAG
H19 BRT-PCR: TCTTCTTGATTCAGAACGAGACGG 
H19 FRT-PCR: ACTTCTCTGCTGCTCTCTGGATC
IGF2 FRT-PCR: GTTCGGACCGCGGCTTCTACTTC
IGF2 BRT-PCR: GCAGCACTCTTCCACGATGCCAC
Snrpn FRT-PCR: CTGCTACTGCTAGCATTGCAG
Snrpn BRT-PCR: CCAGGTGGAGGAGCCATAATG
Gtl2 FRT-PCR: ACGCACAACACGTTGCAAC
Gtl2 BRT-PCR: CAGGTGTCTGTGTCCGTGTGTCC
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Dnmt1 FRT-PCR: CAGATAGCTACCGGTTCTTCGG
Dnmt1 BRT-PCR: AGAGCTTAATCTCCAGGCCAATG
Igf2r FRT-PCR: GCTGGCCTTACTGCTGCATAAG
Igf2r BRT-PCR: TTGAGTACTTGTAGGACACGCCC
Grb10 FRT-PCR: TCGTACTGACACTGTGCCATC
Grb10 BRT-PCR: CATCCAGAGTGAAGAAGGTCTG
Lsh1 FRT-PCR: GGCCGAACAAACGGAGCCTGCGGTG
Lsh1 BRT-PCR: CAATTGCTGTTGTTCCATTTTAGTC
Lentivirus production and infection
Cre-lentivirus production and transduction of cells was done as described (Splinter et al, 2006). With the 
exception that confluent primary CTCF conditional knockout MEFs were transduced and that they were splitted 
1:2 24h after transduction. Virus activity/functionality was tested by serial dilutions on CTCF conditional 
knockout (lox/lox) primary mouse embryonic fibroblasts (MEFs) and were scored for recombination after 
4 days of infection by quantitative RT-PCR. The CAG-Cre construct was made by digesting Cre out of the 
Psp72Cre plasmid using BglII/XhoI and cloned into pNDCAG with BamHI/XhoI. Cre-ires-GFP virus was made 
as described (Sleutels unpublished).
Generation of conditional CTCF knockout mice with a M.m. castaneus distal chromosome 7 
M.m. castaneus mice were backcrossed to M.m. domesticus (C57/Bl6) containing the CTCF conditional 
knockout allele. At each generation the presence of an M.m. castaneus allele at distal 7 was assayed using 
at least two SSLP and RFLP markers flanking the area. Oligo’s used for SSLP and RFLP PCR analysis, if followed 
by digestion restriction enzymes were as indicated between brackets:
D7Nds4_F: GTGACAATACATTCCTGCTGT
D7Nds4_B: CTCAGATCTTATCTCTAGCAC
Drd4_F: TCAACCTGTGCGCCATGAGCGTG
Drd4_B: TGGTTGTAGCGCAGTGGCACGGT
Ins2 HindIII_F (HindIII): CATGTGGTGCTGTTCTGGGAGAT
Ins2 HindIII_B (HindIII): ATGGTGGCTGAAGTTGGTCTGTC
Igf2 NcoI_F (NcoI): TGGCTCTGCTGCTTAGGGAG
Igf2 NcoI_B (NcoI): AGTGCTGGACACTGGACCTGGT
D7mit167_F: CGTGTGAAGGCACACCTG
D7mit167_B: GAGCATCTGTGTGTGTGCCT
Slc22a18_F (KspI): ATCAACAGGACTTTTGCCCC
Slc22a18_B (KspI): CATGAAGAGACACGTTAGC
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Discussion
Goal of the thesis
CTCF is required for the proper regulation of many different processes, for example, the 
regulation of embryonic development, cell cycle progression, imprinted gene expression and 
X-chromosome inactivation. Correct expression of the protein throughout development is of 
fundamental importance for the survival of an organism. CTCF regulates these processes not only 
by activating and repressing genes, as a classical transcription factor would do, it is able to change 
chromatin structure, thereby regulating spatial proximity of genes and their regulatory elements. 
CTCF can also block an enhancer from activating a promoter and is the only protein identified so 
far in vertebrates that can perform such a function. 
The fact that CTCF has such diverse roles makes it difficult to reveal a specific function in 
a distinct process. The variety of processes involving CTCF and their complexity require CTCF to 
interact with other proteins. The goal of the research described in this thesis was to get a better 
insight into the different processes regulated by CTCF. We primarily focused on the identification 
of interacting protein partners. 
The identification of novel CTCF-interacting partners, provides evidence for the involvement 
of CTCF in processes that were not reported before. Our studies provide some clues how these 
processes are regulated. I discuss the implication of these results in the context of what is known 
about the properties and complex function of CTCF in regulating gene expression and chromatin 
organization.
Properties of CTCF in the cell – relationship to tagging approaches
Most transcription factors and chromatin proteins undergo rapid cycles of binding and unbinding 
on chromatin, with dwell times in the order of only a few seconds (Phair et al., 2004). By tagging 
CTCF with GFP its mobility in living cells was analyzed using FRAP. This analysis reveals that 
70% of the CTCF protein present in the nucleus is immobile (Heath manuscript in preparation), 
indicating that CTCF is most of the time tightly bound to DNA, or is interacting with a nuclear 
matrix structure and/or nuclear compartments (Wiesmeijer et al., 2008). Indeed a significant 
portion of CTCF is present in an insoluble nuclear fraction, which represents a combination of 
nuclear matrix material and genomic DNA. DNA, packaged into chromatin is locally constrained 
but its spatial organization in the nucleus of living cells is considered to be dynamic. CTCF might 
therefore form the basis of chromatin loops and tether these to ‘fixed’ structures such as the 
nuclear matrix or nucleolar rim. In Drosophila and yeast, insulators are tethered to the nuclear 
lamina or nuclear pore complex (Ishii et al., 2002; Stewart et al., 2007). Our mass spectrometry 
analysis identifies components of these structures, however these factors were also identified 
in the BirA control experiments. Thus, it is difficult to judge whether CTCF associates with the 
nuclear matrix or nuclear substructures.
Several known CTCF interacting proteins are reported to be a component of the nuclear 
matrix. These include nucleophosmin, PARP, YY1 and the largest subunit of RNA polymerase II 
(Feuerstein and Mond, 1987; Mika and Rost, 2005; Vidakovic et al., 2004). For nucleophosmin 
as well as for the DNA/RNA binding factor YB1 a direct interaction between purified proteins 
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was not reported, leaving the possibility that the interaction is not direct but mediated via other 
proteins, or DNA (Chernukhin et al., 2000; Yusufzai et al., 2004).
Tight control of CTCF protein levels is required for proper development and cellular 
function. This is shown by the fact that both cells overexpressing and lacking CTCF have severe 
problems with proliferation. Modifying CTCF by a tagging approach might therefore be risky. 
Indeed, tagging the N-terminus of CTCF with GFP resulted in low expression levels of the tagged 
protein and a severe reduction in the viability of homozygous knock-in mice (Heath manuscript in 
preparation). Tagging CTCF at the C-terminus with the biotin-tag did not affect expression levels 
of the protein. This indicates that the size or the position of the tag is able to affect the stability 
and/or efficiency of the fusion protein production.
Mice expressing biotinylated CTCF cannot only be used to identify interacting proteins, 
but also to identify CTCF binding sites in the genome, in a temporal and tissue-specific manner. 
Identification of binding sites can be done using ChIP with streptavidin-beads. These are likely to 
give higher enrichment compared to antibodies, due to the high affinity of the biotin-streptavidin 
interaction. Another advantage of this approach is that it can be scaled up, without worrying 
about the quantities of antibody.
Fractionation profiles of nuclear extracts isolated from murine erythroid leukemia (MEL) 
and embryonic stem (ES) cells show CTCF to be present in complexes ranging from about 350 
kD to 5 MD or larger. Other transcription factors like GATA1 and Ldb1 were shown to be present 
in protein complexes of similar sizes (Rodriguez et al., 2005). In MEL cells CTCF is predominately 
present in complexes larger than 670 kD while in ES cells CTCF is mostly present in complexes 
of 2,5 MD or more. This suggests that CTCF forms larger complexes in ES cells. Since we find 
multiple different CTCF-interacting proteins most of which have not been reported before, we 
propose that CTCF interacts with multiple components in a transient way. In the absence of DNA 
interactions are harder to detect, indicating that many interactions are, directly or indirectly, 
mediated via DNA. Several known interacting proteins show binding next to CTCF on specific 
sites. For example, YY1 binds in close proximity to CTCF on the X chromosome, UBF binds to the 
CTCF bound rDNA spacer promoter, Kaiso and nucleophosmin bind to the β-globin insulator and 
the large subunit of RNA polymerase II binds to some CTCF binding sites (Chernukhin et al., 2007; 
Defossez et al., 2005). In this way factors can modulate and fine tune CTCFs action on specific 
sites or mediate its insulator function, and vice versa.
The fact that only a few known CTCF interacting proteins where found back in our analysis 
could be due to the specificity of these interactions with CTCF to a particular cell type. For most 
published CTCF interacting proteins the amount of protein interacting with CTCF cannot be 
judged from immunoprecipitations that were performed since the authors do not indicate the 
enrichment of the pull down compared to the input. Furthermore all immunoprecipitations done 
so far to confirm or identify protein partners were performed in human cervical carcinoma (HeLa) 
cells. The observed interactions could be specific for that cell type. The exception is Yy1 that 
shows an interaction with CTCF at the endogenous level in ES cells (Donohoe et al., 2007). The 
interaction is weak and/or only a minority of Yy1 interacts with CTCF, however we were able to 
confirm this interaction. 
We found chromatin remodeling and transcription (co) factors to bind to CTCF, as well 
as components involved in transcriptional elongation, cell cycle regulation, replication, repair, 
protein modification and rRNA transcription. These data point to a general role for CTCF in the 
nucleus. CTCF might form a platform for multiple proteins allowing multiple processes to take 
place.
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CTCF in ES cells
CTCF is expected to gain binding to the ICR during differentiation of ES cells, since we report a 
(minor) loss of methylation at this site and a gain of ICR mediated interchromosomal interaction 
was reported during the process of ES cell maturation (Zhao et al., 2006). In agreement with this, 
chromatin in undifferentiated ES cells is reported to be globally decondensed and to contain a 
high fraction of only loosely bound architectural chromatin proteins, including linker histone H1 
and HP1 (Meshorer and Misteli, 2006). It would be interesting to study the role of CTCF in ES cell 
differentiation in more detail and test whether a gain of binding upon differentiation is generally 
applicable to CTCF bound insulator sites. Moreover identification of CTCF interacting proteins in 
differentiated ES cells might teach us more about how CTCF can contribute to changes in chromatin 
structures. In pull downs from ES cells no transcription factors were found to interact with CTCF. 
On the other hand, the RNA polymerase I complex and factors involved in cell cycle regulation are 
exclusively identified in ES cells and not in the tissues that were used for pull downs. CTCF might 
interact mainly with transcription factors in a tissue specific manner. To maintain the pluripotent 
state of ES cells, tissue specific transcription factors might be more repressed in these cells and 
interactions could be less favorable. 
Since CTCF is reported to contribute to overall chromatin structure it would be expected that 
ES cells lacking CTCF would not be able to differentiate. ES cells deleted for CTCF show a similar 
phenotype as observed in the MEFs; they stop dividing and can be maintained for multiple days 
until the cultures are taken over by cells that do express the protein. ES cells gradually deleting 
CTCF can be rescued upon expression of the mouse and chicken protein, however CTCFL is not 
able to rescue the deficiency (Sleutels unpublished). It would be interesting to determine whether 
CTCF protein with specific zinc-fingers deletions can also rescue these ES cells.  A read-out for 
these rescue experiments can be simply a gain of cell division. The differentiation capabilities of 
these cells or inter- or intra-chromosomal interaction mediated by CTCF could also be analyzed. 
CTCF and its role in regulating transcription by RNA polymerase I 
Identification of an interaction between CTCF and UBF and a shared function in regulating RNA 
polymerase I was not expected, because only very small amounts of CTCF protein can be detected 
in the nucleolus. CTCF is more enriched in nucleoli of K562 cells, a line derived from patients with 
chronic myeloid leukemia. It was reported that upon differentiation of these cells endogenous 
CTCF is more enriched in the nucleolus. However we could not recapitulate this result (data 
not shown). We also do not observe an enrichment of UBF binding to CTCF in differentiated 
K562 cells (data not shown). The study done by Torrano et al. is performed using constructs 
overexpressing CTCF and adding compounds to stimulate differentiation (Torrano et al., 2006). 
This raises the question to what extend this system mimics the endogenous situation. However 
we do report multiple CTCF binding sites in the human rDNA repeat indicating that CTCF plays, 
also in humans, an important role in regulating rRNA transcription. It would be interesting to fuse 
endogenous CTCF to a nucleolar localization signal and analyze the impact of this with respect to 
rRNA transcription (Mekhail et al., 2007). 
CTCF was shown to interact with another nucleolar protein, nucleophosmin. The interaction 
was suggested to take place at the borders of the nucleolus and to be involved in tethering 
insulator sequences to this site (Yusufzai et al., 2004). Although CTCF is largely excluded from 
the nucleolus we do show it binds to a nucleolar protein and to rDNA sequences. Whether 
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CTCF binding to the rDNA spacer promoter takes place in the nucleolus or at the borders of the 
nucleolus remains to be determined.
The nucleolus is a dynamic nuclear structure that assembles and disassembles during 
each mitotic cell division. Nucleolar proteins were demonstrated to rapidly associate with and 
dissociate from nucleolar components in a continuous exchange with the nucleoplasm (Chen 
and Huang, 2001). The functional significance of this is unclear but it might involve reactivation 
or modification of specific functional components. So in contradiction to CTCF, UBF is a very 
mobile protein not only exchanging rapidly between nucleolus and nucleoplasm but also rapidly 
associating and dissociating from it’s binding to the rDNA. All RNA polymerase I associated 
components undergo rapid exchange at the promoter and stably associate with chromatin only 
when they are incorporated into an elongation complex (Dundr et al., 2002). An approximate 
stoichiometry of 100 UBF dimers for each rRNA gene was calculated (Kermekchiev et al., 1997). 
With about the same amount of UBF and CTCF molecules in a cell, UBF is in clear excess in the 
nucleolus compared to CTCF. The in vitro affinity of the UBF-CTCF interaction is quite high since 
the purified proteins remain bound to each other after high stringency washes. 
It would be interesting to know whether regions exist where CTCF can bind to the rDNA 
locus indirectly by binding to UBF. Dimethyl 3,3’-dithiobispropionimidate (DTBP) is a protein-
protein crosslinking agent that facilitates ChIP of proteins that do not directly contact the DNA 
but are recruited by protein-protein interactions (Kurdistani and Grunstein, 2003). This method 
can be used to analyze CTCF binding along the whole rDNA repeat. CTCF might be involved in 
the formation of single rDNA expression units by the formation of distinct loops. However the 
overall nucleolar structure does not change in the absence of CTCF as judged by a similar staining 
pattern of UBF and RNA polymerase I in the absence of CTCF. This indicates that CTCF does not 
play a major role in this in non-dividing or resting cells. However in activated T-cells the nucleolar 
organization is affected in the absence of CTCF as shown by reduced protein levels of fibrillarin 
and nucleophosmin (Heath submitted).  Indicating that stimulatory signals or cell division are 
needed in order to detect the consequence of absence of CTCF on rDNA transcription and 
nucleolar organisation.
The binding strength of CTCF to the spacer promoter is comparable to other known CTCF 
sites although the repetitive nature of the rDNA should be taken into account. Mammalian cells 
contain about four hundred copies of tandemly repeated ribosomal RNA genes of which about 
half is actively transcribed (Grummt, 2003). If the repetitive nature is taken into account it can 
be concluded that only a few molecules of CTCF bind to the spacer promoter. Bandshifts show 
a higher affinity of CTCF for the spacer promoter fragment compared to the chicken lysozyme 
binding site. This indicates that the in vivo affinity is high but the amount of CTCF molecules 
present to bind to the spacer promoter is limiting, which could explain the low signal of CTCF in 
the nucleolus as detected by immunofluoresence. Whether CTCF binds to the spacer promoter 
on active and not on inactive rDNA repeats or on both is an interesting question that remains to 
be solved. 
Many questions remain unanswered regarding the function of a CTCF-UBF interaction and 
the role of CTCF in regulating RNA polymerase I transcription. It would be interesting to know 
whether CTCF can bind the RNA polymerase I complex directly or only indirectly via an interaction 
with UBF (Figure 6.1). Furthermore the sequence of events regulating transcription from the 
rDNA spacer promoter remains to be determined.  Since UBF and RNA polymerase I binding are 
down regulated specifically at the spacer promoter and enhancer region in the absence of CTCF, 
it seems likely that CTCF is involved in recruiting the proteins to these sites. The binding of UBF, 
RNA polymerase I and CTCF results in transcription from the spacer promoter.
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How exactly CTCF and UBF can enhance transcription from the spacer promoter is not clear. 
It seems likely that they are involved in recruiting and accumulating RNA polymerase I on this site. 
Enhancement of transcription of the 45S pre-rRNA was reported to depend on the enhancers 
and spacer promoter. However spacer promoter transcription is also involved in repression of 
45S pre-rRNA transcription. Short intergenic RNAs that arise from the unstable spacer promoter 
transcript are involved in this (Mayer et al., 2006) (Figure 6.2). Whether these RNAs originate 
from spacer promoters that are adjacent to active or silent rDNA repeats is not known. The fact 
that CTCF activates transcription from the spacer promoter by maintaining RNA polymerase I 
and UBF binding and the observation that under silent conditions, in differentiated 3T3L1 cells, 
CTCF binding is reduced suggest that CTCF binds only to active rDNA repeats. This would than 
also indicate that spacer promoter transcripts are transcribed only from active rDNA repeats 
and suggests the transcripts to work in trans and target specific rDNA repeats for silencing upon 
binding to NoRC.
The similarities between the position of CTCF binding sites in the mouse and Xenopus 
rDNA repeat, together with the enhancer-blocking properties of this element in Xenopus and the 
histone marks present in mouse suggest that CTCF functions as a boundary at this site (Robinett 
et al., 1997). It could potentially block transcripts that are accidentally not terminated and pass 
through the IGS. Alternatively CTCF may function to bring the promoters and enhancers in close 
proximity and in this way provide specificity and directionality of the enhancers to activate the 
appropriate promoter. Such a function for a CTCF bound enhancer-blocking element has been 
described recently (Yoon et al., 2007). Additional evidence for CTCF to function as an enhancer-
blocking boundary at the rDNA spacer promoter are the presence of Cohesin binding on this site 
and the ability of the site to block an enhancer from activating a promoter in an in vitro assay. It 
would also be interesting to know whether CTCF binds this site in a methylation sensitive manner. 
CTCF binding is reported to be methylation sensitive indicating that CTCF is likely to only bind the 
unmethylated (active) rDNA repeats.
Transcripts from the spacer promoter were shown to be important for rDNA silencing by 
tethering NoRC resulting in heterochromatin formation (Mayer et al., 2006) (Figure 6.2). The 
question is why and when silencing needs to be controlled by spacer transcripts. The link of 
epigenetic control of rDNA transcription with cell growth and proliferation is not fully understood. 
The ratio of active and inactive rDNA repeats could be reset during each cell division or the 
number of active/inactive rDNA repeats could be slightly variable during the cell cycle. Limiting 
the number of active rRNA genes might decrease DNA damage and stabilize rDNA by repressing 
homologous recombination. Altogether we propose that CTCF, by regulating spacer promoter 
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Figure 6.1 Mouse RNA polymerase I transcription initiation complex at the spacer promoter 
A. CTCF binds to RNA polymerase I indirectly via its interaction with UBF. B. CTCF binds directly to UBF and RNA polymerase 
I. Grey oval represent factors that were identified from mass spectrometry analysis on CTCF pull downs. The polymerase-
associated factor that is responsible for an interacting of UBF with RNA polymerase I is PAF53 and was found back in our 
mass spectrometry lists.
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transcription is important for controlling silencing of rDNA repeats or plays a role in maintaining 
a balance between active and inactive repeats. In the absence of CTCF we could however not 
detect a difference in 45S rRNA compared to wild-type. This could be explained by the fact that 
cells without CTCF do not divide. Cell division is likely to be needed in order to clear the cell 
from RNA-NoRC complexes and to re-activate the heterochromatic silenced rDNA repeats. It 
would be interesting to determine transcription from the spacer promoter and gene promoter 
in CTCF absent T cells that are able to proliferate upon circumventing T-cell receptor signaling 
with Ionomycin and phorbol ester (PMA) (Heath unpublished observation). Interestingly in vitro 
activation of CTCF negative T cells does results in a defective nucleolar organization (Heath 
submitted).
CTCF and cell cycle regulation
CTCF plays important roles in cell growth control. Enhanced expression of CTCF induces growth 
retardation at multiple points during the cell cycle without apoptosis.  The cell cycle profile of 
these cells is identical to untreated cells and viable cells could be maintained without dividing for 
several days (Rasko et al., 2001). Interestingly we show that MEFs deleted for CTCF show a similar 
phenotype as observed upon enhanced expression of CTCF. Also CTCF deficient T cells show a 
proliferative defect without any obvious block at a specific stage during the cell cycle. Although 
most cell types have an impaired proliferative capacity in the absence of CTCF some cell types like 
γδ T cells proliferate and develop normal without CTCF. 
It is likely that multiple mechanisms are involved in CTCF dependent cell proliferation. CTCF 
was suggested to modulate the transcription of multiple genes involved in cell proliferation such 
as cMyc and Rb. Interestingly conditional expression of CTCF leads to a reduction in cMyc and 
up regulation of p27 and p19ARF in immature B cells (Qi et al., 2003). A misregulation of cMyc is 
however not detected in T cells deleted for CTCF. In those cells we do detect an up regulation of 
two major cell cycle inhibitors p21 and p27 and no change in levels of p53. Normally p21 and p27 
are downregulated at the ISP stage of T cell development to allow transition from G1 to S-phase. 
We show binding of CTCF to the first intron of p21 in MEFs indicating that p21 is a direct target of 
CTCF. By binding to this site CTCF might regulate the transcription of the gene in cis for example 
Figure 6.2 Model depicting the role of spacer promoter 
transcripts in rDNA inactivation
First, intergenic spacer (IGS) transcripts are synthesized by 
the spacer promoter (step 1) This IGS RNA is than processed 
into short intermediates  (step 2). RNA that matches the rDNA 
promoter associates with the chromatin remodeling complex 
NoRC (step 3). Once bound to RNA, NoRC is recruited to the 
rDNA promoter (step 4). The large subunit of NoRC, TIP5, 
interacts with histone modifying enzymes, such as HDACs, 
HMTs, and DNMTs (step 5), leading to heterochromatic 
histone modifications and de novo DNA methylation (step 
6). As a consequence, transcription complex formation is 
impaired and rRNA genes are silenced (step 7). (Adapted 
from (Grummt, 2007))
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by interfering with the elongation of the transcript. This might explain the proliferative block 
observed in CTCF deficient cells. 
The identified CTCF protein partners might solve another piece of the puzzle to clarify the 
role of CTCF in cellular proliferation. The identification of the T-cell specific factors TCF/Lef, does 
not explain the defects observed in T cell development in the absence of CTCF. Interestingly, 
multiple proteins that function during mitosis by associating with the spindle were identified in 
our analysis in ES cells. During mitosis CTCF is reported to remain bound to the chromosomes 
and to associate with the centrosome and mitotic spindle as shown by antibody stainings on fixed 
cells and imaging of GFP-CTCF expressing cells (Burke et al., 2005; Zhang et al., 2004). However 
in CTCF negative ES cells that are rescued with GFP-CTCF the protein could be detected only on 
mitotic chromosomes and not on centrosomes (Heath manuscript in preparation). Interestingly, 
not all CTCF binding sites are occupied by CTCF during mitosis (Burke et al., 2005; Komura et al., 
2007). The specific localization of CTCF on mitotic chromosomes together with the identification 
of a subunit of the Condensin complex suggests that CTCF is perhaps required for regulating the 
condensation of chromatin at mitosis. 
Centrosomes are important for the completion of cytokinesis and cell cycle progression 
through G1 into S phase (Hinchcliffe et al., 2001). They assemble and organize the mitotic bipolar 
spindle that ensures accurate chromosome segregation during mitosis. The association of CTCF 
with mitotic centrosomes is microtubule independent as shown by nocodazole treatment 
indicating that CTCF bind via different means (Zhang et al., 2004). The interacting proteins 
identified from our analysis could be involved in recruiting CTCF to the centrosome. It would be 
very interesting to examine the role of CTCF during mitosis in more detail.
The CP190 protein that binds to CTCF in Drosophila is important for proper insulator function 
and was originally identified as a protein binding to centrosomes. The protein seems to be unique 
in Drosophila since no homologs are detected in mouse or human. Despite its localization to the 
centrosomes the mutant shows no defect in centrosome or microtubule organization during cell 
division indicating that CP190 is not essential for these processes (Butcher et al., 2004).
The effect of CTCF on rRNA transcriptional regulation, its influence on cell cycle regulating 
target genes and its potential involvement in mitosis are likely to contribute to the proliferative 
defect observed in CTCF negative cells.
CTCF in organizing chromatin structure
The CTCF interacting proteins Nucleophosmin, Kaiso and CHD8 have been implicated in regulating 
its insulator function. However this regulatory function of Kaiso and Nucleophosmin have been 
demonstrated only at specific insulator sites. The recent mapping of all CTCF binding sites 
throughout the human genome can now be used to address the question whether regulation of 
CTCF insulator function by these proteins is generally applicable or specific to certain sites. The 
mapping of CTCF binding sites in the human also highlights the importance of CTCF for proper 
regulation of a large part of the genome. The abundance of its binding sites implies a role for CTCF 
not only in regulating the expression of specific genes, but also of whole chromatin domains. This 
is reflected by the fact that 45% of the CTCF binding sites map to intergenic regions where CTCF is 
likely to function as an insulator, while 20% of its binding sites maps to promoter regions (Barski 
et al., 2007).
Whether the intergenic CTCF binding sites all function as insulators or also include 
enhancers remains to be determined. Insulators and enhancers are both shown to coincide with 
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incorporation of the histone variant H2A.Z, high levels of H3K4 methylation and H3K9 mono-
methylation (Barski et al., 2007). In the absence of CTCF a local loss of histone H3 acetylation and 
a gain of H3K27 dimethylation can be observed in the β-globin locus (Splinter et al., 2006). A local 
loss of H3 acetylation, H4 acetylation, H3K4 dimethylation and a loss of the histone variant H2A.Z 
is observed in the absence of CTCF on the rDNA spacer promoter. This indicates a role for CTCF 
in maintaining local histone marks, most likely by interacting with chromatin remodeling factors. 
In this way CTCF is likely to regulate gene expression by locally opening up chromatin thereby 
influencing the accessibility of DNA for RNA polymerase.
The CTCF interacting protein CHD8 is reported to be part of the MLL1 complex that includes 
the WD40-repeat protein WDR5 and is involved in methylation of lysine 4 of histone H3 (Dou et 
al., 2005; Ishihara et al., 2006). However direct evidence for a role of CHD8 in regulating CTCF 
dependent histone modification is lacking. Interestingly we identified the WDR5 component 
of this complex to co-purify with CTCF. WDR5 is required for binding of the methyltransferase 
complex to the methylated lysine 4 of histone H3 (Wysocka et al., 2005). It would therefore be very 
interesting to test whether this protein binds to CTCF and whether it is involved in methylating 
H3K4 at its binding sites. A role for WDR5 in transcription factor dependent regulation of gene 
expression was shown recently. An interaction between WDR5 and Pax7 resulted in local H3K4 
trimethylation at its binding site followed by transcriptional activation (McKinnell et al., 2008). 
Beside CTCF, the β-globin cHS4 boundary protein USF was shown to interact with CHD8. The 
potential CTCF interacting protein Snf2h and WDR5 were also identified as USF interacting 
proteins among other chromatin remodeling factors. Downregulation of USF results in a local 
loss of H3R4 methylation and decreased acetylation of H3 and H4 (Huang et al., 2007). Proteins 
binding to USF like PRMT1, and the histone acetyltransferases (HATs) PCAF and SRC-1 were 
suggested to be important in this.
Comparing the identified CTCF interacting proteins with proteins that are involved in 
regulating the function of other boundary- or architectural factors can learn us more about how 
insulators function. Multiple factors that form boundaries between silenced and active chromatin 
domains in Drosophila, yeast and mouse like SATB1, LSD1 and Dot1 were shown to function 
by distinct mechanism but all involve recruitment of histone modifiying complexes (Altaf et al., 
2007; Lan et al., 2007).
Boundary function and enhancer-blocking abilities were found to be separate functions, 
but how these two functions are performed in still unclear (Kurshakova et al., 2007; Recillas-
Targa et al., 2002). An enhancer-blocking insulator was suggested to participate in pairing the 
correct enhancer and promoter and conferring directionality to the enhancer, rather than solely 
as an element that blocks inappropriate enhancer-activated transcription (Krebs and Dunaway, 
1998). Recent experiments show that enhancer-blocking insulators can function by directly 
interacting with the regulated promoter and enhancer elements (Yoon et al., 2007). CTCF shares 
its enhancer-blocking abilities with the Drosophila proteins Su(Hw), Zw5, BEAF32 and GAGA 
factor. Not much is known about the functioning or interacting proteins of Zw5 and BEAF32. 
The two proteins were reported to bind to each other and BEAF32 was shown to bind to the 
heterochromatin protein D1 (Blanton et al., 2003; Cuvier et al., 2002). 
Su(Hw) can organize chromatin structure and stabilize its insulator function by recruiting 
multiple proteins and a RNA component (Lei and Corces, 2006). The fact that Su(Hw) and 
dCTCF are present together in insulator bodies and share a common interacting protein, CP190, 
is interesting (Gerasimova et al., 2007; Mohan et al., 2007). This indicates that insulators can 
function together and share interacting proteins. 
GAGA is on the other hand known to interact with various other proteins. These proteins 
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function in regulating polycomb group complexes and transcriptional abilities by GAGA and 
include tramtrack, pipsqueak, lolal/batman, SAP18 (Sin3a/ HDAC co-repressor complex), 
PRC1 (polycomb group), NURF and Ssrp1/FACT (Adkins et al., 2006; Lehmann, 2004). Recent 
experiments revealed a role for GAGA and FACT in directing the replacement of histone H3 
with its variant H3.3 (Nakayama et al., 2007). FACT is involved in nucleosome rearrangements 
and disassembly. It was proposed that this replacement is achieved through the disassembly 
of a nucleosome by the GAGA-FACT complex followed by HIRA mediated deposition of a H3.3-
containing nucleosome. This is suggested to be important to counteract the spreading of silent 
chromatin and marks boundaries of cis-regulatory domains (Mito et al., 2007). It would be very 
interesting to find out whether these mechanisms are evolutionarily conserved in vertebrates. 
Interestingly we detect the Ssrp1 and Cdc68 components of the FACT complex to be pulled down 
by CTCF. A potential function of a CTCF-FACT interaction could be similar of that of the GAGA-
FACT complex in incorporating histone variants at specific sites. Alternatively the interaction 
could be important during transcription initiation or elongation when FACT associates with RNA 
polymerase II. Factors involved in elongation were also shown to be pulled down by CTCF and 
include the PAF-complex, MRG15 and Tceb.
The recently reported finding that CTCF binding is often accompanied by the presence of 
the histone variant H2A.Z is confirmed by our experiments. H2A.Z binding to CTCF sites seems 
to be not specific to intergenic sites i.e. potential insulator sites. The CTCF bound Igf2/H19 ICR 
does not show significant H2A.Z levels, but consisted with this variant being also a mark of active 
enhancers it was found to be enriched at the CTCF bound H19 enhancers (Verona et al., 2008; 
Yoon et al., 2007). Furthermore we can detect an enrichment of H2A.Z at the CTCF binding site in 
the cMyc promoter. Recent studies suggest that histone turnover helps to maintain continuous 
access to sequence-specific DNA-binding proteins that regulate epigenetic inheritance, providing 
a dynamic alternative to histone-marking models for the propagation of active chromatin. 
Interestingly it was reported recently that transcription factors like p53 and cMyc can provide 
positioning cues that direct the location of H2A.Z-containing nucleosomes. By doing so these 
factors can regulate transcription in part depending on the position of H2A.Z incorporation 
(Gevry et al., 2007), raising the question whether CTCF can also regulate transcription in part 
by prefentially positioning H2A.Z within chromatin. H2A.Z deposition is not only reduced in the 
absence of CTCF but also in the absence of SRCAP and some histone acetyltransferases (Wong 
et al., 2007; Zhang et al., 2005) Global depletion of H2A.Z from mammalian cells causes a highly 
unstable genome caused by defects in the chromosome segregation process (Rangasamy et al., 
2004). SRCAP is the complex involved in catalyzing the incorporation of H2A.Z in chromatin  (Ruhl 
et al., 2006). The potential CTCF interacting SWI/SNF chromatin remodeling protein BAF57 was 
shown to be part of the SRCAP complex, suggesting that CTCF could be involved in targeting SRCAP 
to specific promoter or insulator regions and in this way regulates incorporation of H2A.Z.
Chromatin structure is not only influenced by post-translational modifications of histones but 
also by the RNAi machinery (yeast, plants and Drosophila) and binding of structural non-histone 
proteins.  The HMG-box family of proteins comprises such a group of structural proteins.
Interestingly we report an interaction of two HMG-box (HMGB) containing proteins 
with CTCF, UBF and the not yet characterized binding to Lef1. Interestingly two other proteins 
copurifing with CTCF, Ssrp1 and BAF57, both share a 50-60% homology with the first HMG-box 
of UBF. This suggest a common theme between CTCF and its binding to non-sequence specific 
architectural HMGB proteins. The HMGB proteins are abundant and highly mobile proteins in 
the cell nucleus that influence chromatin structure and enhance the accessibility of binding 
sites to regulatory factors. Due to their remarkable DNA bending activity, HMGB proteins can 
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increase the structural flexibility of DNA, which could help CTCF in the formation of chromatin 
loops. Members of the HMGB family act as versatile modulators of chromatin function they 
can facilitate nucleosome remodeling (Grasser et al., 2007). One mechanism by which HMGB 
proteins could prime the nucleosome for migration is to loosen the wrapped DNA and so enhance 
accessibility to chromatin-remodeling complexes and possibly also to transcription factors like 
CTCF (Travers, 2003). The interaction of CTCF with another chromatin architectural protein HP1 
is also interesting. 
The recent finding that half of the CTCF binding sites are enriched for Cohesin and that 
Cohesin contributes to CTCF insulator function suggests that Cohesin is the factor involved in 
structural and functional organization of chromatin (Parelho et al., 2008; Stedman et al., 2008; 
Wendt et al., 2008). However an interaction between the two proteins could not be detected 
indicating that not only direct but also indirect interactions via other proteins are important for 
mediating CTCF function. 
The data presented in this thesis have enhanced our understanding of the complex 
functioning of CTCF. The protein partners we identified provide insight in CTCF function and 
provide an exciting challenge to unravel the precise function of specific interactions. 
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Summary
All multi-cellular organisms start as a single fertilized egg. During development cells proliferate 
and differentiate, ultim ately forming complete organs and an organism. Different types of cells 
exist within an organism, with highly specific functions and shapes. For example, muscle cells 
serve to exert force, blood cells serve to transport oxygen and carbon dioxide, and neurons serve 
to transmit signals. Despite enormous differences in appearance and function most cells share 
the same genetic material, which is present as a long strand of DNA that contains multiple genes. 
Not all genes are in use in all cells, some genes are turned ‘on’ others are turned ‘off’. The genes 
that are active determine the function and identity of a cell. The human genome contains about 
25.000 genes, which is only twice as much as the genome of a fruit fly. Genes are transcribed into 
mRNA, which is subsequently translated into a functional product, called protein. These are the 
functional units of the cell and represent the building blocks of the different compartments of a 
cell.  Examples of proteins are enzymes, hormones and antibodies. By turning the transcription of 
genes ‘on’ or keeping it ‘off’ a cell decides over what mRNAs are synthesized and what proteins 
are produced. To a large extent this determines the unique protein composition of a cell and, 
hence, its phenotype.
The Ctcf gene codes for a protein that contains eleven zinc-fingers, with which it can bind 
to DNA or to other proteins. CTCF (CCCTC binding factor) belongs to the family of transcription 
factors, which means it is able to turn the transcription of specific genes ‘on’ or ‘off’. Which 
specific genes are activated is tightly regulated and depends on the cell type and time point during 
development. A lack of correct transcriptional regulation can result in all kinds of diseases such 
as for example cancer. The different proteins it can bind to influence transcriptional regulation 
by CTCF. This thesis describes the work that others and I have done to understand how CTCF 
functions. Chapter 1 gives a broad introduction into the subject, which is needed to understand 
the experiments that are described in the remainder of the thesis. It gives an introduction to 
gene regulation and organisation of DNA in the cell nucleus, and what is known about CTCF.
To better understand the role of CTCF we generated so-called conditional Ctcf “knockout” 
mice, in which the Ctcf gene can be deleted in a spatio-temporally controlled manner. Studies 
in mice with this knockout allele are described in chapter 2. Deletion of the gene will stop the 
production of CTCF protein and cells then have to cope without CTCF. If we switch off the Ctcf 
gene very early in development, we do not obtain embryos without CTCF, indicating that CTCF 
is required for early stages of embryogenesis. This is consistent with published data. We then 
decided to delete the Ctcf gene in so-called T-cells (thymocytes) of the immune system of 
adult mice, since it is well known that mice can survive without an immune system, as long as 
they are not challenged by infections. We show that in the absence of CTCF proliferation and 
differentiation of T-cells in the thymus is blocked and no correct immune response can be build 
up in the absence of CTCF. Our data reveal a new role for CTCF in cell cycle control.
The variety and complexity of processes involving CTCF require that CTCF works together 
with multiple proteins. Thus, interaction of CTCF with other factors largely determines how and 
what CTCF does. Chapter 3 describes experiments that were done to identify as many CTCF 
interacting proteins as possible. Upon coupling of a small protein tag to CTCF, which can be labelled 
with biotin, we could easily affinity-purify biotinylated CTCF with a steptavidin-based affinity 
matrix (streptavidin binds tightly to biotin). By performing this purification under relatively mild 
conditions we were able to co-purify proteins that bind to CTCF from cellular extracts. Afterwards 
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CTCF protein partners were identified and analyzed by mass spectrometry. Embryonic stem cells 
expressing CTCF with the biotin label were injected into blastocysts to generate a Ctcf knock-in 
mouse that expressed biotinylated CTCF in all of its tissues. This mouse was used to identify CTCF 
protein partners in the different tissues. 
We showed that CTCF binds to multiple different factors. Based on what is known about 
those proteins we discuss how they could function together with CTCF. This analysis is described 
in Chapter 3. In Chapter 4, I focus on a CTCF-interacting partner that came out of the biotin-
pull down and that is called UBF (upstream binding factor). UBF is important for the activity of 
genes that code for ribosomal RNA (rRNA). This type of RNA is very important for formation of 
the ribosome, a megadalton complex that is absolutely essential for protein synthesis. We show 
that CTCF, as well as its homolog CTCFL, can bind with their zinc-fingers to the part of the UBF 
protein that is involved in DNA binding. Moreover we show that CTCF together with UBF and 
RNA polymerase I (the enzyme that ensures correct transcription of rRNA) bind to a piece of DNA 
that is important for correct regulation of rRNA transcription. In the absence of CTCF, binding of 
these proteins to DNA is reduced, indicating an important role for CTCF in rRNA transcription. 
Furthermore, we show that CTCF can organize chromatin in a very recognizable manner, by 
regulating the binding of other factors. 
A unique function of CTCF is that it can block the inappropriate activation of a gene. CTCF 
does this by shielding a gene from activating sequences in the neighbourhood. I describe a 
cellular system that can be used to study this feature of CTCF in more detail in chapter 5. The 
system makes use of the fact that CTCF regulates two neighbouring genes, one coding for the 
growth factor Igf2 and another, H19, coding for an RNA that is not translated. These genes are 
imprinted, which means they are expressed from only one of the two parental copies. CTCF sits 
in between the two genes when they are inherited from the mother. This prevents activation of 
the Igf2 gene. When the two genes are inherited from the father CTCF is not bound in between 
the genes and Igf2 is active. Correct activity of the two genes is very important for foetal growth. 
By crossing conditional CTCF knockout mice with mice from another strain we can distinguish 
between the two parental copies. From these mice cells were isolated and tested. As these 
experiments are ongoing no firm conclusion can yet be drawn. However, our experiments do 
show that the activity of both genes is reduced in the absence of CTCF. This indicates that CTCF 
might have an additional role in regulating the activity of these genes. It appears that the cellular 
system can be used to gain a better insight into the role of CTCF in regulating imprinted genes.
In Chapter 6 the data described in this thesis are discussed. Based on our results together 
with what is known from experiments done by other people I speculate about the different 
regulatory mechanisms of CTCF. This results in suggestions for future research and experiments 
that can be performed.
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Samenvatting
Alle multicellulaire organismen beginnen als een bevruchte eicel. Gedurende de ontwikkeling 
vindt vermeerdering en specialisatie van cellen plaats, die zich groeperen en organen vormen. 
Een organisme bestaat uit verschillende typen cellen met elk een specifieke functie en vorm. 
Spiercellen dienen bijvoorbeeld om kracht uit te oefenen, bloedcellen transporteren zuurstof en 
koolstofdioxide, en neuronen dienen om signalen in de hersenen door te geven. Ondanks een 
enorm verschil in uiterlijk en functie hebben deze cellen veel gemeen. Ze bevatten vrijwel allemaal 
het erfelijke materiaal in de vorm van een lange streng DNA waarop een groot aantal genen ligt. 
Niet al deze genen zijn in alle cellen in gebruik, sommige genen staan ‘aan’ en anderen staan ‘uit’. 
De genen die aanstaan bepalen de functie en identiteit van een cel. Het humane genoom bevat 
ongeveer 25.000 genen, wat slechts twee keer zoveel als het genoom van een fruitvliegje. Genen 
worden afgeschreven tot mRNA, wat daarna vertaald wordt in een functioneel product, een 
eiwit. Deze eiwitten doen in de cel het werk en fungeren als bouwstenen van de verschillende 
onderdelen van de cel.  Voorbeelden van eiwitten zijn enzymen, hormonen en antilichamen. 
Door het afschrijven (transcriptie) van genen ‘aan’ of ‘uit’ te zetten kan een cel beslissen welk 
mRNA gevormd wordt en welk type eiwit er geproduceerd wordt. Dit bepaald voor een groot 
gedeelte de unieke eiwit samenstelling en daarmee dus ook de functie en vorm van de cel.
Het Ctcf gen, codeert voor een eiwit met elf zinkvingers waarmee het DNA en andere 
eiwitten kan binden. CTCF (CCCTC binding factor) behoord tot de familie van transcriptiefactoren, 
wat betekend dat het bepaalde genen ‘aan’ en ‘uit’ kan zetten. Welke genen geactiveerd worden 
is strak gereguleerd qua celtype en tijdstip tijdens de ontwikkeling. Een gebrek aan correcte 
regulatie van gen transcriptie resulteert vaak in allerlei ziekten zoals b.v. kanker. Verschillende 
andere eiwitten kunnen aan CTCF binden en daardoor beïnvloeden hoe CTCF transcriptie van 
specifieke genen reguleert. Dit proefschrift beschrijft de experimenten die ik tezamen met andere 
mensen heb gedaan om het functioneren van CTCF beter te begrijpen. Hoofdstuk 1 geeft een 
brede introductie van het onderwerp, hierdoor kan de basis van de experimenten beschreven in 
dit proefschrift beter begrepen worden. Het hoofdstuk geeft een introductie over genregulatie 
en organisatie van het DNA in de celkern. Verder wordt uitgebreid ingegaan op wat tot nu toe 
bekend is over CTCF. 
Om de rol van CTCF beter te begrijpen hebben we zogenaamde conditionele Ctcf “knock-
out” muizen gemaakt waarin we het Ctcf gen kunnen uitschakelen. We kunnen zo zelf de tijd van, 
en het cel type waarin, het uitschakelen van het Ctcf gen plaats vind in de zich ontwikkelende 
muis bepalen. De studies die gedaan zijn met deze Ctcf knock-out muizen worden beschreven in 
hoofdstuk 2. Als we het Ctcf gen uitschakelen stopt de productie van CTCF eiwit en cellen moeten 
dan om zien te gaan met de afwezigheid van CTCF. Als we het Ctcf gen vanaf het begin van de 
ontwikkeling uitschakelen, worden er geen embryo’s zonder CTCF geboren, dit geeft aan dat 
CTCF vereist is voor de vroege stadia in embryogenese. Dit komt overeen met al gepubliceerde 
data. Vervolgens hebben we het Ctcf gen uitgeschakeld in zogenaamde T-cellen van het 
immuunsysteem van een volwassen muis, aangezien het bekend is dat muizen kunnen overleven 
zonder een immuunsysteem, zo lang ze niet blootgesteld worden aan ziekteverwekkers. We laten 
zien dat in de afwezigheid van CTCF de differentiatie van T-cellen in de thymus geblokkeerd is en 
dat geen adequate afweer door het immuunsysteem opgebouwd wordt in de afwezigheid van 
CTCF. Onze data toont een nieuwe rol aan voor CTCF in regulatie van celdeling. 
De variëteit en complexiteit van processen waarbij CTCF betrokken is vereisen dat CTCF 
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functioneert tezamen met meerdere eiwitten. Het contact van CTCF met andere eiwitten bepaald 
hoe en wat CTCF doet. In hoofdstuk 3 worden experimenten beschreven die gedaan zijn om 
eiwitten die aan CTCF binden te identificeren. Door CTCF aan een klein eiwit genaamd biotine 
te koppelen kunnen we CTCF zuiveren met een streptavidine affiniteit matrix (streptavidine bind 
sterk aan biotine). Door deze eiwitzuivering onder milde condities uit te voeren zijn we in staat 
geweest eiwitten die aan CTCF binden te isoleren uit cel extracten. Deze eiwitten zijn door middel 
van massaspectrometrie geanalyseerd en geïdentificeerd. Door embryonale stamcellen die CTCF 
met het biotine label bevatten in te brengen in blastocysten is een Ctcf “knock-in” muis gemaakt, 
die gebiotinyleerd CTCF aanmaakt in alle weefsels. Deze muis is gebruikt om CTCF eiwit partners 
te identificeren uit verschillende weefsels.
We laten zien dat CTCF aan veel verschillende factoren bind en geven aan de hand van wat 
al bekend is van deze eiwitten een discussie over hoe ze samen met CTCF kunnen werken. Deze 
analyse wordt beschreven in hoofdstuk 3. In hoofdstuk 4 ligt de focus op een CTCF interactie 
partner geïdentificeerd uit de biotine zuiveringen, UBF (upstream binding factor) genaamd. UBF 
is belangrijk voor de activiteit van genen die coderen voor ribosomaal RNA (rRNA). Ribosomaal 
RNA is belangrijk voor de vorming van het ribosoom, de plaats waar alle eiwitten in de cel 
aangemaakt worden. We laten zien dat zowel CTCF, als een homoloog CTCFL genaamd, met 
hun zinkvingers kunnen binden aan een gedeelte van het UBF eiwit wat van belang is voor DNA 
binding. Bovendien tonen we aan dat CTCF samen met UBF en RNA polymerase I (het enzym 
dat zorgt voor rRNA transcriptie) bindt aan een stukje DNA wat van belang is voor de correcte 
regulatie van rRNA transcriptie. In de afwezigheid van CTCF is binding van deze eiwitten aan DNA 
afgenomen wat aangeeft dat CTCF een belangrijke rol speelt in de regulatie van rRNA. Bovendien 
laten we zien dat CTCF chromatine kan organiseren op een erg herkenbare manier, door de 
binding van andere factoren te reguleren.
Een unieke functie van CTCF is dat het ongewenste activatie van een gen kan tegenhouden. 
CTCF doet dit door het gen af te schermen van activerende stukjes DNA die in de buurt aanwezig 
zijn. In hoofdstuk 5 beschrijf ik een celsysteem dat gebruikt kan worden om deze eigenschap van 
CTCF in meer detail te kunnen bestuderen. Het systeem maakt gebruik van het feit dat CTCF twee 
naast elkaar liggende genen reguleert, het ene gen codeert voor de groeifactor Igf2 en het andere 
voor het niet-coderende H19 gen. Deze genen zijn ingeprent, wat betekend dat slechts een van de 
twee ouderkopieën actief is. CTCF bevind zich tussen deze twee genen als ze overgeërfd worden 
van de moeder. Dit voorkomt de activatie van het Igf2 gen. Indien de twee genen overgeërfd zijn 
van de vader is CTCF niet gebonden tussen deze genen en is het Igf2 gen actief. Correcte activiteit 
van deze genen is erg belangrijk voor foetale groei. Door conditionele Ctcf knock-out muizen te 
kruisen met muizen van een ander ras kunnen we verschil maken tussen de twee ouderkopieën. 
Uit deze muizen zijn dan ook cellen geïsoleerd en getest. Aangezien deze experimenten nog niet 
afgerond zijn kunnen nog geen duidelijke conclusies getrokken worden. Onze experimenten 
tonen echter aan dat de activiteit van beide genen gereduceerd is in de afwezigheid van CTCF. Dit 
duidt op een mogelijk extra, nog onbekende, rol voor CTCF in de regulatie van de activiteit van 
deze genen. Het cellulaire systeem wat is opgezet kan gebruikt worden om meer duidelijkheid 
te krijgen over de rol van CTCF in de regulatie van ingeprente genen en met name die van Igf2 
en H19.
Tot slot geeft hoofdstuk 6 een discussie over de data die in dit proefschrift beschreven 
wordt. Op basis van onze resultaten en wat bekend is uit onderzoeken gedaan door andere 
mensen wordt gespeculeerd over de diverse regulatie mechanismen van CTCF. Aan de hand 
hiervan worden experimenten die in de toekomst gedaan kunnen worden uiteen gezet.
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In de vijf jaar van mijn promotieonderzoek hebben veel mensen bijgedragen aan het uiteindelijke 
resultaat, en deze mensen wil ik hierbij dan ook graag bedanken !
Ik wil beginnen met mijn promoter Frank Grosveld te bedanken voor de mogelijkheid om 
onderzoek te doen op zijn afdeling. Frank, ik heb veel geleerd van je adviezen en ideeën. Je 
heb me aangemoedigd kritisch te kijken naar mijn experimenten, resultaten en presentatie. 
Bedankt.
Niels, bedankt voor alles ! je optimisme, adviezen en het feit dat je altijd tijd vrij kon maken 
voor vragen en discussies. Ik heb veel geleerd van je kijk op sommige resultaten en de vrijheid die 
je gaf heeft ervoor gezorgd dat ik veel verschillende manieren heb geleerd om een vraagstelling 
experimenteel te beantwoorden. Mijn MacBook Pro is inmiddels alweer 1,5 jaar oud... zeker te 
weten toe aan vervanging? Sorry nog voor die ene keer dat ik wel heel hard moest lachen toen 
je op een snikhete zomerse dag het lab binnen kwam met een T-shirt daarover een overhemd 
met lange mouwen met daaronder een korte broek, twee melkflessen en van die flip-flop plastic 
teenslippers.
At first I want to thank the ‘nuclear side’ of the lab, our small CTCF-group. Happy we are not 
having to deal with depolymerizations and aggregates taking place on the other side of the lab/
nuclear membrane. Helen, I always thought as long as you are in the lab it will take a while before 
I have my defense. But in the end this happened to be not the case and time passed by very 
quickly. I am very happy that we could stay working together and shared the ups and downs of 
our projects. Sometimes we were more enthusiastic about results of the other than of our own. 
Thank you for your happiness, care and advise. 
Frank, toen je hoorde dat ik een gedeelte van een tweeling was moest je wel even slikken. 
Bedankt voor alles wat je me geleerd hebt, het feit dat je altijd tijd voor me had, onze vele 
(wetenschappelijke) discussies en je enthousiasme en humor. Ik zal je bekende en elke keer weer 
grappige kreten als : “ Ja en de jackpot gaat naar..”, “sst daar heb je hem” , “Ja, suzie, jaa” zeker 
missen. Je gewoonte om alle eppen uitsluitend te nummeren van 0 (?) tot 10 of hoger heb ik toch 
maar niet overgenomen. En oh ja, nog bedankt voor de kaart vanaf je exotische vakantieadres :’ik 
ook aan jouw.’ Je ‘de realistische pessimist is beter af dan de optimist’ en ‘alle wetenschappers 
zijn manisch-depressief’ hadden ook goede stellingen geweest. 
Niet alleen mijn onderzoek maar zeker ook de sfeer maakte dat het elke dag weer leuk was om 
naar het lab te gaan. Het mag toch met recht gezegd worden dat lab 10.30 een van de gezelligste 
labs is. De gangmakers: Gideon, Jeffrey, Marco en Frank mede door jullie was het altijd gezellig 
en hebben we wat af gelachen met z’n allen. Niet alleen op het lab, maar ook bij alle andere 
activiteiten die we buiten werktijd met z’n allen deden maakte dat ik mij snel thuis voelde na mijn 
verhuizing naar Rotterdam. Een elk jaar weer terugkomend fenomeen waren de labvideo’s voor 
the pantomime alhoewel het eerste jaar moeilijk te evenaren was. 
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Lab 7.02/7.06: Erik, Robert-Jan, Wouter, Raymond en Sanja bedankt voor jullie interesse en 
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Bas, Kim en Joost (vergeet je de volgende keer je tandenborstel en poster niet ?).
Tevens wil ik graag de leden van mijn kleine commissie bedanken voor hun suggesties en 
het kritisch lezen van dit proefschrift: Dies, Sjaak en Peter, dank je wel.
En niet te vergeten andere mensen die een niet onbelangrijke bijdrage hebben geleverd 
zoals de verzorgers van mijn muizen in het EDC, bedankt voor jullie goede zorgen. Ook de 
computermannen en Melle en Marike bedankt voor jullie ondersteuning.
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en Judith ondanks alle drukte rondom jullie kleine mannetjes beleven jullie altijd geïnteresseerd 
in het wel en wee rondom mijn promotie. Nu heb ik weer meer tijd en hoop ik dat we wat meer 
gezellig met z’n allen uitgaan en bijkletsen. Henja stel het wel even uit tot na 7 mei dan kan je 
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